0///117
‫התשס"ח‬/'‫ו‬
‫רשומות‬
ISRAEL STATE RECORDS
‫ד' באדר א' התשס"ח‬
February 10, 2008
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Extension orders
Notices
Changes in particulars entered
in register
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
‫עמוד‬
Page
4444
4084
4804
4804
4804
4804
4800
4800
‫פטנטים‬
4884
i
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫צווי הארכה‬
‫הודעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
4884
4888
4818
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
4884
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,4 ‫ רח' הסדנא‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה לציבור בימי חול‬,‫ תלפיות‬,4 ‫לשכת הפטנטים נמצאת ברח' הסדנא‬
.0/::1 -‫ ו‬0::1 ‫שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬/..1 ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.1-/404.-/
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on
weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 84.
.₪ 69 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 15141.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
.₪ 0,0./ ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,/6 '‫מס‬
4542
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
Particulars of the applications are
given in the following order:
Number and date of application
And the first four symbols of the
International Classification
Title of invention
(as proposed by applicant)
Applicant
Priority right: Convention country –
Number and date of
Foreign application
‫ לחוק הפטנטים‬09 ‫הודעה לפי סעיף‬
0697 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬:/ ‫בתקנה‬
:0690–‫תשכ"ח‬
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
4543
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
3022121330
169187
FUNGICIDES BASED ON NITROGENCONTAINING HETEROCYCLES
SYNGENTA PARTICIPATIONS AG
GB
0230021.8
23/12/2002
PCT/GB/2003/005261
WO/2004/056829
1022121330
‫קוטלי פטריות המבוססים על הטרוציקלים‬
‫המכילים חנקן‬
169192
NOVEL ETHYLENEDIAMINE
DERIVATIVES
DAIICHI PHARMACEUTICAL CO.,
LTD.
2002JP
24/12/2002
373025
PCT/JP/2003/016556
WO/2004/058728
1022121330
169279
DEOXYRIBONUCLEOTIDES
MANUFACTURING BY ENZYMATIC
REDUCTION OF RIBONUCLEOTIDES
SCINOPHARM SINGAPORE PTE LTD
US
60/436282
23/12/2002
PCT/IB/2003/006168
WO/2004/057010
2223/21330
169631
EFFICIENT MEMORY CONTROLLER
RAYTHEON COMPANY
US
60/484025
30/06/2003
185044104
1158451884
US
PCT/US/2004/018872
WO/2005/006194
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07D
C07D
‫נגזרות חדשות של את'לאנאדיאמין‬
C12P
‫יצור של דאוקסיריבונוקלאוטידים על ידי‬
‫חיזור אנזימטי של ריבונוקלאוטידים‬
G06F
‫שלט זיכרון יעיל‬
4544
1223/21332
171532
SUPERVISORY COMMUNICATION
SYSTEM SERVING CALLERS WITH
RESTRICTED FREEDOM
BV FON TELEKOMMUNIKACIOS
KFT.
HU
P 0500314
18/03/2005
PCT/HU/2005/000083
WO/2006/097775
3/22321330
H04M
‫מערכת תקשורת מפקחת המשרתת‬
‫מתקשרים בעלי חופש מוגבל‬
171590
INVISIBLE SETTING FOR PRECIOUS
STONES
RAVENE SA OF
A44C
‫שיבוץ בלתי נראה לאבנים יקרות‬
PCT/IB/2004/003249
WO/2006/038053
2023/21330
173804
WIRELESS SYSTEMS, METHODS
AND DEVICES EMPLOYING
FORWARD AND/OR RETURN-LINK
CARRIERS HAVING DIFFERENT
NUMBERS OF SUB-BAND CARRIERS
ATC TECHNOLOGIES, LLC
US
60/497269
22/08/2003
PCT/US/2004/026385
WO/2006/062494
1222321330
4545
H04Q
‫ שיטות והתקנים אלחוטיים‬,‫מערכות‬
‫או נושאי מחזירי‬/‫המשמשים להעברה ו‬
‫קשר בעלי מספרים שונים של נושאי תת‬
‫רצועה‬
174030
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PROCESS FOR PRODUCTION OF
ESSENTIALLY SOLVENT-FREE
SMALL PARTICLES
BAXTER INTERNATIONAL INC.
US
10/696384
29/10/2003
PCT/US/2004/035335
WO/2005/044225
3/23/21330
‫תהליך לייצור חלקיקים קטנים החופשיים‬
‫מממס‬
174044
ELECTICAL WIRE AND METHOD OF
FABRICATING THE ELECTRICAL
WIRE
NEWIRE, INC.
US
60/500350
05/09/2003
185488844
8158451884
US
PCT/US/2004/028972
WO/2005/024849
3023/21330
174084
HETEROARYL FUSED PYRIDINES,
PYRAZINES AND PYRIMIDINES AS
CRF1 RECEPTOR LIGANDS
NEUROGEN CORPORATION
US
60/500414
05/09/2003
PCT/US/2004/028899
WO/2005/023806
1/23/21330
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
174123
H01B
‫חוט חשמלי ושיטה לייצור חוט החשמלי‬
C07D
‫ פירזינים ופירימידינים דחוסי‬,‫פירידינים‬
CRF1 ‫הטרואריל כרצפטורים ליגנדים ל‬
H04Q
4546
METHOD FOR MATCHING A MOBILE
TELEPHONE WITH A PERSONAL
CARD
NAGRACARD S.A.
CH
CH
30/09/2003
01660/03
PCT/IB/2004/051908
WO/2005/032153
3/23/21330
174140
‫שיטה להתאמת טלפון נייד עם כרטיס‬
‫אישי‬
H04Q
‫ רב–שידוריות‬,‫רשתות בלתי– חוסמות‬
‫ הניתנות לסידור‬,‫ובעלות מספר דרגות‬
‫מחדש‬
REARRANGEABLY NONBLOCKING
MULTICAST MULTI-STAGE
NETWORKS
TEAK TECHNOLOGIES, INC.
PCT/US/2003/027971
WO/2006/033650
1123/21330
174273
METHOD AND DEVICE FOR
DIGITALLY COATING TEXTILE
TEN CATE ADVANCED TEXTILES
B.V.
NL
1024338
22/09/2003
PCT1051151884
NL
NL03/00841
PCT/EP/2004/010731
WO/2005/028729
2223/21330
4547
174274
D06B
‫מכשיר ושיטה לציפוי באופן דיגיטלי של‬
‫טקסטיל‬
G21K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD AND DEVICE FOR
GENERATING ALFVEN WAVES
QASAR
TECHNOLOGIEENTWICKLUNG
GES.M.B.H
A
AT
15/09/2003
1448/2003
PCT/AT/2004/000313
WO/2005/027142
2123/21330
174276
CONFIGURABLE CONTROLLER
KODAK IL LTD
US
10/667640
22/09/2003
PCT/IL/2004/000625
WO/2005/029207
1/23/21330
174292
A METHOD OF EVALUATING ORGAN
FUNCTION
OXYGENIX CO. LTD.
US
60/506506
29/09/2003
PCT/JP/2004/014566
WO/2005/030264
2/23/21330
174304
KID3 AND KID3 ANTIBODIES THAT
BIND THERETO
RAVEN BIOTECHNOLOGIES, INC.
US
60/504441
18/09/2003
PCT/US/2004/030676
WO/2005/028498
2/23/21330
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
174305
‫שיטה והתקן ליצור גלי אלפבן‬
G05B
‫בקר שניתן לעצבו‬
‫קודאק איי אל בע"מ‬
A61K
‫שיטת הערכה לתפקוד של אורגן‬
C07K
‫ הנקשרים‬KID : ‫ ונוגדנים של‬KID :
‫אליהם‬
C07D
4548
‫– ארילפירימידינים כגורמים אנטי‬.
‫סרטניים‬
5-ARYLPYRIMIDINES AS
ANTICANCER AGENTS
WYETH HOLDINGS CORPORATION
US
60/505487
24/09/2003
PCT/US/2004/030682
WO/2005/030216
1123/21330
174306
‫סוגר‬
A CLOSURE
OBRIST CLOSURES SWITZERLAND
GMBH
EP
03022055.2 01/10/2003
PCT/EP/2004/010636
WO/2005/039996
1323/21330
174414
SALTS AND POLYMORPHS OF A
PYRROLE-SUBSTITUTED
INDOLINONE COMPOUND
PHARMACIA & UPJOHN COMPANY
LLC
US
60/508104
02/10/2003
PCT/IB/2004/003070
WO/2005/033098
2022321330
4549
C07D
‫מלחים ופולימורפים של תרכובת אינדולינון‬
‫המותמרת בפירול‬
174550
MAGNETIC CORE WINDING
METHOD, APPARATUS AND
PRODUCT PRODUCED THEREFROM
ACTOWN ELECTROCOIL, INC.
US
60/511564
15/10/2003
185001044
8158451884
US
PCT/US/2004/033895
WO/2005/039255
1023/21332
B65D
174785
H05K
‫ התקן‬,‫שיטה לכריכה של ליבה מגנטית‬
‫ומוצר המיוצר ממנו‬
G09G
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
FONT GENERATION SYSTEM
NDS LIMITED
GB
0500410.6
10/01/2005
485444841
1158151884
US
PCT/GB/2005/002459
WO/2006/072755
2122321330
174849
‫מערכת ליצירת גופן‬
C12Q
METHOD
POWDERJECT VACCINES, INC.
US
60/510086
10/10/2003
485414441
8451151884
US
485444441
8458451884
US
PCT/US/2004/033391
WO/2005/035779
‫שיטה‬
3/22321330
C07K
174863
COMPOUNDS THAT INHIBIT SERINE
PROTEASES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/510156
10/10/2003
485414440
1451851884
US
PCT/US/2004/033238
WO/2005/037860
2122221330
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
174893
‫תרכובות מעכבי פרוטאז סרין ותכשירי‬
‫רוקחות המכילים אותן‬
A61P
4550
GRADUATED ESTROGEN
CONTRACEPTIVE
WARNER CHILCOTT COMPANY, INC.
US
60/520182
14/11/2003
PCT/US/2004/037975
WO/2005/049142
3/22321330
174900
COMPUTERIZED TRANSACTION
BARGAINING SYSTEM AND
METHOD
CYBERSETTLE, COM, INC.
US
10/683821
10/10/2003
PCT/US/2004/033444
WO/2005/040982
2122321330
4551
C07D
‫– מותמרים פיראזוליל קרבוקסאנילידים‬N
174925
GLYCEROPHOSPHOLIPIDS
CONTAINING OMEGA -3 AND
OMEGA-6 FATTY ACIDS
ENZYMOTEC LTD.
IL
158552
22/10/2003
PCT/IL/2004/000957
WO/2005/037848
1/22221330
G06F
‫מערכת ושיטה לעיסקת מיקוח ממוחשבת‬
174911
N-Substituted pyrazolyl carboxanilides
BAYER CROPSCIENCE AG
DE
10349497.9 23/10/2003
PCT/EP/2004/011396
WO/2005/042480
1222321330
‫אמצעי מניעה להורדת רמת האסטרוגן‬
175688
C07F
‫גליצרופוספוליפידים המכילים חומצות‬
9–‫ ואומגה‬:–‫שומן אומגה‬
‫אנזימוטק בע"מ‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
AZITHROMYCIN
MULTIPARTICULATE DOSAGE
FORMS BY LIQUID-BASED
PROCESSES
PFIZER PRODUCTS INC.
US
60/527405
04/12/2003
PCT/IB/2004/003911
WO/2005/053640
2/22221330
175691
ADJUSTING THE TRANSMIT POWER
LEVEL OF A CELLULAR
COMMUNICATION TERMINAL
CAPABLE OF PEER-TO-PEER
COMMUNICATIONS
QUALCOMM INCORPORATED
US
60/523989
21/11/2003
185844044
1858851884
US
PCT/US/2004/038817
WO/2005/053253
3022121330
175692
METHOD FOR DIAGNOSING
DISEASES BASED ON LEVELS OF
ANTI-GLYCAN ANTIBODIES
GLYCOMINDS, LTD.
US
10/728227
03/12/2003
185044844
1158451884
US
PCT/IB/2004/004389
WO/2005/054853
1223221332
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
175695
‫צורות מינון מולטיפרטיקולריות של‬
‫אזיתרומיצין בתהליכים מבוססי נוזל‬
H04L
‫כוונון העברת רמת האנרגיה של מסוף‬
‫תקשורת סלולרי המסוגל להתחבר אל‬
‫חיבור של אמצעי תקשורת‬
G01N
‫שיטה לאבחון מחלות המבוססת על‬
‫רמות נוגדני אנטיגליקן‬
‫ בע"מ‬,‫גלייקומיינדס‬
C07D
4552
PROCESS FOR THE PREPARATION
OF VALACYCLOVIR
HYDROCHLORIDE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/538362
21/01/2004
485481484
1458451884
US
PCT/US/2005/001951
WO/2005/073233
0223221332
175696
MONTELUKAST SODIUM
POLYMORPHS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/540567
30/01/2004
PCT/US/2005/002899
WO/2005/075427
2/22221330
175697
ENGINE WITH AN ACTIVE MONOENERGY AND/OR BI-ENERGY
CHAMBER WITH COMPRESSED AIR
AND/OR ADDITIONAL ENERGY AND
THERMODYNAMIC CYCLE THEREOF
MDI-MOTOR DEVELOPMENT
INTERNATIONAL S.A.
FR
0313401
17/11/2003
PCT/FR/2004/002929
WO/2005/049968
2/22322///
PHOSPHODIESTERASE 8A
4553
175698
‫תהליך להכנת וולציקלוויר הידרוכלוריד‬
‫טבע תעשיות פרמצבטיות בע"מ‬
C07D
‫פולימורפים של מונטלוקסט סודיום‬
‫טבע תעשיות פרמצבטיות בע"מ‬
F01B
‫או דו–אנרגטי‬/‫מנוע עם תא אקטיבי חד ו‬
‫או אנרגיה נוספת ומעגל‬/‫עם אויר דחוס ו‬
‫תרמו–דינמי לכך‬
C12N
A8 ‫פוספודיאסטרזה‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
ICOS CORPORATION
US
08/951648
PCT/US/1998/021956
WO/1999/019495
16/10/1997
3222121330
175736
MUTEINS OF FIBROBLAST GROWTH
FACTOR 21
ELI LILLY AND COMPANY
US
60/528582
10/12/2003
PCT/US/2004/037200
WO/2005/061712
1/22221330
175795
FIRE RETARDANT SHADES
CPFILMS INC.
US
10/729587
06/12/2003
PCT/EP/2004/013518
WO/2005/054616
0322221330
175857
ANTI-INFLAMMATORY AGENTS
CAMBRIDGE UNIVERSITY
TECHNICAL SERVICES LTD.
GB
0327775.3
01/12/2003
841444444
8458051884
GB
841444441
1858051884
GB
PCT/GB/2004/005030
WO/2005/053702
2022121330
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
175909
C12N
‫ של‬/0 ‫מוטיינים של פקטור הגדילה‬
‫פיברובלסט‬
E06B
‫מחיצות מעכבות אש‬
C07D
‫גורמים נוגדי דלקת‬
C07D
4554
5-FLUORO-, CHLORO-AND CYANOPYRIDIN-2-YL-TERAZOLES AS
LIGANDS OF THE METABOTROPIC
GLUTAMATE RECEPTOR-5
NPS PHARMACEUTICALS, INC.
US
60/530633
19/12/2003
PCT/US/2004/041401
WO/2005/066155
1/23221330
–‫–איל‬/–‫ כלורו וציאנו–פירידין‬,‫– פלואורו‬.
.–‫טטראזולים כליגנדות של קולטן‬
‫גלוטאמט מטאבוטרופי‬
175924
STENT POSITIONING USING INFLATION
TUBE
F.D. CARDIO LTD.
IL
PCT/IL03/00995 25/11/2003
PCT/IL/2004/000456
WO/2005/051224
1/23021332
176040
SAFETY SYRINGE WITH A NEEDLE
SEAT
WEI-SHUI WU
A61F
‫הצבת סטנט תוך שימוש בצינור ניפוח‬
‫ קרדיו בע"מ‬.‫ד‬.‫פ‬
A61M
‫מזרק בטחון עם תושבת למחט‬
PCT/CN/2005/000399
WO/2006/102790
1022221332
176115
PROCESS FOR SETTING ANCHORS
AND ANCHOR WHICH CAN BE USED
IN THIS PROCESS
ATLAS COPCO MAI GMBH
A
AT
23/12/2004
2164/2004
PCT/AT/2005/000475
WO/2006/066288
0322121330
4555
176341
E02D
‫תהליך להנחת עוגנים ועוגן אשר ניתן‬
‫להשתמש בו בתהליך זה‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SYNTHESIS OF ACYLOXYALKYL
CARBAMATE PRODRUGS AND
INTERMEDIATES THEREOF
XENOPORT INC.
US
60/533649
30/12/2003
485484444
1458051884
US
PCT/US/2004/043823
WO/2005/066122
3023121330
‫סינטזה של פרודרגים של קרבמט‬
‫אצילוקסיאלקיל ותוצרי ביניים שלה‬
176419
AN IMPLANT FOR OCCLUDING A
BODY PASSAGE
CARAG AG
A61B
‫שטל לחסימה מעבר בגוף‬
PCT/CH/2004/000059
WO/2005/074813
1122121330
176487
A PROCESS FOR THE PREPARATION OF
ALKYL-AND ARYL-DIPHOSPHONIC
ACIDS AND SALTS THEREOF
LYOGEN LIMITED
IT
MI2003A002582 23/12/2003
IT
MI2004A000080 1158151884
PCT/EP/2004/014556
WO/2005/063779
3223221332
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
176513
C07F
‫תהליך להכנת אלקיל ואריל חומצות‬
‫דיפוספוניות ומלחיהם‬
C07D
4556
DIARYLMETHYL PIPERAZINE
DERIVATIVES, PREPARATIONS
THEREOF AND USED THEREOF
ASTRAZENECA AB
SE
0400027-9
09/01/2004
PCT/SE/2005/000014
WO/2005/066148
1/23221332
‫ תכשירים‬,‫נגזרות דיארילמתיל פיפריזין‬
‫שלהן ושימושיהן‬
179587
F16H
CONTINUOUSLY-VARIABLE NONSLIP TRANSMISSIONS
CVTRON LTD.
IL
162179
27/05/2004
144441
1458451884
IL
PCT/IL/2005/000541
WO/2005/115086
112302133/
‫שיפור לתמסורת רציפה‬
‫סויטרון בע"מ‬
185216
A01N
SULPHONYL COMPOUNDS FOR
SEED TREATMENT
BASF AKTIENGESELLSCHAFT
US
60/664773
24/03/2005
PCT/EP/2006/060961
WO/2006/100271
2/2302133/
‫תרכובות סולפוניל לטיפול בזרעים‬
185217
METHOD FOR PRODUCING 5-HALO2,4,6-TRIFLUOROISOPHTHALIC ACID
BASF AKTIENGESELLSCHAFT
DE
102005013038.0 18/03/2005
PCT/EP/2006/060793
WO/2006/097510
2222121332
4557
C07C
‫– טריפלואורו‬9 ,4 ,/–‫–הלו‬. ‫שיטה ליצור‬
‫חומצה איזופתאלית‬
185218
C08F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫קופולימר אניוני של (מת) אקרילאט‬
‫סתור בחלקו‬
PARTLY NEUTRALISED ANIONIC
(METH) ACRYLATE COPOLYMER
ROHM GMBH & CO. KG
DE
102005007059.0 15/02/2005
PCT/EP/2005/013513
WO/2006/087027
202312133/
185219
METHODS AND REAGENTS FOR
TREATMENT AND DIAGNOSIS OF
AGE-RELATED MACULAR
DEGENERATION
UNIVERSITY OF IOWA RESEARCH
FOUNDATION
US
60/653078
14/02/2005
485414484
8858851884
US
485414041
1458851884
US
485444484
8851151884
US
PCT/US/2006/005313
WO/2006/088950
322302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫שיטות וריאגנטים לטיפול ואבחנה של‬
‫התנוונות כתמית הקשורה לגיל‬
185220
IMPROVING PRODUCT RECOVERY
FROM SIMULATED-MOVING-BED
ADSORPTION
UOP LLC
US
11/072883
03/03/2005
PCT/US/2006/007146
WO/2006/096394
232312133/
C12Q
C07C
‫שיפור בנצילות מסימולציית ספיחה במצע‬
‫מרתף‬
185222
E04G
4558
METHOD FOR REINFORCING BUILDING
STRUCTURES AND COATING OBTAINED
THEREBY
TEC. INN. S.R.L.
IT
RM2005A000066 17/02/2005
PCT/IT/2006/000070
WO/2006/087751
122312133/
185226
ISOXAZOLINE DERIVATIVE AND
NOVEL PROCESS FOR ITS
PREPARATION
LG LIFE SCIENCES LTD.
10-2005KR
26/02/2005
0016203
PCT/KR/2006/000576
WO/2006/090997
3/2312133/
4559
C07D
‫תולדת איזוקסאזולין ותהליך חדש עבור‬
‫הכנתו‬
185228
RADIO TRANSMISSION SYSTEM AND
METHOD FOR THE OPERATION
THEREOF
ROHDE & SCHWARZ GMBH & CO. KG
DE
102005006909.6 15/02/2005
18188484818040
1058451884
DE
PCT/EP/2006/001032
WO/2006/087118
2/2312133/
‫שיטה לחיזוק מבנים וציפויים‬
‫המתקבלים בשל כך‬
185229
H04L
‫מערכת לשידור רדיו ושיטה להפעלתו‬
A61P
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
BISPHOSPHONATES FOR TREATING
ENDOMETRIOSIS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/653526
17/02/2005
PCT/IL/2006/000209
WO/2006/087722
2/2312133/
‫ביספוספונאטים לטיפול באנדומטריוסיס‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
185230
DEVICE FOR SUPPLYING FUEL TO A
GAS TURBINE ENGINE WITH
REGULATED FUEL FLOW RATE
HISPANO-SUIZA
FR
0501641
17/02/2005
PCT/EP/2006/060074
WO/2006/087378
312312133/
‫התקן להספקת דלק למנוע עם טורבינת‬
‫גז בעל קצב זרימת דלק מווסת‬
185231
FLUID TRANSPORT TUBE CONNECTOR
FITTINGS
UNIDELTA SPA
IT
GE2005A000015 16/02/2005
PCT/IT/2006/000054
WO/2006/087749
2/2312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
F02C
185232
F16L
‫מתאם מחבר לצינור להעברת נוזלים‬
A47C
4560
SYSTEM AND METHOD FOR
MAINTAINING AIR INFLATABLE
MATTRESS CONFIGURATION
KCI LICENSING, INC.
US
60/653303
16/02/2005
115444448
1458151884
US
PCT/US/2006/005517
WO/2006/089050
2/2312133/
‫מערכת ושיטה לשמירת תצורה של מזרון‬
‫מתנפח‬
185233
ELECTRIC SUPPLY FOR AN
AIRCRAFT GAS TURBINE ENGINE
EQUIPMENT
HISPANO-SUIZA
FR
0501642
17/02/2005
PCT/EP/2006/060075
WO/2006/087379
2/2312133/
‫אספקת חשמל לציוד למנוע בעל טורבינת‬
‫גז של כלי טייס‬
185234
185235
HIGHLY POTENT FULL AND PARTIAL
AGONISTS AND ANTAGONISTS OF THE
NOCICEPTIN/ORPHANIN FQ RECEPTOR
MENARINI INTERNATIONAL
OPERATIONS LUXEMBOURG S.A.
IT
FE2005A000003 15/02/2005
PCT/EP/2006/050958
WO/2006/087340
3/2312133/
4561
F02C
‫אספקת דלק למנוע של כלי טייס‬
AIRCRAFT ENGINE FUEL SUPPLY
HISPANO-SUIZA
FR
0501640
17/02/2005
PCT/EP/2006/060073
WO/2006/087377
222312133/
H02J
185237
C07K
‫אגוניסטים ואנטגוניסטים של רצפטור‬
‫ בעלי השפעה‬FQ ‫אורפנין‬/‫נוסיספטין‬
‫ חלקית או מלאה‬,‫חזקה‬
B41J
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
OPTICAL PATTERN GENERATOR
USING A SINGLE ROTATING
COMPONENT
RELIANT TECHNOLOGIES, INC.
US
60/652891
14/02/2005
115140884
1858451884
US
PCT/US/2006/004821
WO/2006/088744
2022221332
185238
KINETIC ENERGY ROD WARHEAD
WITH SELF-ALIGNING
PENETRATORS
RAYTHEON COMPANY
US
11/059891
17/02/2005
115848148
1458151884
US
115104411
1858451884
US
PCT/US/2005/041010
WO/2006/098780
2/2322133/
‫מחולל צורות אופטיות המשתמש ברכיב‬
‫מסתובב יחידי‬
‫ראש קרבי בצורת מוט אנרגיה קינטית עם‬
‫גופי חדירה המסתדרים בשורה‬
185239
KINETIC ENERGY ROD WARHEAD
WITH LOWER DEPLOYMENT
ANGLES
RAYTHEON COMPANY
US
11/060179
17/02/2005
PCT/US/2006/001965
WO/2006/088606
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
F42B
185240
F42B
‫ראש קרב מסוג מוט אנרגיה קינטית עם‬
‫זויות הצבה מוקטנות‬
F42B
4562
KINETIC ENERGY ROD WARHEAD
WITH LOWER DEPLOYMENT
ANGLES
RAYTHEON COMPANY
US
11/059891
17/02/2005
PCT/US/2006/001580
WO/2006/137949
2/2312133/
‫ראש קרב מסוג מוט אנרגיה קינטית עם‬
‫זויות הצבה מוקטנות‬
185243
APPARATUS AND METHOD FOR
PROVIDING A MULTI-STAGE LIGHT
TREATMENT
MOSCOVICI LUCIAN
US
60/653998
18/02/2005
PCT/IL/2006/000212
WO/2006/087723
112312133/
222312133/
4563
‫מכשיר ושיטה לקביעת טיפול רב–שלבי‬
‫באור‬
‫מוסקוביץ לוציאן‬
185244
1-SULFONYL-PIPERIDINE-3CARBOXYLIC ACID AMIDE
DERIVATIVES AS INHIBITORS OF 11BETA-HYDROXYSTEROID
DEHYDROGENASE FOR THE
TREATMENT OF TYPE II DIABETES
MELLITUS
F. HOFFMANN-LA ROCHE AG
US
60/658276
03/03/2005
PCT/EP/2006/001603
WO/2006/094633
A61N
C07D
–‫ – סולפוניל‬0 ‫נגזרות אמיד של חומצה‬
–00 ‫–קרבוקסילית כמעכבים של‬:–‫פיפרדין‬
‫ביתא–הידרוקסיסטרואיד דהידרוגנז לטיפול‬
II ‫בסכרת מליטית מסוג‬
185247
A61B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
HIGH THROUGHPUT ENDOILLUMINATOR PROBE
ALCON, INC.
US
60/653265
15/02/2005
PCT/US/2006/005297
WO/2006/088938
302312133/
‫בודק מאיר פנימי בעל תפוקה גבוהה‬
185249
‫קריאה מאזור אחסון קטן בתוך המעבד‬
‫הראשי עבור זיכרון בלתי יציב‬
REGISTER READ FOR VOLATILE
MEMORY
QUALCOMM INCORPORATED
US
60/653020
14/02/2005
115110018
1458451884
US
PCT/US/2006/006995
WO/2006/089313
112312133/
185250
MICROIMPLANTS FOR OCULAR
ADMINISTRATION
ALLERGAN, INC.
US
11/070158
01/03/2005
PCT/US/2006/006279
WO/2006/093758
102312133/
3/2312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫שתל–מיקרו להתקנה עינית‬
185251
SOLID PHARMACEUTICAL
COMPOSITION COMPRISING
TELITHROMYCIN
AVENTIS PHARMA S.A.
FR
0501936
25/02/2005
PCT/FR/2006/000411
WO/2006/090067
G11C
A61K
‫הרכב פרמצבטי מוצק המכיל טליתרומיצין‬
185252
H01L
4564
SEAL MATERIAL FOR
SEMICONDUCTOR PRODUCTION
APPARATUS
NIPPON VALQUA INDUSTRIES, LTD
2005JP
15/02/2005
037746
PCT/JP/2006/302082
WO/2006/087942
3/2312133/
‫חומר אטימה להתקן ייצור של מוליך‬
‫למחצה‬
185253
SPIROKETAL-SUBSTITUTED CYCLIC
KETOENOLS
BAYER CROPSCIENCE AG
DE
102005008021.9 22/02/2005
PCT/EP/2006/001089
WO/2006/089633
112312133/
‫קטואנולים מותמרים בספירוקטאל‬
185254
B32B
‫שכבה פנימית בעלת עיוות נמוך‬
LOW DISTORTION INTERLAYER
SOLUTIA INC.
US
11/061778
22/02/2005
PCT/US/2006/006357
WO/2006/091707
302302133/
185256
METHOD AND COMPOSITION FOR
TREATING PERIPHERAL VASCULAR
DISEASES
SUCAMPO AG
US
60/658144
04/03/2005
PCT/JP/2006/304667
WO/2006/093348
1/2312133/
4565
A01N
A61P
‫שיטה ותכשיר לטיפול במחלות כלי דם‬
‫היקפיות‬
185258
A61P
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
FORMULATION WITH ANTI-TUMOR
ACTION
GENTIUM S.P.A.
IT
MI2005A000336 03/03/2005
485441484
1051851884
US
PCT/EP/2006/060306
WO/2006/094917
222312133/
185259
TETRACYCLIC AMINO AND
CARBOXAMIDO COMPOUNDS AND
METHODS OF USE THEREOF
INOTEK PHARMACEUTICALS
CORPORATION
US
60/656636
25/02/2005
PCT/US/2006/005291
WO/2006/093667
102312133/
185260
DUAL MODE ABSORBENT TAMPON
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/117899
29/04/2005
PCT/US/2006/006288
WO/2006/118633
2/2312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185261
‫פורמולציה עם פעילות אנטי גידולית‬
C07D
‫תרכובות אמינו וקרבוקסאמידו טטרה‬
‫ציקליות והשיטות לשימוש בהן‬
A61F
‫טמפון סופג בעל מוד דואלי‬
G01C
4566
METHOD, APPARATUS AND
COMPUTER PROGRAM FOR
AZIMUTH DETERMINATION E.G.
FOR AUTONOMOUS NAVIGATION
APPLICATIONS
VECTRONIX AG
US
11/067665
28/02/2005
PCT/EP/2006/060072
WO/2006/089864
1/23/2133/
‫ מערכת ותוכנת מחשב לקביעת‬,‫שיטה‬
‫אזימוט לדוגמה עבור יישומי ניווט‬
‫אוטונומים‬
185262
C22C
STEEL COMPOSITIONS, METHODS
OF FORMING THE SAME, AND
ARTICLES FORMED THEREFROM
ATI PROPERTIES, INC.
US
60/712587
30/08/2005
PCT/US/2006/033785
WO/2007/027724
2223021333
‫ שיטות לייצורם ופריטים‬,‫תכשירי פלדה‬
‫שמכינים מהם‬
185264
PHARMACEUTICAL COMPOUNDS FOR
TREATING OXIDATIVE STRESS
NICOX SA
IT
MI99A000753 13/04/1999
PCT/EP/2000/003234
WO/2000/061537
112312133/
4567
185266
C07C
‫תכשירי רוקחות לטיפול בעקה חמצונית‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
ANTI-CANCER AND ANTIMICROBIAL OXAZOLIDINONES AND
ANALOGUES
NEREUS PHARMACEUTICALS, INC.
US
60/655605
22/02/2005
PCT/US/2006/006278
WO/2006/091669
1/2312133/
185267
CRYSTALLINE AND AMORPHOUS 4CYANO-N{(2R)-2-[4-(2,3-DIHYDROBENZO[1,4]DIOXIN-5-YL)PIPERAZIN-1-YL]-PROPYL}-NPYRIDIN-2-YL-BENZAMIDE
HYDROCHLORIDE
WYETH
US
60/657575
01/03/2005
PCT/US/2006/006802
WO/2006/093853
322302133/
185269
CINNOLINE COMPOUNDS AND
THEIR USE AS LIVER X RECEPTOR
MODULATORS
WYETH
US
60/657296
01/03/2005
PCT/US/2006/007224
WO/2006/094034
2/2312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185272
‫אוקסזולידינונים ואנלוגים אנטי–סרטניים‬
‫ואנטי–מיקרוביאליים‬
C07D
–‫–דיהידרו‬N{R2)–2–[4–(3,2–‫– ציאנו‬4
–N–}‫–יל]–פרופיל‬.–‫]דיאוקסין‬4,0[‫בנזו‬
–‫–יל‬/–‫–פרידין‬N–}‫–יל]–פרופיל‬0–‫פיריזין‬
‫בנזאמיד הידרוכלוריד גבישי ואמורפי‬
C07D
‫תרכובות קינוליניות והשימוש בהן‬
‫ כבדי‬X ‫כמאפנני קולטן‬
C07D
4568
BENZOXAZOLE CARBOXAMIDES
FOR TREATING CINV AND IBS-D
AMR TECHNOLOGY, INC.
US
60/653821
17/02/2005
PCT/US/2006/005605
WO/2006/089100
2/2302133/
–‫קרבוקסאמידים בנזוקסאזוליים לטיפול ב‬
D–IBX–‫ ו‬CINV
185274
AGGLOMERATED STARCH
COMPOSITION AND METHODS FOR
THE PRODUCTION THEREOF
BPSI HOLDINGS, LLC.
US
60/664447
23/03/2005
PCT/US/2006/009443
WO/2006/101945
202302133/
185275
N-SULPHONYLPYRROLE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
NYCOMED GMBH
EP
05102019.6 15/03/2005
8418044441
1158851884
EP
PCT/EP/2006/060712
WO/2006/097474
322302133/
4569
185276
C09D
‫תכשיר עמילן צבור ושיטות להכנתו‬
C07D
‫– סולפונילפירול ותכשירי‬N ‫תולדות‬
‫רוקחות המכילים אותם‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SALTS OF 6-HETEROCYCLYL
HEXAHYDROPHENANTHRIDINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
NYCOMED GMBH
EP
05101619.4 02/03/2005
8418044144
1458851884
EP
PCT/EP/2006/060377
WO/2006/092422
302302133/
‫מלחים של תולדות הקסאהידרופנאנתרידין‬
‫ בקבוצה‬9 ‫המותמרות בעמדה‬
‫הטרוציקלית ותכשירי רוקחות המכילים‬
‫אותם‬
185277
PHARMACEUTICAL COMPOSITIONS
CONTAINING ROFLUMILAST FOR
THE TREATMENT OF DIABETES
NYCOMED GMBH
EP
05101772.1 08/03/2005
PCT/EP/2006/060418
WO/2006/094933
122312133/
185278
METHOD FOR PREPARING
PACLITAXEL
SERIPHARM
FR
0501838
23/02/2005
PCT/FR/2006/000387
WO/2006/090057
202312133/
BULLET
SALTECH AG
CH
270/05
PCT/CH/2006/000093
WO/2006/086902
185279
A61P
‫תכשירי רוקחות המכילים רופלומילסט‬
‫לטיפול בסכרת‬
C07D
‫שיטה להכנת פאקליטאקסל‬
F42B
‫קליע‬
16/02/2005
1/2312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185280
C07D
4570
TETRAHYDROINDOLONE AND
TETRAHYDROINDAZOLONE
DERIVATIVES
SERENEX, INC.
US
60/656230
25/02/2005
485484414
8458051884
US
485414844
1051851884
US
PCT/US/2006/006988
WO/2006/091963
3/2312133/
185282
FACIAL RECOGNITION AND THE
OPEN MOUTH PROBLEM
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
11/058171
16/02/2005
PCT/IL/2006/000172
WO/2006/087701
222312133/
185283
INTRAUTERINE FALLOPIAN TUBE
OCCLUSION DEVICE AND METHOD
FOR USE
YALE UNIVERSITY
US
60/653743
15/02/2005
PCT/US/2006/005245
WO/2006/088909
022322133/
4571
185284
‫תולדות של טטראהידרואינדזולון‬
‫וטטראהידרואינדולון‬
G06K
‫הכרת הפנים ובעיית הפה הפתוח‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
A61F
‫מכשיר לחסימת חצוצרות הרחם‬
G01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
TESTING DEVICE FOR EXAMINING
FLUID SPECIMENS PARTICULARLY
URINE
ANALYTE WORKS LTD
US
60/652726
15/02/2005
PCT/IL/2006/000120
WO/2006/087697
1/2312133/
‫מכשיר לבדיקת דוגמיות נוזלים כמו שתן‬
‫אנלייט וורקס בע"מ‬
185287
‫התקן להגשת טיפונת‬
DROPLET DEPOSITION APPARATUS
XAAR TECHNOLOGY LIMITED
GB
0503996.1
26/02/2005
PCT/GB/2006/000687
WO/2006/090179
122312133/
185288
COMBINATIONS AND MODES OF
ADMINISTRATION OF THERAPEUTIC
AGENTS AND COMBINATION
THERAPY
ABRAXIS BIOSCIENCE, INC.
US
60/654245
18/02/2005
PCT/US/2006/006167
WO/2006/089290
122312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B41J
A61K
‫צירופים וצורות מתן של גורמים טיפוליים‬
‫וטיפול משולב‬
185289
C07D
4572
SUBSTITUTED PYRIDO (2,3-D)
PYRIMIDINE DERIVATIVES USEFUL
AS MEDICINES FOR THE
TREATMENT OF AUTOIMMUNE
DISORDERS
4 AZA IP NV
GB
0503506.8
21/02/2005
PCT/EP/2006/001539
WO/2006/087229
3/2302133/
185290
CONTROL OF FLUID CONDITIONS IN
BULK FLUID DISTRIBUTION
SYSTEMS
THE BOC GROUP, INC.
US
60/659047
04/03/2005
115444000
8458451884
US
PCT/US/2006/007859
WO/2006/096610
3/2302133/
185291
CONTROL OF FLUID CONDITIONS IN
BULK FLUID DELIVERY SYSTEMS
BOC EDWARDS, INC.
US
60/659047
04/03/2005
115444148
8458451884
US
PCT/US/2006/007928
WO/2006/096646
102312133/
4573
185292
‫ )–פירידו‬D– 3 , 2( ‫תולדות פירימידניות‬
‫מותמרות המשמשות כתרופות לטיפול‬
‫באי–סדרים אוטואימוניים‬
B67D
‫בקרת תנאי נוזלים במערכות לחלוקת‬
‫נוזלים‬
B67D
‫בקרת תנאי נוזלים במערכות להעברת‬
‫נוזלים‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
NANOPARTICULATE
FORMULATIONS OF DOCETAXEL
AND ANALOGUES THEREOF
ELAN PHARMA INTERNATIONAL
LTD.
US
60/655934
24/02/2005
PCT/US/2006/006535
WO/2006/091780
122312133/
185293
RAPID TOOLING SYSTEM AND
METHOSD FOR MANUFACTURING
ABRASIVE ARTICLES
SAINT GOBAIN ABRASIVES, INC.
US
11/063258
22/02/2005
PCT/US/2006/005914
WO/2006/091518
122312133/
‫תכשירים ננו–חלקיקיים של דוקטקסל‬
‫ואנלוגים שלהם‬
‫מערכת לעיבוד שבבי מהיר ושיטות לייצור‬
‫פריטים משייפים‬
185294
COATED OR BONDED ABRASIVE
ARTICLES
SAINT GOBAIN ABRASIVES, INC.
US
11/062904
22/02/2005
PCT/US/2006/005915
WO/2006/091519
122312133/
2/2312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B24D
‫פריטים משייפים מצופים או מודבקים‬
185295
RAPID TOOLING SYSTEM AND
METHODS FOR MANUFACTURING
ABRASIVE ARTICLES
SAINT GOBAIN ABRASIVES, INC.
US
11/062900
22/02/2005
PCT/US/2006/005916
WO/2006/091520
B24D
B24D
‫מערכת לעיבוד שבבי מהיר ושיטות לייצור‬
‫פריטים משייפים‬
185297
G06F
4574
UNALIGNED MEMORY ACCESS
PREDICTION
QUALCOMM INCORPORATED
US
11/062221
17/02/2005
PCT/US/2006/005782
WO/2006/089194
1/2302133/
185300
NEW PHARMACEUTICAL
COMPOSITIONS USEFUL IN THE
TREATMENT OF PARKINSON'S
DISEASE
OREXO AB
US
60/665376
28/03/2005
PCT/GB/2006/001132
WO/2006/103417
2/2312133/
185301
SYSTEM AND METHOD OF
CORRECTING A BRANCH
MISPREDICTION
QUALCOMM INCORPORATED
US
11/061981
18/02/2005
PCT/US/2006/005776
WO/2006/089189
2/2312133/
185303
METHOD AND APPARATUS FOR
MANAGING A RETURN STACK
QUALCOMM INCORPORATED
US
11/061975
18/02/2005
PCT/US/2006/005775
WO/2006/089188
3022321332
4575
185304
‫חיזוי גישה לזיכרון לא מסודר‬
A61K
‫הרכבים פרמצבטיים חדשים לשימוש‬
‫בטיפול במחלות פרקינסון‬
G06F
‫מערכת ושיטה לתיקון טעות חיזוי של‬
‫ההוראה הבאה במערכת עיבוד מרכזית‬
G06F
‫שיטה והתקן לניהול מידע חוזר הנשלף‬
‫בסדר הפוך להכנסתו‬
H04S
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
NEAR-TRANSPARENT OR
TRANSPARENT MULTI-CHANNEL
ENCODER/DECODER SCHEME
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
US
60/655216
22/02/2005
115808444
1458451884
US
PCT/EP/2005/010685
WO/2006/089570
2/2312133/
‫מפענח רב ערוצי כמעט‬/‫תכנית למקדד‬
‫שקוף או שקוף‬
185306
C07D
ANTIBACTERIAL PIPERIDINE
DERIVATIVES
ASTRAZENECA AB
US
60/654670
18/02/2005
PCT/GB/2006/000529
WO/2006/087543
3/2312133/
‫נגזרות פיפרידין אנטי–בקטריאליות‬
185307
DIRECT DATA FILE STORAGE
IMPLEMENTATION TECHNIQUES IN
FLASH MEMORIES
SANDISK CORPORATION
US
11/060248
16/02/2005
PCT/US/2006/004555
WO/2006/088719
2/2312133/
‫שיטות ליישום אחסון ישיר של קבצי‬
‫נתונים בזכרונות פלאש‬
185308
REPLIKIN PEPTIDES AND USES THEREOF
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06F
C12Q
‫פפטידי רפליקין ושימוש בהם‬
4576
SAMUEL WINSTON BOGOCH
US
60/653083
US
PCT/US2005/14443
PCT/US/2006/005343
WO/2006/088962
222312133/
16/02/2005
1058451884
185309
ISOQUNOLINE COMPOUNDS AND
METHODS OF USE THEREOF
INOTEK PHARMACEUTICALS
CORPORATION
US
60/656638
25/02/2005
PCT/US/2006/005290
WO/2006/093666
322302133/
‫תרכובות איזוקווינוליניות ושיטות לשימוש‬
‫בהן‬
185310
ENDOSCOPE WITH PROTECTIVE
SLEEVE
STRYKER GI LTD.
US
60/658564
04/03/2005
PCT/IL/2006/000279
WO/2006/092791
302312133/
185315
RNAI EXPRESSION CONSTRUCTS
BENITEC, INC.
US
60/649641
03/02/2005
485444408
1458151884
US
PCT/US/2006/004003
WO/2006/084209
202312133/
INSERTABLE WALL MOUNTED
COMPUTING APPARATUS
4577
C07D
185319
A61B
‫אנדוסקופ עם כיסוי מגן‬
‫ בע"מ‬.‫ אי‬.‫סטריקר ג'י‬
C12N
RNAI ‫קונסטרוקטים לביטוי‬
H02G
‫התקן מחשוב לאכסון על קיר‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
CHIPPC ISRAEL LTD.
US
60/654559
115144448
US
PCT/IL/2006/000189
WO/2006/087704
CHIP PC ISRAEL LTD
18/02/2005
8458451884
202312133/
185320
WALL MOUNTED SYSTEM WITH
INSERTABLE COMPUTING
APPARATUS
CHIPPC ISRAEL LTD.
US
60/654559
18/02/2005
115144848
8458451884
US
PCT/IL/2006/000190
WO/2006/087705
202312133/
202312133/
SECURED COMPUTING SYSTEM
USING WALL MOUNTED
INSERTABLE MODULES
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מערכת אכסון מורכבת על קיר עם התקן‬
‫מחשוב‬
CHIP PC ISRAEL LTD
185321
WALL MOUNTED HOUSING FOR
INSERTABLE COMPUTING
APPARATUS
CHIPPC ISRAEL LTD.
US
60/654559
18/02/2005
115140448
8458451884
US
PCT/IL/2006/000191
WO/2006/087706
H02G
H02G
‫התקן אכסנה למערכת מחשוב המורכבת‬
‫על קיר‬
185322
CHIP PC ISRAEL LTD
H04L
‫מערכת מחשוב מאובטחת המורכבת‬
‫מיחידות חישוב המוכנסות בקיר‬
4578
CHIPPC ISRAEL LTD.
US
60/654559
115144184
US
PCT/IL/2006/000192
WO/2006/087707
CHIP PC ISRAEL LTD
18/02/2005
8458451884
322312133/
185323
LOGIC CIRCUIT AND METHOD OF
LOGIC CIRCUIT DESIGN
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
60/653115
16/02/2005
PCT/IL/2006/000129
WO/2006/087698
2/2312133/
185324
APPARATUS AND METHODS FOR
JOINING THE EDGES OF FOLDED
SHEET MATERIAL TO FORM THREEDIMENSIONAL STRUCTURES
INDUSTRIAL ORIGAMI, LLC.
US
60/654545
17/02/2005
PCT/US/2006/005589
WO/2006/089090
102312133/
PYRIDINE-2-CARBOXAMIDE
DERIVATIVES AS mGluR5
ANTAGONISTS
4579
185326
H03K
‫מעגל לוגי ושיטה לתכנון מעגל לוגי‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
B65D
‫התקן ושיטה לחיבור הקצוות של גיליון‬
‫מקופל ליצירת מבנים תלת–מימדיים‬
C07D
‫–קרבוקסאמיד‬/– ‫נגזרות של פיריזין‬
‫כאנטגוניסטים‬
mGluR5 ‫של‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
F. HOFFMANN-LA ROCHE AG
EP
05101701.0 04/03/2005
PCT/EP/2006/001638
WO/2006/094639
312302133/
185327
C07D
‫–קרבוקסאמיד‬/–‫נגזרות של פיריזין‬
‫כאנטגוניסטים‬
mGluR. ‫של‬
PYRAZINE-2-CARBOXAMIDE
DERIVATIVES AS mGluR5
ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
05101704.4 04/03/2005
PCT/EP/2006/001879
WO/2006/094691
2/2312133/
185328
RADIO LINK PROTOCOLS FOR MULTILINK COMMUNICATION SYSTEMS
QUALCOMM INCORPORATED
US
60/654605
18/02/2005
485448441
8458451884
US
485414448
8058851884
US
NOT
1458151884
US
AVAILABLE
PCT/US/2006/005795
WO/2006/089204
202302133/
CONVERSION OF 2-PYRAZOLINES
TO PYRAZOLES USING BROMINE
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H04L
‫פרוטוקולים של קשרי רדיו עבור מערכות‬
‫תקשורת רב–קישוריות‬
185329
C07D
‫ תוך‬,‫–פיראזולינים לפיראזולים‬/ ‫המרה של‬
‫שימוש בברום‬
4580
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/663410
18/03/2005
PCT/US/2006/009617
WO/2006/102025
102312133/
185330
METHOD FOR CONTROLLING NOX
EMISSIONS IN THE FCCU
W.R. GRACE & CO. CONN
US
60/664902
24/03/2005
PCT/US/2006/006543
WO/2006/104612
2/2312133/
BABY CAR SEAT
ZADOK FUERST
IL
166957
148811
IL
PCT/IL/2006/000206
WO/2006/087719
202302133/
FCCU –‫ ב‬NOX ‫שיטה לבקרה על פליטת‬
185331
17/02/2005
8158051884
185332
C07D
‫הכנת חומצות בטא–אמינו טהורות‬
–/–‫אופטית בעלות זיקה לחלבון אלפא‬
‫דלתא‬
185333
RADIOACTIVE HALOGEN-LABELED
PHENYLOXYANILINE DERIVATIVES
4581
B60N
‫מושב לתינוק ברכב‬
‫צדוק פירסט‬
PREPARATION OF OPTICALLY PURE
BETA-AMINO ACIDS HAVING
AFFINITY FOR THE ALPHA-2-DELTA
PROTEIN
PHARMACIA & UPJOHN COMPANY
LLC
US
60/665502
24/03/2005
PCT/IB/2006/000637
WO/2006/100568
1/22121332
B01J
C07C
‫תולדות של פנילאוקסיאנילין המסומן עם‬
‫הלוגן רדיואקטיבי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
TAISHO PHARMACEUTICAL CO.,
LTD.
2005JP
28/02/2005
052527
PCT/JP/2005/024075
WO/2006/092902
132302133/
185334
A MOUNTING PAD, AN ADHESIVE
DEVICE COMPRISING SUCH
MOUNTING PAD, AND METHOD OF
APPLYING SUCH DEVICES TO A
PATIENT
UNOMEDICAL A/S
US
60/663804
21/03/2005
DK
PA200500406 1158451884
PCT/DK/2006/050008
WO/2006/099876
3/2302133/
185335
PROCESS FOR THE PREPARATION
OF SUBSTITUTED BENZOXAZOLE
COMPOUNDS
WYETH
US
60/659138
07/03/2005
PCT/US/2006/007793
WO/2006/096584
112312133/
185339
METHODS AND DEVICES FOR
MIXING FLUIDS
FIVE STAR TECHNOLOGIES, INC.
US
11/063360
23/02/2005
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61M
‫ מכשיר הדבקה המכיל את‬,‫פד הרכבה‬
‫פד הרכבה ושיטה למתן מכשירים כאלו‬
‫למטופל‬
C07D
‫תהליך להכנת תרכובות מותמרות של‬
‫בנזוקסאזול‬
B01F
‫שיטות ומכשירים לערבוב נוזלים‬
4582
PCT/US/2006/006305
WO/2006/091679
1/2312133/
185340
‫ כגורם אנטי גידולי‬NOD0
NOD1 AS AN ANTI-TUMOR AGENT
THE SCRIPPS RESEARCH INSTITUTE
US
60/656175
25/02/2005
485441484
1151151884
US
PCT/US/2006/007013
WO/2006/091965
2323021332
185341
AIR CELL WITH IMPROVED
LEAKAGE RESISTANCE
EVEREADY BATTERY COMPANY,
INC.
A61K
H01M
‫בטרית אויר עם התנגדות משופרת לנזילה‬
PCT/US/2005/008021
WO/2006/098718
1223021332
185342
H01M
‫בטריה הניזונה מנוזלים ואשר כוללת‬
‫מערכת לויסות נוזלים‬
FLUID CONSUMING BATTERY WITH
FLUID REGULATING SYSTEM
EVEREADY BATTERY COMPANY,
INC.
PCT/US/2005/009411
WO/2006/101491
232302133/
185343
2-(4-OXO-4H-QUINAZOLIN-3YL)ACETAMIDES AND THEIR USE
AS VASOPRESSIN V3 ANTAGONISTS
C07D
)‫–איל‬:–‫–קווינאזולין‬H 4 –‫–אוקסו‬4(–/
‫אצטאמידים ושימוש בהם כאנטגוניסטים‬
V: ‫של ואסופרדין‬
PHARMACOPEIA, INC.
4583
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
US
60/660926
485414044
US
PCT/EP/2006/060612
WO/2006/095014
11/03/2005
8858851884
122312133/
185344
‫תרכובות בעלות פארמקוקינטיקה‬
‫משופרת‬
PHARMACOKINETICALLY
IMPROVED COMPOUNDS
SURFACE LOGIX, INC.
US
60/653933
18/02/2005
PCT/US/2006/006048
WO/2006/089276
2/2312133/
185346
ADJUVANT COMPOSITION
COMPRISING ALUMINIUM
PHOSPHATE AND 3D-MPL
NOVARTIS VACCINES &
DIAGNOSTICS, INC.
US
60/653741
16/02/2005
PCT/GB/2006/000557
WO/2006/087563
122312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07D
A61K
‫תכשיר מסייע המכיל אלומיניום פוספאט ו‬
MPL–D: –
185347
C07D
4584
METHODS OF MAKING
PHARMACOKINETICALLY
IMPROVED COMPOUNDS
COMPRISING FUNCTIONAL
RESIDUES OR GROUPS AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING SAID COMPOUNDS
SURFACE LOGIX, INC.
US
60/654519
18/02/2005
PCT/US/2006/006047
WO/2006/089275
2/2312133/
‫שיטות ליצור תרכובות בעלות‬
‫פרמקוקינטיקה משופרת ואשר כוללות‬
‫שיירים או קבוצות פונקציונליות ותכשירי‬
‫רוקחות המכילים תרכובות אלו‬
185352
ORTHOPEDIC PLATE SYSTEM AND
METHOD FOR USING THE SAME
ALPINESPINE, LLC
US
60/654776
18/02/2005
115444481
1458151884
US
PCT/US/2006/005703
WO/2006/089145
302302133/
‫מערכת לוח אורטופדית ושיטה לשימושו‬
185353
AZABICYCLOALKANE DERIVATIVES ,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME AND
METHODS FOR THE PREPARATION
THEREOF
UNIVERSITA' DEGLI STUDI DI MILANO
IT
MI2005A000328 03/03/2005
PCT/IB/2006/000460
WO/2006/092722
2/2312133/
4585
A61B
185358
C07D
‫תולדות אזאביציקלואלקן תכשירי‬
‫רוקחות המכילים אותן ותהליכים‬
‫להכנתן‬
C07K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
IMMUNOGENS FROM
UROPATHOGENIC ESCHERICHIA
COLI
NOVARTIS VACCINES &
DIAGNOSTICS, INC.
US
60/654632
18/02/2005
PCT/US/2006/005912
WO/2006/091517
2/2312133/
COLI ESCHERICHIA ‫אימיונוגנים מ‬
‫אורופתוגנית‬
185359
COLI –‫חלבונים וחומצות גרעין מ‬
‫ הקשור לזיהום דלקת‬ESCHERICHIA
‫קרום המוח‬
PROTEINS AND NUCLEIC ACIDS
FROM MENINGITIS/SEPSISASSOCIATED ESCHERICHIA COLI
THE INSTITUTE FOR GENOMIC
RESEARCH
US
60/654632
18/02/2005
485411418
1858051884
US
PCT/US/2006/005913
WO/2006/089264
122322133/
185360
METHOD FOR DETECTING IN
BISTATIC MODE BY PASSIVELY
OPERATING ON NON-COOPERATING RADIOELECTRIC
TRANSMISSIONS
THALES
FR
0501695
18/02/2005
PCT/EP/2006/050431
WO/2006/087257
102312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07K
G01S
‫שיטה לגילוי תשדורות רדיו–אלקטרוניות‬
‫במצב ביסטני באופן פאסיבי על בסיס של‬
‫אי שיתוף פעולה‬
185361
G06F
4586
SWITCH MATRIX SYSTEM WITH
PLURAL BUS ARBITRATIONS PER
CYCLE VIA HIGHER-FREQUENCY
ARBITER
QUALCOMM INCORPORATED
US
11/066507
24/02/2005
PCT/US/2006/006649
WO/2006/091843
102312133/
185362
SUPPRESSING UPDATE OF A
BRANCH HISTORY REGISTER BY
LOOP-ENDING BRANCHES
QUALCOMM INCORPORATED
US
11/066508
24/02/2005
PCT/US/2006/006531
WO/2006/091778
3/2302133/
‫מערכת מטריצת מתג בעלת אפיק בוררות‬
‫מרובה למעגל דרך בורר בתדר גבוה‬
‫עדכון מודחק של רשימת היסטוריה ענפית‬
‫באמצעות ענפים של לולאת סיום‬
185363
SUBSTITUTED GAMMA LACTAMS
AS THERAPEUTIC AGENTS
ALLERGAN, INC.
US
60/660748
10/03/2005
PCT/US/2006/007797
WO/2006/098918
132312133/
4587
C07D
‫תחליפי לקטמי גאמה כתרופות‬
185366
C07K
‫נוגדן‬
ANTIBODY
HELLENIC PASTEUR INSTITUTE
GB
0503546.4
21/02/2005
PCT/IB/2006/000579
WO/2006/087637
2/2312133/
G06F
185367
A23L
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A METHOD FOR THE PRODUCTION OF
SAUSAGES
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
DE
102005010836.9 07/03/2005
18188481444141
8858451884
DE
PCT/DE/2006/000307
WO/2006/094475
2023021332
‫שיטה לייצור נקניקיות‬
185370
PROCESS AND METHODS FOR THE
PREPARATION OF OPTICALLY
ACTIVE CIS-2-HYDROXYMETHYL-4(CYTOSIN-1'-YL)-1,3-OXATHIOLANE
OR PHARMACEUTICALLY
ACCEPTABLE SALTS THEREOF
SHIRE CANADA, INC.
C07D
–/–‫תהליך ושיטות להכנת ציס‬
–: ,0–)‫ ' –אייל‬0–‫–(ציטוזין‬4–‫הידרוקסימתיל‬
‫אוקסאתיאלאן או מלח רוקחות מתאים‬
‫שלו פעיל אופטית‬
PCT/CA/2005/000384
WO/2006/096954
3/2302133/
185371
BENZIMIDAZOLE DERIVATIVES AND
THEIR USE FOR MODULATING THE
GABAA RECEPTOR COMPLEX
NEUROSEARCH A/S
US
60/670647
13/04/2005
DK
PA200500530 1458451884
PCT/EP/2006/061417
WO/2006/108800
1023121332
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07D
‫תולדות בנזאימידאזול ושימוש בהן לאפנון‬
GABAA ‫תצמיד קולטן‬
185373
G01J
4588
SYSTEM AND METHOD FOR
DETECTING CONCEALED OBJECTS
GLOBAL SECURITY DEVICES LTD.
‫מערכת ושיטה לגילוי חפצים מוסתרים‬
‫גלובל התקני ביטחון בע"מ‬
PCT/IL/2005/000223
WO/2006/090353
2/2312133/
185375
G06F
METHODS AND APPARATUS FOR
CONFIGURING PLASMA CLUSTER
TOOLS
LAM RESEARCH CORPORATION
US
60/656862
25/02/2005
115880844
4158451884
US
PCT/US/2006/005740
WO/2006/093695
3/2302133/
185376
USE OF A COMBINATION OF
MYXOMA VIRUS AND RAPAMYCIN
FOR THERAPEUTIC TREATMENT
ROBARTS RESEARCH INSTITUTE
US
60/658816
07/03/2005
PCT/CA/2006/000315
WO/2006/094385
202312133/
4589
‫שיטות ומיכשור לעיצוב כלי מצרר על‬
‫בסיס פלאזמה‬
C12N
‫שימוש קומבינציה של וירוס מיקסומה‬
‫ורפמאיצין לטיפול תרפויתי‬
185377
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD FOR A MEDICINAL
COMBINATION TREATMENT, AND
MEDICAMENT COMBINATIONS
SUITABLE THEREFOR
LTS LOHMANN THERAPIE-SYSTEME
AG
DE
102005007859.1 21/02/2005
PCT/EP/2006/001312
WO/2006/087160
102312133/
‫שיטה לטיפול רפואי משולב ולשילובי‬
‫תרופות מתאימים‬
185378
‫שיטות והרכבים לקביעת הצמדות או‬
‫נדידה של תא‬
‫אנדותליאלי‬
METHODS AND COMPOSITIONS FOR
PROMOTING ENDOTHELIAL CELL
ADHESION OR MIGRATION
UNIVERSITY OF UTAH RESEARCH
FOUNDATION
US
60/656360
25/02/2005
PCT/US/2006/006526
WO/2006/091775
1/2312133/
185379
BENZOTHIAZOLE,
THIAZOLOPYRIDINE,
BENZOOXAZOLE AND
OXAZOLOPYRIDINE DERIVATIVES
AS ANTIDIABETIC COMPOUNDS
F. HOFFMANN-LA ROCHE AG
EP
05101815.8 09/03/2005
PCT/EP/2006/001843
WO/2006/094682
312302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
C07D
,‫ תיאזולופירידין‬,‫נגזרות של בנזותיאזול‬
‫בנזאוקסזול ואקסזולופירידין כתרכובות נגד‬
‫סכרת‬
185380
C07K
4590
ANTI-MAdCAM ANTIBODY
COMPOSITIONS
PHARMACIA & UPJOHN COMPANY
LLC
US
60/659766
08/03/2005
485410144
1851851884
US
485441411
1851151884
US
485441444
1458151884
US
PCT/US/2006/007554
WO/2006/096490
202302133/
185381
CIS-2,4,5-TRIARYL-IMIDAZOLINES
AND THEIR USE AS ANTI-CANCER
MEDICAMENTS
F. HOFFMANN-LA ROCHE AG
US
60/662516
16/03/2005
PCT/EP/2006/002282
WO/2006/097261
112312133/
185385
AERATING WASTEWATER FOR REUSE
JEREMY WEISSMAN
US
60/655033
22/02/2005
PCT/IL/2006/000242
WO/2006/090382
112312133/
DATA TRANSFER SECURITY
4591
185386
MAdCAM–‫הרכבים של נוגדן אנטי‬
C07D
‫– טריאריל–אימידזולינים‬/ ,4 ,.–‫ציס‬
‫ושימושם כתרופות נגד סרטן‬
C02F
‫הספגת שפכים באוויר לשימוש חוזר‬
‫ירמי ויסמן‬
G06F
‫הבטחת העברת מידע‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
KIDARO (ISRAEL) LTD.
US
60/654465
485400481
US
PCT/IL/2006/000244
WO/2006/090384
‫קידארו (ישראל) בע"מ‬
22/02/2005
8858451884
3/2312133/
ARMOR ASSEMBLY
ISRAELI ARIE
IL
167006
PCT/IL/2006/000162
WO/2006/087699
185389
F41H
‫מכלול שיריון‬
‫אריה ישראלי‬
21/02/2005
122312133/
185390
A SOLID PHARMACEUTICAL
DOSAGE FORMULATION
ABBOTT LABORATORIES
US
11/064467
23/02/2005
PCT/US/2006/005944
WO/2006/091529
3/2302133/
185391
QUINAZOLINONE T-TYPE CALCIUM
CHANNEL ANTAGONISTS
MERCK & CO. INC.
US
60/659954
09/03/2005
PCT/US/2006/008177
WO/2006/098969
302302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185392
A61K
‫צורת מינון רוקחית מוצקה‬
C07D
‫ של‬T ‫אנטגוניסטים לתעלות סידן מסוג‬
‫קוינאזולינון‬
C07K
4592
SCREENING METHOD, PROCESS FOR
PURIFYING OF NON-DIFFUSIBLE ABETA OLIGOMERS, SELECTIVE
ANTIBODIES AGAINST SAID NONDIFFUSIBLE A -BETA OLIGOMERS
AND A PROCESS FOR
MANUFACTURING OF SAID
ANTIBODIES
ABBOTT GMBH & CO. KG
EP
05004858.6 05/03/2005
485444444
1458451884
US
8488444048
1458451884
EP
485448044
4851151884
US
PCT/EP/2006/001984
WO/2006/094724
112312133/
185393
MICROWAVABLE METALLIC
CONTAINER
BALL CORPORATION
US
11/064224
22/02/2005
PCT/US/2006/006602
WO/2006/091821
302302133/
185394
FUSED AROMATIC COMPOUNDS
HAVING ANTI-DIABETIC ACTIVITY
MERCK & CO, INC.
US
60/658661
04/03/2005
PCT/US/2006/007740
WO/2006/096564
122312133/
4593
185395
‫ –בטא‬A ‫ תהליך לטיהור של‬,‫שיטת סינון‬
‫ נוגדנים‬,‫אוליגומרים לא––דיפוזיים‬
‫ –בטא אוליגומרים‬A–‫סלקטיביים כנגד ה‬
‫הלא–דיפוזיים ותהליך לייצור הנוגדנים‬
‫הללו‬
H05B
‫מיכל עשוי ממתכת שניתן לשימוש‬
‫במיקרוגל‬
C07D
‫תרכובות ארומטיות מאוחות בעלות‬
‫פעילות אנטי–סכרתית‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PIPERIDINYL PIPERAZINE
DERIVATIVES USEFUL AS
INHIBITORS OF CHEMOKINE
RECEPTORS
SCHERING CORPORATION
US
60/655572
23/02/2005
PCT/US/2006/006333
WO/2006/091692
122312133/
185396
METHODS OF TREATING
GASTROINTESTINAL
INFLAMMATION
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/655455
22/02/2005
PCT/US/2006/006095
WO/2006/091591
102312133/
185399
PYRIDYL ACETIC ACID
COMPOUNDS
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2005JP
25/02/2005
052018
PCT/JP/2006/304177
WO/2006/090915
102312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185400
‫נגזרות פיפראזין פיפרידיניל שימושיות‬
‫כמעכבים לרצפטורים של כמוקין‬
A01N
‫שיטות טיפול בדלקת קיבתי מעי‬
C07D
‫תרכובות חומצת פירידיל אצטית‬
C07C
4594
SYNTHESIS OF (E) -ALPHA, BETA
UNSATURATED SULFIDES,
SULFONES, SULFOXIDES AND
SULFONAMIDES
TEMPLE UNIVERSITY -OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION
US
60/656204
25/02/2005
PCT/US/2006/006698
WO/2006/091870
3/23/21332
,‫ סולפונים‬,‫סינתזה של סולפידים‬
,‫)–אלפא‬E( ‫סולפוקסידים וסולפונ אמידים‬
‫בתא בלתי רוויים‬
185402
VENTILATION BOARD, VENTILATION
BOX, VENTILATION SYSTEM,
INSULATING BOARD AND METHOD
FOR MANUFACTURING VENTILATION
BOARD AND BOX
VINAY, K. MEHTA
IN
187/MUM/2005 21/02/2005
PCT/IN/2005/000184
WO/2006/087731
322302133/
185403
PERSONAL LUBRICANT AND
CONDOMS COATED THEREWITH
DELSOL PRODUCTS LIMITED
GB
0504547.1
04/03/2005
PCT/GB/2006/000714
WO/2006/092585
4595
B65D
‫ מערכת‬,‫ קופסת אוורור‬,‫לוח אוורור‬
‫ לוח מבודד ושיטה לייצור לוח‬,‫אוורור‬
‫וקופסת אוורור‬
A61K
‫חומר סיכה אישי וכובעון נצפה עמו‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
112312133/
185404
C09D
‫תכשירים הנתנים להדפסה במדפסת‬
‫הזרקת דיו‬
INK JET PRINTABLE COMPOSITIONS
CIMA NANO TECH ISRAEL LTD.
US
60/656455
23/02/2005
PCT/IB/2006/000364
WO/2006/090245
102312133/
185406
DEVICE FOR COUNTERING AND
TRACKING A THREAT WITH
OPTICAL DELAY DEVICE
SAGEM DEFENSE SECURITE
FR
0501834
23/02/2005
PCT/EP/2006/060201
WO/2006/089923
232302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מכשיר להתנגדות ומעקב אחר סכנה עם‬
‫התקן השהיה אופטי‬
185789
PHARMACEUTICAL COMPOSITIONS
CONTAINING A COMBINATION OF A
CANNABINOID RECEPTOR
ANTAGONIST COMPOUND AND AN
ANTIPSYCHOTIC AGENT
SANOFI-AVENTIS
FR
0502508
14/03/2005
PCT/FR/2006/000532
WO/2006/097605
F41G
A61K
‫הרכבים פרמצבטיים המכילים צירוף של‬
,‫תרכובת אנטגוניסטית לקולטן קנבינואידי‬
‫וחומר אנטי פסיכוטי‬
4596
222302133/
185891
NOVEL COMPOUNDS AND THEIR
ISOMERS AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME AS VANILLOID RECEPTOR
ANTAGONISTS
AMOREPACIFIC CORPORATION
10-2005KR
19/03/2005
0022986
485444148
1158451884
US
PCT/KR/2006/000929
WO/2006/101318
2/2302133/
3/2312133/
‫תרכובות חדשות ואיזומרים שלהן ותכשירי‬
‫רוקחות המכילים אותן כאנטגוניסטים‬
‫לקולטי ונילויד‬
185892
NOVEL COMPOUNDS AND THEIR
ISOMERS AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME AS VANILLOID RECEPTOR
ANTAGONISTS
AMOREPACIFIC CORPORATION
10-2005KR
19/03/2005
0022986
485444148
1158451884
US
PCT/KR/2006/000988
WO/2006/101321
4597
C07C
‫תרכובות חדשות ואיזומרים שלהן ותכשירי‬
‫רוקחות המכילים אותן כאנטגוניסטים‬
‫לקולטי ונילויד‬
185917
IMMUNOGENIC MOLECULES
THE COUNCIL OF THE QUEENSLAND
INSTITUTE OF MEDICAL RESEARCH
AU
2005900571 08/02/2005
PCT/AU/2006/000162
WO/2006/084319
032302133/
C07C
185931
C07K
‫מולקולות אימונוגניות‬
C07C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
COMPOSITIONS FOR ORAL
TRANSMUCOSAL DELIVERY OF
METFORMIN
GENEREX PHARMACEUTICALS INC
US
60/666475
30/03/2005
PCT/CA/2006/000472
WO/2006/102752
202302133/
‫תכשירים למתן מטפורמין דרך רירית הפה‬
185955
COMPOSITIONS AND METHOD FOR
STORAGE OF NUCLEIC ACID FROM
BODILY FLUIDS
DNA GANOTEK INC
US
60/662510
16/03/2005
PCT/CA/2006/000380
WO/2006/096973
222302133/
185956
INTERFERENCE CONTROL IN A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/662176
15/03/2005
115140404
1158451884
US
PCT/US/2006/009550
WO/2006/099547
2/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185958
C12N
‫תכשירים ושיטה לאחסון חומצות גרעין‬
‫מנוזלי גוף‬
H04L
‫שליטה בהפרעות במערכת תקשורת‬
‫אלחוטית‬
G01S
4598
‫שיטה לאיתור מיקום במערכת איתור‬
‫גלובלית בעלת הערכת עדכון מגוונת‬
‫לשמירת הספק‬
GPS POSITION TRACKING METHOD
WITH VARIABLE UPDATING RATE
FOR POWER CONSERVATION
QUALCOMM INCORPORATED
US
11/083419
17/03/2005
PCT/US/2006/010082
WO/2006/099632
3/22221333
185959
RADIO LINK PROTOCOL
ENHANCEMENTS TO REDUCE SETUP
TIME FOR DATA CALLS
QUALCOMM INCORPORATED
US
09/437417
10/11/1999
PCT/US/2000/030834
WO/2001/035580
222302133/
‫תוספות לפרוטוקול קישור רדיו להפחתת‬
‫זמן אתחול לקריאת נתונים‬
185960
INTERFERENCE CONTROL IN A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/662176
15/03/2005
115140404
1158451884
US
115184404
8151151884
US
PCT/US/2006/009551
WO/2006/099548
2/2302133/
4599
H04L
185961
H04L
‫שליטה בהפרעות במערכת תקשורת‬
‫אלחוטית‬
H04J
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
CHANNEL STRUCTURES FOR A
QUASI-ORTHOGONAL MULTIPLEACCESS COMMUNICATION SYSTEM
‫מבני אפיק עבור מערכת תקשורת מרובת‬
‫גישות מצטלבת לכאורה‬
QUALCOMM INCORPORATED
US
60/662634
16/03/2005
115118148
1458451884
US
PCT/US/2006/009757
WO/2006/099577
202302133/
185962
ENHANCEMENT OF MACROLIDE
PENETRATION THROUGH HUMAN
SKIN
MACROCHEM CORPORATION
US
60/661031
14/03/2005
PCT/US/2006/009065
WO/2006/099390
2/2302133/
A61F
‫הגברת חדירה של מאקרודולין דרך עור‬
‫אדם‬
185963
G06F
‫שיטה ומערכת לאופטימציה של כניסות‬
‫למאגר זמני בזיכרון לשיפור תרגום כתובת‬
‫וירטואלית לכתובת פיזית‬
METHOD AND SYSTEM FOR
OPTIMIZING TRANSLATION
LOOKASIDE BUFFER ENTRIES
QUALCOMM INCORPORATED
US
11/083691
17/03/2005
PCT/US/2006/010087
WO/2006/099633
222302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
185964
H04Q
4600
METHOD AND APPARATUS BY
WHICH A HOME NETWORK CAN
DETECT AND COUNTERACT VISITED
NETWORK INBOUND TRAFFIC
REDIRECTION
ROAMWARE INC.
US
60/662028
15/03/2005
485448814
1158451884
US
PCT/US/2006/009295
WO/2006/099476
2/22221332
4601
B24B
,‫שיטות וכלי לתחזוקה של משטחים קשים‬
‫ושיטה לייצור הכלי‬
185966
PHYTOPLANKTON-BASED
NUTRACEUTICALS AND METHOD
OF OBTAINING THE SAME
HARPER TOM
US
11/081851
15/03/2005
PCT/CA/2006/000399
WO/2006/096986
202302133/
‫רומוואר בע"מ‬
185965
METHODS AND TOOL FOR
MAINTENANCE OF HARD
SURFACES, AND A METHOD FOR
MANUFACTURING SUCH A TOOL
HTC SWEDEN AB
EP
05005570.6 15/03/2005
115848801
1458451884
US
PCT/EP/2005/012360
WO/2006/097141
222302133/
‫שיטה והתקן המאפשרים לרשת ביתית‬
‫לזהות ולהתנגד להסתה של תעבורה‬
‫נכנסת‬
C12N
‫תכשירים נוטרסוטיקלים המבוססים על‬
‫פיטו–פלנקטון ושיטה לקבלתם‬
185967
A61M
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מזרק הניתן למשיכה אוטומטית‬
‫לאחור‬
AUTO RETRACTABLE SYRINGE
GLOBAL MEDISAFE HOLDINGS
AU
2005901208
AU
PCT/AU2005/001132
1884884414
AU
PCT/AU/2006/000331
WO/2006/096909
2/22221332
LIMITED
14/03/2005
8158051884
1451151884
185968
METHODS AND TOOL FOR
MAINTENANCE OF HARD
SURFACES, AND A METHOD FOR
MANUFACTURING SUCH A TOOL
HTC SWEDEN AB
EP
05005570.6 15/03/2005
115848801
1458451884
US
PCT/EP/2005/012360
WO/2006/097141
222302133/
,‫שיטות וכלי לתחזוקה של משטחים קשים‬
‫ושיטה לייצור הכלי‬
185973
DATA STORAGE DEVICES AND
METHODS
GENERAL ELECTRIC LICENSING,
INC
US
60/662149
16/03/2005
PCT/US/2006/009249
WO/2006/101873
1223/2133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B24B
186000
G02B
‫התקנים לאיחסון מידע ושיטות‬
A61K
4602
METHOD OF REDUCING THE RISK
OF ADVERSE CARDIOVASCULAR
(CV) EVENTS ASSOCIATED WITH
THE ADMINISTRATION OF
PHARMACEUTICAL AGENTS WHICH
FAVOR CV EVENTS
HAROLD RICHARD HELLSTROM
US
60/708728
15/08/2005
485444144
1151151884
US
485401484
1458451884
US
485081488
1858451884
US
115408884
1858451884
US
PCT/US/2006/028631
WO/2007/021460
032302133/
‫שיטה להפחתת הסיכון של אירועים עוינים‬
‫קרדיו וסקולריים הקשורים לניהול של‬
‫גורמים תרופתיים התומכים באירועים‬
‫קרדיו וסקולריים‬
186021
OXAPROZIN OR CLOSELY RELATED
COMPOUND FOR THE TREATMENT
AND PREVENTION OF PRURITUS
ASTION PHARMA A/S
DK
PA200500437 30/03/2005
DK
PA200500438 4858451884
DK
PA200500948 1458451884
DK
PA200500949 1458451884
485484444
1458451884
US
485484848
1058451884
US
PCT/DK/2006/000180
WO/2006/102899
032302133/
4603
186022
C07D
‫אוקסאפרוזין או תרכובת הקרובה לכך‬
‫לטיפול ומניעה של גירוד בעור‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
DERMATOLOGICAL COMPOSITIONS
AND SALTS FOR THE TREATMENT OF
DERMATOLOGICAL DISEASES
ASTION PHARMA A/S
DK
PA200500437 30/03/2005
DK
PA200500438 4858451884
DK
PA200500948 1458451884
DK
PA200500949 1458451884
485484444
1458451884
US
485484848
1058451884
US
PCT/DK/2006/000181
WO/2006/102900
3/2302133/
186030
METHODS AND SYSTEMS FOR
IDENTIFYING AN AREA OF
INTEREST IN PROTECTABLE
CONTENT
BLACK DUCK SOFTWARE, INC.
US
11/084063
18/03/2005
PCT/US/2006/008369
WO/2006/101755
122302133/
186033
HIGH-PERFORMANCE
ELECTROACTIVE POLYMER
TRANSDUCERS
ARTIFICIAL MUSCLE, INC.
US
11/085804
21/03/2005
PCT/US/2006/010120
WO/2006/102273
022302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186034
‫תכשירים דרמטולוגיים ומלחים לטיפול‬
‫במחלות דרמטולוגיות‬
G06F
‫שיטה ומערכות לזיהוי איזור עניין בתוכן‬
‫הניתן להגנה‬
H01L
‫מתמרים פולימריים אלקטרו–אקטיביים‬
‫לביצועים גבוהים‬
C07D
4604
PYRIMIDINE DERIVATIVES FOR USE
AS ANTICANCER AGENTS
ASTRAZENECA AB
GB
0506883.8
05/04/2005
841484444
1151151884
GB
PCT/GB/2006/001195
WO/2006/106307
3/2302133/
186035
4-(PYRID-2-YL) AMINO
SUBSTITUTED PYRIMIDINE AS
PROTEIN KINASE INHIBITORS
ASTRAZENECA AB
GB
0507347.3
12/04/2005
PCT/GB/2006/001283
WO/2006/109026
232302133/
186036
A HOST CELL COMPRISING A
VECTOR FOR PRODUCTION OF
PROTEINS REQUIRING GAMMACARBOXYLATION
ASTRAZENECA AB
SE
0500831-3
13/04/2005
PCT/SE/2006/000426
WO/2006/110083
2/2302133/
4605
186037
‫נגזרות פירימידין לשימוש כגורמים נוגדי‬
‫סרטן‬
C07D
)‫–איל‬/–‫–(פיריד‬4 ‫פירימידינים מותמרי‬
‫אמינו כמעכבי פרוטאין קינאז‬
C12N
‫תא מאכסן המכיל וקטור ליצור חלבונים‬
‫הדורשים גמא–קרבוקסילציה‬
F24F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
FAN ARRAY FAN SECTION IN AIRHANDLING SYSTEMS
HUNTAIR, INC.
US
11/097561
31/03/2005
PCT/US/2006/009842
WO/2006/104735
112302133/
‫חלק איוורור עם מערך מאווררים במערכות‬
‫טיפול באוויר‬
186039
‫צמחי פלפל עם פירות בעלי תכולת‬
‫ויטמינים שונה‬
PEPPER PLANTS HAVING FRUIT
WITH ALTERED VITAMIN CONTENT
STATE OF ISRAEL, MINISTRY OF
AGRICULTURE, AGRICULTURAL
RESEARCH ORGANIZATION
US
60/663878
22/03/2005
PCT/IL/2006/000371
WO/2006/100680
132302133/
312312133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫ מינהל‬,‫ משרד החקלאות‬,‫מדינת ישראל‬
‫המחקר החקלאי‬
186040
METHOD FOR MAKING 1SUBSTITUTED 1H-IMIDAZO[4,5C]QUINOLIN-4-AMINE COMPOUNDS
AND INTERMEDIATES THEREFOR
FERRER INTERNACIONAL, S.A.
EP
05102229.1 21/03/2005
PCT/EP/2006/060887
WO/2006/100226
A01H
C07D
‫– אימידזו‬H 0 ‫שיטה להכנת תרכובות של‬
0 ‫–אמין מותמר בעמדה‬4–‫] קוינולין‬C –.,4[
‫ותוצרי ביניים שלהן‬
186041
C07D
4606
7-AMINO ALKYLIDENYLHETEROCYCLIC QUINOLONES AND
NAPHTHYRIDONES
JANSSEN PHARMACEUTICA N.V.
US
11/084987
21/03/2005
PCT/US/2006/003657
WO/2006/101603
132302133/
186042
BENZOIC ACID ESTER COMPOUNDS,
COMPOSITIONS, USES AND
METHODS RELATED THERETO
‫–אמינו אלקילידניל–הטרוציקלי של‬7
‫קוינולונים ונפתירידונים‬
C07C
,‫תרכובות של אסטר של חומצה בנזואית‬
‫ שימושים ושיטות הקשורות‬,‫הרכבים‬
‫אליהן‬
FERRER INTERNACIONAL S.A.
EP
05102228.3 21/03/2005
PCT/EP/2006/060886
WO/2006/100225
022302133/
186043
PRODUCTION OF HIGHLY
ISOTOPICALLY LABELLED,
SECONDARY, MICROBIAL
METABOLIC PRODUCTS, AND
CORRESPONDING METABOLIC
PRODUCTS
ERBER AKTIENGESELLSCHAFT
AT
A574/2005
05/04/2005
PCT/AT/2006/000129
WO/2006/105563
1/2302133/
4607
186044
C12P
‫ייצור של מוצרים איזוטופיים מאוד‬
‫ מוצרים מיקרוביים‬,‫ משניים‬,‫מתוייגים‬
‫ ומוצרים מטבוליים מקבילים‬,‫מטבוליים‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PROCESS FOR PRODUCTION OF 1-(3(2-(1-BENZOTHIOPHEN-5YL)ETHOXY)PROPYL)AZETIDIN-3OL OR SALTS THEREOF
–0(–/(–:(–0 ‫הליך עבור ייצור של‬
)‫–איל‬.–‫בנזות'יאופן‬
‫–אול או‬:–‫את'וקסי)פרופיל)אזאטידין‬
‫מלחים מזה‬
TOYAMA CHEMICAL CO., LTD.
2005JP
28/03/2005
090831
1884-144440 1458451884
JP
1884-184080 1458451884
JP
1884-148444 8858051884
JP
PCT/JP/2006/306127
WO/2006/104088
022322133/
186045
HUMAN DETECTION AND
TRACKING FOR SECURITY
APPLICATIONS
OBJECTVIDEO, INC.
US
11/139986
31/05/2005
PCT/US/2006/021320
WO/2006/086926
102302133/
186046
ECONOMICAL LOUDNESS
MEASUREMENT OF CODED AUDIO
DOLBY LABORATORIES LICENSING
CORPORATION
US
60/671381
13/04/2005
PCT/US/2006/010823
WO/2006/113047
102302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186047
G06T
‫גילוי אנושי ומעקב עבור יישומי אבטחה‬
H04S
‫מדידה חסכונית של קולניות אודיו מוצפן‬
G10L
4608
‫אימות אודיו למידע אודות נתונים‬
AUDIO METADATA VERIFICATION
DOLBY LABORATORIES LICENSING
CORPORATION
US
60/671361
13/04/2005
PCT/US/2006/011202
WO/2006/113062
2/2302133/
186048
ASSOCIATION BETWEEN
FERROQUINE AND AN
ARTEMISININE DERIVATIVE FOR
TREATING MALARIA
SANOFI-AVENTIS
FR
0503932
20/04/2005
PCT/FR/2006/000842
WO/2006/111647
302302133/
1/2302133/
4609
‫קשר בין פרוקווין ותולדה של ארטמיסינין‬
‫לטיפול במלריה‬
186049
PROPHYLACTIC OR THERAPEUTIC
AGENT FOR DEPRESSION OR
ANXIETY DISORDERS
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2005JP
04/04/2005
107674
PCT/JP/2006/307047
WO/2006/107019
A61K
C07D
‫ או‬,‫חומר למניעת דיכאון או הפרעת–חרדה‬
‫לטיפול בדיכאון או בהפרעת–חרדה‬
186051
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
AN OXINDOLE OXAZOLIDINONE AS
ANTIBACTERIAL AGENT
PHARMACIA & UPJOHN COMPANY
LLC
US
60/668716
06/04/2005
485404888
1458451884
US
PCT/IB/2006/000952
WO/2006/106426
102302133/
186052
BRANCH TARGET ADDRESS CACHE
STORING TWO OR MORE BRANCH
TARGET ADDRESSES PER INDEX
QUALCOMM INCORPORATED
US
11/089072
23/03/2005
PCT/US/2006/010952
WO/2006/102635
102302133/
186053
MINIMIZING MEMORY BARRIERS
WHEN ENFORCING STRONGLYORDERED REQUESTS IN A WEAKL
Y-ORDERED PROCESSING SYSTEM
QUALCOMM INCORPORATED
US
60/665000
23/03/2005
115144848
1851851884
US
PCT/US/2006/010953
WO/2006/102636
102302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186054
‫אוקסינדול אוקסאזולידינון כחומר אנטי‬
‫בקטריאלי‬
G06F
‫מטמון מטרה ענפית לאחסון שתיים או‬
‫יותר כתובות מטרות ענפיות לאינדקס‬
G06F
‫הקטנת מחסומי זיכרון כאשר אוכפים‬
‫בקשות מוסדרות בחוזקה בהליך עיבוד‬
‫מוסדר בצורה חלשה‬
G06F
4610
METHOD AND SYSTEM FOR
VARIABLE THREAD ALLOCATION
AND SWITCHING IN A
MULTITHREADED PROCESSOR
QUALCOMM INCORPORATED
US
11/089474
23/03/2005
PCT/US/2006/011175
WO/2006/102668
3223/2133/
‫שיטה ומערכת עבור הקצאה מגוונת של‬
‫הליך לביצוע משימה וחילוף בהליך עיבוד‬
‫רב משימות‬
186325
TIZANIDINE COMPOSITIONS AND
METHODS OF TREATMENT USING
THE COMPOSITIONS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/704731
01/08/2005
485018844
8458451884
US
PCT/US/2006/030273
WO/2007/016676
3/2232133/
186493
SYSTEM AND METHOD FOR
DEFECTING THE POSITION OF A
LIFT CAGE
INVENTIO AG
EP
06122159.4 12/10/2006
222232133/
186620
LOT OF WATER WITH CHEAP PRICE
4611
A61P
‫הרכבי תיזאנידין ושיטות לטיפול על–ידי‬
‫שימוש בהרכבים‬
‫טבע תעשיות פרמצבטיות בע"מ‬
B66B
‫מערכת ושיטה לגילוי העמדה של תא‬
‫מעלית‬
A47K
‫המון המון מים ובמחיר הרבה יותר זול‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫פורת אהרון שישפורטיש‬
PORAT HARON SISPORTISH
222232133/
186667
ELECTRONIC INSECT DETOURING
DEVICE ATTACHABLE TO
DOMESTIC OBJECT AND METHOD
FOR USE THEREOF
PELES ZALMAN
2/2232133/
‫התקן אלקטרוני להסטת חרקים הניתן‬
‫להצמדה לפריט ביתי ושיטה לשימוש בו‬
‫פלס זלמן‬
186674
SAFETY METHOD FOR CABINET
ACCESS
ERAN MILO
102302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G08B
B65D
‫שיטה בטיחותית לגישה לתאי אחסון‬
‫ערן מילוא‬
186675
H04J
4612
MAC MULTIPLEXING AND TFC
SELECTION PROCEDURE FOR
ENHANCED UPLINK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/676345
29/04/2005
485404114
1858451884
US
115480414
1158451884
US
PCT/US/2006/015275
WO/2006/118831
312322133/
TEC ‫ וכפל ותהליך בחירה של‬MAC
‫לאפלינק מוגבר‬
186676
4-PHENYL-5-OXO-1,4,5,6,7,8HEXAHYDROQUINOLINE
DERIVATIVES AS MEDICAMENTS
FOR THE TREATMENT OF
INFERTILITY
N.V. ORGANON
EP
05103738.0 04/05/2005
PCT/EP/2006/061976
WO/2006/117370
302322133/
–0,7,9,.,4,0–‫–אוקסו‬.–‫–פניל‬4 ‫תולדות‬
‫הקסאהידרוקווינולין כתרופות לטיפול‬
‫בעקרות‬
186677
METHOD FOR CHEMICALLY
MODIFYING POLYSACCHARIDES
EVONIK DEGUSSA GMBH
DE
102005020552.6 03/05/2005
PCT/EP/2006/062020
WO/2006/117386
2/2232133/
4613
C07D
186678
C08B
‫שיטה לשינוי כימי של פוליסכארידים‬
B66B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
BRAKE EQUIPMENT, LIFT
INSTALLATION, A METHOD FOR
DETECTING A FUNCTION OF THE
BRAKE EQUIPMENT, AND A
MODERNISATION SET
INVENTIO AG
EP
06124193.1 16/11/2006
3/2302133/
OIL-BASED SUSPENSION
CONCENTRATES
BAYER CROPSCIENCE AG
DE
102005018262.3
PCT/EP/2006/003202
WO/2006/111279
‫ שיטה לגילוי‬,‫ התקנת מעלית‬,‫ציוד בלימה‬
‫תפקוד של ציוד הבלימה וסט מודרניזציה‬
186679
A01N
‫רכז סוספנסיה המבוססת על שמן‬
20/04/2005
312322133/
186680
METHOD FOR PRODUCING
METHYLGLYCINE-N,N-DIETHANOIC
ACID TRIALKALIMETAL SALTS WITH A
LOW BY-PRODUCT CONTENT
C07C
‫שיטה לייצור מלחי מתכת טריאלקלים‬
‫–חומצה‬N,N–‫של מתילגליצין‬
‫דיאתנואית עם תכולה נמוכה של תוצרי‬
‫לוואי‬
BASF AKTIENGESELLSCHAFT
DE
102005021055.4 06/05/2005
PCT/EP/2006/061968
WO/2006/120129
102302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186681
G02B
4614
‫תצוגה אופטלמית‬
OPHTHALMIC DISPLAY
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE)
FR
0551102
28/04/2005
PCT/FR/2006/050251
WO/2006/114536
122302133/
186682
N-ACETYLCYSTEINE AMIDE (NAC
AMIDE) FOR TREATMENT OF
OXIDATIVE STRESS ASSOCIATED
WITH INFERTILITY
GLENN A. GOLDSTEIN
US
60/673559
21/04/2005
PCT/US/2006/015015
WO/2006/116034
122302133/
122302133/
4615
)‫ אמיד‬NAC( ‫–אצטילציסטאין אמיד‬N
‫לטיפול בדחק חימצוני הקשור לעקרות‬
186683
N-ACETYLCYSTEINE AMIDE (NAC
AMIDE) FOR ENHANCING PLANT
RESISTANCE AND TOLERANCE TO
ENVIRONMENTAL STRESS
GLENN A. GOLDSTEIN
US
60/673560
21/04/2005
PCT/US/2006/015021
WO/2006/132712
C12N
A01N
)‫ אמיד‬NAC( ‫–אצטילציסטאין אמיד‬N
‫להגדלת העמידות והטולרנטיות של צמח‬
‫בפני לחץ סביבתי‬
186684
C07C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
N-ACETYLCYSTEINE AMIDE (NAC
AMIDE) FOR THE TREATMENT OF
DISEASES AND CONDITIONS
ASSOCIATED WITH OXIDATIVE
STRESS
GLENN A. GOLDSTEIN
US
60/673561
21/04/2005
485484844
8458051884
US
PCT/US/2006/015548
WO/2006/116353
2/2232133/
)‫ אמיד‬NAC(‫–אצטילציסטאין אמיד‬N
‫לטיפול במחלות ותנאים הקשורים בדחק‬
‫חמצוני‬
186685
CONTAINERS PARTICULARLY FOR
AGRICULTURAL PRODUCTS
YOSEF HEIMAN (1990) LTD.
2/2232133/
‫מיכלים במיוחד לתוצרת חקלאית‬
‫יוסף הימן‬
186686
NORMALLY-CLOSED OPENING
CLOSURE
SPOUTLOCK LTD.
2/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B65D
A47J
‫סגירת פתח ע"י סגר סגור מטבעו‬
‫ספאוטלוק בע"מ‬
186687
B24D
4616
‫חומר לכרית ליטוש רב–שכבתית עבור‬
‫ליטוש כימי– מכני‬
MULTI-LAYER POLISHING PAD
MATERIAL FOR CMP
CABOT MICROELECTRONICS
CORPORATION
US
11/113498
25/04/2005
PCT/US/2006/014674
WO/2006/115924
2/2232133/
186688
ROD-LESS CYLINDER DEVICE AND
SYSTEM AND METHOD FOR
OPERATING THEREOF
ELIEZER ZEICHNER
US
60/902511
22/02/2007
3/2302133/
‫ מערכת ושיטה‬,‫מכשיר צילינדר חסר מוט‬
‫לשימוש במכשיר‬
‫אלי צייכנר‬
186689
METHODS OF ENHANCING
ISOLATION OF RNA FROM
BIOLOGICAL SAMPLES
NEXGEN DIAGNOSTICS LLC
US
11/109366
19/04/2005
PCT/US/2006/013251
WO/2006/113198
222302133/
1/2302133/
4617
G01N
RNA ‫שיטות להגברת ההפרדה של‬
‫מדוגמאות ביולוגיות‬
186690
METHODS AND DEVICES FOR
LIMITING GASTRIC EXPANSION
NISSIM DARVISH
US
60/672011
18/04/2005
PCT/IL/2006/000468
WO/2006/111961
F15B
A61B
‫שיטות ומכשירים להגבלת התרחבות של‬
‫קיבה‬
‫ניסים דרויש‬
186691
B41N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PROCESS FOR CONTACT PRINTING
OF PATTERN OF ELECTROLESS
DEPOSITION CATALYST
AGFA-GEVAERT
US
11/112013
20/04/2005
8418414444
1858451884
EP
PCT/EP/2006/061055
WO/2006/111451
132302133/
‫תהליך להדפסת–מגע של תבנית זרז‬
‫לשיקוע ללא אלקטרוליזה‬
186692
NOVEL MATERIALS USED FOR
EMITTING LIGHT
TECHNISCHE UNIVERSITAET WIEN
US
60/672986
20/04/2005
485404404
1458451884
US
PCT/EP/2006/061718
WO/2006/111568
302322133/
‫חומרים חדשים המשמשים לפליטת אור‬
186693
ANHYDROUS CRYSTALLINE FORMS OF
N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-NMETHYLAMINO)-7-(4-METHYLPYRIDIN2-Y-AMINO)-1H-PYRAZOLO[4,3D]PYRIMIDINE-3CARBONYL]METHANESULFONAMIDE
PFIZER INC
US
60/680445
485401411
US
PCT/IB/2006/001233
WO/2006/120552
C09K
C07D
N– ‫תצורות גבישיות אנהידרביות של‬
–N–‫–אתיל‬N(–.–)‫[–אתוקסי אתיל‬1–(2
–/–‫–מתילפירדין‬4(–7–)‫מתילאמינו‬
–:,4[‫–פיראזולו‬H0–)‫איל–אמינו‬
–:–‫]פירימידין‬D
‫קרבוניל]מתאנסולפונאמיד‬
12/05/2005
1458451884
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186694
A61N
4618
INGESTIBLE DEVICE FOR NITRIC
OXIDE PRODUCTION IN TISSUE
E-PILL PHARMA, LTD
US
60/682421
19/05/2005
PCT/IL/2006/000593
WO/2006/123346
3023221332
186695
METHOD AND APPARATUS FOR
REQUESTING POINT-TO-POINT
PROTOCOL (PPP) INSTANCES FROM
A PACKET DATA SERVICES
NETWORK
QUALCOMM INCORPORATED
US
09/477278
04/01/2000
PCT/US/2001/000487
WO/2001/050783
1223021332
186697
EVACUATION SYSTEMS AND
METHODS
ESCAPE RESCUE SYSTEMS LTD.
,‫מתקן לייצור תחמוצת–החנקן ברקמה‬
‫הניתן לבליעה‬
‫פיל פארמה בע"מ‬-‫אי‬
H04Q
‫שיטה והתקנים לבקשת מקרי פרוטוקול‬
‫לנקודה מרשת שירותי מדע פקט‬
B66B
‫מערכות ושיטות לפינוי‬
‫אסקייפ רסקיו סיסטמס בע"מ‬
PCT/IL/2005/000433
WO/2006/111947
3/2302133/
186698
BREATH ACTUATED INHALER
KOS LIFE SCIENCES, INC.
US
10/908133
28/04/2005
PCT/US/2006/013087
WO/2006/115732
132302133/
4619
186699
A61M
‫משאף המופעל בנשימה‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD FOR TREATING
ADVANCED OVARIAN CANCER
WITH DOXORUBICIN ENTRAPPED IN
LIPOSOMES
ALZA CORPORATION
US
60/674188
21/04/2005
PCT/US/2006/015528
WO/2006/116341
132302133/
186700
IMMUNOLIPOSOME COMPOSITION
FOR TARGETING TO A HER2 CELL
RECEPTOR
ALZA CORPORATION
US
60/674029
22/04/2005
485444448
1451151884
US
PCT/US/2006/015122
WO/2006/116107
2/2302133/
‫שיטה לטיפול בסרטן שחלות מתקדם עם‬
‫דוקסורוביצין הכלוא בליפוזומים‬
‫הרכב אימונוליפוזומי המיועד לרצפטור תא‬
HER2
186701
C. PERFRINGENS ALPHA TOXOID
VACCINE
SCHERING-PLOUGH LTD.
US
60/672289
18/04/2005
PCT/US/2006/014669
WO/2006/113772
2/22221332
186702
SPHERIC ALIGNMENT MECHANISM
STEPHEN BURNS KESSLER
US
11/108424
18/04/2005
115181418
1858451884
US
PCT/US/2005/041751
WO/2007/081300
132302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
186703
A61K
‫ פרפרינגנס אלפא טוקסואיד‬C ‫חיסון של‬
G21G
‫מכשיר להכוונה כדורית‬
G11B
4620
METHOD AND APPARATUS OF
FORMATTING A THREE
DIMENSIONAL OPTICAL
INFORMATION CARRIER
MEMPILE INC.
US
60/672982
20/04/2005
115188010
8151151884
US
PCT/IL/2006/000488
WO/2006/111972
132302133/
‫שיטה ומערכת לפרמוט נשא אינפורמציה‬
‫אופטי תלת – מימדי‬
186704
A THREE DIMENSIONAL OPTICAL
INFORMATION CARRIER AND A
METHOD OF MANUFACTURING
THEREOF
MEMPILE INC.
US
60/672982
20/04/2005
115188010
8151151884
US
PCT/IL/2006/000489
WO/2006/111973
3/23/2133/
1223221331
4621
‫נשא אינפורמציה אופטי תלת–מימדי‬
‫ושיטה לייצורו‬
186705
HEAT TRANSFER SURFACE FOR
ELECTRONIC COOLING
WOLVERINE TUBE, INC.
US
60/688254
07/06/2005
PCT/US/2006/021959
WO/2006/133211
G11B
H05K
‫משטח להעברת חם עבור קירור אלקטרוני‬
186706
G01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A METHOD FOR IDENTIFICATION,
ISOLATION AND PRODUCTION OF
ANTIGENS TO A SPECIFIC
PATHOGEN
INTERCELL AG
AT
A 130/01
26/01/2001
PCT/EP/2002/000546
WO/2002/059148
322322133/
‫ בידוד ויצור של אנטיגנים‬,‫שיטה לזיהוי‬
‫בררניים לפתוגן‬
186707
MITOTIC KINESIN INHIBITORS AND
METHODS OF USE THEREOF
ARRAY BIOPHARMA INC.
US
60/676890
02/05/2005
PCT/US/2006/016526
WO/2006/119146
212302133/
NUTRITION PRODUCTS
UNILEVER PLC
EP
05076176.6
PCT/EP/2006/003552
WO/2006/122625
C07D
‫מעכבי קינסין מיתותי ושיטות לשימוש‬
186708
A21D
‫תוצרי תזונה‬
19/05/2005
202302133/
186709
PREPARATION CONTAINING AT LEAST
ONE TYPE OF FUNGICIDAL CONAZOLE
BASF AKTIENGESELLSCHAFT
DE
102005017800.6 18/04/2005
PCT/EP/2006/003429
WO/2006/111327
122302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186710
A01N
‫הרכב המכיל לפחות קוטל פטריות‬
‫אחד ממשפחת הקונאזולים‬
C12N
4622
MATERIALS AND METHODS FOR
RESPIRATORY DISEASE CONTROL
IN CANINES
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.
US
60/673443
21/04/2005
PCT/US/2006/015090
WO/2006/116082
0223021333
‫חומרים ושיטות לבקרת מחלות נשימתיות‬
‫בכלביים‬
186711
NEGATIVE PRESSURE WOUND
THERAPY SYSTEM WITH HEATING
AND COOLING PROVISION
KINETIC CONCEPTS, INC.
US
60/127596
02/04/1999
PCT/US/2000/008759
WO/2000/059418
2/2232133/
186713
A METHOD AND DEVICE FOR
WATER DISPENSERS ON THE
SABBATH
NIR NAVE
2/2232133/
4623
‫מערכת טיפול בפציעה ע"י לחץ שלילי‬
‫הכוללת אפשרות לחימום וקירור‬
A47J
‫שיטה ומתקן למכשיר מים ביתי לשימוש‬
‫בשבת‬
‫ניר נווה‬
186714
G01G
‫מאזניים לשימוש חופשי במקומות‬
‫ציבוריים פתוחים‬
‫יאיר משולם‬
SCALE FOR USE IN UNGUARDED,
OUTDOOR LOCATIONS
YAIR MESHULAM
2/2232133/
A61F
186715
F01M
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
AN AUTOMATIC SYSTEM TO STOP
WATER LEAKAGE
HAIM AHARONOVIS
132302133/
‫מערכת אוטומטית לעצירת דליפת מים‬
‫חיים אהרונוביץ‬
186716
A CAMERA HOLDER DEVICE AND
METHOD THEREOF
M.S.T. MEDICAL SURGERY
TECHNOLOGIES LTD
US
60/672010
18/04/2005
485484188
8458051884
US
485414844
1458851884
US
485414841
1458851884
US
PCT/IL/2006/000478
WO/2006/111966
132302133/
2/2232133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מתקן ושיטה להחזקת מצלמה‬
‫ מדיקל סורג'רי טכנולוג'יס בע"מ‬.‫טי‬.‫אס‬.‫אמ‬
186717
DEVICE AND METHODS OF
IMPROVING LAPAROSCOPIC
SURGERY
M.S.T. MEDICAL SURGERY
TECHNOLOGIES LTD
US
60/672010
18/04/2005
485484188
8458051884
US
485414844
1458851884
US
485414841
1458851884
US
PCT/IL/2006/000478
WO/2006/111966
G06F
G06F
‫התקן ושיטה לשיפרו ניתוחים‬
‫לפרוסקופיים‬
‫ מדיקל סורג'רי טכנולוג'יס בע"מ‬.‫טי‬.‫אס‬.‫אמ‬
186718
G09C
4624
SYSTEM AND METHOD FOR
CONNECTING BETWEEN A WORKREVIEW REQUESTOR AND A
REVIEWER AND PROVIDING THE
WORK-REVIEW
MOSHE TEREM
2/2302133/
‫מערכת ושיטה לקישור בין מבקש של‬
‫בדיקת עבודה לבין בודק וספק בדיקת‬
‫עבודה‬
‫משה טרם‬
186719
CATALYST-COATED SUPPORT,
METHOD FOR PRODUCING THE SAME,
REACTOR COMPRISING THE SAME
AND USE THEREOF
UHDE GMBH
DE
102005019000.6 22/04/2005
PCT/EP/2006/003502
WO/2006/111340
1/2302133/
186720
DEVICE AND A METHOD FOR
APPLYING AN EVEN, THIN FLUID
LAYER TO SUBSTRATES
SCHMID TECHNOLOGY SYSTEMS
GMBH
DE
102005019686.1 22/04/2005
PCT/EP/2006/002797
WO/2006/111247
2/2302133/
4625
186721
B01J
,‫ שיטות לייצורו‬,‫תומך עטוף בזרז‬
‫ריאקטור המכיל אותו ושימוש בו‬
H01L
‫התקן ושיטה להוספת שכבה דקה‬
‫שווה של נוזל למצעים‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫הרכבים מוגברים ביולוגית‬
BIOENHANCED COMPOSITIONS
RUBICON RESEARCH PVT. LTD.
IN
477/MUM/2005 18/04/2005
IN
MUM/200658414 8458451884
PCT/US/2006/014422
WO/2006/113631
102302133/
186722
IMMOBILISATION OF ANTIGENIC
CARBOHYDRATES TO SUPPORT
DETECTION OF PATHOGENIC
MICRO-ORGANISMS
RNA HOLDING B.V.
EP
05075967.9 22/04/2005
PCT/NL/2006/000218
WO/2006/112708
2/2232133/
‫אימוביליזציה של קרבונהידרטים אנטיגנים‬
‫לצרכי איבחון מיקרואורגניזמים פתוגניים‬
186723
METHOD AND APPARATUS FOR
SELF-LICENSING DATA
GENERAL ELECTRIC COMPANY
US
11/591770
02/11/2006
2/2232133/
186724
APPARATUS AND METHOD FOR
ENDOSCOPIC EXAMINATION
BORIS LEVIN
3223/2133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G01N
G06F
‫שיטה והתקן לרישוי עצמי של נתונים‬
A61B
‫התקן ושיטה לבדיקה אנדוסקופית‬
‫בוריס לוין‬
186725
A21C
4626
A METHOD AND AN APPARATUS
FOR ROLLING FOOD DOUGH AND
DISK-SHAPED FOOD DOUGH
MANUFACTURED BY THE METHOD
RHEON AUTOMATIC MACHINERY
CO., LTD.
2005JP
03/06/2005
163837
1884-118488 1858451884
JP
1884-111140 1158451884
JP
1884-444811 1451151884
JP
PCT/JP/2006/310996
WO/2006/129759
322322133/
DISPENSING DEVICE
MYOZONE LTD
NZ
539854
PCT/NZ/2006/000095
WO/2006/118479
132302133/
‫שיטה ומתקן לגלגול בצק ובצק בצורת‬
‫דיסק המיוצר לפי השיטה‬
186726
‫מתקן למוצרים לשימוש חד פעמי‬
05/05/2005
186727
AUTOMATIC REMESHING BY
MAPPING A 2D GRID ON 3D GENUSG MESHES BASED ON
TOPOLOGICAL ANALYSIS
4627
G09G
‫ אוטומטי ע"י מיפוי רשת‬MESHING–RE
‫) תלת–ממדית‬MESHES( ‫דו–ממדית לרשת‬
‫ בהתבסס על ניתוח‬GENUS G–‫עם‬
‫טופולוגי‬
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
60/672614
18/04/2005
PCT/IL/2006/000492
WO/2006/111976
3/2322133/
A61J
186729
‫מוסד הטכניון למחקר ופתוח בע"מ‬
H01L
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD FOR RESIST STRIP IN
PRESENCE OF REGULAR LOW K
AND/OR POROUS LOW K
DIELECTRIC MATERIALS
LAM RESEARCH CORPORATION
US
11/126648
10/05/2005
PCT/US/2006/017917
WO/2006/122119
2123/2133/
‫שיטה להסרת מיסוך בנוכחות חומרים‬
‫ נמוך‬K ‫או‬/‫ נמוך רגילים ו‬K ‫מבודדים בעלי‬
‫נקבוביים‬
186730
CANCER TREATMENT USING
VIRUSES, FLUOROPYRIMIDINES
AND CAMPTOTHECINS
WELLSTAT BIOLOGICS
CORPORATION
US
60/699195
14/07/2005
PCT/US/2006/027018
WO/2007/011601
222302133/
186732
METHODS AND APPARATUS FOR
DENTAL IMPLANTATION
DENX ADVANCED MEDICAL
SYSTEMS LTD
US
60/672615
18/04/2005
PCT/IL/2006/000473
WO/2006/111964
2/2232133/
186733
A TUBE DISPENSER
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
,‫טיפול בסרטן על–ידי שימוש בוירוסים‬
‫פלואורופירימידינים וקמפטותצינים‬
A61C
‫שיטות והתקנים עבור השתלות שיניים‬
‫דנקס מערכות תוכנה רפואיות בע"מ‬
A01G
‫ממטרה להשקיה‬
‫דן מקלר‬
IRRIGATION SPRINKLER
DAN MEKLER
2/2232133/
A61K
186734
B65D
‫מנפק שפופרתי‬
4628
‫מאיר גיטליס‬
MEIR GITLIS
2/2232133/
186736
METHOD FOR MANUFACTURING AN
ABRASIVE TOOL
TAL GAUMAN
2/2232133/
‫שיטת עשיה של כלי השחזה‬
‫שמעון גויזמן‬
186737
186738
PYRIZOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
JAPAN TOBACCO INC.
2005JP
23/05/2005
148847
485404844
1458451884
US
1884-444104
1851151884
JP
485444018
8458151884
US
PCT/JP/2006/310603
WO/2006/126695
102302133/
ANTIBODIES TO MYOSTATIN
PFIZER, INC.
4629
A47G
‫מגן מוטות משקפיים‬
‫יוסף אלייב‬
EYEGLASS SHAFT PROTECTOR
HAI MODAHI
112322133/
B24D
C07D
‫תולדות פיריזול ותכשירי רוחקות המכילים‬
‫אותן‬
186739
C07K
‫נוגדנים למיוסטטין‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
US
60/674933
PCT/US/2006/015407
WO/2006/116269
25/04/2005
2/2232133/
186740
METHOD AND DEVICE FOR SAMPLE
VAPORIZATION FROM A FLOW OF A
SOLUTION
AVIV AMIRAV
222302133/
186741
OPTICAL PROBE FOR DELIVERY OF
LIGHT
ONDINE INTERNATIONAL LTD.
US
60/673689
21/04/2005
115484440
8458451884
US
PCT/US/2006/013380
WO/2006/115761
132302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186742
H01J
‫שיטה והתקן לאידוי דוגמה מזרימת‬
‫תמיסה‬
‫אביב עמירב‬
A61B
‫בחן אופטי להעברת אור‬
H04N
4630
METHOD AND APPARATUS FOR
COMMUNICATION AMONG
FACSIMILE MACHINES OVER
DIGITALLY COMPRESSED AUDIO
CHANNELS AND DISCRIMINATION
OF CALL TYPE
VIASAT, INC.
US
60/673632
21/04/2005
485444411
1158451884
US
PCT/US/2006/014966
WO/2006/116008
1/2302133/
‫שיטה והתקן לתיקשורת בין מכונת‬
‫פקסימיליה דרך ערוצי שמע דחוסים‬
‫סיפרתית וגילוי של סוג קריאה‬
186743
‫ של כוהל‬Z –‫ ו‬E ‫שיטה להפרדת איזומרים‬
‫אלקן‬
METHOD OF SEPARATINGE AND Z
ISOMERS OF AN ALKENE ALCOHOL
INNOVAROMA SA
US
11/115359
27/04/2005
PCT/US/2006/015659
WO/2006/116419
1/2302133/
186744
HETEROCYCLIC COMPOUNDS THAT
INHIBIT PROTEIN KINASE ACTIVITY
SUPERGEN, INC.
US
60/676467
28/04/2005
PCT/US/2006/016423
WO/2006/116733
102302133/
4631
C07C
C07D
‫תרכובות הטרוציקליות המעכבות פעילות‬
‫קינז חלבון‬
186745
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
NEW THIAZOLIDINONES WITHOUT
BASIC NITROGEN, THEIR
PRODUCTION AND USE AS
PHARMACEUTICAL AGENTS
BAYER SCHERING PHARMA AG
DE
102005020104 25/04/2005
PCT/EP/2006/004225
WO/2006/114333
302322133/
186746
GLUCAGON-LIKE-PEPTIDE-2 (GLP-2)
ANALOGUES
ZEALAND PHARMA A/S
US
60/678066
04/05/2005
PCT/GB/2006/001633
WO/2006/117565
102302133/
,‫תיאזולידינונים חדשים ללא חנקן בסיסי‬
‫ייצורם והשימוש בהם כגורמים רוקחיים‬
–/( / –‫אנלוגים של גלוקגון–דמוי–פפטיד‬
)GLP
186747
NEW THIAZOLIDINONES WITHOUT
BASIC NITROGEN, THEIR
PRODUCTION AND USE AS
PHARMACEUTICAL AGENTS
BAYER SCHERING PHARMA AG
DE
102005020105 25/04/2005
PCT/EP/2006/004226
WO/2006/114334
312322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07K
186748
C07D
,‫תיאזולידינונים חדשים ללא חנקן בסיסי‬
‫ייצורם והשימוש בהם כגורמים רוקחיים‬
C07D
4632
4 - PHENYL - 5 - OXO 1, 4, 5, 6, 7, 8 HEXAHYDROQUINOLINE
DERIVATIVES FOR THE TREATMENT
OF INFERTILITY
N.V. ORGANON
EP
05103735.6 04/05/2005
PCT/EP/2006/061972
WO/2006/117368
2/2302133/
,. ,4 ,0 – ‫ – אוקסו‬. – ‫ – פניל‬4 ‫נגזרות של‬
‫ – הקסאהידרוקווינולין לטיפול‬0 ,7 ,9
‫בעקרות‬
186749
DIHYDROTHIENOPYRIMIDINES FOR
THE TREATMENT OF INFLAMMATORY
DISEASES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102005019201.7 21/04/2005
PCT/EP/2006/061680
WO/2006/111549
212322133/
186750
PTERIDINES USEFUL AS HCV
INHIBITORS AND METHODS FOR
THE PREPARATION THEREOF
TIBOTEC PHARMACEUTICALS LTD.
US
60/680393
12/05/2005
8418411144
8458451884
EP
8484404444
8458451884
EP
PCT/EP/2006/062289
WO/2006/120251
3/23/2133/
4633
C07D
‫דיהידרותיאנופירימידינים לטיפול‬
‫במחלות דלקתיות‬
C07D
HCV ‫פטרידינים שימושיים כמעכבי‬
‫ושיטות להכנתם‬
186751
C01B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A PROCESS FOR PRODUCING SILICA
AND SODIUM SULFITE WITH SODIUM
SULFATE
DEGUSSA WELLINK SILLICA
(NANPING) CO. LTD
CN
200510200314.7 08/06/2005
PCT/CN/2006/001226
WO/2006/131064
3/2322133/
MOTILIDE COMPOUNDS
PFIZER INC
US
60/684612
485414484
US
485440080
US
115414418
US
PCT/US/2006/017672
WO/2006/127252
186752
‫תהליך לייצור סיליקה ונתרן גופריתי‬
‫עם נתרן גופרתי‬
C07H
‫תרכובות מוטילידיות‬
24/05/2005
8058851884
8051151884
8158451884
302302133/
186753
WATER-SWELLABLE HYBRID
MATERIAL, WITH INORGANIC
ADDITIVES AND PROCESS FOR ITS
PREPARATION
GEOHUMUS INTERNATIONAL
RESEARCH & DEVELOPMENT GMBH &
CO. KG
DE
102005021221.2 07/05/2005
PCT/EP/2006/003053
WO/2006/119828
132302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186754
C08F
‫חומר בן כלאיים התופח במים עם‬
‫תוספים אנאורגנים ותהליך להכנתו‬
A61K
4634
USE OF POLYPEPTIDES AND
NUCLEIC ACIDS FOR THE
PREPARATION OF MEDICAMENTS
FOR THE TREATMENT OF CANCER
AND/OR ARTHRITIS
LABORATOIRES SERONO SA
EP
05103402.3 26/04/2005
485401441
1458451884
US
PCT/EP/2006/061710
WO/2006/114387
2/23021332
‫שימוש של פוליפפטידים וחומצות‬
‫נוקלאיות להכנת תרופות לטיפול בסרטן‬
‫או דלקת מפרקים‬/‫ו‬
186755
G06F
‫שליחת תוכן המבוססת על הקשרות‬
‫משתמש המשתמשת בחיבור נציגויות‬
‫בנקודת קצה‬
CONTENT DELIVERY BASED ON
USER AFFINITY USING
CONNECTION END-POINT PROXIES
RIVERBED TECHNOLOGY INC.
PCT/US/2005/013285
WO/2006/112845
3123/2133/
186756
MODIFIED-RELEASE COMPOSITION
OF AT LEAST ONE FORM OF
VENLAFAXINE
BIOVAIL LABORATORIES
INTERNATIONAL S.R.L.
US
60/686461
02/06/2005
485481101
1458451884
US
PCT/US/2006/021519
WO/2006/130843
232322133/
4635
A61K
‫תכשיר המשתחרר באופן מותאם המכיל‬
‫לפחות צורה אחת של ונלפקסין‬
186759
A21D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
COMPOSITE NUTRITIONAL PRODUCTS
UNILEVER PLC
EP
05076176.6
19/05/2005
EP
PCT/EP06/003552 1158451884
PCT/EP/2006/004855
WO/2006/122833
1/2302133/
186760
REMOTE DEVICE ACCESS CONTROL
METHOD
HUTCHISON WHAMPOA THREE G IP
(BAHAMAS) LIMITED
GB
0508454.6
26/04/2005
PCT/GB/2006/001537
WO/2006/114629
322302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H04L
‫שיטה לבקרת גישה להתקן מרוחק‬
186761
METHOD FOR PRODUCING A CORE
MATERIAL REINFORCEMENT FOR
SANDWICH STRUCTURES AND SAID
SANDWICH STRUCTURES
EVONIK ROHM GMBH
DE
102005035681.8 27/07/2005
PCT/EP/2006/003110
WO/2007/012353
3/23/2133/
‫מוצרי תזונה מרוכבים‬
186762
B29C
‫שיטה לייצור ליבת חומר חיזוק למבני‬
'‫סנדוויץ' ומבני סנדוויץ‬
C01B
4636
A PROCESS FOR PRODUCING SILICA,
SODIUM SULFITE AND SODUIM
HYDROGEN SULFITE WITH SODUIM
SULFATE
DEGUSSA WELLINK SILLICA
(NANPING) CO. LTD
CN
200510200324.0 10/06/2005
PCT/CN/2006/001227
WO/2006/131065
132302133/
‫ נתרן גופריתי‬,‫תהליך להכנת סיליקה‬
‫ונתרן מימן גופריתי עם נתרן גופרתי‬
186763
SYSTEM AND METHOD FOR
INTERCEPTING CELLULAR
SATELLITE COMMUNICATION
ELTA SYSTEMS LTD.
IL
168150
20/04/2005
PCT/IL/2006/000491
WO/2006/111975
132302133/
1/2302133/
4637
‫שיטה ומערכת ליירוט תקשורת לווינים‬
‫סלולרית‬
‫אלתא מערכות בע"מ‬
186764
A SYSTEM AND METHOD FOR
PROCESSING SATELLITE
COMMUNICATION DATA
ELTA SYSTEMS LTD.
IL
168149
20/04/2005
PCT/IL/2006/000490
WO/2006/111974
H04B
H04B
‫שיטה ומערכת לעיבוד של נתוני תקשורת‬
‫לוויין‬
186765
‫אלתא מערכות בע"מ‬
C12P
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD AND BIOREACTOR FOR
PRODUCING SYNFUEL FROM
CARBONACEOUS MATERIAL
GEOSYNFUELS, LLC
US
11/100348
05/04/2005
PCT/US/2006/011622
WO/2006/107696
132302133/
186767
METHOD AND SYSTEM FOR
DETECTING BOMBS IN TRASH CANS
EISENMAN KALMAN ISHAK
IL
168181
21/04/2005
PCT/IL/2006/000485
WO/2006/111969
2/2232133/
‫שיטה וביוריאקטור לייצור דלק מחומר‬
‫פחמני‬
‫שיטה ומערכת לגילוי פצצות בפחי–אשפה‬
186768
186769
RELIGIOUS GARMENT WITH MEANS
FOR RESISTING THE ANGULAR
DISPLACEMENT OF THE STRANDS
THEREOF
MATITYAHU TENENBAUM
102322133/
FLUID DISCHARGE NOZZLE
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫קטוע אריה‬
A61B
‫מערכת וגלאי לזיהוי עצירת נשימה‬
‫בתינוקות‬
‫שקד רחמים‬
INFANT APNEA DETECTOR AND
SYSTEM
SHAKED RAHAMIM
2/2232133/
B65F
186770
A47D
‫פריט לבוש דתי עם אמצעי המתנגד‬
‫לתנועה סיבובית של הפתילים שלו‬
B67C
‫זרבובית לשחרור פלואידים‬
4638
EVERGREEN PACKAGING
INTERNATIONAL B.V.
US
11/109520
19/04/2005
PCT/US/2006/002614
WO/2006/112907
132302133/
186771
METHOD AND SYSTEM FOR
DETECTING AND MANAGING PEERTO-PEER TRAFFIC OVER A DATA
NETWORK
NETBARRAGE LTD
US
60/674375
22/04/2005
PCT/IL/2006/000486
WO/2006/111970
222322133/
P2P ‫שיטה ומערכת לזיהוי וניהול תעבורת‬
‫ברשת מידע‬
186772
GLP-1 PEGYLATED COMPOUNDS
ELI LILLY AND COMPANY
US
60/680688
13/05/2005
PCT/US/2006/018284
WO/2006/124529
2/2302133/
186773
A SIGHT FOR A HANDHELD
WEAPON
SCHULST MICHAEL HENRY
ZA
2005/03291 22/04/2005
PCT/IB/2006/000893
WO/2006/111813
302322133/
METHOD OF PEPTIDE SYNTHESIS
LONZA AG
4639
H04L
186774
‫נטבארג' בע"מ‬
A61K
‫ שעבר פגילציה‬GLP–1 ‫תרכובות‬
F41G
‫כוונת לנשק ידני‬
C07K
‫שיטה לסינטזת פפטיד‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
EP
05009758.3
485488041
US
PCT/EP/2006/004192
WO/2006/117227
04/05/2005
1058451884
132302133/
186775
TGF BETA 1 SPECIFIC ANTIBODIES
ELI LILLY AND COMPANY
US
60/674082
22/04/2005
PCT/US/2006/014943
WO/2006/116002
222322133/
PACKAGE FOR GOODS
NOVARTIS AG
EP
05010449.6
PCT/EP/2006/004431
WO/2006/119992
186776
C07K
0 ‫ בטא‬TGF –‫נוגדנים ספציפיים ל‬
B65D
‫אריזה לטובין‬
13/05/2005
102302133/
186777
(3,4-DIHYDRO-QUINAZOLIN-2-YL) (2-ARYLOXY-ETHYL) - AMINES
HAVING AN ACTIVITY ON THE 5 HT RECEPTOR
F. HOFFMANN-LA ROCHE AG
EP
05103744.8 04/05/2005
PCT/EP/2006/061779
WO/2006/117305
2/2302133/
186778
STABILIZED COMPOSITION
EISAI R&D MANAGEMENT CO, LTD.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07D
–/( – )‫–יל‬/–‫– דיהידרו–קווינזולינ‬: ,4(
‫ארילוקסי–אתיל) – אמינים בעלי פעילות‬
HT –5 ‫על הרצפטור‬
A61K
‫תרכובת יציבה‬
4640
2005130695
PCT/JP/2006/308065
WO/2006/118017
JP
28/04/2005
302322133/
186780
COMBINATION THERAPY IN THE
TREATMENT OF CANCER
DUKE UNIVERSITY
US
60/677482
04/05/2005
PCT/US/2006/016825
WO/2006/119285
302322133/
1/23/21331
CONTROLLED RELEASE
COMPOSITION AND METHOD OF
PRODUCING THE SAME
4641
‫שילוב בתרפיה בטיפול בסרטן‬
186781
ANTITUMORAL TETRAHYDROPYRIMIDINES
PHARMA MAR, S.A.
EP
05076037.0 03/05/2005
PCT/EP/2006/004117
WO/2006/117197
C07K
C07D
‫טטרההידרו פירימידינים בעלי פעילות נגד‬
‫גידולים‬
186782
A61K
‫הרכב שחרור מבוקר ותהליך ליצירתו‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2001JP
29/06/2001
199484
1881-448884 8451151881
JP
PCT/JP/2002/006527
WO/2003/002092
2/2232133/
186784
SYSTEMS AND METHODS FOR
PREPARING DRINKS
COFFEE AND JUICE GENERATION
LTD.
302302133/
‫מערכות ושיטות להכנת משקאות‬
‫קופי אנד ג'וס ג'נריישן בע"מ‬
186786
A COVERING FOR AN
ENDOPROSTHETIC DEVICE AND
METHODS OF USING FOR
ANEURYSM TREATMENT
MEDINOL LTD.
US
60/673304
19/04/2005
PCT/IB/2006/000471
WO/2006/111801
2/2232133/
FOLDABLE CRATE WITH
BIDIRECTIONAL MANUALLY
RELEASABLE LATCH MECHANISM
POLYMER LOGISTICS LTD.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A47J
A61F
‫מכסה להתקן תותב פנימי ושיטות שימוש‬
‫עבור טיפול במפרצת‬
‫מדינול בע"מ‬
186787
B65D
‫ארגז מתקפל עם מנגנון נעילה משתחרר‬
‫ידני בשני כיוונים‬
‫פולימר לוג'יסטיקס בע"מ‬
4642
2/2302133/
186788
NUTRITIONAL SUPPLEMENT FOR
HIV PATIENTS
N.V. NUTRICIA
US
60/673341
21/04/2005
8418414441
1158451884
EP
PCT/NL/2006/050091
WO/2006/112716
2/2302133/
186789
NUTRITIONAL SUPPLEMENT FOR A
CATEGORY OF HIV PATIENTS
N.V. NUTRICIA
US
60/673342
21/04/2005
8418414844
1158451884
EP
PCT/NL/2006/050092
WO/2006/112717
122322133/
186790
THROMBIN PURIFICATION
KING PHARMACEUTICALS
RESEARCH & DEVELOPMENT, INC.
US
11/140374
26/05/2005
115448440
1458451884
US
PCT/US/2006/020412
WO/2006/127990
122302133/
4643
186791
A23L
)HIV( ‫תוסף מזון לחולי איידס‬
A23L
‫תוסף מזון לאוכלוסיה של חולי תסמונת‬
‫הכשל החיסוני הנרכש‬
C12N
‫טיהור תרומבין‬
A01C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD OF EXTRACTING
CONTECTS FROM SEALED FLEXIBLE
CONTAINERS USING IRRIGATION
WATER, DEVICE FOR
IMPLEMENTING SAME AND
ASSOCIATED CONTAINER
MELCART PROJECTS, S.L.
ES
P200501014 26/04/2005
PCT/ES/2006/000203
WO/2006/114464
322322133/
186792
DELIVERY OF TIGECYCLINE IN THE
PRESENCE OF WARFARIN
WYETH
US
60/678204
06/05/2005
PCT/US/2006/016542
WO/2006/121666
322322133/
186793
PEPTIDE CONJUGATE
COMPOSITIONS AND METHODS FOR
THE PREVENTION AND TREATMENT
OF ALZHEIMER'S DISEASE
MERCK & CO., INC.
US
60/677886
05/05/2005
PCT/US/2006/016481
WO/2006/121656
132302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186794
‫שיטה לחילוץ תכולה ממיכלים גמישים‬
,‫אטומים באמצעות שימוש במי השקייה‬
‫התקן ליישום השיטה ומיכל שייך‬
A61K
‫מתן טיגציקלין בנוכחות וורפארין‬
A61K
‫תרכובות תצמידי חלבון ושיטות למניעה‬
‫ולטיפול במחלת אלצהיימר‬
G06K
4644
SYSTEM AND METHOD FOR
PRODUCING AN AUGMENTED
IMAGE OF AN ORGAN OF PATIENT
VISIONSENSE LTD.
US
60/673257
20/04/2005
PCT/IL/2006/000474
WO/2006/111965
2/2302133/
‫מערכת ושיטה ליצירת תמונה מוגברת של‬
‫איבר של מטופל‬
186795
THE PLANTING OF PLANT
MATERIAL
PRECISION DRIP B.V.
NL
1028815
19/04/2005
PCT/NL/2006/000203
WO/2006/112700
2/2302133/
186796
GREENHOUSE PANELS
DOW GLOBAL TECHNOLOGIES INC.
US
60/681106
13/05/2005
PCT/US/2006/014598
WO/2006/124179
1/2302133/
186798
‫ויז'נסנס בע"מ‬
A01G
‫שתילה של חומר צימחי‬
A01G
‫פנלים לחממות‬
A61B
‫ לשימוש בדימות תהודה‬.‫ג‬.‫ק‬.‫כבל א‬
‫מגנטית‬
ECG CABLE FOR USE IN MRI
IVY BIOMEDICAL SYSTEMS, INC.
US
60/675951
28/04/2005
PCT/US/2006/016231
WO/2006/116677
232302133/
4645
186799
F01K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
LNG-BASED POWER AND
REGASIFICATION SYSTEM
ORMAT TECHNOLOGIES INC.
US
11/110935
21/04/2005
PCT/IL/2006/000450
WO/2006/111957
122302133/
186800
LIQUID DETERGENT COMPOSITION
COLGATE-PALMOLIVE COMPANY
US
60/673685
21/04/2005
PCT/US/2006/015108
WO/2006/116099
2/2232133/
186801
BEVERAGE AND FOOD WARMING
DEVICE AND KIT
ROMEO GOLDHAMER
2023/2133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C11D
‫תכשיר דטרגנט נוזלי‬
A47J
‫התקן לחימום משקה ומזון וערכה‬
‫רומאו גולדהמר‬
186802
OXYNTOMODULIN ANALOGUES
AND COMPOSITIONS CONTAINING
THE SAME
IMPERIAL INNOVATIONS LIMITED
GB
0511986.2
13/06/2005
841180040
1458451884
GB
841188844
1458451884
GB
841188044
1458451884
GB
848144448
8058151884
GB
PCT/GB/2006/002155
WO/2006/134340
3/2322133/
‫מערכת כח וגזיפיקציה המבוססת על‬
LNG
186803
C07K
‫אנלוגים של אוקסינטומודיולין ותכשירים‬
‫המכילים אותם‬
C07C
4646
PROCESSES FOR PREPARING
BIARYL UREA DERIVATIVES AND
ANALOGS THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/679022
09/05/2005
PCT/US/2006/017817
WO/2006/122072
102302133/
186805
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN ACTIVE VITAMIN
D COMPOUND
NOVACEA, INC.
US
60/673812
22/04/2005
485411144
1058851884
US
PCT/US/2006/015281
WO/2006/116204
122232133/
4647
A43B
‫מערכת לעיגון סנדלים על רגלו של הנועל‬
186807
STICKING DEDICATION CARD
SHMAIA REFAEL
US
60/673703
21/04/2005
PCT/IL/2006/000496
WO/2006/111978
2/2302133/
C07C
‫תכשירי רוקחות המכילים תרכובת ויטמין‬
‫ פעילה‬D
186806
A SYSTEM FOR SECURING SANDALS
ONTO ONE'S FOOT
YARON BEN-EZRI
102302133/
‫תהליכים להכנת תולדות ביאריל שתנן‬
‫ואנולוגים שלהן‬
186808
‫עזרי‬-‫ירון בן‬
B42D
‫כרטיס הקדשה להדבקה‬
‫רפאל שמעיה‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
TOPIRAMATE COMPOSITIONS FOR
TREATMENT OF HEADACHE
CURT HENDRIX
US
60/673099
19/04/2005
485444184
1158451884
US
115484844
1058451884
US
PCT/US/2006/014846
WO/2006/113853
1/2302133/
‫הרכבי טופירמט לטיפול בכאב ראש‬
186809
SOLID FORMS OF 1-(5-(IH-I,2,4TRIAZOL-5-YL)(1H-INDAZOL-3-YL))3-(2-PIPERIDYLETHOXY)BENZENE
C07D
–I–IH,4,2(–.(–0 ‫צורות מוצקות של‬
–:–))‫–איל‬:–‫–אינדזול‬H0( )‫–איל‬.–‫טריאזול‬
‫–פיפרידילאתוקסי)בנזן‬/(
CELGENE CORPORATION
US
60/676693
29/04/2005
PCT/US/2006/017057
WO/2006/130297
122302133/
186810
SYSTEM AND METHOD FOR
INTELLIGENT CURRENCY
VALIDATION
THEODORE G. PARASKEVAKOS
US
60/673374
21/04/2005
PCT/US/2006/014998
WO/2006/116029
2/2212133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186811
G06K
‫מערכת ושיטה לוולידציה נבונה של כסף‬
A23L
4648
NUTRITIONAL SUPPLEMENT WITH
COLOSTRUM AND EPA OR DHA OR
GLA
N.V. NUTRICIA
EP
05103257.1 21/04/2005
PCT/NL/2005/050082
WO/2006/112694
132302133/
‫ או‬DHA ‫ או‬EPA ‫תוסף מזון עם קולוסטרום‬
GLA
186812
‫מכשיר ושיטות לטיפול ברקמות בעזרת‬
‫זרם ישיר‬
DC TISSUE TREATMENT
ECPOINT MEDICAL INC.
US
60/673781
485444448
US
PCT/IL/2006/000484
WO/2006/111968
132302133/
22/04/2005
4158151884
186813
HYBRID JET/ELECTRIC VTOL
AIRCRAFT
YOUNGREN, HAROLD
US
60/673166
20/04/2005
485484488
4858451884
US
PCT/US/2006/014902
WO/2006/113877
132302133/
4649
A61N
186814
B64C
‫כלי טיס להמראה ונחיתה אנכיים בעל‬
‫חשמלית‬/‫הנעה משולבת סילונית‬
C12N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHODS, COMPOSITIONS AND
ARTICLES OF MANUFACTURE FOR
ENHANCING SURVIVABILITY OF
CELLS, TISSUES, ORGANS AND
ORGANISMS
FRED HUTCHINSON CANCER
RESEARCH CENTER
US
60/673037
20/04/2005
485444184
1858451884
US
485414844
4158051884
US
485441448
1051851884
US
485441441
1458151884
US
PCT/US/2006/015158
WO/2006/113914
2/2322133/
‫ תכשירים ומוצרים לשיפור יכולת‬,‫שיטות‬
‫ רקמות איברים‬,‫ההישרדות של תאים‬
‫ואורגניזמים‬
186815
–:–‫ טטרה–חלופיות‬,–‫תולדות טרי‬
‫אמינופיררולידין‬
TRI- OR TETRA-SUBSTITUTED-3AMINOPYRROLIDINE DERIVATIVES
DAIICHI SANKYO COMPANY,
LIMITED
2005JP
19/05/2005
146386
1884-444414 1851151884
JP
1884-808418 1458451884
JP
PCT/JP/2006/310069
WO/2006/123792
122232133/
186816
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G08B
‫מתקן אזעקה אופטואלקטרוני לעשן‬
‫שריפה‬
FIRE SMOKE OPTOELECTRONIC
ALARM DEVICE
OVCHINNIKOV VALERY
VASILIEVICH
RU
2007122290 15/06/2007
122232133/
C07D
186817
H04L
4650
METHOD FOR TRANSMITTING
SIGNALS
(VARIANTS)
OVCHINNIKOV VALERY VASILIEVICH
RU
RU2007125262 04/07/2007
122232133/
)‫שיטה עבור שידור אותות (משתנים‬
186818
METHOD FOR GENERATING SIGNALS
IN CONTROL UNIT
OVCHINNIKOV VALERY VASILIEVICH
RU
RU2007130365 08/08/2007
112322133/
4651
‫שיטה עבור יצירת אותות ביחידת בקרה‬
186819
MICROWAVE PLATFORM FOR
GENERATING MARKS ON FOOD
PRODUCTS AND METHOD FOR
USING SAME
NESTEC S.A.
US
11/146833
06/06/2005
PCT/EP/2006/062480
WO/2006/131441
H04B
H05B
‫מצע של מיקרוגל עבור יצירת סימנים על‬
‫מוצרי מזון ושיטה לשימוש הנ"ל‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2/2302133/
186820
INHIBITORS OF MICROSOMAL
TRIGLYCERIDE TRANSFER PROTEIN
AND APO-B SECRETION
SURFACE LOGIX, INC.
US
60/672778
19/04/2005
485444488
4851151884
US
PCT/US/2006/015146
WO/2006/113910
122232133/
186821
APPARATUS AND METHOD FOR
GENERATING A CLOCK SIGNAL
MARVELL SEMICONDUCTOR
ISRAEL LTD
US
60/862264
20/10/2006
485044400
8451151884
US
485040014
8451151884
US
122302133/
186822
ELECTROMAGNETIC TREATMENT
DEVICE
KSM, INC.
US
60/673398
21/04/2005
PCT/US/2006/015551
WO/2006/116354
122302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186823
C07C
‫מעכבים של חלבון העברה טריגלצריד‬
B–APO ‫מיקרוזומלי והפרשת‬
G06F
‫מתקנים ושיטה ליצירת שעון‬
‫מרבל סמיקונדקטור ישראל בע"מ‬
A61N
‫התקן טיפול אלקטרומגנטי‬
G06F
4652
METHODS AND APPARATUS FOR
DETERMINING ASPECTS OF
MULTIMEDIA PERFORMANCE OF A
WIRELESS DEVICE
QUALCOMM INCORPORATED
US
60/674108
21/04/2005
PCT/US/2006/015137
WO/2006/116120
1/2302133/
‫שיטות והתקנים לשם קביעת אספקטים‬
‫של ביצוע מולטימדיה של מכשיר אלחוטי‬
186824
APPARATUS AND METHODS FOR
THE DESTRUCTION OF ADIPOSE
TISSUE
LIPOSONIX, INC.
US
60/676197
29/04/2005
PCT/US/2006/016073
WO/2006/118960
122302133/
186825
METHODS AND APPARATUS FOR
PROVIDING WIRELESS DEVICECENTRIC CONTROL OF AN
EXTERNAL COMPUTING DEVICE
QUALCOMM INCORPORATED
US
60/763867
21/04/2005
PCT/US/2006/014994
WO/2006/116026
112232133/
4653
186826
A61F
‫התקן ושיטות להרס רקמת שומן‬
H04Q
‫שיטות והתקנים לשם הספקת שליטה‬
‫מרכזית למכשיר אלחוטי של מכשיר‬
‫חישוב חיצוני‬
H02N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
AUTONOMOUS ELECTROMAGNETIC
GENERATOR
KHMELNIK SOLOMON
322322133/
‫גנרטור אלקטרומגנטי אטונומי‬
‫חמלניק סולומון‬
186827
METHOD AND APPARATUS FOR
TRANSMITTING MANAGEMENT
INFORMATION IN A WIRELESS
COMMUNICATION SYSTEM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/678643
06/05/2005
115414014
8458451884
US
PCT/US/2006/017447
WO/2006/121879
232322133/
‫שיטה ומכשיר לשידור מידע ניהולי‬
‫במערכת תקשורת אלחוטית‬
186828
186829
METHOD FOR PRODUCTION OF 1ALKYL- 3 - PHENYLURACILS
BASF AKTIENGESELLSCHAFT
DE
102005024448.3 24/05/2005
PCT/EP/2006/062414
WO/2006/125746
312322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C12N
‫תכשיר חיסון‬
VACCINE COMPOSITION
GLAXO GROUP LIMITED
US
60/680389
12/05/2005
PCT/EP/2006/004854
WO/2006/120034
2/2322133/
H04L
186831
C07D
– : – ‫ – אלקיל‬0 ‫שיטה לייצור‬
‫פנילאורצילים‬
C07D
4654
4-PHENYL- 5-OXO - 1,4,5,6,7,8 HEXAHYDROQUINOLINE
DERIVATIVES AS MEDICAMENTS
FOR THE TREATMENT OF
INFERTILITY
N.V. ORGANON
EP
05103741.4 04/05/2005
PCT/EP/2006/061978
WO/2006/117371
3/2322133/
0,7,9,.,4,0 – ‫ – אוקסו‬. – ‫ – פניל‬4 ‫תולדות‬
‫– הקסאהידרוקווינולין כתרופות לטיפול‬
‫בעקרות‬
186832
PROCESS FOR THE PREPARATION
OF A CARBOXAMIDE DERIVATIVES
BAYER CROPSCIENCE S.A.
EP
05356080.1 13/05/2005
PCT/EP/2006/004566
WO/2006/120031
3/23/2133/
‫תהליך להכנת נגזרות של קרבוקסאמיד‬
186833
A PROCESS FOR PRODUCING SILICA
AND SODIUM SULFITE WITH SODIUM
SULFATE
DEGUSSA WELLINK SILLICA
(NANPING) CO. LTD
CN
200510200315.1 08/06/2005
PCT/CN/2006/001228
WO/2006/131066
132302133/
4655
C07D
186834
C01B
‫שיטה לייצור סיליקה ונתרן גופריתי עם‬
‫נתרן גופרתי‬
G01S
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD AND SYSTEM FOR
CALIBRATION OF A RADIO
DIRECTION FINDER
ELTA SYSTEMS LTD.
US
11/113129
25/04/2005
PCT/IL/2006/000480
WO/2006/114784
122302133/
186835
BENZODIOXANE AND
BENZODIOXOLANE DERIVATIVES
AND USES THEREOF
WYETH
US
60/673884
22/04/2005
PCT/US/2006/015201
WO/2006/116158
132302133/
186836
HYBRID ORTHOGONAL FREQUENCY
DIVISION MULTIPLE ACCESS
SYSTEM AND METHOD
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/673872
22/04/2005
115484040
1858451884
US
PCT/US/2006/014947
WO/2006/116003
122302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186837
‫מערכת ושיטה לכיול של מוצא כיוון רדיו‬
‫אלתא מערכות בע"מ‬
C07D
‫תולדות בנזודיאוקסן ובנזודיאוקסולאן‬
‫ושימושיהן‬
H04B
‫מערכת ושיטה רבת כניסות לחלוקת‬
‫תדירות מעורבת אורתוגונלית‬
C07D
4656
CHROMANE AND CHROMENE
DERIVATIVES AND USES THEREOF
WYETH
US
60/673820
22/04/2005
PCT/US/2006/015208
WO/2006/116165
112232133/
186838
186839
CUTTING TOOL WITH
PROTRUSIONS, AND METHODS OF
USE THEREOF
NO SCREW LTD
122302133/
4657
B23B
‫אלמנט חיתוך בעל בליטות ושיטות‬
‫לשימוש בו‬
‫בלי בורג בע"מ‬
186840
PHOTODETECTION UNIT,
PHOTODETECTOR, AND X-RAY
COMPUTED TOMOGRAPHY
APPARATUS
HAMAMATSU PHOTONICS K.K.
2005JP
22/04/2005
125408
PCT/JP/2006/308425
WO/2006/115204
1123021332
B01F
‫מתקן אוורור‬
‫ מגן טכנולוגיות בע"מ‬.‫ח‬.‫ש‬
AERATION DEVICE
S.H. MAGEN TECHNOLOGIES LTD
112232133/
‫תולדות כרומאן וכרומן ושימושים בהן‬
186841
A61B
‫ ומכשור‬,‫ חיישן אור‬,‫יחידה לחישת אור‬
‫לטומוגרפיה מחושבת רנטגן‬
F24C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫תנור בעל זרימת אויר חם אחידה בחלל‬
‫הפעיל‬
OVEN HAVING A UNIFORM HOT AIR
FLOW IN THE PREPARATION SPACE
KONINKLIJKE FABRIEK INVENTUM
B.V
PCT/NL/2005/000303
WO/2006/112692
122302133/
186842
‫מנוע ומשאבה לנוזל‬
FLUID PUMP AND MOTOR UNIT
PEARSON, COLIN, ALFRED
GB
0508229.2
23/04/2005
PCT/GB/2006/001484
WO/2006/114591
122302133/
186843
APPARATUS FOR MANUFACTURING
STERILIZED WATER, AND
PORTABLE APPARATUS FOR
MANUFACTURING STERILIZE SALT
SOLUTION
DOLKI KOREA LTD.
10-2005KR
26/04/2005
0034697
18-18841858451884
KR
8844104
B01D
C02F
‫מכשיר להפקת מים סטריליים ומכשיר נייד‬
‫להפקת תמיסת מלח סטרילית‬
PCT/KR/2006/001560
WO/2006/115370
1/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186844
B65H
4658
CORELESS ROLL OF WEB MATERIAL,
MACHINE AND METHOD FOR ITS
PRODUCTION
FABIO PERINI S.P.A.
IT
FI2005A00086 02/05/2005
PCT/IT/2006/000288
WO/2006/117821
212322133/
186845
PYRAZOLYLAMINOPYRIMIDINE
DERIVATIVES USEFUL AS TYROSINE
KINASE INHIBITORS
ASTRAZENECA AB
US
60/681515
16/05/2005
485411101
4858851884
US
PCT/GB/2006/001760
WO/2006/123113
112322133/
186846
A PROCESS FOR THE DYNAMIC
RESOLUTION OF SUBSTITUTED (R)OR (S)-MANDELIC ACID
ASTRAZENECA AB
GB
0510546.5
24/05/2005
PCT/GB/2006/001861
WO/2006/125964
2123/2133/
4659
186847
‫ מכונה‬,‫גליל של חומר ארג ללא ליבה‬
‫ושיטת יצור‬
C07D
‫נגזרות פיראזולילאמינופירימידין‬
‫המשמשות כמעכבי טירוזין קינאז‬
C07C
‫תהליך להפרדה דינמית של חומצה‬
))S ‫) או‬R( ‫מנדלית מותמרת‬
C07C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PROCESS FOR PREPARING
TETRAFLUOROBENZENE
CARBALDEHYDE ALKYL ACETAL
SHOWA DENKO K.K.
2005JP
22/06/2005
181973
PCT/JP/2006/312187
WO/2006/137347
102302133/
‫שיטה להכנת טטראפלואורובנזן‬
‫קרבאלדהיד אלקיל אצטל‬
186848
APPARATUS AND METHOD FOR INLINE READING AND CONTROL OF
WARP THREADS IN A LOOM
GIRONI SYSTEM S.R.L.
IT
FI2005A000080
PCT/IB/2006/001211
WO/2006/117673
D03D
‫מתקנים ושיטה לקריאת שורה ברצף‬
‫ושליטה בשרשרת מאמרים מפותלת‬
‫המופיעה באופן לא ברור‬
29/04/2005
2/2322133/
186851
STYRYLSULFONAMIDES, THEIR
MANUFACTURE AND USE AS
PHARMACEUTICAL AGENTS
F. HOFFMANN-LA ROCHE AG
EP
05010982.6 20/05/2005
8488188441
1058151884
EP
PCT/EP/2006/004756
WO/2007/054139
3/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186852
C07C
‫ ייצורם ושימושם‬,‫סטירילסולפונאמידים‬
‫כחומרים פרמקולוגיים‬
C07C
4660
BENZOIC ACID DERIVATIVES THAT
ARE MODULATORS OR AGONISTS
OF GLYR
ASTRAZENECA AB
SE
0501058-2
09/05/2005
PCT/SE/2006/000547
WO/2006/121390
102232133/
186853
186854
UREA DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
PROSKELIA-SAS
FR
0504360
29/04/2005
PCT/EP/2006/004166
WO/2006/117211
202302133/
186855
IDENTITY DOCUMENT AND
METHOD FOR THE MANUFACTURE
THEREOF
SDU IDENTIFICATION B.V.
NL
1028776
14/04/2005
PCT/NL/2006/050085
WO/2006/110038
3123/2133/
4661
G06K
‫מערכת טביעת אצבע‬
‫שלמה מאיר עזריאל‬
FINGERPRINT SYSTEM
SHLOMI AZRIEL
102302133/
‫תולדות חומצה בנזואית שהן מודולטורים‬
GLYR ‫או אגוניסטים של‬
186857
C07D
‫תולדות שתנן ותכשירי רוקחות המכילים‬
‫אותן‬
B42D
‫תעודת זהות ותהליך לייצורה‬
C07K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
POLYPEPTIDES HAVING
ANTIMICROBIAL ACTIVITY AND
POLYNUCLEOTIDES ENCODING
SAME
NOVOZYMES A/S
PA 2005
DK
06/06/2005
00823
PA 2005
1451851884
DK
01435
PCT/EP/2006/062884
WO/2006/131504
1123/2133/
186858
LARGE MESH DEFORMATION USING
THE VOLUMETRIC GRAPH
LAPLACIAN
MICROSOFT CORPORATION
US
11/158428
22/06/2005
PCT/US/2006/024562
WO/2007/002453
222322133/
–‫פוליפפטידים בעלי פעילות אנטי‬
‫מיקרוביאלית ופולינוקליאוטידים המקודדים‬
‫אותם‬
‫דפורמצית רשת גדולה המשתמשת בגרף‬
‫ולומטרי לאפלסיאני‬
186859
FAST DRYING GYPSUM PRODUCTS
UNITED STATES GYPSUM COMPANY
US
11/152661
14/06/2005
PCT/US/2006/018123
WO/2006/137997
302322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06G
186860
C04B
‫מוצרי גבס המתייבשים במהירות‬
G06K
4662
RATE CONTROL OF SCALABLY
CODED IMAGES
DTS (BVI) AZ RESEARCH LIMITED
US
11/131709
18/05/2005
PCT/US/2006/017081
WO/2006/124304
132302133/
186861
METHOD AND APPARATUS FOR
RECORDING A DIGITAL
INFORMATION SIGNAL
KONINKLIJKE PHILIPS
ELECTRONICS N.V.
EP
05103368.6 26/04/2005
8418441444
8858051884
EP
PCT/IB/2006/051216
WO/2006/114729
222322133/
186862
NOVEL PHENYL-PYRIDINYLPIPERAZINE DERIVATIVES, A
METHOD FOR THE PRODUCTION
THEREOF AND PHARMACEUTICAL
COMPOSITIONS CONTAINING SAID
DERIVATIVES
LES LABORATOIRES SERVIER
FR
0504758
12/05/2005
PCT/FR/2006/001050
WO/2006/120349
132302133/
4663
186863
‫בקרת קצב של דמויות המקודדות באופן‬
‫מדורג‬
G11B
‫שיטה ומערכת להקלטת סיגנל מידע‬
‫דיגיטלי‬
C07D
‫תולדות פניל–פרידיניל–פיפראזיניות‬
‫ שיטה לייצורן ותכשירי רוקחות‬, ‫חדשות‬
‫המכילים אותן‬
C12N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SELECTING, CULTURING AND
CREATING LINEAGE COMMITTED
HEMATOPOIETIC STEM CELLS
AUSTRALIAN STEM CELL CENTRE
LIMITED
US
60/678047
04/05/2005
PCT/AU/2006/000529
WO/2006/116793
102232133/
‫ תרבות ויצירה של שושלת תאי גזע‬,‫בחירה‬
‫מחוייבים למערכת הדם‬
186864
‫משחק לוח כדורגל‬
‫ניוגרופ בע"מ‬
SOCCER BOARD GAME
NEWGROUP LTD
102322133/
186865
HETEROARYL BENZAMIDE
DERIVATIVES FOR USE AS GLK
ACTIVATORS IN THE TREATMENT
OF DIABETES
ASTRAZENECA AB
GB
0510852.7
27/05/2005
841414444
8858451884
GB
841418444
8858051884
GB
841404144
1451151884
GB
PCT/GB/2006/001887
WO/2006/125972
322322133/
SUBSTITUTED BUTYROPHENONE
DERIVATIVES
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A63F
186866
C07D
‫נגזרות בנזאמיד הטרואריל לשימוש‬
‫ בטיפול בסוכרת‬GLK ‫כמפעילי‬
C07D
‫ מותמרות‬BUTYROPHENONE ‫נגזרות‬
4664
CLERA INC.
US
60/675881
PCT/CA/2006/000672
WO/2006/116848
1/2302133/
29/04/2005
186867
PHARMACEUTICAL DOSAGE FORMS
COMPRISING A LIPID PHASE
GALENICA TECHNOLOGY AB
SE
0500966-7
28/04/2005
PCT/SE/2006/050102
WO/2006/115463
102302133/
‫תצורות מינון פרמצבטיות הכוללות פאזה‬
‫ליפידות‬
186868
ANTENNA ARRAY CALIBRATION
FOR WIRELESS COMMUNICATION
SYSTEMS
QUALCOMM INCORPORATED
US
60/674190
22/04/2005
485481440
1458451884
US
485444818
8151151884
US
PCT/US/2006/015726
WO/2006/116453
312322133/
4665
A61K
186869
H04B
‫כיול מערך אנטנות עבור מערכות‬
‫תקשורת אלחוטית‬
A61L
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
APPARATUS AND METHOD FOR
PURIFICATION AND DISINFECTION
OF LIQUID, SOLID OR GASEOUS
SUBSTANCES
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
EP
05447095.0 29/04/2005
8484448441
4151851884
EP
PCT/BE/2006/000043
WO/2006/116828
102232133/
‫מכשיר ושיטה לטהור וחיטוי של חמרים‬
‫ מוצקים וגזיים‬,‫נוזליים‬
186870
‫זרבובית שמוסיפה טעם‬
A FLAVORING SPOUT
T.O.D. TASTE ON DEMAND INC.
1/2302133/
186872
MULTIPLE - RNAi EXPRESSION
CASSETTES FOR SIMULTANEOUS
DELIVERY OF RNAi AGENTS
RELATED TO HETEROZYGOTIC
EXPRESSION PATTERNS
BENITEC. LTD
US
60/676206
28/04/2005
PCT/US/2006/016507
WO/2006/116756
102232133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A47J
C07H
‫ להעברה בו זמנית‬RNAi ‫מערך ביטוי רב‬
‫ הקשורים לתבניות ביטוי‬RANi ‫של גורמי‬
‫הטרוזיגוטינות‬
186873
A61K
4666
MARKER AND THERAPEUTIC
TARGET FOR ALZHEIMER'S DISEASE
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
102232133/
‫סמן ומטרה תרפוטית למחלת האלצהיימר‬
186874
AN ADAPTIVE TRACK MECHANISM
YEFIM KERETH
1223021332
186875
GAS TURBINE ENGINE COOLING
SYSTEM AND METHOD
WILLIAMS INTERNATIONAL CO.,
L.L.C.
‫ידע חברה למחקר ופיתוח בע"מ‬
B61K
‫מנגנון מסילה הניתן להתאמה‬
‫יפים קרת‬
F02C
‫מערכת ושיטה לקירור מנוע טורבינת גז‬
PCT/US/2005/013950
WO/2006/115484
1223021332
186876
PROCESS OF ENCRYPTION AND
OPERATIONAL CONTROL OF
TAGGED DATA ELEMENTS
TECSEC, INCORPORATED
H04L
‫שיטה להצפנה ולבקרה תפעולית של‬
‫יחידות נתונים בעלות תג‬
PCT/US/2005/014282
WO/2006/115491
102232133/
4667
186877
H05F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
WEARABLE ARTICLE WITH BAND
PORTION ADAPTED TO INCLUDE
TEXTILE-BASED ELECTRODES AND
METHOD OF MAKING SUCH
ARTICLE
TEXTRONICS INC.
US
11/553680
27/10/2006
102232133/
186878
METHOD AND APPARATUS FOR
ENABLING COMMUNICATIONS
BETWEEN USERS
T-JAT SYSTEMS 2006 LTD.,
212322133/
‫מוצר הניתן ללבישה עם חלק רצועה‬
– ‫המותאם להכיל אלקטרודות מבוססות‬
‫אריג ושיטה ליצור מוצר כזה‬
‫שיטה ומכשיר המיועדים לאפשר תקשורת‬
‫בין משתמשים‬
‫ בע"מ‬/119 ‫ג'את מערכות‬-‫טי‬
186879
MATERIALS AND METHODS FOR
REGULATING BLOOD FLOW
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.
US
60/680217
12/05/2005
PCT/US/2006/018808
WO/2006/124820
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06F
186880
C12N
‫חומרים ושיטות להסדרת זרימת דם‬
C07K
4668
–‫פוליפפטידים שהתפתחו מאינטרפרון‬
‫אלפא‬
EVOLVED INTERFERON ALPHA
POLYPEPTIDES
MAXYGEN, INC.
US
60/682769
18/05/2005
PCT/US/2006/019088
WO/2007/044083
212322133/
186881
PYRIDO [2, 3 - D] PYRIMIDINES
USEFUL AS HCV INHIBITORS, AND
METHODS FOR THE PREPARATION
THEREOF
TIBOTEC PHARMACEUTICALS LTD.
US
60/680405
12/05/2005
8418411448
8458451884
EP
8484404444
8458451884
EP
PCT/EP/2006/062290
WO/2006/120252
312322133/
‫] פירימידינים שימושיים‬D – : ,/[ ‫פירידו‬
‫ ושיטות להכנתם‬,HCV ‫כמעכבי‬
186882
DEVICE FOR CHANGING BRIDGES,
SIDE ARMS AND BROWBARS OF
RIMLESS SPECTACLES, AND FOR
CHANGING BRIDGES AND SIDE ARMS
OF METALLIC AND PLASTIC
SPECTACLE FRAMES
MICHAEL STRENZ
DE
102005020738.3 04/05/2005
18188481414848
8058451884
DE
PCT/DE/2006/000765
WO/2006/116988
102322133/
4669
C07D
186883
G02C
‫ זרועות צד וחלק‬,‫התקן לשינוי גשרים‬
,‫קדמי של משקפים ללא מסגרת‬
‫ולשינוי גשרים וזרועות צד של מסגרות‬
‫משקפים העשויות מפלסטיק וממתכת‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
BENZIMIDAZOLE-CARBOXAMIDE
COMPOUNDS AS 5-HT4 RECEPTOR
AGONISTS
THERAVANCE, INC.
US
60/684466
25/05/2005
485404440
1458451884
US
485440414
8051151884
US
PCT/US/2006/020085
WO/2006/127815
1/2302133/
186885
SYSTEMS AND METHODS FOR
MANAGING A HIERARCHICAL
STRUCTURE
SPRINGBOARD RETAIL NETWORKS
LICENSING SRL
US
60/675843
29/04/2005
PCT/IB/2006/001062
WO/2006/117626
1/2302133/
186886
ELECTRONIC SHOPPING CART
HANDLE
SPRINGBOARD RETAIL NETWORKS
LICENSING SRL
US
60/675849
29/04/2005
PCT/IB/2006/001063
WO/2006/117627
1/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186888
‫תרכובות בנזאמידאזול–קרבוקסאמיד‬
HT–54 ‫כאגוניסטים לקולטנים של‬
G06F
‫מערכות ושיטות לניהול מבנה הירארכי‬
B62B
‫ידית של עגלת קניות‬
G06F
4670
SYSTEMS AND METHODS FOR
MANAGING AND DISPLAYING
DYNAMIC AND STATIC CONTENT
SPRINGBOARD RETAIL NETWORKS
LICENSING SRL
US
60/675843
29/04/2005
PCT/IB/2006/001070
WO/2006/117632
1/2302133/
186889
PORTABLE INFORMATION
TERMINAL MOUNTABLE ON
SHOPPING CART AND REMOVABLE
MEMORY DEVICE USABLE WITH
SAME
SPRINGBOARD RETAIL NETWORKS
LICENSING SRL
US
60/675849
29/04/2005
PCT/IB/2006/001072
WO/2006/117633
1/2302133/
‫מערכות ושיטות לניהול והצגה של תוכן‬
‫דינאמי וסטטי‬
‫מסוף נתונים נייד הניתן להרכבה על עגלת‬
‫קניות והתקן זיכרון נשלף לשימוש בו‬
186891
COMMUNICATING INFORMATION
WITH A PERSONAL SHOPPING
DEVICE
SPRINGBOARD RETAIL NETWORKS
LICENSING SRL
US
60/675843
29/04/2005
PCT/IB/2006/001076
WO/2006/117636
1/2302133/
4671
B62B
186893
G06F
‫העברת מידע להתקן קניות אישי‬
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
VIRTUAL MEDIA SYSTEMS,
METHODS AND DEVICES
AVOCENT CORPORATION
US
60/675842
29/04/2005
115418804
1458451884
US
PCT/US/2006/015909
WO/2006/118921
1/2302133/
‫ שיטות והתקנים‬,‫מערכות מדיה וירטואלית‬
186894
SURGICAL TOURNIQUET
APPARATUS FOR MEASURING LIMB
OCCLUSION PRESSURE
WESTERN CLINICAL ENGINEERING
LTD
US
11/122600
05/05/2005
PCT/CA/2006/000474
WO/2006/116837
1/2302133/
2/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫התקן חוסמת עורקים למדידת לחץ‬
‫סתימה באבר‬
186895
METHODS FOR TREATING EYE
CONDITIONS
BIOLASE TECHNOLOGY, INC.
US
60/675162
26/04/2005
485404881
8458451884
US
485484804
1458451884
US
485488444
1858051884
US
485444814
1158151884
US
PCT/US/2006/016066
WO/2006/116621
A61B
A61B
‫שיטות לטיפול במצבים הקשורים לעיניים‬
186896
B01F
4672
APPARATUS FOR CONTINUOUS
BLENDING
HARSCO CORPORATION
US
11/113492
25/04/2005
PCT/US/2006/014586
WO/2006/115910
322322133/
186897
TRANSFER SYSTEM AND TRANSFER
DEVICE
STERIS INC.
US
60/678319
06/05/2005
PCT/US/2006/017572
WO/2006/121947
1/23021332
186898
PHARMA-INFORMATICS SYSTEM
PROTEUS BIOMEDICAL, INC
US
60/676145
28/04/2005
485484840
1458451884
US
485414408
8158851884
US
485488444
8458451884
US
PCT/US/2006/016370
WO/2006/116718
102302133/
4673
186900
‫התקן עבור ערבוב מתמשך‬
A47B
‫מערכת העברה ומכשיר העברה‬
G06F
‫מערכת פארמה–אינפורמטיקה‬
F16L
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
AIR INVERSION AND STEAM CURE
OF CURED IN PLACE LINERS
APPARATUS AND METHOD
INA ACQUISITION CORP.
US
60/674420
25/04/2005
485488441
1858451884
US
115411114
1458451884
US
PCT/US/2006/015404
WO/2006/116266
122302133/
186901
WOOD-ROTTING BASIDIOMYCETES
FOR PRODUCTION OF
LIGNINOLYTIC ENZYMES
MYCOENZYME LTD.
US
60/675017
26/04/2005
PCT/IL/2006/000502
WO/2006/114787
102232133/
‫מערכת ושיטה להקשייה בקיטור של‬
‫ציפויים פנימיים‬
WOOD–ROTTING BASIDIOMYCETES
‫להפקה של אנזימים ליגינוליטיים‬
186902
THE TECHNIQUE OF OVERCOMING
THE RECEIVER'S SENSITIVITY
THRESHOLD AND IMPROVING ITS
PROTECTION FROM EXTERNAL
INTERFERENCES
BUNIN GENNADI
122232133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C12N
186903
‫מיקו אנזים‬
G08B
‫טכניקת התגברות על סף הרגישות של‬
‫המקלט ושיפור הגנתו בפני הפרעות‬
‫חיצוניות‬
‫גנאדי בונין‬
G09F
4674
‫תיק–כרית לפרסום‬
ADVERTISING CUSHION-BAG
BARUCH NAEH-CREATIVE
BRANDING LTD.
‫ברוך נאה קריאטיב ברנדינג בע" מ‬
202302133/
186904
NOVEL COMPOUNDS FOR TREATING
INFLAMMATORY DISEASES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102005019718.3 28/04/2005
18188481418440
1858451884
DE
18188484444444
1858451884
DE
PCT/EP/2006/061586
WO/2006/114371
122232133/
186905
4675
‫תרכובות חדשות לטיפול במחלות‬
‫דלקתיות‬
F17C
‫מערכת הכלה עבור דליפת גזים‬
‫ריאקטיביים‬
LEAK CONTAINMENT APPARATUS
FOR REACTIVE GASES
AIR PRODUCTS AND CHEMICALS,
INC.
US
11/590029
31/10/2006
222302133/
C07D
186906
A01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫צירופים של חומרים פעילים קוטלי‬
‫חרקים‬
COMBINATIONS OF PESTICIDAL
ACTIVE SUBSTANCE
BAYER CROPSCIENCE AG
DE
102005019713.2 28/04/2005
18188481114444
1458451884
DE
PCT/EP/2006/003487
WO/2006/114212
222302133/
186907
4-(PYRIDIN-3-YL)-2-(PYRIDIN-2-YL)-1,2DIHYDRO-3H-PYRAZOL-3-ONE
DERIVATIVES AS SPECIFIC
HIFPROLYL-4-HYDROXYLASE
INHIBITORS FOR TREATING
CARDIOVASCULAR AND
HAEMATOLOGICAL DISEASES
BAYER HEALTHCARE AG
DE
102005019712.4 28/04/2005
PCT/EP/2006/003488
WO/2006/114213
122302133/
1/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
–/–‫–(פירידין‬/–)‫–יל‬:–‫–(פירידין‬4 ‫תולדות‬
‫–און‬:–‫–פיראזול‬H3–‫–דיהידרו‬/,0–)‫יל‬
‫–הידרוקסילאז‬4–‫כמעכבי היפרוליל‬
‫ספציפיים לטיפול במחלות של הלב‬
‫וכלי הדם והמטולוגיות‬
186908
TRPV1 AGONIST COMPOUNDS AND
METHODS FOR MAKING AND USING
THE SAME
NEUROGESX, INC.
US
60/675027
25/04/2005
PCT/US/2006/015785
WO/2006/116485
C07D
C07C
‫ ושיטות להכנה‬TRPV 0 ‫תרכובות אגוניסט‬
‫ושימוש בהן‬
186909
C23C
4676
COATING PROCESS FOR
MANUFACTURE OR REPROCESSING
OF SPUTTER TARGETS AND X-RAY
ANODES
H.C. STARCK INC.
US
60/678052
05/05/2005
PCT/EP/2006/003969
WO/2006/117145
1/2322133/
186910
VOLUTIONARY SYNTHESIS OF A
MODEM FOR BAND-LIMITED NONLINEAR CHANNELS
SYMSTREAM TECHNOLOGY
HOLDINGS PTY LTD
US
60/685133
27/05/2005
115441441
1458451884
US
PCT/US/2006/020325
WO/2006/127947
3/2322133/
186911
COMPOSITIONS FOR
ADMINISTERING RNAIII INHIBITING
PEPTIDES
NAOMI BALABAN
US
60/679516
10/05/2005
PCT/US/2006/017935
WO/2006/122127
1/2322133/
4677
186912
‫תהליך ציפוי לייצור או עיבוד מחדש של‬
X ‫מטרות ספוטר ואנודות של קרני‬
H04L
‫סינתזה אבולוציונית של מודם לערוצים‬
‫מוגבלי–פס שאינם קוויים‬
A61K
RNAIII ‫תכשירים למתן פפטידים מעכבי‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
INHIBITORS OF CYTOSOLIC
PHOSPHOLIPASE A2
WYETH
US
60/685564
27/05/2005
PCT/US/2006/020847
WO/2006/128142
112322133/
‫ ציטוזוליים‬A2 ‫מעכבי פוספוליפאז‬
186913
PROCESS FOR PREPARING (ALPHA S,
BETA R)-6-BROMO-ALPHA-[2(DIMETHYLAMINO)ETHYL]-2METHOXY-ALPHA-1NAPHTHALENYL-BETA-PHENYL-3QUINOLINEETHANOL
JANSSEN PHARMACEUTICA N.V.
EP
05104482.4 25/05/2005
PCT/EP/2006/062502
WO/2006/125769
3/23/2133/
–R)–6 ‫ בתא‬,S ‫תהליך להכנת (אלפא‬
–/–]‫–(דימתילאמינו)אתיל‬/[–‫ברומו–אלפא‬
–:–‫–נפתזניל–בתא–פניל‬0–‫מתוקסי–אלפא‬
‫קווינולינאתנול‬
186914
INHIBITORS OF SOLUBLE ADENYLATE
CYCLASE
BAYER SCHERING PHARMA AG
DE
102005027274.6 08/06/2005
PCT/EP/2006/005608
WO/2006/131398
122302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07F
186915
C07D
‫מעכבי אדנילאט ציקלאז מסיס‬
E04H
4678
‫מחסום הנפרס במהירות ושיטה לשימוש‬
‫בו‬
RAPID DEPLOYMENT BARRIER AND
METHOD OF USING THE SAME
FROMM BARRIER INCORPORATED
US
60/674477
25/04/2005
115441880
1858451884
US
PCT/US/2006/015649
WO/2007/040626
302322133/
186916
USE OF INSP052 POLYPEPTIDE FOR
THE PREPARATION OF A
MEDICAMENT FOR TREATING
DISEASES
LABORATOIRS SERONO SA
EP
05103791.9 06/05/2005
485401441
1458451884
US
PCT/EP/2006/062063
WO/2006/120160
302322133/
‫ להכנת‬INSP052 ‫שימוש בפוליפפטיד‬
‫תרופה לטיפול במחלות‬
186917
ALL-OVER COATING OF VESSEL
STENTS
HEMOTEQ AG
DE
102005021622.6 05/05/2005
485404448
8458451884
US
PCT/DE/2006/000766
WO/2006/116989
312322133/
4679
A61K
186918
A61L
‫ציפוי כללי של סטנטים לכלי דם‬
G01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫שיטה ספקטרוסקופית לאיתור‬
‫אנליטים‬
SPECTROSCOPIC METHOD FOR THE
DETECTION OF ANALYTES
THERAINVENTION GMBH
DE
102005020384.1 02/05/2005
PCT/DE/2006/000756
WO/2006/116981
1/2302133/
186919
EXPOSURE METHOD, EXPOSURE
APPARATUS, AND DEVICE
MANUFACTURING METHOD
NIKON CORPORATION
2005JP
28/04/2005
131866
PCT/JP/2006/309002
WO/2006/118258
1/2302133/
‫ מתקן חשיפה ושיטת ייצור‬,‫שיטת חשיפה‬
‫המתקן‬
186920
ELECTROMECHANICAL LOCK
DEVICE
ASSA AB
SE
0500975-8
29/04/2005
PCT/SE/2006/000504
WO/2006/118519
1/2302133/
186921
ELECTROMECHANICAL LOCK
DEVICE
ASSA AB
SE
0500976-6
29/04/2005
PCT/SE/2006/000505
WO/2006/118520
1/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H01L
186922
E05B
‫התקן נעילה אלקטרו מכני‬
E05B
‫התקן נעילה אלקטרו מכני‬
E05B
4680
ELECTROMECHANICAL LOCK
DEVICE
ASSA AB
SE
0500977-4
29/04/2005
PCT/SE/2006/000506
WO/2006/118521
2/2302133/
186923
STEROID KIT AND FOAMABLE
COMPOSITION AND USES THEROF
FOAMIX LTD
US
11/114410
26/04/2005
PCT/IB/2006/002832
WO/2007/012977
122232133/
186924
A METHOD OF CONTENT
ADAPTATION FOR ELECTRONIC
DISPLAYS
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
3/2322133/
4681
A61K
‫ערכה סטרואידית ומרקם קצף ומגוון‬
‫שימושיהם‬
‫פואמיקס בע"מ‬
H05F
‫שיטה לאימוץ תוכן לצגים אלקטרונים‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
186925
PHARMACEUTICAL COMPOSITIONS
COMPRISING IMATINIB AND A
RELEASE RETARDANT
NOVARTIS AG
US
60/679607
10/05/2005
PCT/US/2006/017558
WO/2006/121941
1/2302133/
‫התקן נעילה אלקטרו מכני‬
186926
A61K
‫תכשירים רפואיים המכילים אימטניב‬
‫ומעכב שחרור‬
A01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
MATERIALS AND METHODS FOR
ENHANCED DEGRADATION OF
MUTANT PROTEINS ASSOCIATED
WITH HUMAN DISEASE
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.
US
60/675143
27/04/2005
485414100
8451851884
US
PCT/US/2006/016368
WO/2006/116716
1/2302133/
186927
HUMAN MILK FAT SUBSTITUTES
ENZYMOTEC LTD.
IL
168263
27/04/2005
PCT/IL/2006/000511
WO/2006/114791
1/2302133/
186928
POLAR LIPIDS MIXTURE, THEIR
PREPARATION AND USES
ENZYMOTEC LTD.
IL
168294
28/04/2005
PCT/IL/2006/000510
WO/2006/114790
1/2302133/
186929
MULTIPLY SUBSTITUTED
FERROCENES
SOLVIAS AG
CH
0748/05
28/04/2005
PCT/EP/2006/061861
WO/2006/114438
312322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186930
‫חומרים ושיטות להגברת פירוק חלבונים‬
‫מוטנטים הקשורים למחלה באדם‬
A23L
‫תחליפי חלב אם‬
‫אנזימוטק בע"מ‬
A23L
‫ הכנתן‬,‫תערובות של ליפידי פולרי‬
‫ושימושיהן‬
‫אנזימוטק בע"מ‬
C07F
‫פרוצנים רב–מותמרים‬
A01N
4682
‫תרכובות של מדבירים‬
PESTICIDAL COMPOSITIONS
SYNGENTA PARTICIPATIONS AG
GB
0508993.3
03/05/2005
PCT/EP/2006/004094
WO/2006/117192
1/2302133/
186931
AN IMPROVED PLASMA TORCH FOR
USE IN A WASTE PROCESSING
CHAMBER
E.E.R. ENVIRONMENTAL ENERGY
RESOURCES (ISRAEL) LTD.
IL
168286
28/04/2005
PCT/IL/2006/000513
WO/2006/114793
122232133/
1/2302133/
4683
‫ החברה למשאבי סביבה ואנרגיה‬.‫אר‬.‫אי‬.‫אי‬
‫(ישראל) בע"מ‬
A61B
‫שיטות וערכות לאנליזה של תחום השפעה‬
‫של סרטן בלוטת הערמונית‬
186937
EPITHELIAL POCKET EXPANDING
TOOL AND COMBINATION
EPITHELIAL DELAMINATING
DEVICE AND CORNEAL REFORMER
TISSUE ENGINEERING REFRACTION
INC.
US
60/676601
28/04/2005
PCT/US/2006/016419
WO/2006/116732
1/2302133/
‫לפיד פלזמה משופר לשימוש בתא לעיבוד‬
‫פסולת‬
186935
PROSTATE CANCER FIELD EFFECT
ANALYSIS METHODS AND KITS
VERIDEX, LLC
US
60/855640
31/10/2006
H05H
A61F
‫כלי להרחקת כיס אפיתליאלי ושילוב בין‬
‫התקן לפיצול שכבות אפיתליאליות ומתקן‬
‫קרנית‬
186938
A61F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
EPITHELIAL DELAMINATING
DEVICE (V) AND BLADES USEFUL IN
THAT DEVICE
TISSUE ENGINEERING REFRACTION
INC.
US
60/675506
27/04/2005
485404181
1058451884
US
PCT/US/2006/016034
WO/2006/116601
1/2302133/
‫) לפיצול שכבות אפיתליאליות‬V( ‫התקן‬
‫ולהבים שימושיים בהתקן זה‬
186939
PYRIMIDINE DERIVATIVES AND THEIR
USE AS
P2Y12 RECEPTOR ANTAGONISTS
C07K
‫תולדות פירימידין ושימוש בהן‬
‫כאנטגוניסטים של‬
P2Y12 ‫קולטן‬
ACTELION PHARMACEUTICALS LTD.
EP
PCT/EP2005/04578 28/04/2005
IB
PCT/IB2005/53711 1851151884
PCT/IB/2006/051318
WO/2006/114774
2/2322133/
186940
LOW FRICTION COATINGS FOR USE
IN DENTAL AND MEDICAL DEVICES
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/681443
17/05/2005
PCT/IL/2006/000578
WO/2006/123336
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
186941
A61B
‫ציפויים בעלי חיכוך נמוך לשימוש‬
‫במכשירים רפואיים ודנטלים‬
‫מכון אקדמי טכנולוגי חולון‬
C07K
4684
–‫ננובודיס משופרים נגד גורם נמק סרטני‬
‫אלפא‬
)ALPHA–TNF(
IMPROVED NANOBODIES TM
AGAINST TUMOR NECROSIS
FACTOR-ALPHA
ABLYNX N.V.
US
60/682332
PCT/EP/2006/004678
WO/2006/122786
202302133/
18/05/2005
186942
CONFIGURABLE DEVICE FOR
CLEANING THE BARREL OF A
FIREARM, AND FIREARM CLEANING
KIT CONTAINING COMPONENTS OF
DEVICE
THE OTIS PATENT TRUST
US
11/113649
25/04/2005
PCT/US/2006/013838
WO/2007/046856
122302133/
‫התקן הניתן לעיצוב עבור ניקוי קנה של‬
‫ וערכה לניקוי נשק המכילה רכיבים‬,‫נשק‬
‫של ההתקן‬
186943
CONNECTOR ASSEMBLY
3M INNOVATIVE PROPERTIES
COMPANY
US
11/114287
26/04/2005
PCT/US/2006/015590
WO/2006/116377
3/2322133/
186944
POLYETHYLENE GLYCOL COLONIC
PURGATIVE COMPOSITION
SALIX PHARMACEUTICALS, INC.
US
60/678181
06/05/2005
PCT/US/2006/017885
WO/2006/122104
1/2302133/
4685
F41A
186945
H01R
‫הרכב מחבר‬
A61K
‫תכשיר משלשל של פוליאתילן גליקול‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SOLID TRANSDERMAL
THERAPEUTIC SYSTEM
COMPRISING UV ABSORBER
BAYER SCHERING PHARMA AG
EP
05009579.3 02/05/2005
PCT/EP/2006/003959
WO/2006/117139
122302133/
‫מערכת רפואית מוצקה להעברה דרך‬
UV ‫העור המכילה סופג קרינת‬
186946
‫התקן להשתלה דנטלית‬
DENTAL IMPLANTOLOGY DEVICE
GERARD SCORTECCI
FR
0551123
29/04/2005
PCT/EP/2006/061761
WO/2006/117298
122302133/
186947
MULTISPECTRAL BIOMETRIC
SENSORS
LUMIDIGM, INC.
US
60/675776
27/04/2005
115448844
1458451884
US
PCT/US/2006/015950
WO/2006/116566
1/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06K
‫חיישנים ביומטרים מולטיספקטראלים‬
186948
MONOCLONAL ANTIBODIES AND
METHODS FOR THEIR USE IN THE
DETECTION OF CERVICAL DISEASE
TRIPATH IMAGING, INC.
US
60/675305
27/04/2005
485410801
1458851884
US
PCT/US/2006/015706
WO/2006/116442
A61C
C07K
‫נוגדנים מונוקלונים ושיטות לשימוש בהם‬
‫באיתור מחלה של הצוואר‬
4686
102302133/
186949
SYSTEM AND METHOD OF
EXECUTING PROGRAM THREADS IN
A MULTI-THREADED PROCESSOR
G06F
‫מערכת ושיטה של הוצאה לפועל של‬
‫הליך לביצוע שהוא חלק מיישום במעבד‬
‫רב יישומים‬
QUALCOMM INCORPORATED
US
11/115917
26/04/2005
PCT/US/2006/015390
WO/2006/116257
1/2302133/
186950
A METHOD OF FORMING AN
INJECTABLE RADIOACTIVE
COMPOSITION OF A CARBON
ENCAPSULATED RADIOACTIVE
PARTICULATE
THE AUSTRALIAN NATIONAL
UNIVERSITY
AU
2005902180 29/04/2005
PCT/AU/2006/000554
WO/2006/116798
102302133/
186952
SYSTEM AND METHOD FOR
RESTORING DATA ON DEMAND FOR
INSTANT VOLUME RESTORATION
NETWORK APPLIANCE, INC.
US
60/674430
25/04/2005
PCT/US/2006/015442
WO/2006/116293
102302133/
4687
186953
A61K
‫שיטה ליצירת הרכב רדיואקטיבי של‬
,‫פרטיקולאט רדיואקטיבי עטוף פחמן‬
‫הניתן להזרקה‬
G06F
‫מערכת ושיטה לשיחזור נתונים בכל עת‬
‫לצורך שיחזור שטח אחסון מיידי‬
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מערכת ושיטה לאחסון מערכת קבצים‬
‫לרשת בזיכרון מטמון‬
SYSTEM AND METHOD FOR
CACHING NETWORK FILE SYSTEMS
NETWORK APPLIANCE, INC.
US
60/674609
25/04/2005
PCT/US/2006/015279
WO/2006/116203
3/23022///
186955
PHARMACOLOGICALLY ACTIVE
PEPTIDE CONJUGATES HAVING
REDUCED TENDENCY TOWARDS
ENZYMATIC HYDROLYSIS
ZEALAND PHARMA A/S
DK
0317/98
09/03/1998
PCT/DK/1999/000118
WO/1999/046283
322322133/
3/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫קוניוגטים של פפטיד הפעיל באופן‬
‫פארמקולוגי אשר יש להם נטייה מופחתת‬
‫לגבי הידרוליזה אנזימתית‬
186956
UNSOLVATED AND HOST-GUEST
SOLVATED CRYSTALLINE FORMS
OF (2E,4S)-4-[(N-{[(2R)-1ISOPROPYLPIPERIDIN-2-yl]CARBONYL}-3-METHYL-LVALYL)(METHYL)AMINO]-2,5DIMETHYLHEX-2-ENOIC ACID AND
THEIR PHARMACEUTICAL USES
EISAI CO, LTD.
US
60/677811
05/05/2005
PCT/US/2006/017408
WO/2006/121857
C07K
C07D
‫צורות של גבישים שאינם מומסים‬
S4–E2)–4–( ‫ומומסים של פונדקאי–אורח‬
–/–‫([–איזופרופילפיפארידין‬N–{[(2R)–1
–L–‫–מת'יל‬:–}‫איל]–קארבוניל‬
–/– ‫–דימת'ילקס‬/,.–]‫ואליל)(מת'יל)אמינו‬
‫אנויק חומצה ושימוש בתכשירים רוקחיים‬
‫שלהם‬
186957
C07D
4688
MODULATORS OF INDOLEAMINE
2,3-DIOXYGENASE AND METHODS
OF USING THE SAME
INCYTE CORPORATION
US
60/679507
10/05/2005
PCT/US/2006/017983
WO/2006/122150
2/2302133/
186959
PEPTIDES AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
THE UNIVERSITY OF ALABAMA
RESEARCH FOUNDATION
US
60/676431
29/04/2005
485484484
8458451884
US
PCT/US/2006/014839
WO/2006/118805
1/2302133/
–/,: ‫מאפננים של אינדולאיאמין‬
‫דיוקסיג'נאס ושיטות של שימוש של הנ"ל‬
‫פפטידים ותכשירי רוקחות המכילים אותם‬
186960
METHODS OF SUPPRESSING UV
LIGHT-INDUCED SKIN
CARCINOGENESIS
JOHNS HOPKINS UNIVERSITY
US
60/675847
29/04/2005
485448441
1451151884
US
PCT/US/2006/016012
WO/2006/118941
1/2232133/
4689
A61K
186961
A61P
‫שיטות לדיכוי מחוללי סרטן עור מושרה‬
‫אור על–סגול‬
A61K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
INHALATION DEVICE FOR
SIMULTANEOUS TREATMENT OF
MULTIPLE PATIENTS
MOSHE HIRSHFELD
1/2232133/
‫מכשיר אינהילציה לטיפול במקביל‬
‫במספר מטופלים‬
‫משה הירשפלד‬
186962
‫מערכת להרתעת מזיקים‬
‫זאב אפרת‬
PEST DETERRENT SYSTEM
ZEEV EFRAT
1/2302133/
186964
METHOD AND APPARATUS FOR THE
TREATMENT OF THE
INTERVERTEBRAL DISC ANNULUS
ANULEX TECHNOLOGIES, INC.
US
11/120750
03/05/2005
PCT/US/2006/016292
WO/2006/119034
1/2302133/
CUTTING HEAD OF A REAMER
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61F
–‫שיטה ומכשיר לטיפול בטבעת דיסק בין‬
‫חולייתית‬
186965
ANTI-IL-6 ANTIBODIES,
COMPOSITIONS, METHODS AND
USES
CENTOCOR, INC.
US
60/676498
29/04/2005
485444418
8458451884
US
PCT/US/2006/016457
WO/2006/119115
1/2232133/
A01M
186967
A61K
‫ שיטות‬,‫ הרכבים‬,IL–6–‫נוגדני אנטי‬
‫ושימושים‬
B23C
‫ראש חיתוך למקדד‬
4690
‫ישקר בע"מ‬
ISCAR LTD.
1/2302133/
186968
APPARATUS AND METHODS FOR
ASSOCIATING A GEOGRAPHICAL
POSITION WITH AN EVENT
OCCURING ON A WIRELESS DEVICE
QUALCOMM INCORPORATED
US
60/675739
27/04/2005
115148481
1458451884
US
PCT/US/2006/016062
WO/2006/116618
122302133/
‫התקנים ושיטות לשיוך מיקום גיאוגרפי‬
‫יחד עם התרחשות אירוע במכשיר אלחוטי‬
186969
MULTI-CARRIER OPERATION IN
DATA TRANSMISSION SYSTEMS
QUALCOMM INCORPORATED
US
60/676109
28/04/2005
115480084
8458451884
US
PCT/US/2006/015115
WO/2006/116102
3/2322133/
186970
THIAZOLE COMPOUNDS AND
METHODS OF USE
ACHILLION PHARMACEUTICALS,
INC.
US
60/679133
09/05/2005
PCT/US/2006/017692
WO/2006/122011
3/2302133/
4691
H04Q
186971
H04L
‫פעולה רבת צלילי תקשורת במערכות‬
‫שידור נתונים‬
C07D
‫תרכובות תיאזול ושיטות שימוש‬
H04B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PORTABLE ANTENNA POSITIONER
APPARATUS AND METHOD
SPENCER, WEBB
US
11/115960
26/04/2005
PCT/US/2006/016282
WO/2006/116695
1/2302133/
‫התקן נייד לעמדת אנטנה ושיטה‬
186972
C07D
‫תרכובת לאקטאם חדשה‬
NOVEL LACTAM COMPOUND
AJINOMOTO CO., INC.
2005JP
28/04/2005
130879
PCT/JP/2006/309349
WO/2006/118341
3/2322133/
186974
‫התקן לאספקת מדיה ליחידות תרבות‬
‫תאים‬
APPARATUS FOR PROVIDING MEDIA
TO CELL CULTURE MODULES
SAXONIA BIOTEC GMBH
EP
05103824.8 09/05/2005
485401814
1458451884
US
PCT/CA/2006/000739
WO/2006/199622
2/2322133/
186975
MATERIAL DELIVERY SYSTEM
BYPASS, INC.
US
60/675477
28/04/2005
IL
PCT/IL2005/000749 1458451884
PCT/IL/2006/000087
WO/2006/114783
1/2232133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C12M
186976
A61M
‫מערכת הבאת חומרים‬
A63B
4692
‫אינפרו–קלאב‬
‫משה כרמלי‬
INFRO-CLUB
MOSHE CARMELI
2/2302133/
186977
‫סיבים ומוצרים שאינם ארוגים מבוססי‬
‫פוליפרופילן‬
POLYPROPYLENE BASED FIBERS
AND NONWOVENS
EXXONMOBIL CHEMICAL PATENTS
INC.
US
11/119193
29/04/2005
PCT/US/2006/014692
WO/2006/118794
1/2232133/
C08K
186980
C12Q
CHARACTERIZING PROSTATE
CANCER
VERIDEX, LLC
US
60/855423
31/10/2006
302322133/
‫איפיון סרטן הערמונית‬
186981
METHOD FOR ISOLATING METHYL
GLYCINE-N-N-DIACETONITRILES
FROM AN AQUEOUS CRUDE MIXTURE
C07C
–N,N–‫שיטה לבידוד מתיל גליצין ניטריל‬
‫דיאצטוניטרילים מתערובת מימית‬
‫גולמית‬
BASF AKTIENGESELLSCHAFT
DE
102005021056.2 06/05/2005
PCT/EP/2006/062008
WO/2006/120144
3/23/2133/
4693
186982
H01Q
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
LIGHTWEIGHT SPACE-FED ACTIVE
PHASED ARRAY ANTENNA SYSTEM
MACDONALD, DETTWILER AND
ASSOCIATES LTD.
US
60/689473
09/06/2005
PCT/CA/2006/000960
WO/2006/130993
3223/2133/
A PUMP
ITT MANUFACTURING
ENTERPRISES, INC.
SE
0501542-5
PCT/SE/2006/000662
WO/2007/004943
‫מערכת אנטנה קלת משקל למערך פאזה‬
‫אקטיבי‬
186983
F04D
‫משאבה‬
01/07/2005
1/2302133/
186984
GAMING CONSOLE WIRELESS
PROTOCOL FOR PERIPHERAL
DEVICES
MICROSOFT CORPORATION
US
11/126023
10/05/2005
PCT/US/2006/016275
WO/2006/121645
212322133/
302322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫פרוטוקול אלחוטי ליחידת בקרת משחקים‬
‫עבור התקנים פריפריאליים‬
186986
COMPOSITIONS AND METHODS FOR
MODULATING IMMUNE RESPONSES
ZYMOGENETICS INC.
US
60/680374
12/05/2005
485481414
1458451884
US
485484884
1458451884
US
PCT/US/2006/018537
WO/2006/124667
H04J
C07K
‫תכשירים ושיטות לאפנון תגובות חיסוניות‬
186987
G01N
4694
SYNTHETIC AND STANDARDIZED
PRION INFECTUOUS MATERIAL,
AND USES THEREOF AS AN
INFECTING INOCULUM
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES
FR
0504545
04/05/2005
PCT/FR/2006/000999
WO/2006/117483
302322133/
‫ ושימושים בו‬,‫חומר זיהומי סינתטי מתוקנן‬
‫כתרכיב מזהם‬
186988
EPIGENETIC AND GENETIC
TREATMENT METHOD AND SYSTEM
FRED ZACOUTO
FR
0551180
04/05/2005
8444840
8451851884
FR
8444444
1151151884
FR
PCT/FR/2006/050413
WO/2007/000523
1/2302133/
C12N
‫מערכת ושיטת טיפול אפיגנטית וגנטית‬
186989
‫תכשירים טיפוליים‬
THERAPEUTIC COMPOSITIONS
CUBIST PHARMACEUTICALS, INC.
US
60/676146
29/04/2005
PCT/US/2006/016030
WO/2006/118948
222322133/
4695
A61K
186990
B29C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
CROSSLAMINATE OF ORIENTED FILMS
AND METHODS AND APPARATUS FOR
MANUFACTURING SAME
OLE-BENDT RASMUSSEN
GB
0509615.1
11/05/2005
841148448
8458451884
GB
EP
PCT/EP2006/000281 8458151884
PCT/EP/2006/062260
WO/2006/120238
1/2232133/
186991
186992
IMPROVED STRIPPABLE CABLE
SHIELD COMPOSITIONS
GENERAL CABLE TECHNOLOGIES
CORPORATION
US
11/117395
29/04/2005
PCT/US/2006/016350
WO/2006/119067
3/23221333
186993
ATTENUATED MICROORGANISMS
FOR THE TREATMENT OF
INFECTION
MICROSCIENCE LIMITED
GB
9910812.8
10/05/1999
PCT/GB/2000/001749
WO/2000/068261
1/2302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B01D
‫מערכת לטיהור מים‬
‫ווטרשיר בע"מ‬
WATER PURIFICATION SYSTEM
WATERSHEER LTD
322322133/
‫קרוסלאמינט של פילמים מכוונים‬
‫ושיטות ומערכת לייצורו‬
186994
H02B
‫תרכובות לסיכוך כבלים משופר הניתן‬
‫להסרה‬
A61K
‫מיקרואורגניזמים מופחתי עוצמה עבור‬
‫הטיפול דלקת‬
G06F
4696
‫הקצבת נתונים תוך ארכיטקטורה של‬
‫מערכת אחסון‬
DATA ALLOCATION WITHIN A
STORAGE SYSTEM ARCHITECTURE
NETWORK APPLIANCE INC.
US
11/118681
29/04/2005
PCT/US/2006/016243
WO/2006/119021
1/2302133/
186995
‫תמיכה לרקמות רכות‬
SOFT TISSUE SUPPORT
GARY PIERRE LAURYSSEN
ZA
2004/8764
29/04/2005
PCT/IB/2006/001056
WO/2006/117622
0223/21332
186996
STORAGE SYSTEM ARCHITECTURE
FOR STRIPING DATA CONTAINER
CONTENT ACROSS VOLUMES OF A
CLUSTER
NETWORK APPLIANCE INC.
US
11/119278
29/04/2005
PCT/US/2005/030889
WO/2006/118592
1/2302133/
4697
G06F
‫ארכיטקטורת מערכת אחסון לסימון תוכן‬
‫מבנה נתונים על פני נפחי יחידה לאחסון‬
) )CLUSTER ‫נתונים‬
186997
A METHOD AND AN APPARATUS
FOR PROVISIONING CONTENT DATA
HINGI LTD.
US
60/675926
29/04/2005
485418844
1458851884
US
485441040
8451151884
US
PCT/IL/2006/000514
WO/2006/117777
322322133/
A61F
186999
H04M
‫שיטה ומכשיר לאספקת נתוני תוכן‬
‫הינג'י בע"מ‬
H04Q
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
USING ASSIGNMENT MESSAGES
FOR EFFICIENT SIGNALING OF
HANDOFF
QUALCOMM INCORPORATED
US
60/678363
05/05/2005
PCT/US/2006/017417
WO/2006/121864
032322133/
‫שימוש במסרי משימה לשם העברה יעילה‬
‫של מסרים בין אפיקים המחוברים לרשת‬
187000
TREATMENT OF LIVER DISEASES IN
WHICH IRON PLAYS A ROLE IN
PATHOGENESIS
NOVARTIS AG
US
60/685848
485481080
US
485444404
US
PCT/US/2006/020677
WO/2006/130532
A61P
‫טיפול במחלות כבד בהן ברזל קשור‬
‫לפתוגנזה‬
31/05/2005
1158451884
8858451884
222322133/
187001
PREPARATION OF (S)-4FLUROMETHYL-DIHYDRO-FURAN 2-ONE
F. HOFFMANN-LA ROCHE AG
EP
05104408.9 24/05/2005
PCT/EP/2006/062291
WO/2006/125728
322322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07D
–‫–פלואורומתיל–דיהידרו–פורנ‬S)–4( ‫הכנת‬
‫–ון‬/
187002
C12Q
4698
AMPLIFICATION AND CLONING OF
SINGLE DNA MOLECULES USING
ROLLING CIRCLE AMPLIFICATION
THE J. CRAIG VENTER INSTITUTE
US
60/675850
29/04/2005
485411848
4858851884
US
485414488
1151851884
US
PCT/US/2006/016349
WO/2006/119066
2/2322133/
‫שכפול ושיבוט של מולקולות דנ"א בודדות‬
‫על ידי שכפול מעגלי מתמשך‬
187003
IMIDAZOQUINOLINES AS LIPID
KINASE INHIBITORS
NOVARTIS AG
GB
0510390.8
20/05/2005
PCT/EP/2006/004725
WO/2006/122806
3/23/2133/
‫אימידזוקווינולינים כמעכבי ליפיד קינאז‬
187004
PROCESS FOR PREPARING RENIN
INHIBITORS
NOVARTIS AG
GB
0511686.8
08/06/2005
PCT/EP/2006/005370
WO/2006/131304
1/2302133/
312322133/
4699
C07D
‫תהליך להכנת מעכבים של רנין‬
187005
DIACYLGLYCEROL
ACYLTRANSFERASE INHIBITORS
F. HOFFMANN-LA ROCHE AG
US
60/679521
10/05/2005
PCT/EP/2006/061900
WO/2006/120125
C07D
C07C
‫מעכבים של דיאצילגליצרול אצילטרנספרז‬
187006
C07F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
FERROCENYL LIGANDS,
PRODUCTION AND USE THEREOF
SOLVIAS AG
CH
0776/05
03/05/2005
PCT/EP/2006/061973
WO/2006/117369
032232133/
187007
THE AUTOMATIC PURIFIER AND
SCENTER
YOSEF ELIYAHU
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A47K
‫מחטא ומבשם האוטומטי‬
‫יוסף אליהו‬
187008
VACCINE COMPOSITION
COMPRISING B-SUBUNIT OF E. COLI
HEAT TOXIN AND AN ATIGEN AND
AN ADJUVANT
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0510280.1
19/05/2005
841448444
4851151884
GB
PCT/GB/2006/001832
WO/2006/123155
1/2322133/
‫ ייצורם ושימושם‬,‫ליגנדים של פרוסניל‬
187009
A61K
‫ של‬B ‫תכשיר חיסוני המכיל תת יחידה‬
‫רעלן חם‬
‫ אטיגן וחומר מסייע‬,E.COLI ‫של‬
A61K
4700
‫ בעלי שיירים של‬G–CSF ‫פוליפפטידים‬
‫פוליאתילן גליקול‬
‫) ושיטות לייצורם‬PEG(
PEGYLATED G-CSF POLYPEPTIDES
AND METHODS OF PRODUCING
SAME
MAXYGEN HOLDINGS LTD.
US
60/686726
01/06/2005
PCT/DK/2006/000292
WO/2006/128460
1123/2133/
187010
HIGH COLOUR DIAMOND
ELEMENT SIX LIMITED
GB
0512728.7
22/06/2005
485488444
1458451884
US
PCT/IB/2006/001694
WO/2006/136929
222322133/
187011
HYBRID INSTANT ONLINE LOTTERY
GAME
GTECH RHODE ISLAND
CORPORAION
US
60/680607
12/05/2005
PCT/US/2006/018508
WO/2006/124645
212322133/
187012
METHODS OF USING PNKP30, A
MEMBER OF THE B7 FAMILY, TO
MODULATE THE IMMUNE SYSTEM
ZYMOGENETICS INC.
US
60/680109
12/05/2005
485488484
1858051884
US
PCT/US/2006/018538
WO/2006/124668
302322133/
4701
187013
C23C
‫יהלום בעל צבע חזק‬
G07F
‫משחק הגרלה און ליין מעורב ומיידי‬
C07K
B7 ‫ ממשפחת‬,PNKP30 ‫שיטות לשימוש‬
‫לאפנון מערכת החיסון‬
A01H
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD FOR PRODUCTION OF
SAPONARIA FROM MICROSPORES
NATIONAL RESEARCH COUNCIL OF
CANADA
US
60/677952
04/05/2005
PCT/CA/2006/000725
WO/2006/116876
102322133/
‫ מנבגים צעירים‬SAPONARIA ‫שיטה ליצור‬
187014
PYRIDINE COMPOUNDS FOR
COMBATING ARTHROPOD PESTS
AND NEMATODES
BASF AKTIENGESELLSCHAFT
US
60/684614
25/05/2005
PCT/EP/2006/004992
WO/2006/125641
032232133/
C07D
‫תרכובות פירידין להשמדת פרוקי רגליים‬
‫ונמטודות‬
187015
‫מבנה תלת–מימדי בר הקמה‬
‫סעדיה בנימינוב‬
ERECTABLE 3D STRUCTURE
SAADYA BINYAMINOV
2/2322133/
187016
THIAZOLE CARBOXYLIC ACID
ANILIDES
BASF AKTIENGESELLSCHAFT
DE
102005023606.5 18/05/2005
PCT/EP/2006/062345
WO/2006/122933
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B65D
187017
C07D
‫אנילידים של תיאזול חומצה‬
‫קרבוקסילית‬
A61K
4702
USE OF TNF INHIBITOR FOR
TREATMENT OF EROSIVE
POLYARTHRITIS
ABBOTT BIOTECHNOLOGY LTD.
US
60/681645
16/05/2005
PCT/US/2006/019982
WO/2006/125229
2023/2133/
187018
GYPSUM PRODUCTS UTILIZING A
TWO-REPEATING UNIT DISPERSANT
AND A METHOD FOR MAKING THEM
UNITED STATES GYPSUM COMPANY
US
11/152418
14/06/2005
115448814
8858451884
US
PCT/US/2006/022956
WO/2006/138289
3/23/2133/
‫ לטיפול‬TNF ‫שימוש במעכב‬
‫בפוליארטרטריטיס מכרסם‬
‫מוצרי גבס המשתמשים בחומר מפזר בעל‬
‫שתי יחידות חוזרות והשיטה לייצורם‬
187019
HIGH STARCH LIGHT WEIGHT
GYPSUM WALLBOARD
UNITED STATES GYPSUM COMPANY
US
60/688839
09/06/2005
115448144
8458451884
US
PCT/US/2006/022371
WO/2006/135707
3/23/2133/
4703
C04B
187020
B23B
‫קיר גבס מעומלן בעל משקל נמוך‬
B32B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD OF IMPORVING
DISPERSANT EFFICACY IN MAKING
GYPSUM PRODUCTS
UNITED STATES GYPSUM COMPANY
US
60/688839
09/06/2005
115444884
8158451884
US
PCT/US/2006/022014
WO/2006/135613
2023/2133/
‫שיטה לשיפור יעילות של חומר מפזר‬
‫בייצור מוצרי גבס‬
187021
‫מתאמים למי גבס עכורים והשיטה‬
‫לשימוש בהם‬
MODIFIERS FOR GYPSUM SLURRIES
AND METHOD OF USING THEM
UNITED STATES GYPSUM COMPANY
US
11/152317
14/06/2005
115448840
8858451884
US
PCT/US/2006/022936
WO/2006/138277
032232133/
187022
A COMPOSITION AND DISPENSER
FOR PERSONAL HYGIENE
SIMON SIGLER
312322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A47K
‫תכשיר ומחלק להיגיינה אישית‬
‫שמעון סיגלר‬
187023
COMPOSITIONS FOR DELIVERING A
TRANSGENE TO THE SPINAL CORD
GENZYME CORPORATION
US
60/677213
02/05/2005
485488114
8058451884
US
PCT/US/2006/016943
WO/2006/119341
2/22122///
C04B
A61K
‫תכשירים לאספקת טרנסגן לחוט השדרה‬
187024
C07D
4704
P38 KINASE-INHIBITING DIARYLSUBSTITUTED CONDENSED
PYRIMIDINONE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/034288
18/12/1996
805011444
1858451884
US
805041814
1858451884
US
PCT/US/1997/023392
WO/1998/027098
222322133/
‫תולדות פירימידינון דחוסות המותמרות‬
P38 ‫בשתי קבוצות אריל מעכבי קינז‬
‫ותכשירי רוקחות המכילים אותן‬
187026
SUBSTITUTED ACRYLAMIDE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
DAIICHI SANKYO COMPANY,
LIMITED
2005JP
12/05/2005
140019
PCT/JP/2006/309445
WO/2006/121095
032232133/
MOVIE KEY
MOVIE KEY LTD
US
11/554145
1223/21332
4705
C07D
‫תולדות אקרילאמיד מותמרות ותכשירי‬
‫רוקחות המכילים אותן‬
187027
H03M
‫החסן נייד למידע דיגיטלי‬
‫מובי קי בע"מ‬
30/10/2006
187028
G01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SYSTEM AND METHOD FOR
CHARACTERISATION OF A PARTICLE
FLOW
BUHLER AG
CH
PCT/CH2005/00429 02/05/2005
PCT/CH/2005/000429
WO/2006/116882
032232133/
‫מערכת ושיטה לאפיון זרימה של‬
‫חלקיק‬
187029
B60Q
‫מחוון לסטיה במהירות‬
‫ברודי הנדסה בע"מ‬
SPEED DEVIATION INDICATOR
BRODY ENGINEERING LTD.
1123/21333
187030
USE OF RETIGABINE FOR THE
TREATMENT OF NEUROPATHIC
PAIN
XCEL PHARMACEUTICALS, INC.,
US
406135
27/09/1999
PCT/EP/2000/009284
WO/2001/022953
312322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07C
‫שימוש ברטיגבין לטיפול בכאב ניאופאטי‬
187032
A01K
4706
DISPENSER DEVICE WITH REMOTECONTROLLED DISPENSER FOR THE
RELEASE OF DISPENSER MATERIALS
FOR AN ANIMAL AND
CORRESPONDING METHOD
GROSS, FRITZ
DE
102005021878.4 04/05/2005
18188481844141
1458451884
DE
18188481808444
8458451884
DE
18188481144144
1858451884
DE
18188488184444
8458151884
DE
PCT/DE/2006/000839
WO/2006/116994
302322133/
187033
METHODS FOR MEASURING
CHOLESTEROL METABOLISM AND
TRANSPORT
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/677672
03/05/2005
115414041
8158451884
US
PCT/US/2006/017167
WO/2006/119438
032232133/
187034
4707
A61K
‫שיטות למדידת מטבוליזם והעברת‬
‫כולסטרול‬
B23C
‫כלי חיתוך‬
‫ישקר בע"מ‬
CUTTING TOOL
ISCAR LTD.
032232133/
‫התקן הנפקה עם מנפק המבוקר‬
‫מרחוק לשיחרור חומרי המנפק לבעלי‬
‫חיים ושיטה תואמת‬
187035
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
CONFIGURABLE RANDOM NUMBER
GENERATOR
SANDISK IL LTD.
032232133/
187036
RE-FLASH PROTECTION FOR FLASH
MEMORY
SANDISK IL LTD.
032232133/
187037
FAST UPDATE FOR HIERARCHICAL
INTEGRITY SCHEMES
SANDISK IL LTD.
032232133/
187038
SECURE DATA PROCESSING FOR
UNALIGNED DATA
SANDISK IL LTD.
032232133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מחולל מספרים אקראיים בעל תצורה‬
‫נשלטת‬
‫סנדיסק אייאל בע"מ‬
G06F
‫הגנת זיכרון בלתי–נדיף נגד מתקפת‬
‫העתקה‬
‫סנדיסק אייאל בע"מ‬
G06F
‫עדכון מהיר בשיטות לשמירת שלמות‬
‫נתונים היררכית‬
‫סנדיסק אייאל בע"מ‬
G06F
‫עיבוד בטוח של נתונים לא מיושרים‬
‫סנדיסק אייאל בע"מ‬
187039
G06F
4708
SECURE OVERLAY MANAGER
PROTECTION
SANDISK IL LTD.
032232133/
‫הגנה מובטחת למנהל שכבות תוכנה‬
‫סנדיסק אייאל בע"מ‬
187040
‫שמירה בזיכרון מטמון בשיטות לשמירה‬
‫מבנית של שלמות נתונים‬
‫סנדיסק אייאל בע"מ‬
CACHING FOR STRUCTURAL
INTEGRITY SCHEMES
SANDISK IL LTD.
032232133/
OPTIMIZED HIERARCHICAL
INTEGRITY PROTECTION FOR
STORED DATA
SANDISK IL LTD.
032232133/
WRITE FAILURE PROTECTION FOR
HIERARCHICAL INTEGRITY
SCHEMES
SANDISK IL LTD.
032232133/
4709
G06F
187041
G06F
‫שמירת שלמות היררכית אופטימאלית של‬
‫נתונים מאוכסנים‬
‫סנדיסק אייאל בע"מ‬
187042
G06F
‫הגנה מפני כשלי כתיבה בשיטות לשמירת‬
‫שלמות נתונים היררכית‬
‫סנדיסק אייאל בע"מ‬
187043
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מנהל בטוח לשרשרת עיבוד‬
‫סנדיסק אייאל בע"מ‬
SECURE PIPELINE MANAGER
SANDISK IL LTD.
032232133/
187044
FAST SECURE BOOT
IMPLEMENTATION
SANDISK IL LTD.
032232133/
‫מימוש מהיר ובטוח לאיתחול‬
‫סנדיסק אייאל בע"מ‬
187045
SOFTWARE PROTECTION AGAINST
FAULT ATTACKS
SANDISK IL LTD.
032232133/
187046
MEMORY RANDOMIZATION FOR
PROTECTION AGAINST SIDE
CHANNEL ATTACKS
SANDISK IL LTD.
032232133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06F
G06F
‫הגנה בתוכנה נגד מתקפות תקלה‬
‫סנדיסק אייאל בע"מ‬
G06F
‫רנדומיזציה של זיכרון לצורך הגנה נגד‬
‫מתקפות בערוץ צדדי‬
‫סנדיסק אייאל בע"מ‬
187048
A43B
4710
METHOD FOR MANUFACTURING A
SHOE
CHEN CHUANO-CHUAN
TW
095140135
30/10/2006
322322133/
187049
PASSIVELY SHIELDED INDUCTIVE
SENSOR SYSTEM FOR PERSONNEL
SCREENING
GENERAL ELECTRIC COMPANY
US
11/125646
10/05/2005
PCT/US/2006/016592
WO/2006/121672
1/2302133/
187050
FABRIC CARE COMPOSITION
COMPRISING POLYMER
ENCAPSULATED FABRIC OR SKIN
BENEFICIATING INGREDIENT
COLGATE-PALMOLIVE COMPANY
US
11/123578
06/05/2005
PCT/US/2006/016177
WO/2006/121639
232322133/
4711
187051
‫שיטה לייצור נעליים‬
G01R
‫מערכת חיישן השראתית מוגנת סבילית‬
‫עבור סינון כח אדם‬
C11D
‫תכשיר לטיפול בבדים המכיל מרכיב‬
‫המיטיב עם בד או עור ועטוף בפולימר‬
G01N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
COMPETITIVE PARTICLE
IMMUNOASSAY METHODS
UTILIZING FLUORESCENT
MICROSCOPY
EMBREX, INC.
US
60/679717
11/05/2005
PCT/US/2006/018085
WO/2006/124456
3023221332
‫שיטות תחרותיות של חלקיקי אימיונואסיי‬
‫בניצול פלואורואסנס מיקרוסקופיים‬
187052
METHOD AND APPARATUS FOR
POSITIONING A BIVENTRIVULAR
PACEMAKER LEAS AND
ELECTRODE
PAIEON INC.
A61N
‫שיטה ומערכת למיקום התקן דו–חדרי‬
PCT/IL/2005/000462
WO/2006/117773
2/2322133/
187053
METHOD AND SYSTEM FOR
REPORTING EVOLVED UTRAN
CAPABILITIES
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/682634
19/05/2005
115441401
1158451884
US
PCT/US/2006/018834
WO/2006/124840
122302133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187054
H04Q
‫שיטה ומערכת לדיווח יכולות מתפתחות‬
UTRAN ‫של‬
C07D
4712
‫צורות גבישיות חדשות של טיאוטרופיום‬
‫ברומיד‬
NOVEL CRYSTALLINE FORMS OF
TIOTROPIUM BROMIDE
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
60/676760
02/05/2005
PCT/EP/2006/061765
WO/2006/117300
122302133/
187055
‫צורות גבישיות חדשות של תיאוטרופיום‬
‫ברומיד‬
NOVEL CRYSTALLINE FORMS OF
TIOTROPIUM BROMIDE
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
60/676807
02/05/2005
PCT/EP/2006/061763
WO/2006/117299
222322133/
187056
SYNTHESIS OF BIS (THIOHYDRAZIDE AMIDE) SALTS
SYNTA PHARMACEUTICALS CORP.
US
60/681263
16/05/2005
PCT/US/2006/018653
WO/2006/124736
022232133/
4713
C07C
)‫סינטזה של מלחי ביס (תיאו–הדרזיד אמיד‬
187057
F24F
‫מערכת אוורור לשימוש עם קופסת‬
‫הפרשות‬
‫רון‬-‫חנן בן‬
VENTILATION SYSTEM FOR USE
WITH LITTER BOXES
HANAN BEN-RON
322322133/
C07D
187059
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
MONO-LYSINE SALTS OF AZOLE
COMPOUNDS
EISAI R & D MANAGEMENT CO. LTD.
US
60/676932
03/05/2005
PCT/JP/2006/309435
WO/2006/118351
3/23221332
187060
BASE STATION SYNCHRONIZATION
FOR HANDOVER IN A HYBRID
GSM/CDMA NETWORK
QUALCOMM INCORPORATED
US
09/479414
07/01/2000
PCT/US/2001/000574
WO/2001/052567
3/23221332
187061
BASE STATION SYNCHRONIZATION
FOR HANDOVER IN A HYBRID
GSM/CDMA
NETWORK
QUALCOMM INCORPORATED
US
479414
07/01/2000
PCT/US/2001/000574
WO/2001/052567
3/23221332
187062
BASE STATION SYNCHRONIZATION
FOR HANDOVER IN A HYBRID
GSM/CDMA NETWORK
QUALCOMM INCORPORATED
US
09/479414
07/01/2000
PCT/US/2001/000574
WO/2001/052567
3/23221332
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187063
‫מלחי מונוליזין של תרכובות אזול‬
H04Q
‫סנכרון תחנת בסיס למסירה ברשת‬
CDMA/GSM ‫משולבת‬
H04Q
‫סנכרון תחנת בסיס למסירה ברשת‬
GSM/CDMA ‫משולבת‬
H04Q
‫סנכרון תחנת בסיס למסירה ברשת‬
CDMA/GSM ‫משולבת‬
H04Q
4714
BASE STATION SYNCHRONIZATION
FOR HANDOVER IN A HYBRID
GSM/CDMA
NETWORK
QUALCOMM INCORPORATED
US
09/479414
07/01/2000
PCT/US/2001/000574
WO/2001/052567
3223221332
187064
SYSTEM FOR RAPID ANALYSIS OF
MICROBIOLOGICAL MATERIALS IN
LIQUID SAMPLES
RON EMBURGH
‫סנכרון תחנת בסיס למסירה ברשת‬
GSM/CDMA ‫משולבת‬
G01N
‫שיטה לאנליזה מהירה של חומרים‬
‫מיקרוביולוגיים בדגימות נוזליות‬
PCT/CA/2005/000686
WO/2006/116835
122302133/
187065
G09G
‫מערכת ושיטה להנעת אלמנטים של‬
–‫תצוגה במערכות מיקרו‬
‫אלקטרומכאניקליות‬
SYSTEMS AND METHODS OF
ACTUATING MEMS DISPLAY
ELEMENTS
QUALCOMM INCORPORATED
US
60/678473
05/05/2005
PCT/US/2006/015696
WO/2006/121608
3/23221332
187066
BASE STATION SYNCHRONIZATION
FOR HANDOVER IN A HYBRID
GSM/CDMA NETWORK
QUALCOMM INCORPORATED
US
09/479414
07/01/2000
PCT/US/2001/000574
WO/2001/052567
3/2322133/
4715
187067
H04Q
‫סנכרון תחנת בסיס למסירה ברשת‬
GSM/CDMA ‫משולבת‬
G11B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
IMAGING AND ANALYSIS OF
MOVEMENT OF ERYTHROCYTES IN
BLOOD VESSELS IN RELATION TO
THE CARDIAC CYCLE
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/678238
06/05/2005
PCT/US/2006/017645
WO/2006/121984
322222133/
‫ידע חברה למחקר ופיתוח בע"מ‬
187070
A UNIVERSAL MULTIFUNCTIONAL
STRETCHER - FRIEDMAN'S METHOD
MISHA FRIEDMAN
322222133/
‫דימות ואנליזה של תנועת ארירוציטים‬
‫בכלי דם ביחס למחזור הלב‬
‫אלונקה אוניברסלית רב תכליתית – שיטת‬
‫פרידמן‬
‫מישה פרידמן‬
187071
NOVEL ULTRA LOW POWER, OFDM
TRANSMITTER
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
322222133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61G
187072
H04L
‫ חדשני בעל צריכת הספק‬OFDM ‫משדר‬
‫נמוכה ביותר‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
H04J
4716
‫ חדשני בעל צריכת הספק‬OFDM ‫מקלט‬
‫נמוכה יותר‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
NOVEL, ULTRA LOW POWER, OFDM
RECEIVER
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
322222133/
187073
RADIX 2, CURRENT MODE
FLOATING GATE MULTIPLIER
BUTTERFLY CELL FOR FFT, IFFT
AND LINEAR BLOCK TRANSFORM
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
322222133/
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
322222133/
4717
‫ הפועל באופן‬/ ‫מעגל פרפר מסוג רדיקס‬
‫זרם והבנוי מטרנזיסטור בעל שער‬
‫ והמטמרות בלוק‬FFT,IFFT ‫להטמרות‬
‫לניאריות‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
187074
RADIX 4, CURRENT MODE
FLOATING GATE MULTIPLIER
BUTTERFLY CELL FOR FFT, IFFT
AND LINEAR BLOCK TRANSFORM
G06F
G06F
‫ הפועל באופן‬4 ‫מעגל פרפר מסוג רדיקס‬
‫זרם והבנוי מטרנזיסטור בעל שער צף‬
‫ והמטמרות בלוק‬FFT,IFFT ‫להמטרות‬
‫לניאריות‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
187075
H04L
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
CURRENT MODE MICRO POWER
MULTIPLIER WITH FLOATING GATE
OFFSET CANCELLATION
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
322222133/
187076
NOVEL ULTRA LOW POWER
SYNCHRONIZATION CIRCUIT FOR
OFDM RECEIVER
A.M.P.S-ADVANCED MICRO POWER
SEMI-CONDUCTORS L.T.D
322222133/
187077
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H04L
OFDM ‫מעגל סינכרון חדשני למקלט‬
‫בצריכת הספק נמוכה ביותר‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
G08B
‫שיטת בקרה לפיקוח אבטחה בבקרה‬
‫מרחוק‬
REMOTE CONTROL SECURITY
SUPERVISORY CONTROL METHOD
EVERSPRING INDUSTRY CO., LTD
312322133/
‫מכפל הפועל באופן זרם הבנוי עם‬
‫טרנזיסטור בעל שער צף לקיזוז שער‬
‫היסט‬
‫אדבנסד מיקרופאואר‬-‫אס‬.‫פי‬.‫אם‬.‫איי‬
‫סמיקונדקטורס בע"מ‬
187078
C12N
4718
A PHARMACEUTICAL COMPOSITION
CONTAINING AN AAV VECTOR
GENZYME CORPORATION
US
60/677057
02/05/2005
485404080
4158451884
US
PCT/US/2006/017242
WO/2006/119458
302322133/
187079
AN OLIGOADENYLATE
SYNTHETASE 1 PROTEIN,
THERAPEUTIC COMPOSITIONS
CONTAINING THE SAME AND
SCREENING METHODS
ILLUMIGEN BIOSCIENCES, INC.
US
60/677680
04/05/2005
PCT/US/2006/016983
WO/2006/119363
322222133/
187080
A DIAGNOSTIC METHOD AND
APPARATUS
MED-I-DYNAMIX FLUID
MONITORING LTD.
102322133/
4719
AAV ‫תכשיר רוקחות המכילים וקטור‬
C12N
‫ תכשירי‬,0 ‫חלבון אוליגואדנילט סינתטז‬
‫רוקחות המכילים אותו ושיטות לסינון‬
A61B
‫שיטה והתקן איבחוני‬
‫דינמיקס ניטור נוזלים בע"מ‬-‫י‬-‫מד‬
187081
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
MICROORGANISM AND PROCESS
FOR PRODUCTION OF MACROLIDE
COMPOUND USING THE SAME
‫מיקרואורגניזם ושיטה להכנת תרכובת‬
‫מקרולידית המשתמשת בו‬
MERCIAN CORPORATION
2005JP
26/05/2005
154114
PCT/JP/2006/310835
WO/2006/126723
322222133/
187082
METHOD AND DEVICE FOR
PROVIDING DATA CAPABILITIES TO
VIDEO TERMINALS
OPOINT-MEDIA LTD
2/2322133/
187083
PRETREATMENT OF A BIOLOGICAL
SAMPLE FROM AN AUTOIMMUNE
DISEASE SUBJECT
GENENTECH, INC.
US
60/682990
20/05/2005
PCT/US/2006/019576
WO/2006/127517
122322133/
INTEGRATED NATIVE LANGUAGE
TRANSLATION
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187084
H04N
‫שיטה והתקן להקניית יכולות מידע‬
‫למסופי ווידאו‬
‫אייפוינט מדיה בע"מ‬
G01N
‫טיפול מקדים של דגימה ביולוגית מאדם‬
‫הלוקה במחלה אוטואימונית‬
G06F
‫מתרגם משולב לשפת מקור‬
4720
MICROSOFT CORPORATION
US
11/137894
26/05/2005
PCT/US/2006/020370
WO/2006/127965
322222133/
187086
BONE PLATE WITH VARIABLE
TORSIONAL STIFFNESS AT FIXED
ANGLE HOLES
DEPUY PRODUCTS INC
US
11/557429
07/11/2006
312322133/
SOLID REDISPERSIBLE EMULSION
DEGUSSA GMBH
4721
‫לוחית עצם עם קשיחות פיתול משתנה‬
‫בחורים זוויתיים קבועים‬
187087
CRYSTALLINE FORM OF 1 - CHLORO
- 4 - (? - D - GLUCOPYRANOS - 1 - YL)
- 2 - [4-((S) - TETRAHYDROFURAN - 3
- YLOXY) -BENZYL]- BENZENE, A
METHOD FOR ITS PREPARATION
AND THE USE THEREOF FOR
PREPARING MEDICAMENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05009669.2 03/05/2005
8481081144
1858051884
EP
PCT/EP/2006/061956
WO/2006/117359
302322133/
A61B
C07D
– D – ?( – 4– ‫ – כלורו‬0 ‫צורה גבישית של‬
– )S(– 4[ – / – )‫ – איל‬0 – ‫גלוקופיראנוז‬
]‫ – אילאוקסי) בנזיל‬: – ‫טטראהידרופוראן‬
‫ שיטה לייצורו ושימוש ליצור תרופות‬,‫בנזן‬
187088
B01J
‫אמולסיה מוצקה הניתנת לבידור מחדש‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
DE
102005020551.8
PCT/EP/2006/062019
WO/2006/117385
322222133/
03/05/2005
187089
DEVICE USER INTERFACE
INCLUDING MULTI-REGION USER
INTERACTION SURFACE
EMBLAZE MOBILE LTD
US
11/860597
25/09/2007
3/2322133/
202302133/
‫מתקן ממשק הכולל משטח רב–אזורי‬
‫לתקשורת בין משתמשים‬
‫אמבלייז מובייל בע"מ‬
187090
ANTIGEN BINDING MOLECULES
HAVING MODIFIED Fc REGIONS
AND ALTERED BINDING TO Fc
RECEPTORS
GLYCART BIOTECHNOLOGY AG
US
60/678776
09/05/2005
PCT/IB/2006/002888
WO/2007/039818
187091
187093
POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE
OTO MELARA S.P.A.
TO2006A
IT
15/12/2006
000894
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07K
Fc ‫מולקולות קושרות אנטיגן בעלות אתרי‬
Fc ‫משתנים וקישור משתנה לרצפטורי‬
POWER ABSORBER SYSTEM AND
METHOD
RAYTHEON COMPANY
US
11/129262
12/05/2005
PCT/US/2006/009040
WO/2006/124104
322222133/
G06F
H03G
‫מערכת ושיטה לספיגת כוח‬
B60K
‫גלגל המונע בכח לרכב צבאי‬
4722
312322133/
187094
C12Q
COMPOSITION AND METODS FOR
CANCER DIAGNOSIS UTILIZING THE
MIR 17-92 CLUSTER
UNIVERSITIY OF NORTH CAROLINA
US
60/677090
02/05/2005
PCT/US/2006/016987
WO/2006/119365
112322133/
‫תרכובת ושיטות לאבחון סרטן‬
MIR 07–6/ ‫המשתמשות במקבץ‬
187095
‫תולדות חדשות של כרומן או‬
‫טטרהידרונפטלן המותמרות באמינו‬
‫ המווסתות את‬: – ‫ – סולפוניל‬0 ‫בעמדה‬
‫הרצפטור‬
HT6.
NOVEL 8 - SULFONYL - 3
AMINOSUBSTITUTED CHROMAN OR
TETRAHYDRONAPHTALENE
DERIVATIVES MODULATING THE
5HT6 RECEPTOR
ASTRAZENECA AB
SE
0501165-5
8481144-1
SE
PCT/SE/2006/000592
WO/2006/126938
122322133/
23/05/2005
1458451884
187096
FILTERING DEVICE FOR FILTERING
WATER AND LIQUIDS IN GENERAL
LAICA S.P.A.
IT
PD2005A000153 25/05/2005
48144 810 84
1451151884
EP
4723
C07C
C02F
‫מכשיר סינון לסינון מים ונוזלים באופן‬
‫כללי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PCT/IT/2006/000393
WO/2006/126237
3223/21333
187097
METHODS AND COMPOSITIONS FOR
DETECTING PATHOLOGICAL
EVENTS
EXONHIT THERAPEUTICS S.A.
FR
99/11563
16/09/1999
PCT/FR/2000/002439
WO/2001/020027
2/2322133/
‫שיטות והרכבים לגילוי מקרים פתולוגיים‬
187098
DERIVATIVES OF 4 - (2 - AMINO - 1
HYDROXYETHYL) PHENOL AS
AGONISTS OF THE BETA2
ADRENERGIC RECEPTOR
LABORATORIOS ALMIRALL, S.A.
ES
P200501229 20/05/2005
PCT/EP/2006/004680
WO/2006/122788
112322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07C
– 0 – ‫ – אמינו‬/( – 4 ‫נגזרות של‬
‫הידרוקסיאתיל) פנול כאגוניסטים‬
/‫לרצפטור האדרינרגי בטא‬
187099
NOVEL 8-SULFONYLAMINO - 3
AMINOSUBSTITUTED CHROMAN OR
TETRAHYDRONAPHTALENE
DERIVATIVES MODULATING THE
5HT6 RECEPTOR
ASTRAZENECA AB
C12Q
C07C
‫תולדות חדשות של כרומן או‬
‫טטרהידרונפטלן המותמרות באמינו‬
‫ המווסתות‬: – ‫ – סולפונילאמינו‬0 ‫בעמדה‬
HT59 ‫את הרצפטור‬
4724
SE
0501166-3
8481140-8
SE
PCT/SE/2006/000593
WO/2006/126939
23/05/2005
1458451884
2/2322133/
187100
HIGH - LEVEL EXPRESSION OF
RECOMBINANT ANTIBODY IN A
MAMMALIAN HOST CELL
LONZA BIOLOGICS PLC.
GB
0510277.7
20/05/2005
841144444
8458451884
GB
841444140
1051151884
GB
PCT/EP/2006/004767
WO/2006/122822
322222133/
187101
FILTER CONNECTOR WITH HIGH
FREQUENCY SHIELD
ITT MANUFACTURING
ENTERPRISES, INC.
US
60/860117
20/11/2006
312322133/
187102
SYSTEM AND METHOD FOR 3 - D
POSITION DETERMINATION USING
RFID
C07K
‫ביטוי ברמה גבוהה של נוגדן רקומביננטי‬
‫בתא מאכסן של יונק‬
H05K
‫מחבר של מסנן עם מגן לתדר גבוה‬
G08B
‫מערכת ושיטה לקביעת מיקום שלושה‬
‫ממדים תוך שימוש בזיהוי תדרי רדיו‬
))RFID
QUALCOMM INCORPORATED
US
11/121403
03/05/2005
PCT/US/2006/017123
4725
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
WO/2006/119412
322322133/
SYSTEM FOR IMAGE
RECONSTRUCTION
ULTRASPECT LTD
US
60/676311
PCT/IL/2006/000520
WO/2006/117781
187103
G06T
‫מערכת לשחזור דמות‬
‫אולטראספקט בע"מ‬
02/05/2005
302322133/
187105
NOVEL COMPUNDS AS GLP-I
AGONISTS
CADILA HEALTHCARE LTD.
IN
558/MUM/2005 05/05/2005
IN
MUM/20055444 4158451884
PCT/IN/2006/000154
WO/2007/017892
1/2302133/
187106
SCLEROSTIN BINDING AGENTS
UCB PHARMA S.A.
US
60/677583
03/05/2005
485444044
1458151884
US
485401144
1458451884
US
485481444
1458451884
US
115411884
1458451884
US
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07K
GLP–I ‫תרכובות חדשות כמעכבי‬
C07K
‫חומרים קושרי סקלרוזין‬
4726
PCT/US/2006/016441
WO/2006/119107
312322133/
187108
HUMAN MONOCLONAL
ANTIBODIES TO PROGRAMMED
DEATH 1 (PD-1) AND METHODS FOR
TREATING CANCER USING ANTI - PD
- 1 ANTIBODIES ALONE OR IN
COMBINATION WITH OTHER
IMMUNOTHERAPEUTICS
ONO PHARMACEUTICAL CO., LTD.
US
60/679466
09/05/2005
485440444
1151151884
US
485440818
8051151884
US
PCT/JP/2006/309606
WO/2006/121168
212322133/
‫נוגדנים הומניים חד–שבטיים למוות מתוכנן‬
‫) ושיטות לטיפול בסרטן בעזרת‬PD–0( 0
‫ לבדם או בשילוב עם‬PD – 0 – ‫נוגדנים אנטי‬
‫טיפולים חיסוניים אחרים‬
187109
ACCESS AND CLOSURE DEVICE AND
METHOD
ARSTASIS, INC.
US
60/680388
12/05/2005
PCT/US/2006/018915
WO/2006/124896
1/2302133/
187110
METHOD FOR COATING A
SUBSTRATE SURFACE AND COATED
PRODUCT
H. C. STARCK GMBH
US
60/678057
05/05/2005
PCT/EP/2006/003967
WO/2006/117144
4727
C12N
A61B
‫התקן ושיטה לגישה ולסגירה‬
C23C
‫שיטה לציפוי פני שטח של סובסטרט‬
‫ומוצר מצופה‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
3/2322133/
187111
USE OF TFPI TO TREAT SEVERE
BACTERIAL INFECTIONS
NOVARTIS AG
US
60/678465
06/05/2005
PCT/US/2006/017956
WO/2006/122139
032322133/
187112
INDUCTIVELY POWERED REMOTE
OXYGEN SENSOR
GLAXO GROUP LIMITED
US
60/686594
02/06/2005
PCT/US/2006/020666
WO/2006/130528
322322133/
187113
VASCULAR DISEASE THERAPIES
FIBROGEN, INC.
US
60/678495
05/05/2005
485488844
1458451884
US
485444444
8451151884
US
PCT/US/2006/017759
WO/2006/122046
322322133/
187114
DIAGNOSTIC MARKER FOR
DIABETIC VASCULAR
COMPLICATIONS
FIBROGEN, INC.
US
60/678251
05/05/2005
PCT/US/2006/017755
WO/2006/122043
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫ לטיפול בזיהומים‬TFPI ‫שימוש ב‬
‫בקטריאליים חריפים‬
G01N
‫גלאי חמצן הנשלט מרחוק ומופעל‬
‫בהשראה‬
C07K
‫תרופות למחלות כלי דם‬
G01N
‫סמן אבחוני לסיבוכי סכרת בכלי דם‬
4728
322322133/
187115
CARDIOVASCULAR DISEASE
THERAPIES
FIBROGEN, INC.
US
60/678495
05/05/2005
485488844
1458451884
US
485444444
8451151884
US
PCT/US/2006/017760
WO/2006/122047
302322133/
187116
A METHACRYLATE-BOUND
PHOTOISOMERIZABLE
CHROMOPHORE, METHODS FOR ITS
SYNTHESIS AND OF ITS
INTERMEDIATES
MEMPILE INC.
US
60/677824
05/05/2005
PCT/IL/2006/000536
WO/2006/117791
232322133/
187117
CURRENT SENSOR
CORPORATION NUVOLT INC.
US
60/679997
12/05/2005
PCT/CA/2006/000760
WO/2006/119634
4729
C07K
‫תרופות למחלות כלי דם לבביים‬
C07C
‫כרומופור מתאקרילאטי ושיטה להכנתו‬
G01R
‫חיישן זרם‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
302322133/
187118
FAST SECURE SESSION ON HALFDUPLEX VOICE NETWORK
CHANNELS
MOTOROLA, INC.
US
11/132707
18/05/2005
PCT/US/2006/017357
WO/2006/124326
302322133/
187119
METHOD AND APPARATUS FOR
RAPID SECURE SESSION
ESTABLISHMENT ON HALF-DUPLEX
AD-HOC GROUP VOICE CELLULAR
NETWORK CHANNELS
MOTOROLA, INC.
US
11/132643
18/05/2005
PCT/US/2006/016928
WO/2006/124286
312322133/
187120
PHARMACEUTICAL COMPOSITIONS
COMPRISING CASEIN DERIVED
PEPTIDES AND METHODS OF USE
THEREOF
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H04L
‫תקשורת מהירה ומאובטחת בערוצי קול‬
‫חד– כיווניים ברשת‬
H04B
‫שיטה ומערכת לייסוד תקשורת מהירה‬
‫ומאובטחת בערוצי רשת קול סלולריים‬
‫חד–כיוונים קבוצתיים‬
A61K
‫תכשירים רפואיים המכילים פפטידים‬
‫שנגזרים מקזאין ושיטות לשימוש בהם‬
4730
THE STATE OF ISRAEL- MINISTRY
OF AGRICULTURE & RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION
VOLCANI CENTER
US
60/676292
02/05/2005
485400484
8858451884
US
PCT/IL/2006/000524
WO/2006/117784
2/2302133/
187121
COMPOSITIONS FOR THE REMOVAL
OF POST-ETCH AND ASHED
PHOTORESIST RESIDUES AND BULK
PHOTORESIST
MALLINCKRODT BAKER, INC.
US
60/678534
06/05/2005
PCT/US/2006/014466
WO/2006/121580
302322133/
4731
A61K
‫טיפול במחלות תוך שימוש בתאים מתים‬
‫או גוססים‬
‫טולרקס בע"מ‬
187123
AUTOMATED IMAGE ANALYSIS
CYTYC CORPORATION
US
11/120437
02/05/2005
PCT/US/2006/015720
G03F
‫תכשירים להורדת שאריות שעברו חריטה‬
‫ושאריות אפר של חומר פעיל אור וחומר‬
‫פעיל אור‬
187122
DISEASE THERAPY USING DYING
OR DEAD CELLS
TOLAREX LTD.
US
11/121048
04/05/2005
PCT/IL/2006/000527
WO/2006/117786
122302133/
‫מילאוטיס בע"מ‬
G06T
‫ניתוח תמונה אוטומטי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
WO/2006/118888
3/2322133/
187124
‫מערכת משולבת לשכפול ולהדפסה‬
‫דיגיטאלית‬
‫קורנית דיגיטל בע"מ‬
COMBINED STENCIL AND DIGITAL
PRINTING SYSTEM
KORNIT DIGITAL LTD.
US
11/123201
06/05/2005
PCT/IL/2006/000526
WO/2006/120668
302322133/
187125
PHTHALOCYANINE DERIVATIVES,
PROCESS FOR THEIR PREPARATION,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM, AND THEIR USE
L. MOLTENI & C. DEI FRATELLI
ALITTI SOCIETA' DI ESERCIZIO S.P.A.
IT
FI2005A00092 05/05/2005
PCT/EP/2006/062062
WO/2006/117399
2122121332
187126
PROCESS FOR THE PREPARATION
OF 4 HALOALKYLNICOTINONITRILES
BAYER CROPSCIENCE AG
DE
10061967.3 13/12/2000
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
B41L
C07D
,‫ שיטות לייצורם‬,‫נגזרות פתלוציאנין‬
‫תכשירים רוקחיים המכילים אותם‬
‫ושימוש בהם‬
C07D
– 4 ‫תהליך להכנת‬
‫הלואלקילניקוטינוניטרילים‬
4732
1811801844
DE
1814441144
DE
PCT/EP/2001/014584
WO/2002/048111
1458451881
1158851881
302322133/
187127
PROCESS FOR PREPARING CHLORIDES
OF PHTHALOCYANINE DERIVATIVES
COMPRISING AT LEAST A
QUATERNARY AMMONIUM GROUP
L. MOLTENI & C. DEI FRATELLI ALITTI
SOCIETA' DI ESERCIZIO S.P.A.
IT
FI2005A000093 05/05/2005
PCT/EP/2006/062059
WO/2006/117396
3222121332
‫תהליך ליצירת כלורידים של נגזרות‬
‫פטאלוציאנינים המכילים לפחות קבוצת‬
‫אמוניות רבעוני‬
187129
IMPROVEMENTS RELATING TO
STRUTLESS-TYPE UMBRELLA
CHAIM SIMCHA AMZEL
IL
PCT/IL2005/000450 01/05/2005
485411440
8451851884
US
PCT/IL/2005/001296
WO/2006/117774
302322133/
TURNOVER PROBES AND USE
THEREOF FOR NUCLEIC ACID
DETECTION
ENSEMBLE DISCOVERY
CORPORATION
4733
C07D
187130
A45B
‫שכלולים המתייחסים למטריה‬
‫חסרת תמוכות‬
‫חיים שמחה אמזל‬
C12Q
‫מאבחני תחלופת תאים ושימוש בהם‬
‫לגילוי חומצת גרעין‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
US
60/677056
PCT/US/2006/016999
WO/2007/008276
03/05/2005
322322133/
187132
INSULATED GLAZING UNITS AND
METHODS
DAVID H. STARK
US
60/678570
06/05/2005
485484444
1158051884
US
115401444
8458451884
US
115401441
8458451884
US
PCT/US/2006/017595
WO/2006/121954
222322133/
‫יחידות זיגוג מבודדות ושיטות‬
187133
187134
AMINOPIPERIDINE QUINOLINES
AND THEIR AZAISOSTERIC
ANALOGUES WITH ANTIBACTERIAL
ACTIVITY
ASTRAZENECA AB
US
60/684030
24/05/2005
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
F25B
‫מקרר קריאוגנטי מצב–מוצק‬
SOLID STATE CRYOCOOLER
RAYTHEON COMPANY
US
11/130424
06/05/2005
PCT/US/2006/018561
WO/2006/124679
102322133/
H01H
C07D
‫אמינופיפרידין קווינולינים והאנלוגים‬
–‫האזאיזוסטריים שלהם בעלי פעילות אנטי‬
‫בקטריאלית‬
4734
PCT/GB/2006/001889
WO/2006/125974
102302133/
187135
2-AMIDO-6-AMINO-8-OXOPURINE
DERIVATIVES AS TOLL-LIKE
RECEPTOR MODULATORS FOR THE
TREATMENT OF CANCER AND
VIRAL INFECTIONS, SUCH AS
HEPATITIS C
PFIZER LIMITED
US
60/678054
04/05/2005
PCT/IB/2006/001181
WO/2006/117670
3/2322133/
3/2322133/
G06F
‫מעגל חשמלי לחיזוי אלמנט–סרק ולוגיקה‬
‫מונעת הנעה‬
187137
APPARATUS AND METHOD FOR
CHANNEL INTERLEAVING IN
COMMUNICATIONS SYSTEM
QUALCOMM INCORPORATED
US
60/680855
12/05/2005
115484448
1451151884
US
PCT/US/2006/017993
4735
‫ – אמינו – אוקסופורין‬9 – ‫–אמידו‬/ ‫תולדות‬
‫ לטיפול‬, TOLL ‫כמאפנני רצפטורים דמויי‬
.C ‫בסרטן וזיהומים נגיפיים כגון הפטיטיס‬
187136
IDLE-ELEMENT PREDICTION
CIRCUITRY AND ANTI-THRASHING
LOGIC
QUALCOMM INCORPORATED
US
11/126442
10/05/2005
PCT/US/2006/017880
WO/2006/122102
C07D
H03M
‫מתקנים ושיטה למרווחי ערוץ במערכות‬
‫תקשורת‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
WO/2006/124428
2/2322133/
187138
COMPOSITIONS AND METHODS FOR
TREATING CONDITIONS RELATED
TO EPHRIN SIGNALING WITH
CUPREDOXINS
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
60/682812
20/05/2005
115144184
8451851884
US
485444448
8458151884
US
PCT/US/2006/019684
WO/2007/018671
232322133/
‫הרכבים ושיטות לטיפול במצבים‬
‫הקשורים בסינגלים של אפרין באמצעות‬
‫קופרדוקסינים‬
187139
IRRIGATION SYSTEM AND
ASSOCIATED METHODS
HYMAN D. GESSER
US
11/126073
10/05/2005
PCT/CA/2006/000749
WO/2006/119628
302222133/
187140
HIGH FREQUENCY ELECTRONIC
BALLAST FOR HIGH INTENSITY
DISCHARGE LAMPS AND IMPROVED
DRIVE METHOD THEREFOR
METROLIGHT LTD.
US
11/559897
15/11/2006
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07K
A01G
‫מערכת השקייה ושיטות קשורות‬
H05B
‫בלסט אלאקטרוני בתדר גבוה עבור‬
‫מנורות בעלות פריקה בעוצמה גבוהה‬
‫ושיטת הנעה משופרת‬
‫מטרולייט בע"מ‬
4736
322322133/
187141
RECOMBINANT ANTIBODIES
AGAINST CD55 AND CD59 AND USES
THEREOF
QUARK PHARMACEUTICALS, INC.
US
60/677752
04/05/2005
485488814
1458451884
US
485444848
8451151884
US
PCT/IL/2006/000521
WO/2006/117782
3122321331
187143
PHENYL-PIPERAZINE DERIVATIVES
AS SEROTONIN REUPTAKE
INHIBITORS
H. LUNDBECK A/S
DK
PA200101466 04/10/2001
PCT/DK/2002/000659
WO/2003/029232
302222133/
DOLL AND DOLL KIT
DALIT KAHAN
4737
187144
A61K
CD.. ‫ ו‬CD.6 ‫נוגדנים רקומביננטים ל‬
‫ושימושם‬
C07D
‫נגזרות פניל–פיפרזין כמעכבי ספיגה‬
‫מחדש של סרוטונין‬
A63H
‫בובה וערכת בובה‬
‫דלית קהן‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
302322133/
187145
METHOD AND APPARATUS FOR
INCREASING PERFORMANCE OF
HTTP OVER LONG-LATENCY LINKS
VENTURI WIRELESS,
INCORPORATED
US
11/122868
04/05/2005
PCT/US/2006/017278
WO/2006/119465
302322133/
1/2302133/
‫ דרך‬HTTP ‫שיטה והתקן להגברת ביצועי‬
‫קישורים ארוכים מוסווים‬
187146
RESOURCE ALLOCATION IN MULTIACCESS POINT WIRELESS
NETWORKS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/677561
04/05/2005
115144444
8158451884
US
PCT/US/2006/016932
WO/2006/119338
AUTOMATIC MECHANISM FOR
LOCKING AND OPENING OF DOOR
SAFETY DOOR LTD
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H04Q
–‫חלוקת משאבים במערכות תקשורת אל‬
‫חוטיות לרבות נקודות כניסה‬
187147
LIFTING APPLIANCE OR JACK FOR
VEHICLE
JAMES HOWARD
FR
0504270
26/04/2005
PCT/IB/2006/001014
WO/2006/114694
322222133/
G06F
187148
B66F
‫התקן להרמה או מנוף לכלי רכב‬
E05B
‫מנגנון נעילה ופתיחה אוטומטי לדלת‬
‫סייפטי דור בע"מ‬
4738
322222133/
187149
CONTROL MECHANISM FOR
LOCKING OF ENTRANCE DOORS
SAFETY DOOR LTD
322222133/
‫מנגנון שליטה לנעילה של דלת כניסה‬
‫סייפטי דור בע"מ‬
187150
A SAFETY LOCK FOR ENTRANCE
DOORS THAT IS CONCEALED IN THE
DOOR AND DOOR JAMP
SAFETY DOOR LTD
322222133/
187151
STRAIGHT JAMP FOR ENTRANCE
DOOR
SAFETY DOOR LTD
4739
E05B
‫סגר ביטחון לדלת כניסה החבוי בתוך‬
‫המשקוף והדלת‬
‫סייפטי דור בע"מ‬
E05D
‫ציר נסתר לדלת‬
‫סייפטי דור בע"מ‬
CONCEALED DOOR HINGE
SAFETY DOOR LTD
322222133/
E05B
187152
E05D
‫משקוף ישר לדלת כניסה‬
‫סייפטי דור בע"מ‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
322222133/
187153
MECHANISIM FOR SEALING AND
STOPPING DOOR AT VARIED
OPENING ANGLES
SAFETY DOOR LTD
322222133/
‫מנגנון אטימה ועצירת דלת בזווית פתיחה‬
‫משתנה‬
‫סייפטי דור בע"מ‬
187154
‫עו"ד יונתאן כותאב‬
187155
PROCESS FOR PRODUCTION OF 4BIPHENYLAZETIDIN-2-ONES
MICROBIA, INC.
US
60/678336
06/05/2005
485414818
1451851884
US
PCT/US/2006/017706
WO/2006/122020
322222133/
MINIATURE COMPUTER POINTING
DEVICE
TOPO DITO LTD
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06F
‫ארנק אלקטרוני‬
ELECTRONIC WALLET
ELECTRONIC POCKET MONEY
COMPANY LTD.
3/2322133/
E05C
C07D
‫–אונים‬/–‫–ביפנילאזטידינ‬4 ‫תהליך להכנת‬
187156
G06N
‫מכשיר הצבעה זעיר למחשב‬
‫טופו דיטו בע"מ‬
4740
122322133/
187157
‫מחזקים של רצפטור אמפא‬
AMPA RECEPTOR POTENTIATORS
ELI LILLY AND COMPANY
EP
05380117.1 06/06/2005
8440810444
1058051884
EP
485414184
8451851884
US
PCT/US/2006/020204
WO/2006/132811
3/2322133/
187158
USE OR ANTIBODY- LIGAND
BINDING TO CHARACTERISE
DISEASES
NOVARTIS AG
GB
0509512.0
10/05/2005
PCT/EP/2006/004275
WO/2006/119942
2/2322133/
4741
G01N
‫שימוש בקישור נוגדן– ליגנד לאפיון מחלות‬
187160
COMPOSITIONS AND METHODS FOR
TREATING HIV INFECTION WITH
CUPREDOXIN AND CYTOCHROME C
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
60/682833
20/05/2005
115144184
8451851884
US
485408040
1858451884
US
PCT/US/2006/019565
WO/2006/127514
C07D
C07K
‫ עם‬HIV ‫תרכובות ושיטות לטיפול בזיהום‬
C ‫קופרדוקסין וציטוכרום‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2/2322133/
187161
COMPOSITIONS AND METHODS FOR
TREATING MALARIA WITH
CUPREDOXIN AND CYTOCHROME
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
60/682813
20/05/2005
115144184
8451851884
US
485408040
1858451884
US
PCT/US/2006/019492
WO/2006/127477
322322133/
187162
AUTHENTICITY VERIFICATION BY
MEANS OF OPTICAL SCATTERING
INGENIA TECHNOLOGY LTD.
GB
0509635.9
11/05/2005
PCT/GB/2006/001646
WO/2006/120398
2/2322133/
187163
NOVEL FLUORENE DERIVATIVES,
COMPOSITION CONTAINING SAID
DERIVATIVES AND THE USE
THEREOF
AVENTIS PHARMA S.A.
FR
0505037
19/05/2005
PCT/FR/2006/001137
WO/2006/123061
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C12P
‫תרכובות ושיטות לטיפול המלריה עם‬
‫קופרדוקסין וציטוכרום‬
G06K
‫אימות אמינות ע"י אמצעים של פיזור‬
‫אופטי‬
C07D
‫ תרכובת‬,‫תולדות חדשה של פלוארן‬
‫ ושימוש בה‬,‫המכילה תולדות אלה‬
4742
2/2322133/
187164
MEMBRANE FOR FILTERING OF
WATER
AQUAPORIN APS
DK
PA200500740 20/05/2005
485404444
1858451884
US
DK
PA200501309 1858851884
485410088
1858851884
US
PCT/DK/2006/000278
WO/2006/122566
2/2322133/
3/23/2133/
H04Q
‫שיטה ומערכת ליישום תקשורת ללא ידיים‬
‫בין רשתות תקשורת רדיו המיישמות‬
‫טכנולוגיות שונות לגישת רדיו‬
187166
METHOD AND SYSTEM FOR
CONVEYING BACKHAUL LINK
INFORMATION FOR INTELLIGENT
SELECTION OF A MESH ACCESS
POINT
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/690244
14/06/2005
115444488
4158451884
US
PCT/US/2006/022056
WO/2006/138122
4743
‫קרום לסינון מים‬
187165
METHOD AND APPARATUS FOR
IMPLEMENTING A HANDOFF
BETWEEN RADIO ACCESS
NETWORKS DEPLOYED UNDER
DIFFERENT RADIO ACCESS
TECHNOLOGIES
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/682516
19/05/2005
485484844
1858451884
US
115411144
1458451884
US
PCT/US/2006/019007
WO/2006/124950
B01D
H04B
‫שיטה ומערכת להעברת מידע קישורי‬
‫בקהאול לבחירה מושכלת של נקודת‬
MESH ‫גישה ברשת‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2/2322133/
187168
IMPROVED NANOBODIESTM FOR
THE TREATMENT OF
AGGREGATION-MEDIATED
DISORDERS
ABLYNX N.V.
US
60/683474
20/05/2005
PCT/EP/2006/004773
WO/2006/122825
322222133/
187169
APPARATUS AND METHOD FOR
RETAINING POSITIVE PRESSURE IN
A PRESSURIZRD LIQUID
ILAN HAREL
1223/2133/
187170
SATELLITE COMMUNICATIONS
APPARATUS AND METHODS USING
ASYMMETRICAL FORWARD AND
RETURN LINK FREQUENCY REUSE
ATC TECHNOLOGIES, LLC
US
60/703842
29/07/2005
115440444
1858451884
US
PCT/US/2006/028450
WO/2007/015972
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07K
‫ננובודיס משופרים לטיפול באי סדרים‬
‫הקשורים לאגרגציה‬
B67D
‫מתקן ושיטה לשמר על לחץ חיובי בנוזל‬
‫דחוס‬
‫אילן הראל‬
H04B
‫מתקן תקשורת לוויני ושיטות לשימוש‬
‫שליחה וחזרה של חוליה מקשרת‬
‫אסימטרית לשימוש חוזר‬
4744
3/23/2133/
187171
SATELLITE COMMUNICATIONS
SYSTEMS AND METHODS USING
SUBSTANTIALLY CO-LOCATED
FEEDER LINK ANTENNAS
ATC TECHNOLOGIES, LLC
US
60/706823
09/08/2005
PCT/US/2006/030880
WO/2007/021685
322222133/
‫מערכות תקשורת לווינית ושיטות שימוש‬
‫ממשיות במזין דו מיקומי של חוליית קישור‬
‫של אנטנה‬
187172
187174
METHODS FOR REDUCING
HYDROSTATIC ORGAN PRESSURE
YAIR FELD
US
60/594772
05/05/2005
485440014
8858451884
US
PCT/IL/2006/000525
WO/2006/117785
022322133/
4745
A61F
‫ערכה לתיקון הרניה‬
‫ניר הלוי‬
HERNIA REPAIR KIT
HALEVY NIR
302322133/
H04B
A61B
‫שיטות להורדת לחץ הידרוסטטי באיברים‬
187175
‫יאיר פלד‬
C07K
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
BACKBONE CYCLIZED
MELANOCORTIN STIMULATING
HORMONE (alpha - MSH) ANALOGS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/685482
31/05/2005
PCT/IL/2006/000640
WO/2006/129317
3/2322133/
‫ בעלי‬MSH – alpha ‫אנלוגים של‬
‫ציקליזציית שלד‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
187177
F41C
‫נרתיק לאקדח בעל נעילה אוטומטית‬
‫ובטיחות גבוהה‬
AUTOMATICALLY LOCKING HIGH
SECURITY HOLSTER
JOHN, N. RASSIAS
US
60/678504
06/05/2005
PCT/US/2006/017608
WO/2006/121965
3/23/22///
187179
PROCESS FOR PREPARING
DOCOSAHEXAENOIC ACID AND
DOCOSAPENTAENOIC ACID
SUNTORY LIMITED
JP
8/193516
23/07/1996
PCT/JP/1997/001946
WO/1998/003671
3222321333
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫שיטה להכנת חומצת דוכוסאהקסאנוית‬
‫וחומצת דוכוסאפנטאנוית‬
187180
E04C
4746
‫רכיבי בניין מחומר מרוכב ושיטה‬
‫לייצורם‬
COMPOSITE BUILDING COMPONENTS,
AND METHOD OF MAKING SAME
MASONITE CORPORATION
US
09/538766
30/03/2000
US
PCT/US00/8520 4858451888
PCT/US/2000/027575
WO/2001/075245
2/23/22///
187181
C07D
POLYMORPH OF A
PHARMACEUTICAL
ABBOTT LABORATORIES
US
09/119345
20/07/1998
885414884
8458451888
US
PCT/US/1999/016334
WO/2000/004016
1/2322133/
‫פולימורף של חומר רוקחי‬
187182
CARTRIDGE FOR STORAGE AND
DELIVERY OF A TWO-PHASE
COMPOUND
TECRES S.P.A.
IT
VI2005A000152 20/05/2005
PCT/IB/2006/000148
WO/2006/123205
3/2322133/
187183
PHARMACEUTICAL FORMULATION
OF APOMORPHINE FOR BUCCAL
ADMINISTRATION
AMARIN PHARMACEUTICALS
IRELAND LIMITED
GB
0509317.4
06/05/2005
PCT/GB/2006/001665
WO/2006/120412
4747
A61F
‫מחסנית לאחסון ואספקה של תרכובת‬
‫דו–פאזית‬
A61K
‫תכשיר רוקחות של אפו–מורפין לשימוש‬
‫דרך הלחיים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
322322133/
187184
PROCESS OF MAKING GEMINAL
BISPHOSPHONIC ACIDS AND
PHARMACEUTICALLY ACCEPTABLE
SALTS AND/OR HYDRATES
THEREOF
MEDICHEM, S.A.
US
60/678425
06/05/2005
PCT/IB/2006/002169
WO/2007/023342
2022122///
‫תהליך להכנת חומצות ביספוספוניות‬
‫או הידראטים רוקחיים‬/‫גמינליות ומלחים ו‬
‫שלהן‬
187185
CALIBRATION FOR WIRELESS
LOCATION SYSTEM
TRUEPOSITION, INC.
US
09/227764
08/01/1999
PCT/US/1999/029505
WO/2000/041403
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H04Q
‫כיול עבור מערכת איתור אלחוטית‬
187186
SUBSTITUTED OXADIAZOLE
DERIVATIVES AS POSITIVE
ALLOSTERIC MODULATORS OF
METABOTROPIC GLUTAMATE
RECEPTORS
ADDEX PHARMA SA
GB
0510138.1
18/05/2005
848148848
1458151884
GB
PCT/IB/2006/001881
WO/2006/123255
C07F
C07D
‫תולדות אוקסאדיאזול מותמרות כמאפננים‬
‫אלוסטריים חיוביים של קולטני גלוטאמאט‬
‫מטאבוטרופיים‬
4748
2/2322133/
187187
PHENYL-3-{(3-1H-PYRROL-2-YL)[1,2,4]OXADIAZOL-5-YL]PIPERIDIN1-YL}-METHANONE DERIVATIVES
AND RELATED COMPOUNDS AS
POSITIVE ALLOSTERIC
MODULATORS OF METABOTROPIC
GLUTAMATE RECEPTORS
ADDEX PHARMA SA
GB
0510141.5
18/05/2005
PCT/IB/2006/002047
WO/2006/123257
3123/2133/
2/2322133/
A61K
‫מולקולות אינטרפרון משופרות ושימושיהן‬
187189
NOVEL HETEROCYCLIC
COMPOUNDS AS POSITIVE
ALLOSTERIC MODULATORS OF
METABOTROPIC GLUTAMATE
RECEPTORS
ADDEX PHARMA SA
GB
0510139.9
18/05/2005
PCT/IB/2006/001882
WO/2006/129199
4749
–)‫–איל‬/–‫–פירול‬H0(–:{–:–‫תולדות פניל‬
–0–‫–איל]פיפרידין‬.–‫]אוקס דיאזול‬4,/,0[
‫איל}מתאנון ותרכובות הקשורות לתולדות‬
‫אלו כמאפננים אלוסטרים חיוביים של‬
‫קולטני גלוטמאט מטאבוטרופיים‬
187188
IMPROVED HUMAN INTERFERON
MOLECULES AND THEIR USES
AMBRX, INC.
US
60/687173
03/06/2005
485444444
1151151884
US
PCT/US/2006/021738
WO/2006/133089
C07D
C07D
‫תרכובות הטרוציקליות חדשות כמאפננות‬
‫אלוסטרים חיוביים של קולטני גלוטמאט‬
‫מתאבוטרופים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2/2322133/
187190
NOVEL OXADIAZOLE DERIVATIVES
AND THEIR USE AS POSITIVE
ALLOSTERIC MODULATORS OF
METABOTROPIC GLUTAMATE
RECEPTORS
ADDEX PHARMA SA
GB
0510142.3
18/05/2005
PCT/IB/2006/001674
WO/2006/123249
3123/2133/
‫תולדות אוקסאדיאזול חדשות ושימושן‬
‫כמאפננות אלוסטרים חיוביים של קולטני‬
‫גלוטמאט מתאבוטרופים‬
187191
INCORPORATION OF NONNATURALLY ENCODED AMINO
ACIDS INTO PROTEINS
AMBRX, INC.
US
60/687603
03/06/2005
PCT/US/2006/021463
WO/2006/132969
322322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C12P
‫הכנסת חומצות אמינו לא טבעיות‬
‫מקודדות לחלבונים‬
187192
COMPOSITIONS AND METHODS FOR
MODULATING CELLS VIA CD14 AND
TOLL-LIKE RECEPTOR 4 SIGNALING
PATHWAY
THE SCRIPPS RESEARCH INSTITUTE
US
60/678393
06/05/2005
115410444
8458451884
US
PCT/US/2006/017432
WO/2006/121871
C07D
A61K
‫תכשירים ושיטות לאפנון תאים באמצעות‬
TLR4 ‫ וסימון דרך של‬CD14
4750
222322133/
187193
‫מערכת לתיקון עמוד השדרה‬
SPINAL CORRECTION SYSTEM
SPINEFORM LLC
US
60/679886
11/05/2005
115114401
1158451884
US
PCT/US/2006/018110
WO/2006/122194
2/2322133/
A61B
187194
C07D
–/,0–‫–יל)אמינו‬/–‫–(אימידזולין‬0 ‫תרכובות‬
‫דיפנילאתאן למלחמה במזיקים שהם בעלי‬
‫חיים‬
1-(IMIDAZOLIN-2-YL)AMINO-1,2DIPHENYLETHANE COMPOUNDS
FOR COMBATING ANIMAL PESTS
BASF AKTIENGESELLSCHAFT
US
60/684122
24/05/2005
485444414
1451151884
US
PCT/EP/2006/062419
WO/2006/125748
2/2322133/
187195
1-(1,2-DIPHENYL-ETHYL)-3-(2HYDROXYETHYL)THIOUREA
COMPOUNDS FOR COMBATING
ANIMAL PESTS
BASF AKTIENGESELLSCHAFT
US
60/683666
23/05/2005
PCT/EP/2006/062413
WO/2006/125745
4751
A01N
–/(–:–)‫–דיפניל–אתיל‬/,0(–0 ‫תרכובות‬
‫הידרוקסיאתיל)–תיואוראה למלחמה‬
‫במזיקים שהם בעלי חיים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
322302133/
187196
SUB-BAND VOICE CODEC WITH
MULTI-STAGE CODEBOOKS AND
REDUNDANT CODING
MICROSOFT CORPORATION
US
11/142605
31/05/2005
PCT/US/2006/012686
WO/2006/130229
222222133/
187197
SUN/HEAT/RADIATION SHIELD TO
ELECTRONIC AND DIGITAL
INSTRUMENT
YONI PARYENTE E.D
2/2322133/
‫ תת–רצועה תדר קולי עם ריבוי‬CODEC
‫ וקידוד עודף‬CODEBOOKS ‫שלבי‬
A47G
‫קרינה למכשירים‬/‫חום‬/‫מגן שמש‬
‫אלקטרוניים ודיגיטליים‬
‫מני נקטלוב‬
187198
INFORMATION USING
HETEROGENEOUS NETWORK
HANDOVER MODULE IN MOBILE
COMMUNICATION SYSTEM
LG ELECTRONICS INC.
10-2005KR
18/05/2005
0041659
PCT/KR/2006/001865
WO/2006/123907
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G10L
H04Q
‫מידע המשתמש במודול רשת מעורבת‬
‫במערכת תיקשורת ניידת‬
4752
102322133/
187199
UTILIZING LIPOPOLYSACCHARIDE
IN EXHALED BREATH CONDENSATE
TO DIAGNOSE GRAM NEGATIVE
PNEUMONIA
THE CHARLOTTE-MECKLENBURG
HOSPITAL AUTHORITY
US
11/135265
23/05/2005
PCT/US/2006/019911
WO/2006/127704
3/2222133/
‫שימוש בליפופוליסקריד בנשיפה מעובה‬
‫לאיבחון דלקת ריאות גרם שלילי‬
187201
SOLAR ENERGY CONVERSION
DEVICE AND METHOD
MAGENTA-TECH LTD
3/2222133/
4753
A61M
‫משאף אבקה יבשה‬
‫אספירה בע"מ‬
DRY POWDER INHALER
AESPIRA LTD.
3/2222133/
C12Q
187202
F24J
‫מכשיר ושיטה של המרת אנרגית השמש‬
‫טק בע"מ‬-‫מג'נטה‬
187204
G06N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
COMPUTER (OR WEB) BASED
PROGRAMS FOR COMPREHENSIVE
INDIVIDUALIZED GENETIC
INFORMATION OR GENETIC
COUNSELING
‫תוכנה מקיפה ואישית לנתונים גנטיים או‬
‫ המיושמת במחשב או רשת‬,‫יעוץ גנטי‬
‫האינטרנט‬
MOR RESEARCH APPLICATIONS LTD
US
60/924230
04/05/2007
1123/21331
187205
WRINKLE FREE GARMENT AND
METHOD OF MANUFACTURE
GUANGDONG ESQUEL TEXTILES
CO., LTD.
CN
01129786.7 18/10/2001
185844444
1158151881
US
PCT/CN/2002/000511
WO/2003/032763
2022221330
187206
DIRECT CONVERSION WITH
VARIABLE AMPLITUDE LO
SIGNALS
QUALCOMM INCORPORATED
US
10/295639
15/11/2002
PCT/US/2003/036549
WO/2004/047324
232322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187208
‫מור ישום מחקרים בע"מ‬
A41D
‫בגד ללא קמטים ושיטת ייצור‬
H04B
‫המרה‬
C07D
4754
ANTAGONISTS OF THE VANILLOID
RECEPTOR SUBTYPE 1 (VR1) AND
USES THEREOF
ABBOTT LABORATORIES
US
60/679708
11/05/2005
PCT/US/2006/018256
WO/2006/122250
3/2322133/
187209
DOSE COUNTER FOR METERED
DOSE INHALERS
KOS LIFE SCIENCES, INC
US
60/594852
12/05/2005
PCT/US/2006/018253
WO/2006/124517
3/2322133/
187210
VACUUM BAGGING METHODS AND
SYSTEMS
AMERICAN CONSULTING
TECHNOLOGY AND RESEARCH
US
60/678691
06/05/2005
485444480
1151151884
US
115410048
8458451884
US
PCT/US/2006/017796
WO/2006/122064
4755
–‫אנטגונסטים לרצפטור של ונילואיד תת‬
‫) ושמושים שלהם‬VR1( 0 ‫סוג‬
A61M
‫מונה מנות למשאפים עם מינון מדוד‬
B29C
‫שיטות ומערכות לאריזה בואקום‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
232302133/
187211
ACUTE LEUKEMIA AND
LYMPHOBLASTIC LYMPHOMASPECIFIC CD43 EPITOPE AND USE
THEREOF
DINONA INC.
US
60/679910
11/05/2005
18-18841458051884
KR
8844884
115411114
US
PCT/KR/2006/000870
WO/2006/121240
C07K
‫ ספציפי ללאוקמיה אקוטית‬CD43 ‫אפיטופ‬
‫וללימפומה לימפובלסטית ושימוש בו‬
1851151884
2023/2133/
187212
METHOD OF MAKING A GYPSUM
SLURRY WITH MODIFIERS AND
DISPERSANTS
UNITED STATES GYPSUM COMPANY
US
11/152323
14/06/2005
115448804
8858451884
US
PCT/US/2006/022932
WO/2006/138273
3/2222133/
187213
MOBILE AND/OR IMMOBILE
SUPPLIER OF PURE DRINKING
WATER AND ELECTRICAL ENERGY
MISHA FRIEDMAN
3/2222133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187214
C04B
‫שיטה להכנת מי גבס עם חומרים‬
‫מתאמים וחומרים מפזרים‬
A47J
‫או נייחת לאספקת מי‬/‫מערכת ניידת ו‬
‫שתיה טהורים ואנרגיה חשמלית‬
‫מישה פרידמן‬
A61K
4756
ENRICHED BUFFING DEVICE FOR
COSMETIC AND/OR THERAPEUTIC
TREATMENT OF NAILS
EREZ ZABARI
3/2222133/
‫או‬/‫התקן ליטוש מועשר לטיפול קוסמטי ו‬
‫רפואי בציפורניים‬
‫ערן יצחק פריזנט‬
187215
‫סיר לילה‬
‫צחי ורסנו‬
CHAMBER POT
TZACHI VARSANO
3/2222133/
187216
REDUCED GUARD BAND FOR
POWER OVER ETHERNET
MICROSEMI CORP - ANALOG MIXED
SIGNAL GROUP LTD
US
60/865432
12/11/2007
3022321332
187217
CELL NUCLEUS-ENTERING
COMPOSITIONS
UNIVERSITAET ERLANGENNUERNBERG
US
60/684993
27/05/2005
PCT/US/2005/035716
WO/2006/130171
3/2222133/
4757
A47K
187218
H04L
‫איזור הגנה מצומצם לאספקת מתח על‬
‫גבי תשתית אטרנט‬
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
‫גרופ בע"מ‬
A61K
‫תרכובות החודרות לגרעין התא‬
G07F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A SYSTEM AND A METHOD FOR AN
AUTOMATIC PARKING METER
AVRAHAM BAKAL
US
60/857499
08/11/2006
122322133/
SMART CASE
MAOR MARKOVICH
US
60/684220
PCT/IL/2006/000620
WO/2006/126204
‫שיטה ומערכת למדחן חניה אוטומטי‬
‫אברהם בקאל‬
187219
H02B
‫כלי נשיאה חכם‬
‫מאור מרקוביץ‬
25/05/2005
3/2322133/
187220
PHARMACEUTICAL COMPOSITIONS
COMPRISING OF ARSENOUS ACID,
ITS SODIUM SALT AND ITS
DERIVATIVES INTENDED FOR THE
TREATMENT OF UROGENITAL
CANCER AND ITS METASTASIS
KOMIPHARM INTERNATIONAL CO.
LTD
EP
05076071.9 09/05/2005
PCT/KR/2006/001731
WO/2006/121280
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫תרכובות פרמצבטיות המכילות חומצה‬
‫ מלח נתרני שלה ותולדות שלה‬,‫ארסנואית‬
‫לטיפול בסרטן‬
4758
3/2222133/
187221
/ ‫תחנת כח המופעלת באמצעות גלי ים‬
‫מים‬
‫מיכאל מיכיילוב‬
WAVE HYDRO- POWER STATION
MICHAIL MICHAILOV
3/23/2133/
187222
METHOD AND DEVICE FOR
APPLYING IMAGES ON A BEVERAGE
CAN LID
MRC DESIGN STOCKHOLM
US
60/595325
23/06/2005
PCT/US/2006/022046
WO/2007/001766
3/2222133/
187223
A FIBER OPTIC MICROPHONE AND A
COMMUNICATION SYSTEM
UTILIZING SAME
OPTOACOUSTICS, LTD.
3/2322133/
4759
E03B
187224
B21D
‫התקן ושיטה להוספת דמויות על גבי‬
‫מכסה פחית משקה‬
H04R
‫מיקרופון סיב–אופטי ומערכת תיקשורת‬
‫המשתמשת בו‬
‫אופטואקוסטיקס בע"מ‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
BICYCLIC DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/679691
10/05/2005
PCT/US/2006/017699
WO/2006/122014
3/2222133/
‫תולדות ביציקליות ותכשירי רוקחות‬
‫המכילים אותן‬
187225
A CUTTING TOOL INSERT FOR
MILLING OF COMPACTED GRAPHITE
IRON
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0602457-4
20/11/2006
3/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫תותבת עבור מכשיר חיתוך לכרסום של‬
‫ברזל גרפיט דחוס‬
187227
DEVICE AND METHOD FOR
OPENING VASCULAR
OBSTRUCTIONS
EYOCA MEDICAL LTD
IL
168569
11/05/2005
140440
1158451884
IL
148411
1158051884
IL
PCT/IL/2006/000541
WO/2006/120674
B23C
A61M
‫התקן ושיטה לפתיחת חסימות וסקולריות‬
‫איוקה מדיקל בע"מ‬
4760
102322133/
187228
TRICYCLYC SPIRO DERIVATIVES.
THEIR PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
LABORATORIES SERONO S.A.
EP
05104428.7 24/05/2005
485400441
8058451884
US
PCT/EP/2006/062545
WO/2006/125784
232322133/
‫תולדות ספירו טריציקליות הכנתן ותכשירי‬
‫רוקחות המכילים אותן‬
187229
PROCESSES FOR PREPARING OF
GLUCOPYRANOSYL-SUBSTITUTED
BENZYL-BENZENE DERIVATIVES
AND INTERMEDIATES THEREIN
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05010115.3 10/05/2005
8481014440
1458051884
EP
8418040444
1458851884
EP
PCT/EP/2006/062191
WO/2006/120208
1/2322133/
187230
INSULIN RESISTANCE IMPROVER
ASUBIO PHARMA CO., LTD
2005JP
27/05/2005
155312
PCT/JP/2006/310590
WO/2006/126688
222322133/
187231
PHARMACEUTICAL FORMULATIONS
OF HDAC INHIBITORS
4761
C07D
C07H
‫תהליכים להכנת גלוקופיראנוזילים‬
‫מותמרים בתולדות בנזיל–בנזן וחומרי‬
‫ביניים לשם כך‬
A61K
‫משפר תנגודת לאינסולין‬
A61K
HDAC ‫הרכבי רוקחות של מעכבי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
TOPOTARGET UK LIMITED
US
60/681215
13/05/2005
485401144
1458451884
US
PCT/GB/2006/001737
WO/2006/120456
222322133/
187232
MINERAL MATERIALS CONTAINING
CARBONATE WITH REDUCED
EMISSION OF COMBUSTIBLE FOSSIL
CARBONACEOUS GAS ON
DECOMPOSITION THEREOF AND
METHOD FOR PRODUCTION AND
USE THEREOF
OMYA DEVELOPMENT AG
FR
05/05053
20/05/2005
84511811
1451151884
FR
PCT/IB/2006/001321
WO/2006/123235
3/2222133/
,‫חומרים מינרליים המכילים קרבונאטים‬
‫בעלי פליטה מופחתת של גז דליק פחמני‬
‫בהתפרקותם ושיטה ליצורם ולשימוש‬
‫בהם‬
187233
COMPARTMENTAL DISPENSER
COVER
MICHAEL EKSTEIN
2023/2133/
B65D
‫מכסה תאי מושיט‬
‫מיכאל אקשטיין‬
187234
EFFECTIVE USE OF DISPERSANTS IN
WALLBOARD CONTAINING FOAM
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C01B
C04B
‫שימוש יעיל בחומרים מפזרים בדיקט‬
‫המכיל קצף‬
4762
UNITED STATES GYPSUM COMPANY
US
11/152404
14/06/2005
115448111
8858451884
US
PCT/US/2006/022942
WO/2006/138280
112322133/
187235
2,6 QUINOLINYL DERIVATIVES,
PROCESSES FOR PREPARING THEM
AND THEIR USE AS MEDICAMENT
UCB PHARMA S.A.
GB
0511781.7
09/06/2005
115184140
1058051884
US
848811444
8458151884
GB
PCT/ep/2006/004811
WO/2006/131200
232322133/
‫ תהליכים להכנתן‬,‫ קווינוליניל‬/ ,9 ‫תולדות‬
‫ושימושן כתרופות‬
187237
COMPOSITIONS AND METHODS FOR
SKIN CARE
DERMIPSOR LTD
US
60/679329
10/05/2005
PCT/IL/2006/000552
WO/2006/120681
3/2322133/
187239
AUTOMATED DETECTION OF SLEEP
AND WAKING STATES
THE SALK INSTITUTE FOR
BIOLOGICAL STUDIES
US
60/679951
10/05/2005
PCT/US/2006/018120
WO/2006/122201
222322133/
4763
C07D
187240
A01N
‫תכשירים ושיטות לטיפוח העור‬
‫דרמיפסור בע"מ‬
A61B
‫גילוי אוטומטי של מצבי שינה ועירנות‬
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SYSTEM AND METHOD OF
CONTROLLING AND MONITORING
COMPUTER PROGRAM USAGE
APPROTECT LTD.
US
60/680230
13/05/2005
115410440
1051151884
US
PCT/IL/2006/000555
WO/2006/120684
222322133/
‫ פרוטאקט בע"מ‬.‫ פי‬.‫אי‬
187241
GENE-BASED ALGORITHMIC
CANCER PROGNOSIS
UNIVERSITE LIBRE DE BRUXELLES
US
60/680543
13/05/2005
8444414441
8451151884
EP
PCT/BE/2006/000051
WO/2006/119593
1/2322133/
‫שיטה ומערכת לשליטה ובקרה בשימוש‬
‫בתכנת מחשב‬
‫אלגוריתם לאיבחון של סרטן המבוסס על‬
‫גנים‬
187242
NOVEL PROCESS FOR ENZYMATIC
ACRYLAMIDE REDUCTION IN FOOD
PRODUCTS
DSM IP ASSETS B.V.
EP
05104683.7 31/05/2005
PCT/EP/2006/062673
WO/2006/128843
222322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G06F
C12N
‫תהליך חדש להפחתת אקרילאמיד‬
‫אנזימתי במוצרי מזון‬
187243
C07D
4764
CRYSTAL OF INDOLE DERIVATIVE
HAVING PIPERIDINE RING AND PROCESS
FOR PRODUCTION THEREOF
EISAI R&D MANAGEMENT CO., LTD.
JP
PCT/JP2005/008632 11/05/2005
115114188
1158451884
US
1884-414411
1851151884
JP
PCT/JP/2006/309459
WO/2006/121104
3/2322133/
187244
NOVEL GALECTIN SEQUENCES AND
COMPOSITIONS AND METHODS
UTILIZING SAME FOR TREATING OR
DIAGNOSING ARTHRITIS AND
OTHER CHRONIC INFLAMMATORY
DISEASES
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
11/125263
10/05/2005
PCT/IL/2006/000548
WO/2006/120678
1/2322133/
202312133/
4765
C07K
‫רצפי גלקטין חדשים ותרכיבים ושיטות‬
‫העושים שימוש בם לטיפול ודיאגנוזה של‬
‫ארתיטיס ושאר מחלות דלקתיות כרוניות‬
‫קרן מחקרים ופיתוח תשתיות שליד המרכז‬
‫הרפואי תל אביב ע"ש סוראסקי‬
187248
NOVEL MCHR1 ANTAGONISTS AND
THEIR USE FOR THE TREATMENT OF
MCHR1 MEDIATED CONDITIONS
AND DISORDERS
ASTRAZENECA AB
US
60/685832
31/05/2005
PCT/SE/2006/000621
WO/2006/130075
‫גביש של נגזרת של אינדול בעלת‬
‫טבעת פיפרידין ותהליך להכנתו‬
C07D
MCHR1 ‫אנטגוניסטים חדשים של‬
‫ושימושם בטיפול במצבים ומחלות מתווכי‬
MCHR1
187249
C07H
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
AN OLIGONUCLEOTIDE OR ITS
FUNCTIONAL HOMOLOGUE, A
COMPOSITION COMPRISING THE SAME
AND A METHOD OF TREATING B CELL
NEMOPLASM
CHANGCHUN HUAPU
BIOTECHNOLOGY CO. LTD.
CN
200510069576.4 17/05/2005
PCT/CN/2006/000216
WO/2006/122464
3223/2133/
187251
OPTICAL COHERENCE
TOMOGRAPHY (OCT) USING
SPECTRALLY RESOLVED
BANDWIDTH
BOARD OF REGENTS
US
60/687930
06/06/2005
PCT/US/2006/021629
WO/2006/133030
3/2222133/
TO-BE-INTRODUCED
IMPROVEMENTS FOR CABINETS
HOUSING TELECOMMUNICATION
EQUIPMENT
NILKO METALURGIA LTDA.
3/22122///
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫אוליגונוקלאוטיד או הומולוג‬
‫ תרכובת המכילה‬,‫פונקציונאלי שלו‬
B ‫אותם ושיטה לטיפול בגידול תאי‬
A61B
‫) על‬OCT( ‫טומוגרפיה קוהרנטית אופטית‬
‫ידי שימוש ברוחב–פס מופרד מבחינת‬
‫ספקטרום‬
187253
A47F
‫ארוניות איחסון משופרות לציוד תקשורת‬
187254
C12N
4766
ANTISENSE NUCLEOTIDES,
ANTIBODIES AND COMPOSITIONS
COMPRISING THEREOF, AND THEIR
USE IN MODULATING ACTIVATION
OF NF-kB
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
09/210060
10/12/1998
PCT/US/1999/029371
WO/2000/034447
232322133/
‫ נוגדנים ותרכובות‬,‫נוקלאוטידים אנטיסנס‬
‫ ושימושיהם לאיפנון עירור‬,‫הכוללות אותם‬
NF–kB ‫של‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
187255
METHOD AND DATABASE FOR
MOBILE POSITIONING IN MOBILE
NETWORKS
HUTCHISON WHAMPOA THREE G IP
(BAHAMAS) LIMITED
GB
0509498.2
10/05/2005
PCT/GB/2006/001722
WO/2006/120447
232322133/
3/23/2133/
4767
‫שיטה ומאגר מידע למיצוב נייד ברשתות‬
‫ניידות‬
187256
METHOD AND SYSTEM FOR
RESELECTING AN ACCESS POINT
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/679834
11/05/2005
115418011
1051151884
US
PCT/US/2006/018208
WO/2006/122233
H04Q
H04Q
‫שיטה ומערכת לבחירה מחדש של נקודת‬
‫כניסה‬
187257
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
COMPOSITIONS AND METHODS FOR
INHIBITION OF THE JAK PATHWAY
RIGEL PHARMACEUTICALS, INC.
US
60/689032
08/06/2005
485484440
8058051884
US
485444444
1458151884
US
PCT/US/2006/022590
WO/2006/133426
3/2322133/
187258
NANOPARTICULATE CLOPIDOGREL
FORMULATIONS
ELAN PHARMA INTERNATIONAL
LTD.
US
60/679398
10/05/2005
PCT/US/2006/017941
WO/2007/086914
3222121332
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫הרכבים של כלופידוגרל בצורת חלקיקים‬
‫זעירים‬
187259
FLEXIBLE INDEPENDENT MULTILAYER CONTAINER AND METHOD
FOR FORMING
ENVIRONMENTAL PACKAGING
TECHNOLOGIES, LTD.
US
11/124982
09/05/2005
PCT/US/2005/043694
WO/2006/121470
112322133/
JAK ‫תכשירים ושיטות לעיכוב נתיבי‬
B65D
‫מיכל רב שכבתי גמיש ובלתי תלוי ושיטה‬
‫ליצורו‬
187260
C07D
4768
PYRAZOLE - 1 - CARBOXYLIC ESTER
DERIVATIVE, METHOD FOR
PRODUCING THE SAME AND
METHOD FOR PRODUCING
PYRAZOLE DERIVATIVES
SAGAMI CHEMICAL RESEARCH
CENTER
2005JP
23/05/2005
148889
PCT/JP/2006/310600
WO/2006/126692
3023/21333
,‫ – אסטר קרבוקסילי‬0 – ‫תולדת פיראזול‬
‫שיטה ליצורו ושיטה ליצור תולדת פיראזול‬
187261
CRYSTALS OF THE SODIUM SALT OF
PRAVASTATIN
LEK PHARMACEUTICAL AND
CHEMICAL COMPANY d.d.
SI
P-9900191
06/08/1999
PCT/IB/2000/001103
WO/2001/010813
2323221332
187262
VECTOR PROCESSOR WITH SPECIAL
PURPOSE REGISTERS AND HIGH
SPEED MEMORY ACCESS
TELAIRITY SEMICONDUCTOR, INC.
A61K
‫קריסטלים לש מלח הסודיום של‬
‫פרבסטטין‬
G06F
‫מעבד ווקטור עם מטרת רישום מיוחדת‬
‫וגישה מהירה לזיכרון‬
PCT/US/2005/016485
WO/2006/121444
2323221332
4769
187263
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
DIRECT MEMORY ACCESS (DMA)
METHOD AND APPARATUS AND
DMA FOR VIDEO PROCESSING
TELAIRITY SEMICONDUCTOR, INC.
‫) והתקן‬DMA( ‫שיטה לגישה ישירה לזיכרון‬
‫וגישה מהירה לזיכרון עבור עיבוד ווידאו‬
PCT/US/2005/016402
WO/2006/121443
212322133/
187266
SMART-SWITCH MANAGEMENT
MODULE SYSTEM AND METHOD
AVOCENT FREMONT CORP.
US
11/127850
12/05/2005
PCT/US/2006/018464
WO/2006/124612
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מודול ניהול עם מיתוג חכם ושיטה‬
187267
HIGH PERFORMANCE CDxZN1-xTE
X-RAY AND GAMMA RAY
RADIATION DETECTOR AND
METHOD OF MANUFACTURE
THEREOF
II-VI INCORPORATED
US
60/681381
16/05/2005
PCT/US/2006/018779
WO/2007/024302
G06F
G01T
CDxZN1–xTE ‫ וגאמא מסוג‬X ‫גלאי קרינת‬
‫בעל ביצועים ברמה גבוהה ושיטה לייצורו‬
4770
212322133/
187268
METHODS OF CHROMOGEN
SEPARATION-BASED IMAGE
ANALYSIS
TRIPATH IMAGING, INC.
US
60/680991
13/05/2005
PCT/US/2006/018516
WO/2006/124651
212322133/
‫שיטות לאנליזה של תמונה המבוססות על‬
‫הפרדת כרומוגנים‬
187269
DIARYLSULFONE SULFONAMIDES
AND USES THEREOF
WYETH
US
60/681080
13/05/2005
115441400
1858451884
US
PCT/US/2006/018886
WO/2006/124875
2/2322133/
187270
SKID AND ROLL-OVER PROTECTION
SYSTEM AND METHOD FOR
VEHICLES
DCRYPT CONSULTANCY SERVICES
LTD.
US
60/682538
19/05/2005
PCT/IB/2006/051586
WO/2006/123313
102302133/
4771
G06T
187272
C07C
‫דיארילסולפון סולפונאמידים ושימושים‬
‫שלהם‬
B60B
‫מערכת ושיטת הגנה נגד גלישה‬
‫והתהפכות עבור כלי רכב‬
A61B
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
POINT - OF - CARE FLUIDIC
SYSTEMS AND USES THEREOF
THERANOS, INC.
US
60/678801
09/05/2005
485484408
8458051884
US
485414181
1458851884
US
485411884
1058851884
US
PCT/US/2006/011090
WO/2006/121510
1/2322133/
‫מערכות לנוזלים בנקודת טיפול ושימושים‬
‫בהן‬
187279
‫תרכובות הידנטואין‬
HYDANTOIN COMPOUNDS
EISAI CO, LTD.
US
60/685594
27/05/2005
PCT/US/2006/020848
WO/2006/128143
222322133/
187280
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫תכשיר שלפוחית ליפידית‬
LIPID VESICLE COMPOSITION
TOKYO METROPOLITAN
ORGANIZATION FOR MEDICAL
RESEARCH
2005JP
11/05/2005
139174
PCT/JP/2006/309878
WO/2006/121199
222322133/
C07D
187282
C07D
4772
METHOD FOR PRODUCING INDOLE
DERIVATIVE HAVING PIPERIDINE RING
EISAI R&D MANAGEMENT CO., LTD.
JP
PCT/JP2005/008632 11/05/2005
115114188
1158451884
US
1884-414414
1851151884
JP
PCT/JP/2006/309461
WO/2006/121106
222222133/
187286
187291
187294
STENT FABRICATION METHOD AND
APPARATUS
MEDINOL LTD.
US
08/774970
26/12/1996
222222133/
4773
A61H
‫מכשיר עיסוי לחניכיים‬
‫אברהם אליהו‬
GINGIVAL MASSAGINS DEVICE
ABRAHAM ELIYAHOU
1222122///
A47J
‫מכשיר האכלה‬
‫רמי גראיסה‬
A FEEDING APPARATUS
RAMI GARAYSA
222222133/
‫שיטה להכנת תולדות אינדול עם‬
‫טבעת פיפרידין‬
187305
A61F
‫התקן ושיטה לייצור סטנט‬
‫מדינול בע"מ‬
C12N
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
METHOD OF PRODUCING ACID
SPHINGOMYELINASE GENE
PRODUCT, PHARMACEUTICAL
COMPOSITION COMPRISING IT AND
USE THERE OF IN THE
PREPARATION OF A MEDICAMENT
OF FOR THE TREATMENT OF
NIEMANN-PICK DISEASE
MOUNT SINAI MEDICAL CENTER
US
695472
03/05/1991
212222133/
187306
METHOD AND SYSTEM
MANAGEMENT OF MULTI TIER
BENEFIT MEMBERS SHOPPING CLUB
MG-ADVANCED MAGNESIUM
TECHNOLOGIES LTD.
202222133/
G09B
‫שיטה ומערכת לתפעול בשיווק רב שכבתי‬
‫של מועדון חברים המחלק הטבות בהתאם‬
‫לקניות חברים‬
‫טכנולוגיות מגנזיום מתקדמות בע"מ‬-‫מג‬
187333
COMBINED UTRASOUND AND
LASER /IR ENERGY DELIVERY, NONINVASIVE THERAPEUTIC SYSTEM
JACOB SHEMESH
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫שיטה להכנת תוצר של הגן החומצי‬
‫ספינגומילינז תכשיר רוקחי המכיל אותו‬
‫ושימוש להכנת תרופה לטיפול במחלת‬
‫נימן–פיק‬
A61F
‫ המשלבת‬,‫מערכת טיפולית לא פולשנית‬
‫אינפרה אדום‬/‫אנרגית אולטרהסאונד וליזר‬
‫יעקב שמש‬
4774
202222133/
187350
AN APPARATUS FOR LATCHING AN
EQUIPMENT CARRIAGE AT THE TOP
OF A POLE
P.L.H LIGHTING ENGINEERING LTD.
202222133/
‫התקן לנעילת מינשא מיטען בראש עמוד‬
‫ הנדסת תאורה בע"מ‬.‫ה‬.‫ל‬.‫פ‬
187355
187367
A DISPENSER OF CLEANING
SUBSTANCE
RAFI AMIRAS
202222133/
B65D
‫מנפק חומר ניקוי‬
‫רפי אמירס‬
187370
PROCESS TO OBTAIN WATER
BODIES LARGER THAN 15,000 M3
FOR RECREATIONAL USE WITH
COLOR, TRANSPARENCY AND
CLEANNESS CHARACTERISTICS
SIMILAR TO SWIMMING POOLS OR
TROPICAL SEAS AT LOW COST
CRYSTAL LAGOONS CORPORATION
LLC.
CL
3225-2006
21/11/2006
4775
A01G
‫טפטפת‬
‫איתי גרוס‬
DRIPPER
ITAI GROSS
202222133/
F21V
E02B
‫תהליך בעלות נמוכה להשגת שטחי מים‬
‫ המיועדים לבילוי‬M 15,000:–‫של יותר מ‬
‫ שקיפות וניקיון הדומים לבריכות או‬,‫בצבע‬
‫ימים טרופיים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
202222133/
187373
KNAPSACK WITH DETACHABLE
PORTION
KALGAV LTD.
2/2322133/
‫תיק גב בעל חלק מתפרק‬
‫קלגב בע"מ‬
187375
ANTI-GM-CSF ANTIBODIES AND
USES THEREFOR
MORPHOSYS AG
US
60/682009
18/05/2005
PCT/EP/2006/004696
WO/2006/122797
222322133/
C07K
‫ והשימושים בהם‬GM–CSF ‫נוגדנים נגד‬
187376
METHOD OF ASSESSING THE
EFFECTIVENESS OF A TREATMENT
REGIMEN
UNIVERSITY OF MARYLAND,
BALTIMORE
US
60/680868
13/05/2005
PCT/US/2006/018281
WO/2006/124526
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A45F
G01N
‫שיטות להערכת האפקטיביות של שיטת‬
‫טיפול‬
4776
222322133/
187377
STEAM AND HYDROGEN
GENERATOR
ENGINEUITY RESEARCH AND
DEVELOPMENT LTD.
US
60/681165
16/05/2005
PCT/IL/2006/000570
WO/2006/123330
2/2322133/
‫מחולל קיטור ומימן‬
‫אנג'יניואיטי מחקר ופיתוח בע"מ‬
187378
METHOD AND APPARATUS FOR
WIRELESS MULTI-CARRIER
COMMUNICATIONS
QUALCOMM INCORPORATED
US
60/682181
17/05/2005
PCT/US/2006/019433
WO/2006/125149
2/23/2133/
4777
H04Q
‫שיטה והתקן לתקשורות אלחוטיות‬
‫מרובות נתמכים‬
187379
PHOTOGRAPHY-TASK-SPECIFIC
DIGITAL CAMERA APPARATUS AND
METHODS USEFUL IN
CONJUNCTION THEREWITH
SHAI SILBERSTEIN
US
11/175791
05/07/2005
PCT/IL/2006/000708
WO/2007/004207
C01B
H04N
–‫מערכת מצלמה דיגיטלית לצילום‬
‫משימתי–ספציפי ושיטה שימושית לצירוף‬
‫לאחר מכן‬
‫שי סילברשטיין‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
222322133/
187380
‫פולי(אורתאן אוריאה) פוליסולפידים‬
‫עמידים לפגיעות חזקות‬
HIGH IMPACT POLY (URETHANE
UREA) POLYSULFIDES
PPG INDUSTRIES OHIO, INC.
US
11/141636
31/05/2005
PCT/US/2006/018889
WO/2006/130339
122302133/
187381
SELECTIVE WET ETCHING OF
OXIDES
SACHEM INC.
US
60/680685
13/05/2005
PCT/US/2006/015372
WO/2006/124201
212322133/
222322133/
H01L
‫איכול סלקטיבי רטוב של תחמוצות‬
187382
BICYCLIC DERIVATIVES AS
MODULATORS OF ION CHANNELS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/681519
16/05/2005
PCT/US/2006/018669
WO/2006/124744
C08G
C07D
‫נגזרות דו–מעגליות כמאפננים ערוצי יונים‬
187383
A61K
‫טבלת בוסטרן המתפרקת בצורת‬
‫תבדיר‬
DISPERSIBLE BOSERTAN TABLET
ACTELION PHARMACEUTICALS LTD.
EP
PCT/EP2005/05367 17/05/2005
PCT/IB/2006/051519
WO/2006/123285
112322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187384
H04Q
4778
ADVANCED TRIGGERS FOR
LOCATION-BASED SERVICE
APPLICATIONS IN A WIRELESS
LOCATION SYSTEM
TRUEPOSITION, INC
US
11/150414
10/06/2005
PCT/US/2006/019863
WO/2006/135542
3/23/2133/
187385
NEW DERIVATIVES OF
PYRROLYLTRIAZINE TOGETHER
WITH METHODS FOR OBTAINING
THEM AND THEIR USE AS
PROTECTING AGENTS AGAINST UV
RADIATION
ISDIN, S.A.
PES
03/06/2005
200501334
PCT/EP/2006/062937
WO/2006/128920
2223/2133/
C07D
‫ שיטות‬,‫תולדות חדשות של פירולילטריאזין‬
‫להכנתן והשימוש בהן כגורמים המגינים‬
UV ‫נגד קרינת‬
187386
III-V SEMICONDUCTOR COREHETEROSHELL NANOCRYSTALS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/690474
15/06/2005
PCT/IL/2006/000695
WO/2006/134599
4779
‫טריגרים מתקדמים ליישומי שירות מבוססי‬
‫מיקום במערכת מיקום אלחוטית‬
H01L
‫גבישים זעירים הבנויים מגרעין מוליך‬
‫ מצופה בשכבות‬III–V ‫למחצה‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
1223/2133/
187387
SOLID DOSAGE FORMULATIONS OF
NARCOTIC DRUGS HAVING
IMPROVED BUCCAL ADSORPTION
ALPEX PHARMA S.A.
US
11/186925
22/07/2005
PCT/EP/2006/007189
WO/2007/009806
1223/22///
1223/22///
C12N
‫שימוש בקונג'וגט להכנת תכשיר לטיפול‬
‫בנזק רקמתי שניוני ומצבים דלקתיים‬
‫אחרים‬
187389
NUCLEIC ACID MOLECULE
ENCODING A CONJUGATE FOR
TREATING ACTIVATED IMMUNE
CELLS
OSPREY PHARMACEUTICALS
LIMITED
US
09/120523
22/07/1998
PCT/CA/1999/000659
WO/2000/004926
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫הרכבים למינונים מוצקים של תרופות‬
‫נרקוטיות בעלי ספיגה משופרת מהלחי‬
187388
USE OF A CONJUGATE FOR
PREPARING A COMPOSITION FOR
TREATING SECONDARY TISSUE
DAMAGE AND OTHER
INFLAMMATORY CONDITIONS
OSPREY PHARMACEUTICALS
LIMITED
US
09/120523
22/07/1998
PCT/CA/1999/000659
WO/2000/004926
A61K
C12N
‫מולקולה של חומצת גרעין המקודד‬
‫לקונג'וגט לטיפול בתאים אימוניים‬
‫מופעלים‬
4780
2/2322133/
187390
METHOD AND APPARATUS FOR
POWER CONTROL IN A MULTIPLE
ANTENNA SYSTEM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/681869
17/05/2005
115148141
4858851884
US
PCT/US/2006/019008
WO/2006/124951
102322133/
187391
THIAZOLE DERIVATIVES, THEIR
PREPARATION AND USE AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
LABORATOIRES SERONO SA
EP
05104418.8 24/05/2005
485404144
8158451884
US
PCT/EP/2006/062602
WO/2006/125807
102322133/
187392
THIAZOLE DERIVATIVES, THEIR
PREPARATION AND USE
LABORATOIRES SERONO SA
EP
05104394.1 24/05/2005
485404148
8158451884
US
PCT/EP/2006/062595
WO/2006/125805
222222133/
4781
187393
H04L
‫שיטה ומכשיר לבקרת הספק במערכת‬
‫רבת אנטנות‬
C07D
‫ הכנתן והשימוש בהן‬,‫תולדות תיאזול‬
‫ותכשירי רוקחות המכילים אותן‬
C07D
‫ הכנתן והשימוש בהן‬,‫תולדות תיאזול‬
B67C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
DISPOSABLE, MULTIPLE-STAGE
CONTAINER FOR PACKAGING OF
FOOD PRODUCTS SOLD TO THE
GENERAL PUBLIC
KFIR APEL
212322133/
‫מיכל חד פעמי בעל מספר שלבים המיועד‬
‫לאריזת מוצרי מזון הנמכרים לציבור הרחב‬
‫כפיר אפל‬
187395
LAMINATED FELT ARTICLES
HONEYWELL INTERNATIONAL INC.
US
11/130361
16/05/2005
PCT/US/2006/018814
WO/2006/124825
232322133/
APO-2 LIGAND/TRAIL
FORMULATIONS
GENENTECH, INC.
US
11/136842
PCT/US/2006/018137
WO/2006/127284
187396
B32B
‫פריטי לבד שעברו למינציה‬
C07K
‫עקבה‬/‫ ליגנד‬APO–/ ‫פורמולציות‬
24/05/2005
2/2322133/
187397
METHOD AND SYSTEM FOR
ENHANCING VIDEO GAMES AND
VIDEOGAME SYSTEMS
GOOGLE INC.
US
60/681477
17/05/2005
PCT/CA/2006/000801
WO/2006/122411
222222133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187398
A63F
‫שיטה ומערכת להגדלת משחקי וידאו‬
‫ומערכות למשחקי וידאו‬
H02J
4782
AN ELECTRIC POWER GENERATING
METHOD AND SYSTEM
C. COGEN
102322133/
187399
A RECOMBINANT METHOD FOR
PRODUCTION OF AN
ERYTHROPOIESIS STIMULATING
PROTEIN
AVESTHA GENGRAINE
TECHNOLOGIES PVT. LTD
IN
627/CHE/2005 24/05/2005
PCT/IB/2006/001353
WO/2006/126066
102322133/
187400
RECOMBINANT METHOD FOR THE
PRODUCTION OF A MONOCLONAL
ANTIBODY TO CD52 FOR THE
TREATMENT OF CHRONIC
LYMPHOCYTIC LEUKEMIA
AVESTHA GENGRAINE
TECHNOLOGIES PVT. LTD
IN
625/CHE/2005 24/05/2005
PCT/IB/2006/001356
WO/2006/126068
4783
‫תחנות חשמל קטנות עד בינוניות‬
‫סי קוגן‬
C07K
‫שיטה רקומביננטית לייצור חלבון‬
‫הממריץ יצור כדוריות דם אדומות‬
C07K
–‫שיטה רקומביננטית לייצור נוגדן חד‬
‫ לטיפול בלוקמיה‬CD52 –‫שבטי ל‬
‫לימפוציטית כרונית‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
022322133/
187401
A METHOD FOR OPTIMIZED
PRODUCTION OF A RECOMBINANT
FORM OF TISSUE PLASMINOGEN
ACTIVATOR
AVESTHA GENGRAINE
TECHNOLOGIES PVT. LTD
IN
673/CHE/2005 02/06/2005
PCT/IB/2006/001481
WO/2006/129191
2/23/2133/
2/2322133/
‫שיטה ליצור יעיל של צורה רקומביננטית‬
‫של מפעיל רקמת פלסמינוגן‬
187402
SCALABLE COMPRESSED AUDIO BIT
STREAM AND CODEC USING A
HIERARCHICAL FILTERBANK AND
MULTICHANNEL JOINT CODING
DTS (BVI) LIMITED
US
60/691558
17/06/2005
115441881
1158451884
US
PCT/IB/2006/003986
WO/2007/074401
ELECTRIC DOUBLE LAYER
CAPACITOR
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
H03M
‫רצף סיביות שמע דחוס הניתן למדידה לפי‬
‫ המשתמש בפילטר‬CODEC – ‫קנה מידה‬
‫בנק היררכי ומחבר קידוד רב–ערוצי‬
187403
COMPOSITIONS AND METHODS FOR
METABOLIC SELECTION OF
TRANSFECTED CELLS
BIOFACTURA, INC.
US
60/681969
18/05/2005
PCT/US/2006/019344
WO/2006/125126
3/22221332
C12N
187404
C08B
‫תכשירים ושיטות לבחירה מטבולית של‬
‫תאים אשר הועבר אליהם גן‬
H01G
‫קבל חשמלי דו–שכבתי‬
4784
FOC FRANKENBURG OIL COMPANY
EST.
US
60/247593
09/11/2000
1881114448
1458451881
RU
PCT/EP/2001/012837
WO/2002/039468
2/2322133/
187406
TRANSDERMAL METHOD AND
PATCH FOR NAUSEA
ABEILLE PHARMACEUTICALS, INC.
US
60/682251
18/05/2005
485481444
1458451884
US
485448401
1458151884
US
115408140
1458451884
US
PCT/US/2006/018786
WO/2006/124807
3/23/2133/
187407
SUGAR-COATED PREPARATION
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2005JP
10/06/2005
171443
PCT/JP/2006/311618
WO/2006/132360
1/2322133/
4785
187409
A61F
‫שיטה טרנסדרמלית ורטייה לבחילה‬
A61K
‫תכשיר מצופה סוכר‬
C07C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
SULFONAMIDE DERIVATIVES
USEFUL AS LIVER CARNITINE
PALMITOYL TRANSFERASE (LCPT1) INHIBITORS
F. HOFFMANN-LA ROCHE AG
EP
05104904.7 06/06/2005
PCT/EP/2006/062652
WO/2006/131452
032322133/
187410
QUINOLINE DERIVATIVES AS NK3
ANTAGONISTS
ASTRAZENECA AB
US
60/687418
03/06/2005
PCT/SE/2006/000630
WO/2006/130080
022322133/
187411
PEST CONTROL AGENT
THE KITASATO INSTITUTE
2005JP
01/06/2005
161019
PCT/JP/2006/310883
WO/2006/129714
222222133/
187412
APPARATUS FOR MOVING AND
LIFTING HANDICAPPED PERSON
CHALIVA NADIN
1/2322133/
NOVEL INDOLINE COMPOUNDS
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫נגזרות סולפונאמיד שימושיות כמעכבי‬
‫קארניטין פאלמיטואיל טרנספראז כבדי‬
)L–CPT0(
C07D
NK3 ‫נגזרות קוינולין כאנטגוניסטים של‬
A01N
‫חומר לשליטה במזיקים‬
A61G
‫מתקן להנעת והנפת נכים‬
‫נדין חליוה‬
187413
C07D
‫תרכובות אינדולין חדשות‬
4786
LABORATOIRES FOURNIER S.A.
FR
0505432
30/05/2005
PCT/FR/2006/050487
WO/2007/000550
222322133/
187414
H04N
‫התקן ושיטת ניטור‬
‫היומן מוניטורינג בע"מ‬
MONITORING METHOD AND DEVICE
HUMAN MONITORING LTD
US
60/681047
16/05/2005
PCT/IL/2006/000572
WO/2006/123331
1/23/2133/
187415
SYSTEM FOR ENABLING HOSTINDEPENDENT SOFTWARE
PORTABILITY OF A SELFCONTAINED DEVICE
CEEDO TECHNOLOGIES (2005) LTD
US
60/720562
27/09/2005
485418441
1458851884
US
PCT/IL/2006/001126
WO/2007/036935
3023/21333
4787
‫מערכת המאפשרות ניידות של תכונה‬
‫שאינה תלויה במארח של התקן העומד‬
‫ברשות עצמו‬
‫ ) בע"מ‬/11.( ‫סידו טכנולוגיות‬
187416
PHARMACEUTICAL COMPOSITIONS
COMPRISING A HMG CoA
REDUCTASE INHIBITOR
ASTRAZENECA AB
GB
0001621.2
26/01/2000
PCT/GB/2000/003017
WO/2001/054669
2123/2133/
H04J
C07D
‫תערובות רוקחיות המכילות מעכב של‬
HMG CoA ‫רדוקטאז‬
187417
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
NEW OXABISPIDINE COMPOUNDS FOR
THE TREATMENT OF CARDIAC
ARRHYTHMIAS
ASTRAZENECA AB
SE
PCT/SE2005/000891 13/06/2005
8481444-8
1451151884
SE
PCT/SE/2006/000688
WO/2006/135316
2/2322133/
187418
CONNECTING ELEMENTS FOR
CONSTRUCTION
GAL INDYK
US
60/681687
17/05/2005
485484111
1058451884
US
PCT/IL/2006/000580
WO/2006/123337
3223/2133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
F16B
‫יסודות חיבור לבנייה‬
‫גל אינדיק‬
187419
HETEROARYLETHENYL
DERIVATIVES, THEIR
MANUFACTURE AND USE AS
PHARMACEUTICAL AGENTS
F. HOFFMANN-LA ROCHE AG
EP
05014789.1 07/07/2005
8488188048
1058451884
EP
PCT/EP/2006/006523
WO/2007/006459
‫תרכובות אוקסאביספידין חדשות‬
‫לטיפול בהפרעות קצב לב‬
C07D
‫ ייצורם ושימושם‬,‫נגזרות הטרוארילאתניל‬
‫כחומרים פרמצבטיים‬
4788
3/23/2133/
187420
MODIFIED RELEASE 1 - [(3 HYDROXY - ADAMANT - 1 YLAMINO) - ACETYL] PYRROLIDINE - 2 -(S) CARBONITRILE FORMULATION
NOVARTIS AG
US
60/689719
10/06/2005
485488488
1458451884
US
PCT/US/2006/022416
WO/2006/135723
3/23/2133/
– :([ – 0 ‫שחרור שונה של הפורמולציה‬
– )‫ – ילאמינו‬0 – ‫הידרוקסי – אדאמאנט‬
‫ – קרבוניטריל‬S) 2( / – ‫אצטיל] – פירולידין‬
187421
PROCESS FOR THE SYNTHESIS OF 5(METHYL-1H-IMIDAZOL-1-YL)-3-(TRI
FLUOROME TH YL)-BENZENEAMINE
NOVARTIS AG
US
60/688977
485484488
US
PCT/US/2006/022155
WO/2006/135641
2/2322133/
4789
C07D
– H1 – ‫ – (מתיל‬. ‫תהליך לסינתזה של‬
‫ – (טרי פלואורום‬YL) – 3 – 0 – ‫אימידזול‬
‫) – בנזנאמין‬TH YL
09/06/2005
8458051884
187422
INHIBITORS OF VEGF RECEPTOR
AND HGF RECEPTOR SIGNALING
METHYLGENE, INC.
US
60/683038
20/05/2005
PCT/IB/2006/003903
WO/2007/054831
3/23/2133/
A61K
187423
C07D
‫ וקולטן‬VEGF ‫מעכבי איתות של קולטן‬
HGF
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
(5Z)-5-(6QUINOXALINYLMETHYLIDENE)-2[(2,6-DICHLOROPHENYL) AMINO]1,3-THIAZOL-4(5H)-ONE
SMITHKLINE BEECHAM
CORPORATION
US
60/688671
08/06/2005
PCT/US/2006/022385
WO/2006/135712
032322133/
–/–)‫ –קוינוקסאלינילמתילידן‬Z5 )–5–(6(
H (4–‫–תיאזול‬:,0–]‫–דיכלורופניל)אמינו‬9,/([
‫)–און‬5
187424
C5a ‫אנטגוניסטים של קולטני‬
C5a RECEPTOR ANTAGONISTS
JERINI AG
EP
05011620.1 30/05/2005
PCT/EP/2006/005141
WO/2006/128670
102322133/
187425
3-METHANESULFONYLQUINOLINES
AS GABA-B ENHANCERS
F. HOFFMANN-LA ROCHE AG
EP
05104786.8 02/06/2005
PCT/EP/2006/062514
WO/2006/128802
102322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07C
‫–מתאנסולפונילקווינולינים כאנהנסורים‬:
B– GABA–‫ל‬
187426
PIPERIDIN-4-YL-AMIDE
DERIVATIVES AND THEIR USE AS
SST RECEPTOR SUBTYPE 5
ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
05104774.4 02/06/2005
PCT/EP/2006/062515
WO/2006/128803
C07C
C07D
‫–יל– אמיד ושימושם‬4–‫נגזרות פיפרדין‬
. ‫ תת–סוג‬SST ‫כאנטגוניסטים לקולטני‬
4790
312222133/
187428
CYLINDER/PISTON UNIT HAVING A
NON-CYLINDRICAL CHAMBER
LTS-LOHMANN THERAPIE-SYSTEME
AG
DE
102005054600.5 14/11/2005
PCT/EP/2006/010506
WO/2007/054233
222222133/
‫ בוכנה בעלת תא לא גלילי‬/‫יחידת גליל‬
187429
METHOD AND SYSTEM OF
SEARCHING
DAVID GROSS
US
11/559976
15/11/2006
3/2322133/
2/2222133/
4791
G06F
‫שיטה ומערכת לחיפוש‬
‫דוד גרוס‬
187430
HETEROARYL-CARBOXYLIC ACID
(SULFAMOYL ALKYL) AMIDEDERIVATIVES AS FACTOR XA
INHIBITORS
SANOFI AVENTIS
EP
05010929.7 20/05/2005
PCT/EP/2006/004255
WO/2006/122661
A61M
C07D
‫נגזרות חומצה הטרוארילית קרבוקסילית‬
‫(סולפמואיל אלקיל) אמידת כמעכבי‬
XA ‫פקטור‬
187432
B67C
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
ADJUSTABLE CONDUCTOR FOR
TUBE AND FLEXIBLE CONTAINER
‫מוביל מתכוונן לטיובה ושפופרת‬
‫דורון חמדי‬
2/2222133/
187433
‫עט למדידת לחץ אחיזה‬
‫שחר טרסר‬
PIP - PRESSURE INDICATOR PEN
SHACHAR TRESSER
3/23/2133/
187434
HETEROCYCLIC COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
JAPAN TOBACCO INC.
2005JP
08/06/2005
168901
485481848
1458451884
US
1884-814884 8458151884
JP
485441444
1458151884
US
1884-140141 1458451884
JP
PCT/JP/2006/311975
WO/2006/132436
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
G09B
C07D
‫תרכובות הטרוציקליות ותכשירי רוקחות‬
‫המכילים אותן‬
4792
0223221332
187435
LAWFUL INTERCEPTION METHOD
AND ARCHITECTURE FOR
TRANSPARENT TRANSMISSION OF
INTERCEPTION INFORMATION
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
H04L
‫שיטה ומבנה מחשב לירוט חוקי עבור‬
‫שידור שקוף של מידע מיורט‬
PCT/EP/2005/052488
WO/2006/128495
3223/2133/
187436
LIQUID CONTAINER,LIQUID
SUPPLYING SYSTEM AND CIRCUIT
BOARD FOR LIQUID CONTAINER
CANON KABUSHIKI KAISHA
2005JP
01/06/2005
161316
PCT/JP/2006/311472
WO/2006/129882
1/2322133/
‫ מערכת לאספקת נוזלים ולוח‬,‫מיכל נוזלים‬
‫מעגל עבור מיכל נוזלים‬
187437
SLOW COOKING HEATING
FORMULA
TEMPRA TECHNOLOGY, INC.
US
60/685134
27/05/2005
PCT/US/2006/020777
WO/2006/128118
112322133/
4793
B41J
187438
F24J
‫תערובת מתחממת לבישול אטי‬
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
PYRROLOPYRIDINE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/683554
20/05/2005
PCT/US/2006/019711
WO/2006/127587
2/2322133/
187439
COMPOUNDS USEFUL FOR
TREATING NEURODEGENERATIVE
DISORDERS
SATORI PHARMACEUTICALS, INC.
US
60/681662
17/05/2005
PCT/US/2006/019014
WO/2006/124956
2/2322133/
‫תולדות פירולופירידין ותכשירי רוקחות‬
‫המכילים אותן‬
‫תרכובות המשמשות לטיפול באי–סדרים‬
‫של התנוונות העצב‬
187440
IMAGE PRESENTATION AND MICROOPTIC SECURITY SYSTEM
NANOVENTIONS HOLDINGS, LLC
US
60/682231
18/05/2005
485404844
1858451884
US
PCT/US/2006/019810
WO/2006/125224
302322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C07J
187441
A61B
–‫הצגת תמונה ומערכת אבטחה מיקרו‬
‫אופטית‬
C07D
4794
DERIVATIVES OF 6,7-DIHYDRO-5HIMIDAZO[1,2-A] IMIDAZOLE-3SULFONIC ACID
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
60/682462
19/05/2005
PCT/US/2006/016903
WO/2007/027233
2/2222133/
187443
187444
TISSUE TREATMENT DEVICE AND
METHOD
BIOLASE TECHNOLOGY, INC.
US
60/687256
03/06/2005
PCT/US/2006/021691
WO/2006/133065
122322133/
187445
DEVICE HAVING ACTIVATED
TEXTURED SURFACES FOR
TREATING ORAL TISSUE
BIOLASE TECHNOLOGY, INC.
US
60/684418
25/05/2005
485484841
1858451884
US
485448144
1451151884
US
PCT/US/2006/020501
WO/2006/128021
4795
A63F
‫משחק מזל‬
‫נאים‬-‫אבי בן‬
GAME OF CHANCE
AVI BENNAIM
3223/2133/
,0[‫–אימידזו‬H .–‫ –דיהידרו‬7, 9 ‫תולדות של‬
‫–חומצה סולפונית‬:–‫]–אימידאזול‬A–/
A61N
‫התקן ושיטה לטיפול ברקמה‬
A61F
‫התקן עם משטחי מרקמים מעוררים‬
‫לטיפול ברקמות הפה‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2/23/2133/
TOILET DEVICE
MEDLOGIC LTD
IB
PCT/IL2005/00653
PCT/IL/2006/000700
WO/2006/137055
3023/2133/
187446
‫התקן אסלה‬
‫מדלוג'יק בע"מ‬
19/06/2005
187447
REFILLABLE DEVICE AND METHOD
OF FILLING
ADORAM LESHEM
IL
168994
03/06/2005
PCT/IL/2006/000645
WO/2006/129322
0223021330
E03D
187448
THREE-DIMENSIONAL TISSUE
EQUIVALENT USING MACROMASS
CULTURE
RELIANCE LIFE SCIENCES PVT. LTD.
B65D
‫התקן המתמלא ושיטה למלא אותו‬
‫אדורם לשם‬
C12N
‫אקוויוולנט תלת ממדי של רקמה על ידי‬
‫שימוש בתרבית מאקרו–מסה‬
PCT/IN/2004/000086
WO/2005/095585
2/2322133/
187449
VARIANTS AT CHR8Q24.21 CONFER
RISK OF CANCER
DECODE GENETICS EHF
US
60/682147
18/05/2005
485484440
1058451884
US
PCT/IS/2006/000012
WO/2006/123369
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
187450
C12Q
‫ כזיהוי של‬CHR8Q24.21 ‫ואריאנטים של‬
‫סיכון לסרטן‬
C07K
4796
METHODS FOR TREATING FIBROTIC
CONDITIONS
BIOGEN IDEC INC.
US
60/682005
18/05/2005
485441044
8451151884
US
PCT/US/2006/019404
WO/2006/125140
3/23/2133/
‫שיטות לטיפול במצבים פיברוטיים‬
187451
OXADIAZOLE DERIVATIVES AS
DGAT INHIBITORS
ASTRAZENECA AB
GB
0511851.8
11/06/2005
841081444
1458851884
GB
PCT/GB/2006/002067
WO/2006/134317
2/2322133/
2123/2133/
4797
C02F
‫מכשיר ושיטה לייצוב לא כימי של מוצקים‬
‫ביולוגים‬
187453
THE PREPARATION AND USES OF
COMPOUNDS AS ASPARTYL
PROTEASE INHIBITORS
SCHERING CORPORATION
US
60/690413
14/06/2005
PCT/US/2006/022920
WO/2006/138266
1123/2133/
DGAT ‫נגזרות אוקסאדיאזול כמעכבי‬
187452
APPARATUS AND METHOD FOR
THE NON-CHEMICAL
STABILIZATION OF BIO-SOLIDS
WM INTERNATIONAL LTD.
US
60/681465
17/05/2005
PCT/CA/2006/000814
WO/2006/122418
C07D
C07D
‫הכנה ושימוש בתרכובות כמעכבי פרוטיאז‬
‫אספרטיל‬
187454
C07D
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
CRYSTALLINE BASE OF
ESCITALOPRAM AND
ORODISPERSIBLE TABLETS
COMPRISING ESCITALOPRAM BASE
H. LUNDBECK A/S
DK
PA200500912 22/06/2005
PCT/DK/2006/000366
WO/2006/136169
2123/2133/
‫בסיס קריסטליני של אציטלופראם‬
‫וטבליות מסיסות בפה המכילות בסיס‬
‫אציטלופראם‬
187455
HETEROCYCLIC ASPARTYL
PROTEASE INHIBITORS,
PREPARATION AND USE THEREOF
SCHERING CORPORATION
US
60/690541
14/06/2005
PCT/US/2006/022919
WO/2006/138265
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מעכבים הטרוציקלים של אספרטיל‬
‫ הכנה ושימוש שלהם‬,‫פרוטיאז‬
187456
APPARATUS AND METHOD FOR
DISTRIBUTING GAS AND LIQUID
DURING BACKWASH IN FILTER
UNDERDRAIN FLUMES USING
DUAL SEPARATION
THE F.B. LEOPOLD COMPANY, INC.
US
60/681592
17/05/2005
PCT/US/2006/018965
WO/2006/130341
C07D
B01D
‫מכשיר ושיטה לחלוקת גז ונוזל במהלך‬
‫זרימה אחורנית בתעלות ניקוז של פילטר‬
‫באמצעות שימוש בהפרדה דואלית‬
4798
2/2222133/
187465
A MEAN FOR MOVING UP ON THE
WATER BY A SLIDING WALK
METHOD
DROR DONAG
2/2222133/
‫אמצעי לתנועה על פני המים בשיטת‬
‫ההליכה בהחלקה‬
‫דרור דונג‬
187466
187476
187478
A METHOD FOR THE PRODUCTION OF
MONOCLONAL ANTIBODY TO CD20
FOR THE TREATMENT OF B-CELL
LYMPHOMA
AVESTHA GENGRAINE
TECHNOLOGIES PVT. LTD
IN
624/CHE/2005 24/05/2005
PCT/IB/2006/001358
WO/2006/126069
4799
G01N
‫מערכת למעקב אחרי מים‬
WATER MONITORING SYSTEM
CYMTOX LIMITED
GB
0510709.9
26/05/2005
PCT/GB/2006/001803
WO/2006/125954
102322133/
A41G
‫פאה נוכרית‬
‫יטה אתי רוזנפלד‬
A WIG
ITA ETY ROZENFELD
2/2322133/
A63C
C07K
CD /1–‫שיטה ליצור נוגדן חד שבטי ל‬
B–‫בטיפול בלימפומה של תאי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2023/2133/
187479
ANTIGEN CONJUGATES AND USES
THEREOF
CYTOS BIOTECHNOLOGY AG
US
60/690094
14/06/2005
PCT/EP/2006/063198
WO/2006/134125
3/23/2133/
1/2322133/
‫תצמידי אנטיגן ושימוש בהם‬
187480
METHOD AND COMPOSITION FOR
TREATING INFLAMMATORY
DISORDERS
BIOLIPOX AB
US
60/688698
09/06/2005
485484444
8458451884
US
PCT/GB/2006/002090
WO/2006/131737
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A61K
‫שיטה והרכב לטיפול בהפרעות דלקתיות‬
187481
IMPROVED IMMUNOASSAY
METHODS
ONCIMMUNE LIMITED
US
60/685422
27/05/2005
841884444
1458451884
GB
PCT/GB/2006/001944
WO/2006/126008
0223221332
A61K
187482
G01N
‫שיטות תבחין אימוני משופרות‬
A61K
4800
NEW CRYSTALLINE AND
AMORPHOUS FORM OF A
TRIAZOLO(4,5-D)PYRIMIDINE
COMPOUND
ASTRAZENECA AB
GB
0013407.2
02/06/2000
PCT/SE/2001/001239
WO/2001/092262
1123/2133/
‫צורה גבישית ואמורפית חדשה של‬
‫תרכובת של‬
‫) פירימידין‬D– 5, 4( ‫טריאזולו‬
187483
PROCESS FOR PREPARING
AMORPHOUS ROSUVASTATIN
CALCIUM FREE OF IMPURITIES
LEK PHARMACEUTICALS D.D.
SI
P200500188 24/06/2005
PCT/EP/2006/006007
WO/2006/136407
2/2222133/
4801
‫תהליך להכנת רוסווסטטין סידן נקי חסר‬
‫צורה‬
187485
DESIGNED CONSOLE FOR
PROVIDING A VARIETY OF
CELLULAR SERVICES TO A DRIVER
OF A MOTOR VEHICLE AND HIS
ENVIRONMENT
I. WAY MOBILE LTD
C07D
H04Q
‫קונסולה מעוצבת המותקנת ברכב לספק‬
‫מגוון שירותים סלולארים לנהג ולסביבתו‬
‫ וואי מובייל בע"מ‬.‫איי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
102322133/
187487
CRYSTALLINE AND OTHER FORMS
OF 4-AMINO-5-FLUORO-3-[6-(4METHYLPIPERAZIN-1-YL)-1HBENZIMIDAZOL-2-YL]-1HQUINOLIN-2-ONE LACTIC ACID
SALTS
NOVARTIS AG
US
60/683999
23/05/2005
PCT/US/2006/020296
WO/2006/127926
1323/2133/
‫גבישים וצורות אחרות של מלחי חומצה‬
–4(–9[–:–‫–פלואורו‬.–‫–אמינו‬4 ‫לקטית של‬
–/– ‫– בנזימידזול‬H1–)‫–יל‬0–‫מתילפיפרזינ‬
‫–און‬/–‫–קווינולינ‬H1–]‫יל‬
187488
187489
NOVEL SUBSTRATE FOR RPN 11
ENZYMATIC ACTIVITY
PROTEOLIX, INC.
US
60/685426
27/05/2005
485488448
1858051884
US
PCT/US/2006/021080
WO/2006/128196
2/2322133/
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A01N
‫הרכב קוטל פטריות הכולל נגזרת של‬
‫ תרכובת מסוג‬,‫חומצה פוספורית‬
‫מנדלאמיד ותרכובת קוטלת פטריות‬
‫נוספת‬
FUNGICIDE COMPOSITION
COMPRISING A PHOSPHOROUS ACID
DERIVATIVE, A MANDELAMIDE
TYPE COMPOUND AND A FURTHER
FUNGICIDE COMPOUND
BAYER CROPSCIENCE SA
EP
05356110.6 21/06/2005
PCT/EP/2006/063349
WO/2006/136551
032322133/
C07D
C07K
00 ‫סובסטרט חדש לפעילות אנזימטית של‬
RPN
187490
B29C
4802
APPARATUS AND METHOD FOR
SUPPLYING POWDER
QUANTITATIVELY AND MATERIAL
SUPPLYING APPARATUS
INCLUDING THE APPARATUS FOR
SUPPLYING POWDER
FINE TECHNICS CO., LTD.
10-2005KR
23/05/2005
0043208
18-18841158451884
KR
8841041
‫מתקנים ושיטה לאספקה כמותית של‬
‫אבקה ומתקני אספקת חומרים כולל‬
‫המתקנים לאספקת אבקה‬
PCT/KR/2006/001833
WO/2006/126795
122322133/
187491
CONTROLLED ELECTROPORATION
AND MASS TREANSFER ACROSS
CELL MEMBRANES IN TISSUE
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
11/139012
26/05/2005
PCT/US/2006/020626
WO/2006/128068
2/2222133/
187492
INFORMATION PROTECTION
DEVICE
HUMAN INTERFACE SECURITY LTD.
IL
185795
06/09/2007
104444
8451851884
IL
122322133/
4803
187493
C12N
‫אלקטרופורציה מבוקרת והעברת מסה‬
‫דרך ממברנות תאיות ברקמה‬
G06F
‫התקן להגנת מידע‬
‫היומן אינטרפייס סקיוריטי בע"מ‬
G06F
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
LOW POWER MICROPROCESSOR
CACHE MEMORY AND METHOD OF
OPERATION
QUALCOMM INCORPORATED
US
11/137183
25/05/2005
PCT/US/2006/020640
WO/2006/128079
3023/2133/
‫מעבד מיקרו של זיכרון מטמון בעל צריכת‬
‫מתח נמוכה ושיטה לתפעול‬
187494
ADVANCED DIGITAL TV SYSTEM
NDS LIMITED
US
60/705430
04/08/2005
PCT/GB/2006/002463
WO/2007/015047
112322133/
187495
H04N
‫מערכת טלוויזיה דיגיטלית מתקדמת‬
C07D
PYRIMIDINE OR TRIAZINE FUSED
BICYCLIC METALLOPROTEASE
INHIBITORS
ALANTOS-PHARMACEUTICALS, INC.
US
60/683470
20/05/2005
485484444
8058051884
US
485444881
8851151884
US
PCT/US/2006/020970
WO/2006/128184
‫מעכבי מטאלופרוטאז ביציקלם מאוחים‬
‫עם פירמידין או טראזין‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
- ‫ לחוק הפטנטים תשכ"ז‬/9 ‫הודעה לפי סעיף‬
0679
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬07 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬:1 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬.7 ‫הפטנטים בדרך הקבועה בתקנה‬
.0690 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4804
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
according to the Eighth Edition of the
International Patent Classification (2006)
4805
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬0/19
‫המהדורה השמינית של הסיווג הבינלאומי‬
)2006 ‫של פטנטים (משנה‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
001111
‫מודולטורים של קולטנים ממשחת–העל‬
‫ הכנתם והשימוש בהם‬NGF/TNF
]20[
MODULATORS OF TNF/NGF
SUPERFAMILY RECEPTORS,
THEIR PREPARATION AND USE
]11[
]22[
]/2[
]/2[
15.12.1994
Int. Cl.8 A61K 038/17, C07K 014/705, C12N 015/12, 015/19
109632
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
KIRYAT WEIZMANN,
‫ נס ציונה‬,‫קרית ויצמן‬
NES ZIONA 76110
]/0[
[57] A DNA sequence encoding a protein
capable of binding to the intracellular
domain of the FAS ligand receptor (FASR), selected from the group consisting of:
(a) a DNA sequence encoding a protein
herein designated protein HF1, and
(b) DNA sequences which are degenerate
as a result of the genetic code to the DNA
sequence defined in (a) and which encode
a biologically active FAS-R intracellular
domain-binding protein.
__________.
]22[]12[
]20[
ISOLATED ANTIBODY THAT
SPECIFICALLY BINDS TO
HEREGULIN - ALPHA
POLYPEPTIDE OR PORTION
THEREOF
]11[
]02[
20.05.1992
07/705256
]01[ 24.05.1991
3/2//2121
1293/92//2
3/2//3/32
3/92292//2
3/2/0//00
3/93092//1
3/2//3/2/
2293292//1
Int. Cl.8 C07K 016/22
DIVISION FROM 101943
GENENTECH, INC., U.S.A.
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
]22[
]/1[
]/2[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
018321
‫נוגדן מבודד הנקשר באופן ספציפי‬
‫ או לחלק ממנו‬a – ‫לפוליפפטיד הרגולין‬
]00[
US
US
US
US
US
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
‫אביב‬
4806
[57] An isolated antibody that specifically
binds to a heregulin-α polypeptide or
portion thereof wherein said heregulin-α or
portion thereof is able to stimulate tyrosine
phosphorylation of p185HER2 in MDA-MB453 cells comprising:
(a) a human heregulin (HRG) polypeptide
which is encoded by nucleic acid which
hybridizes with a complement of nucleic
acid encoding human heregulin-α
polypeptide having the amino acid
sequence in Fig. 4, under stringent
conditions; or
(b) the N-terminal domain and growth
factor domain (MTD-GED) of human
heregulin-α polypeptide, S2-K241 in Fig.
15; or
(c) the growth factor domain (GED) of
human heregulin-α polypeptide, G175K241 in Fig. 15, all figures as shown in the
specification; or
(d) the amino acid sequence: Ala-Gl-LysGlu-Lys-Thr-Phe-Cys-Val-Asn-Gly-GlyGlu-Cys-Phe-Met-Val-Lys-Asp-Leu-SerAsn-Pro-;
wherein the antibody is optionally
immobilized on a water-insoluble matrix
and/or bound to a detectable label.
__________
]22[]12[
012320
‫אדהסינים הטרומולטיימר כימריים‬
‫ תכשירי‬,‫ שיטה להכנתכם‬,‫רקומביננטיים‬
,‫ תאי מאכסן‬,‫ וקטורים‬,‫ נוגדנים‬,‫רוקחות‬
‫מוצרים ושיטות לשימוש בהם‬
]20[
RECOMBINANT CHIMERIC
HETEROMULTIMER ADHESINS,
METHOD FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS, ANTIBODIES,
VECTORS, HOST CELLS,
ARTICLES OF MANUFACTURE
AND METHODS OF USE
THEREOF
]11[
]02[
08.07.1997
60/021640
]01[ 12.07.1996
]00[ US
3/2///01/
2393192///
US
Int. Cl.8 A61K 038/17, 039/395, A61P 009/00, 025/02, 029/00, 035/00, C07K
014/475, 014/71, 016/28, 019/00, C12N 005/10, 015/12, 015/13, 015/62, 015/63
GENENTECH, INC., U.S.A.
WO/1998/002540
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
]22[
]/2[
]//[
]/0[
[57] Isolated recombinant chimeric
heteromultimer adhesion comprising: a
first amino acid sequence comprising an
extracellular domain of an ErbB2 receptor
monomer or fragment thereof, having the
4807
biological activity of said extracellular
domain, and a first heterologous
multimerization domain; an additional
amino acid sequence comprising an
extracellular domain of an ErbB receptor
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
monomer other than ErbB2, or fragment
thereof, and a second heterologous
multimerization domain; wherein the
multimerization domain of the first amino
acid sequence and additional amino acid
sequence each comprises an
immunoglobulin constant region or
fragment thereof; wherein the extracellular
domain of the first amino acid sequence
and the extracellular domain of the
additional amino acid sequence are
brought together via interaction of the
multimerization domain of the first amino
acid sequence and the multimerization
domain of the additional amino acid
sequence to form a binding domain of a
chimeric heteromultimer adhesin having
10-1 to 106 fold affinity for a ligand relative
to a monomer of the receptor or a
homomultimer of the receptor; and
wherein the chimeric heteromultimer
adhesin is soluble in an aqueous solution.
__________
]22[]12[
]20[
METHOD FOR PRODUCING
TRANSGENIC ANIMAL MODELS
WITH MODULATED
PHENOTYPE AND ANIMALS
PRODUCED THEREFROM
]11[
]02[
15.10.1997
60/028937
]01[ 21.10.1996
/3231//22
2192292///
3/2/3022/
3093/92///
Int. Cl.8 A01K 067/027, C12N 015/00
UNIVERSITY OF SOUTH FLORIDA,
U.S.A.
WO/1998/017782
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]22[
]/2[
]//[
]/0[
[57] A method of preparing a transgenic
rodent with enhanced amyloid pathology
for Alzheimer's Disease by producing an
F1 generation by crossing a first transgenic
rodent whose genome comprises at least
one transgene comprising a DNA sequence
encoding mutant presenilin, having the
same phenotypic effect as presenilin PS1
M146L, operably linked to a promoter
with a second transgenic rodent whose
genome comprises at least one transgene
comprising a DNA sequence encoding a
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
012910
‫שיטה לייצור מודלים של בעלי חיים בעלי‬
‫תכונות פנוטיפיות משוככות ובעלי חיים‬
‫המיוצרים מהם‬
]00[
US
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
mutant Amyloid Precursor Protein (APP),
having the same phenotypic as APP695
isoform K670N, M671L, operably linked
to a promoter, wherein the first transgenic
rodent expresses the DNA sequence
encoding the mutant presenilin and
wherein the second transgenic rodent
expresses the DNA sequence encoding the
APP; and
selecting among the offspring of the cross
for those transgenic rodents whose genome
comprises at least one transgene
4808
comprising a DNA sequence encoding
mutant presenilin, having the same
phenotypic effect as presnisilin PS1
M146L, operably linked to a promoter and
at least one transgene comprising a DNA
sequence encoding a mutant APP, having
the same phenotypic as APP695 isoform
K670N, M671L, operably linked to a
promoter, and identifying an F1 rodent
which expresses both transgenes such that
the F1 rodent develops an enhanced
amyloid pathology for Alzheimer's
Disease.
__________
]22[]12[
080013
–‫שיטה ומכשיר לאיבחון מצב הלם או טרום‬
‫הלם‬
]20[
METHOD AND APPARATUS FOR
DIAGNOSIS OF ACTUAL OR
PRE-SHOCK STATE
]11[
]22[
]/2[
]/0[
26.07.1999
Int. Cl.8 A61B 005/046, 005/103, A61N 001/38
CARDIOSENSE LTD.
,‫קרדיוסנס בע"מ‬
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A method for the diagnosis of preshock state in a patient and of recovery of
the patient from an actual state of shock by
measuring the filling time of blood vessels
subjacent to a skin area (106, 107) of said
patient, comprising illuminating an area to
be gauged for color with a modulated light
radiation (101), filtering background noise
to obtain a base-line measurement, and
determining the filling time of the blood
vessels in said area by comparison of the
color of the area with the base-line
neasurement.
__________
4809
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
ERYTHROMYCIN 9 - OXIME
DERIVATIVES, THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]11[
]02[
]22[
]/2[
]/1[
26.02.1998
97/02352
]01[ 27.02.1997
Int. Cl.8 C07H 017/08
AVENTIS PHARMA S.A., FRANCE
CONSTANTINE AGOURIDAS,
JEAN-FRANCOIS CHANTOT,
ALEXIS DENIS, CLAUDE
FROMENTINE, JEAN-MARIE PEJAC
WO/1998/038199
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]/0[
080831
‫ הכנתן‬,‫ – אוקסים‬6 – ‫תולדות אריתרומיצין‬
‫ותכשירי רוקחות המכילים אותן‬
]00[
FR
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] Compounds of the formula
in which A and B form together with the
atoms to which they are linked a group:
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4810
R1 represents an NH2 radical or an NHalkyl, NH-alkenyl or NH-alkynyl radical
containing up to 18 atoms of carbon or an
NH(CH2)nAr or N=CH(CH2)nAr radical in
which n represents an integer between 1
and 6, and Ar represents an optionally
substituted aryl or heteroaryl radical, Z
represents a hydrogen atom or the
remainder of a carboxylic acid containing
up to 18 carbon atoms, and R represents: a
hydrogen atom, a heterocyclic radical
containing at least one nitrogen atom and
optionally another heteroatom, aromatic or
non aromatic, saturated or unsaturated,
mono or bicyclic, containing up to 12
members, optionally substituted on the
nitrogen atom, a linear, branched or cyclic
alkyl, alkenyl or alkynyl radical,
containing up to 18 carbon atoms
optionally substituted by one or more
groups; hydroxyl, halogen, cyano, nitro,
amidinyl, guanidinyl, heterocyclic, as
defined previously,
alkoxy, alkenyloxy or alknyloxy having at
most 6 carbon atoms,
alkylthio, alkenylthio or alkynylthio
having at most 6 carbon atoms, the sulphur
atom being optionally oxidized into the
sulphoxide or into the sulphone, aryl,
aralkyl, aryloxy, aralkyloxy, arylthio,
aralkylthio, the sulphur atom being
optionally oxidized into the sulphoxide or
into the sulphone,
in which:
either R'1 and R'2, identical or different,
represent a hydrogen atom, a linear,
branched or cyclic alkyl, alkenyl or
alkynyl radical, containing up to 18 carbon
atoms, an aryl or aralkyl radical, each of
these R'1 and R'2 radicals being optionally
substituted by one or more of the following
radicals: hydroxy, alkyloxy, alkenyloxy,
alkynyloxy, alkylthio, alkenylthio or
alkynylthio containing up to 8 carbon
atoms, by an Si(alk)3 or Si(Oalk)3 in which
alk represents an alkyl radical containing
up to 4 carbon atoms, by a heterocyclic
radical as defined previously, or R'1 and
R'2 form together with the nitrogen atom to
which they are linked a mono or bicyclic
heterocycle radical, optionally containing
another aromatic or non aromatic,
saturated or unsaturated heteroatom,
containing up to 12 members; a quaternary
ammonium group, 1, 2-epoxyethyl or 2, 2dimethyl 1, 2-epoxyethyl or a radical
resulting from the opening of this group by
a nucleophilic reagent,
4811
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
in which B1 represents either an alkyl or
alkyloxy radical having at most 6 carbon
atoms, or an aryl, aralkyl, aryloxy or
aralkyloxy radical, free or protected
formyl, free, esterified or salified carboxy,
thiocyanato. acyl or carbamoyl, (CH2)nR',
R' representing the remainder of an amino
acid, and n representing an integer between
0 and 6, as well as the addition salts with
acids of the compounds of formula (I).
__________
]22[]12[
]20[
USE OF ANTI-CD40L IN THE
MANUFACTURE OF
PHARMACEUTICAL
COMPOSITIONS
]11[
]02[
15.05.1998
60/046791
]01[ 17.05.1997
/3230/0//
2293/92///
/323/2202
2193292///
Int. Cl.8 A61K 039/395
THE UNITED STATES OF AMERICA
AS REPRESENTED BY THE
SECRETARY OF THE U.S.
DEPARTMENT OF THE NAVY,
DEPUTY COUNSEL FOR NAVY
INTELLECTUAL PROPERTY,
OFFICE, U.S.A.
BIOGEN IDEC MA INC., U.S.A.
WO/1998/052606
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]22[
]/2[
]//[
]/0[
[57] Use of an anti-CD40L (anti-CD154)
antibody or antibody derivative for the
manufacture of a medicament for:
(a) inhibiting rejection of a tissue graft by
a primate graft recipient;
(b) reversing acute rejection of grafted
tissue in a primate graft recipient;
081331
‫ – בהכנת תכשירי‬CD40L ‫שימוש באנטי‬
‫רוקחות‬
]00[
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
(c) prolonging survival of grafted tissue in
a primate graft recipient; or
(d) attenuating immunological
complications of failure of grafted tissue in
a primate graft recipient wherein the tissue
graft consists of isolated or suspended
cells.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4812
]22[]12[
088338
‫תולדות של חומצה‬
‫ ותרופות‬,‫אמינואתילפנוקסיאצטית‬
‫המכילות אותן ותהליך להכנתן‬
]20[
AMINOETHYLPHENOXYACETIC
ACID DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND PROCESS FOR THE
PREPARATION OF SAID
COMPOSITIONS
]11[
]02[
]22[
]/2[
15.07.1998
9-233239
]01[ 25.07.1997
]00[ JP
Int. Cl.8 A61K 031/13, A61P 013/04, C07C 217/60
KISSEI PHARMACEUTICAL CO.,
LTD., JAPAN
WO/1999/005090
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] An aminoethylphenoxyacetic acid
derivative of the formula:
(wherein R1 represents a hydrogen atom, a
lower alkyl group or an aralkyl group; R2
represents a hydrogen atom or a halogen
atom; the carbon atom marked with (R)
represents a carbon atom in (R)
configuration; and the carbon atom marked
with (S) represents a carbon atom in (S)
configuration) or a pharmaceutically
acceptable salt thereof.
__________
4813
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
083332
‫ של קולטן‬TIE ‫הומולוגים של ליגנדים‬
‫טירוזין קינאז‬
]20[
TIE RECEPTOR TYROSINE
KINASE LIGAND HOMOLOGUES
]11[
]02[
]22[
]/2[
]//[
]/0[
14.09.1998
08/934494
]01[ 19.09.1997
]00[ US
Int. Cl.8 A61K 038/18, C07K 014/475, 014/515, 016/22, C12N 015/12
GENENTECH, INC., U.S.A.
WO/1999/015654
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] An isolated nucleic acid molecule
comprising a nucleotide sequence
encoding a polypeptide having at least
90% sequence identity with the amino acid
sequence of native human NL2
polypeptide (TIE ligand homolog) (SEQ
ID NO:2).
51040445144440
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]20[
2-HALO-6-O-SUBSTITUTED
KETOLIDE DERIVATIVES
]11[
]02[
29.10.1998
08/959881
]01[ 29.10.1997
3/222010/
2/93/92///
Int. Cl.8 C07H 017/08
ABBOTT LABORATORIES, U.S.A.
WO/1999/021871
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]22[
]/2[
]//[
]/0[
089902
–9–‫– הלו‬/– ‫נגזרים של קטוליד המותמר ב‬
O
]00[
US
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,00461 .‫ד‬.‫ ת‬, 0/4 ‫אבן גבירול‬
[57] A compound selected from the group
consisting of:
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4814
and pharmaceutically acceptable salts and
esters thereof, wherein Rp is hydrogen or a
hydroxy protecting group;
X is F, Cl, Br, or I; and
R1 is selected from the group consisting of
(1) C1-C6-alkyl optionally substituted with
one or more substituents selected from the
group consisting of
(a) aryl,
(b) substituted aryl,
(c) heteroaryl,
(d) substituted heteroaryl,
(e) –NR3R4 wherein R3 and R4 are
independently selected from hydrogen and
C1-C3-alkyl, or R3 and R4 are taken
together with the atom to which they are
attached to form a 3-7 membered ring
containing the N atom of the –NR3R4
group and a moiety selected from the
group consisting of –O-, -NH-, -N(C1-C6alkyl-)-, -N(aryl-C1-C6-alkyl-)-, N(substituted aryl-C1-C6-alkyl-)-, -
N(heteroaryl- C1-C6-alkyl)-, and –
N(substituted heteroaryl- C1-C6-alkyl-)-;
(2) –CH2-CH=CH-Y, wherein Y is
selected from the group consisting of
(a) H,
(b) aryl,
(c) substituted aryl,
(d) heteroaryl,
(e) substituted heteroaryl;
(f) –CH=CH2,
(g) –CH=CH-aryl,
(h) –CH=CH-substituted aryl,
(i) –CH=CH-heteroaryl, and
(j) –CH=CH-substituted heteroaryl,
(k) (aryl) oyl,
(l) (substituted aryl) oyl,
(m) (heteroaryl) oyl, and
(n) (substituted heteroaryl) oyl; and
(3) –CH2-C≡C-Y, wherein Y is as defined
previously, with the proviso that in
compounds of formula (II) wherein R1 is
selected from option (1) the C1-C6-alkyl
group must be substituted.
__________
4815
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
‫אלקטרומכניקה קרדיולוגית‬
]20[
CARDIAC ELECTROMECHANICS
]11[
]22[
]/1[
]/2[
]/1[
08.01.1996
Int. Cl.8 A61B 005/04
DIVISION FROM 116699
BIOSENSE LTD.
SHLOMO BEN HAIM, MAIER
FENSTER
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]/0[
089321
[57] A method of constructing a map of
the heart having a heart cycle comprising:
(a) bringing a probe into contact with a
location on a wall of the heart;
(b) determining a position of the probe at
the location;
‫ חיפה‬,‫ביוסנס בע"מ‬
‫ מאיר פנסטר‬,‫שלמה בן חיים‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(c) repeating (a) and (b) for a multiplicity
of locations of the heart; and
(d) combining the determined positions of
the probe to determine a structural map of
at least a portion of the heart.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4816
]22[]12[
089232
–0(‫שימוש של מיסו–טטראקיס‬
‫)איל פורפירינים‬:– ‫ (או‬/–‫אלקילפיריד‬
,‫קווטרניים בייצור תרופות לתועלות שונות‬
‫וכמה פורפירינים חדשים כאלה‬
]20[
USE OF QUATERNARY MESOTETRAKIS(1-ALKYLPYRID-2(OR
-3)-YL PORPHYRINS IN THE
MANUFACTURE OF
MEDICAMENTS FOR VARIOUS
PURPOSES AND SOME SUCH
NEW PORPHYRINS
]11[
]02[
]22[
]/2[
]/1[
03.11.1998
60/064116
]01[ 03.11.1997
]00[ US
Int. Cl.8 A61K 031/409, 031/555, A61P 011/00, 025/00, C07D 487/22
DUKE UNIVERSITY, U.S.A.
IRWIN FRIDOVICH, INES BATINICHABERLE
WO/1999/023097
JEREMY M. BEN-DAVID & CO.
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
LTD.,
,4.107 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
HAR HOTZVIM HI-TECH PARK,
‫ירושלים‬
P.O.B. 45087,
JERUSALEM 91450
]//[
]/0[
[57] Use of at least one compound having
any of formulae
4817
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein
each R is, independently, a C1-C8 alkyl
group,
each A is, independently, hydrogen or a
halogen,
M is a metal selected from the group
consisting of manganese, iron, copper,
cobalt, nickel or zinc, and
Z-is a counterion, in the manufacture of a
medicament for protecting cells in vivo or
in vitro from oxidant-induced toxicity, for
treating a pathological condition resulting
from oxidant-induced toxicity and/or from
degradation of NO, or for treating
inflammatory lung disease, substantially as
described in the specification.
Also claimed as new is a compound having
any of the above formulae wherein A, M
and Z- have the meanings stated above and
each R is independently ethyl or isopropyl.
__________
]22[]12[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
083132
4818
‫ייצור חלבונים בצמחי אלפלפה טרנסגנים‬
]20[
PROTEIN PRODUCTION IN
TRANSGENIC ALFALFA PLANTS
]11[
]02[
]22[
10.11.1998
2220563
]01[ 10.11.1997
]00[ CA
Int. Cl.8 A01H 001/04, 005/00, C07K 001/14, 001/22, 014/435, 016/18, C12N
015/13, 015/82
HER MAJESTY THE QUEEN IN
RIGHT OF CANADA AS
REPRESENTED BY THE MINISTER
OF AGRICULTURE AND AGRIFOOD CANADA, CANADA
UNIVERSITE LAVAL, CANADA
HEMA-QUEBEC, CANADA
WO/1999/024592
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]/2[
]//[
]/0[
[57] Method for the stable production of
an extractable protein comprising:
(a) growing at least one transformed alfalfa
genotype so as to produce said protein,
said genotype:
(i) being perennial;
(ii) exhibiting an embryogenic potential of
at least one embryonic callus per 20 leaf
discs or other explant tissue; and
(iii) exhibiting 100% protein concentration
stability of the extractable protein over at
least 1 hour in extracts made from said
genotype, said transformed alfalfa
genotype expressing said extractable
protein; and
(b) extracting said protein from tissues of
said plant.
__________
]22[]12[
4819
082231
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫ רדוקטז‬HMG–CoA ‫תהליך לקבלת מעכבי‬
‫בעלי ניקיון גבוה‬
]20[
PROCESS FOR OBTAINING HMGCOA REDUCTASE INHIBITORS
OF HIGH PURITY
]11[
]02[
]22[
]/2[
17.02.1999
P-9800046
]01[ 18.02.1998
]00[ SI
Int. Cl.8 C07B 063/00, C07C 069/33, C07D 309/30, C12P 007/62, 017/06
LEK PHARMACEUTICAL AND
CHEMICAL COMPANY D.D.,
SLOVENIA
ZLATKO PFLAUM, DUSAN
MILIVOJEVIC, DAVID SENICA
WO/1999/042601
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]/1[
]//[
]/0[
[57] A process for the isolation and
purification of HMG-CoA reductase
inhibitors from mycelium biomass which
comprises: clarifying a mycelium broth
and concentrating the clarified broth to a
lower volume, acidifying the concentrate
to a pH value in the range of 4.5 to 7.5,
followed by extracting the HMG-CoA
reductase inhibitor with ethyl acetate;
optionally performing lactonization;
crystallizing the HMG-CoA reductase
inhibitor from:
(i) a water-miscible first organic solvent;
and
(ii) a second organic solvent having
limited miscibility or solubility with water
selected from the group consisting of nbutanol, isobutanol, amyl alcohol, hexanol,
2-ethylhexanol. benzyl alcohol,
cyclohexanol, methylbutyl ketone, methyl
isobutyl ketone, cyclohexanone, methyl
acetate, ethyl acetate, n-propyl acetate,
isopropyl acetate, isobutyl acetate, secbutyl acetate, amyl acetate, diethyl ether,
diisopropyl ether, methylene chloride,
chloroform, and mixtures of these solvents.
__________
]22[]12[
]20[
EXPANDABLE MEDICAL DEVICE
WITH DUCTILE HINGES
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
083139
‫התקן רפואי מתרחב בעל צירים גמישים‬
4820
]11[
]02[
]22[
]/2[
]//[
]/0[
26.03.1999
60/079881
]01[ 30.03.1998
3/22/0222
1/92392///
Int. Cl.8 A61F 002/06, A61M 029/00
INNOVATIONAL HOLDINGS, LLC,
U.S.A.
WO/1999/049928
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] An expandable medical device made
of a metal, said device comprising: a
plurality of struts (88); and means for
concentration of stress/strain arranged
]00[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
between said struts to form an expandable
cylindrical tube; characterized in that a
beneficial agent is contained in a plurality
of holes (92) in the struts.
__________
]22[]12[
]20[
4821
MIXED VECTOR/SCALAR
REGISTER FILE
082191
‫קובץ אוגר וקטור\סקלר מעורב‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]11[
]02[
]22[
]/2[
]//[
]/0[
09.03.1999
09/084304
]01[ 27.05.1998
]00[ US
Int. Cl.8 G06F 007/48, 007/544, 009/30, 009/34, 009/345, 009/38
ARM LIMITED, UNITED KINGDOM
WO/1999/061996
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] An apparatus for processing data,
said apparatus comprising: a register bank
having a plurality of registers, each register
operable as either a vector register or a
scalar register; and instruction decoding
and execution logic for decoding data
processing instructions, at least one of said
data processing instructions having at least
an operation specifying code specifying an
operation for execution and a first register
specifying field specifying a first register
within said register bank; wherein said
instruction decoding and execution logic
executes an operation using a given
register as either a scalar register or a
vector register, execution with said given
register being a scalar register comprising
executing said operation once upon an
operand stored in said given register and
execution with said given register being a
vector register comprising executing said
operation a plurality of times upon
operands stored within a predetermined
sequence of registers of said register bank
selected in dependence upon a register
specifying field for said given register; and
said instruction decoding and execution
logic is responsive to said first register
specifying field and is independent of said
operation specifying code to determine
whether said operation is to be executed
using said first register as either a vector
register or a scalar register.
__________
]22[]12[
]20[
USE OF SILDENAFIL IN THE
MANUFACTURE OF A
MEDICAMENT FOR TREATING
OR PREVENTING PULMONARY
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
082122
‫שימוש בסילדנפיל בייצור תרופה לטיפול‬
‫או למניעת יתר לחץ ראתי‬
4822
HYPERTENSION
]11[
]02[
]22[
]/2[
]/0[
26.10.2000
9925970.7
]01[ 02.11.1999
]00[ GB
33301029/
2293191333
GB
Int. Cl.8 A61K 031/395, A61P 011/00, C07D 401/04, 405/14, 471/12, 487/02
PFIZER INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] Use of sildenafil or a salt thereof in
the manufacture of a medicament for
treating or preventing pulmonary
hypertension.
__________
]22[]12[
031332
‫ליגנדים עם כושר קשירה גבוה לקולטן‬
ORL–1 ‫הנוסיספטין‬
]20[
HIGH AFFINITY LIGANDS FOR
NOCICEPTIN RECEPTOR ORL-1
]11[
]02[
]22[
26.07.1999
09/122878
]01[ 27.07.1998
]00[ US
Int. Cl.8 A61K 031/445, A61P 011/06, 025/00, 043/00, C07D 211/52, 211/58,
401/04, 471/10
SCHERING CORPORATION, U.S.A.
WO/2000/006545
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,00461 .‫ד‬.‫ ת‬, 0/4 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]/2[
]//[
]/0[
[57] Compounds of the formula
or pharmaceutically acceptable salts or
solvates thereof, wherein:
the dotted line represents an optional
4823
double bond;
X1 is R5-(C1-C12) alkyl, R6-(C3C12)cycloalkyl, R7-aryl, R8-heteroaryl, or
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
R10-(C3-C7) heterocycloalkyl; X2 is –CHO,
-CN, -NHC (=NR26) NHR26, CN(=NOR26), -NHOR26, R7-aryl, R7-aryl
(C1-C6) alkyl, R7-aryl (C1-C6) alkenyl, R7-
aryl (C1-C6)-alkynyl, -(CH2)vOR13,
(CH2)vCOOR27, -(CH2)vCONR14R15, (CH2)vNR21R22 or or X1 is
and X2 is hydrogen;
or X1 and X2 together form a spiro
group of the formula
m is 1 or 2;
n is 1, 2 or 3, provided that when n is 1,
one of R16 and R17 is –C(O)R28;
p is 0 or 1;
Q is –CH2-, -O-, -S-, -SO-, -SO2- or –
NA17-;
R1, R2, R3 and R4 are independently
selected from the group consisting of
hydrogen and (C1-C6) alkyl, or (R1 and R4)
or (R2 and R3) or (R1 and R3) or (R2 and
R4) together can form an alkylene bridge
of 1 to 3 carbon atoms; R5 is 1 to 3
substituents independently selected from
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
the group consisting of H, R7-aryl, R6-(C3C12) cycloalkyl, R8-heteroaryl, R10-(C3-C7)
heterocycloalkyl, -NR19R20, -OR13 and –
S(O)0-2R13; R6 is 1 to 3 substituents
independently selected from the group
consisting of H, (C1-C6) alkyl, R7-aryl, NR19R20, -OR13 and –SR13;
R7 is 1 to 3 substituents independently
selected from the group consisting of
hydrogen, halo (C1-C6)alkyl, R25-aryl, (C3C12) cycloalkyl, -CN, -CF3, -OR19, -( C1C6) alkyl-OR19, -OCF3, -NR19R20, (C1-C6)
alkyl-NR19R20 –NHSO2R19, -SO2N(R26)2, -
4824
SO2R19, -SOR19, -SR19, -NO2, -CONR19R20,
-NR20COR19, -COCF3, -OCOR19, OCO2R19, -COOR19; -(C1-C6) alkyl –
NHCOOC(CH3)3, -(C1-C6) alkyl-
NHCOCF3, -(C1-C6) alkyl-NHSO2-(C1-C6)
alkyl, -(C1-C6) alkyl-NHCONH-(C1-C6)alkyl or
wherein f is 0 to 6; or R7 substituents on
adjacent ring carbon atoms may together
form a methylenedioxy or ethylenedioxy
ring;
R8 is 1 to 3 substituents independently
selected from the group consisting of
hydrogen, halo (C1-C6) alkyl, R25-aryl, (C3-
C12) cycloalkyl, -CN, -CF3, -OR19, -(C1-C6)
alkyl-OR19, -OCF3, -NR19R20, -(C1-C6)
alkyl –NR19R20, R11 is independently
selected from the group consisting of H,
R5-(C1-C6) alkyl, R6 (C3-C12) cycloalkyl, (C1-C6) alkyl (C3-C12) cycloalkyl, -(C1-C6)
alkyl-OR19, -(C1-C6) alkyl-NR19R20 and
wherein q and a are as defined above;
R12 is H, (C1-C6) alkyl, halo, -NO2, -CF3, OCF3, -OR19, -(C1-C6) alkyl-OR19, NR19R20 or -(C1-C6) alkyl-NR19R20;
R13 is H, (C1-C6) alkyl, R7-aryl, -(C1-C6)
alkyl –OR19, -(C1-C6) alkyl-NR19R20 or -
(C1-C6) alkyl-SR19; R14 and R15 are
independently selected from the group
consisting of H, R5-(C1-C6) alkyl, R7-aryl
and
wherein q is 1 to 3 and a is 1 or 2;
R16 and R17 are independently selected
from the group consisting of hydrogen, R5(C1-C6) alkyl, R7-aryl, (C3-C12) cycloalkyl,
R8-heteroaryl, R8-heteroaryl-(C1-C6) alkyl,
-C(O)R28, -(C1-C6) alkyl (C3-C7)heterocycloalkyl, -(C1-C6) alkyl –OR19 and
-(C1-C6) alkyl-SR19;
R19 and R20 are independently selected
from the group consisting of hydrogen, (C1-C6) alkyl, (C3-C12) cycloalkyl, aryl and
aryl -(C1-C6) alkyl; R21 and R22 are
independently selected from the group
consisting of hydrogen, -(C1-C6) alkyl,
(C3-C12) cycloalkyl, (C3-C12) cycloalkyl (C1-C6) alkyl, (C3-C7) heterocycloalkyl, (C1-C6) alkyl (C3-C7)-heterocycloalkyl, R7aryl, R7-aryl -(C1-C6) alkyl, R8-heteroaryl (C1-C12) alkyl, -(C1-C6) alkyl-OR19, -(C1C6) alkyl-NR19R20, -(C1-C6) alkyl-SR19, (C1-C6) alkyl –NR18--(C1-C6) alkyl-O-(C1C6) alkyl and -(C1-C6) alkyl-NR18 -(C1-C6)
alkyl-NR18-(C1-C6) alkyl;
R18 is hydrogen or -(C1-C6) alkyl;
Z1 and Z2 are each R7-aryl;
Z3 is hydrogen or -(C1-C6) alkyl;
4825
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
R25 is 1-3 substituents independently
selected from the group consisting of H, (C1-C6) alkyl, -(C1-C6) alkoxy and halo;
R26 is independently selected from the
group consisting of H, -(C1-C6) alkyl and
R25-C6H4-CH2-;
R27 is H, -(C1-C6) alkyl, R7-aryl -(C1-C6)
alkyl, or (C3-C12) cycloalkyl;
R28 is -(C1-C6) alkyl, -(C1-C6) alkyl (C3C12) cycloalkyl, R7-aryl, R7-aryl-(C1-C6)
alkyl, R8-heteroaryl, -(C1-C6) alkylNR19R20, -(C1-C6) alkyl –OR19 or -(C1-C6)
alkyl-SR9;
provided that when X1 and X2 together are
and Z1 and Z2 are each R7-phenyl, R7 is not
–OCH2 aryl and at least one R7 is orthohalo or ortho-C1-C6 alkyl; aryl (including
the aryl portion of arylalkyl) represents a
carbocyclic group containing from 6 to 15
carbon atoms and having at least one
aromatic ring (e.g., aryl is phenyl),
wherein said aryl group optionally can be
fused with aryl, (C3-C7) cycloalkyl,
heteroaryl or hetero (C3-C7) cycloalkyl
rings; and wherein R7-aryl means that any
of the available substitutable carbon and
nitrogen atoms in said aryl group and/or
said fused ring(s) is optionally and
independently substituted, and wherein the
aryl ring is substituted with 1-3 R7 groups,
examples of aryl groups are phenyl,
naphthyl and anthryl; heteroaryl represents
cyclic groups having one to three
heteroatoms selected from O, S and N, said
heteroatom(s) interrupting a carbocyclic
ring structure and having a sufficient
number of delocalized pi electrons to
provide aromatic character, with the
aromatic heterocyclic groups containing
from 5 to 14 carbon atoms, wherein said
heteroaryl group optionally can be fused
with one or more aryl, cycloalkyl,
heteroaryl or heterocycloalkyl rings; and
wherein any of the available substitutable
carbon or nitrogen atoms in said
heteroaryl group and/or said fused ring(s)
may be optionally and independently
substituted, and wherein the heteroaryl
ring can be substituted with 1-3 R8 groups;
and heterocycloalkyl represents a saturated
ring containing from 3 to 7 carbon atoms,
preferably from 4 to 6 carbon atoms,
interrupted by 1 to 3 heteroatoms selected
from –O-, -S- and –NR21-, wherein R21 is
as defined above, and wherein optionally,
said ring may contain one or two
unsaturated bonds which do not impart
aromatic character to the ring; and wherein
any of the available substituted carbon
atoms in the ring may be substituted, and
wherein the heterocycloalkyl ring can be
substituted with 1-3 R10 groups;
representative heterocycloalkyl groups
include 2- or 3-tetrahydrofuranyl, 2-or 3tetrahydrothienyl, 1-, 2-, 3- or piperidinyl,
2- or 3-pyrrolidinyl, 1-, 2- or 3-piperizinyl,
2- or 4-dioxanyl, morpholinyl,
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4826
wherein R17 is as defined above and t is 0,
1 or 2.
__________
]22[]12[
‫הקלטה של פרמטרים משתנים‬
]20[
VARIABLE PARAMETER
RECORDING
]11[
]02[
26.02.1998
60/038337
]01[ 27.02.1997
/3230301/
3293092///
/32323/3/
1/93092///
Int. Cl.8 G01D 009/40
DIVISION FROM 123496
OMEGA ENGINEERING, INC.,
U.S.A.
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]22[
]/1[
]/2[
]/0[
031303
[57] A method for the production of a
circular chart recording having at least one
trace corresponding to at least one
respective variable parameter, said method
comprising feeding audio information
representative of the at least one variable
parameter or a function thereof to an
information processor, utilizing said
]00[
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
processor to control a printer or plotter,
inserting in said printer or plotter a
rectangular sheet of paper, and causing the
printer or plotter to print a respective trace
in spaced relationship with a recording
chart web showing variation of the
parameter.
__________
]22[]12[
031202
‫ אנושי‬IXa/IX ‫נוגדנים לאנטיפקטור‬
]20[
HUMAN ANTI-FACTOR IX/IXA
ANTIBODIES
]11[
]02[
26.08.1999
60/098233
]01[ 28.08.1998
]00[ US
/32211///
3093092///
US
Int. Cl.8 A61K 039/395, A61P 007/02, C07K 016/40, C12N 001/19, 001/21, 005/10,
015/13, 015/63, C12P 021/08
GENENTECH, INC., U.S.A.
WO/2000/012562
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[
]/2[
]//[
4827
]/0[
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
[57] Composition comprising a human
antibody or antibody fragment reactive
with the factor IX/IXa Gla domain.
__________
]22[]12[
030183
‫פורמולציות אורליות לאגוניסטים או‬
HT4– . ‫אנטגוניסטים של‬
]20[
ORAL FORMULATIONS FOR 5HT4 AGONISTS OR
ANTAGONISTS
]11[
]02[
19.08.1999
9818340.3
]01[ 21.08.1998
]00[ GB
//100//9/
1/92392///
GB
//2301391
3293292///
GB
//2232/92
2193292///
GB
Int. Cl.8 A61K 009/20, 045/00, 045/06, C07D 209/14
NOVARTIS AG, SWITZERLAND
WO/2000/010526
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]22[
]/2[
]//[
]/0[
[57] A solid oral pharmaceutical
composition comprising Compound A
or its salts; comprising a disintegrant
which is present in an amount of at least
15% by weight based on the total weight
of the composition, wherein the
disintegrant is a member selected from the
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
group consisting of crospovidone,
pregelatinised starch, sodium starch
glycolate, carboxymethylcellulose sodium,
carboxymethylcellulose calcium, sodium
alginate, and a mixture thereof.
4828
__________
]22[]12[
030323
‫ביטוי יתר של חלבונים רצויים בתאים‬
‫אוקריוטים המתווח ע"י בטוי יתר של‬
DI ‫צ'קלין‬
]20[
OVEREXPRESSION OF DESIRED
PROTEINS IN EUKARYOTIC
CELLS MEDIATED BY CYCLIN DI
OVEREXPRESSION
]11[
]02[
11.08.1999
60/096086
]01[ 11.08.1998
]00[ US
3/20/203/
2393/92///
US
Int. Cl.8 C07K 014/47, C12N 005/10, 015/12, 015/67
AMGEN, INC., U.S.A.
WO/2000/009714
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]22[
]/2[
]//[
]/0[
[57] A mammalian cell comprising:
(a) an inserted gene construct for a cyclin
D gene product, wherein the cyclin D gene
product is functionally expressed in the
cell at a level greater than the level of
expression of said cyclin D gene product in
the cell before said insertion; and
(b) an inserted gene construct for a protein
of interest, wherein the protein of interest
is expressed in the cell at a level greater
than the level of expression of said protein
of interest in the cell before said insertion.
__________
]22[]12[
031881
]20[
BALLOON CATHETER DEVICE
‫התקן של צנטר מסוג בלון‬
]11[
]22[
]/2[
]/0[
29.03.2001
Int. Cl.7 A61F 002/06, A61M 025/10
XTENT, INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
[57] A stent delivery system comprising:
a catheter (100) having a distal end (108)
4829
and an inflatable balloon (104) near the
distal end for expanding a stent
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
surrounding the ballon, the catheter
carrying a plurality of stents and having a
positioner slidable longitudinally along the
catheter independently of said plurality of
stents for moving said plurality of stents
relative to said balloon from a first position
proximal to the distal end to a second
position closer to the distal end in which at
least one of said plurality of stents
surrounds the balloon.
__________
]22[]12[
031282
‫טלפוניה רב–קווית דרך מגשר בין רשתות‬
‫תקשורת‬
]20[
MULTI-LINE TELEPHONY VIA
NETWORK GATEWAYS
]11[
]02[
]22[
]/2[
22.10.1999
09/177712
]01[ 23.10.1998
]00[ US
Int. Cl.8 H04L 012/28, 012/56, H04M 011/06, H04Q 011/00
VERIZON LABORATORIES INC.,
U.S.A.
WO/2000/025481
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4830
[57] A communication system for
providing call connections to customer
premises telephone devices from plural
connecting telephone devices, the
communication system comprising: a
gateway for processing calls to and from a
public switched telephone network; at least
one gatekeeper including an address table
for processing the calls between the
customer premises telephone devices and
the gateway by accessing an address table
for a corresponding address of the
gateway; and a point-of-presence entity
programmed to provide and control a
simultaneous connection between the
customer premises telephone device and at
least two of the connecting telephone
devices, the entity being programmed to
control the at least one gatekeeper to
transmit multiplexed voice data packets
from the connecting telephone devices to
the customer premises device.
__________
]22[]12[
]20[
NETWORK PRESENCE FOR A
COMMUNICATIONS SYSTEM
OPERATING OVER A COMPUTER
NETWORK
]11[
]02[
]22[
]/2[
22.10.1999
09/178130
]01[ 23.10.1998
Int. Cl.8 H04L 012/28, 012/56, 012/66
VERIZON LABORATORIES INC.,
U.S.A.
WO/2000/025480
]//[
4831
031239
‫רשת תקשורת עבור מערכת תקשורת‬
‫הפועלת ברשת מחשב‬
]00[
US
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]/0[
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A communication system for
interacting with a switched circuit network
and for establishing a network presence to,
under predetermined conditions, provide
network-based services for handling
incoming calls directed to a terminal endpoint, the system comprising: a gateway in
communication with the switched circuit
network, the gateway being operative to
translate switched circuit networkcompatible signals into computer networkcompatible signals; a signal routing agent
in communication with the gateway, with
the terminal end-point, and with one or
more network-resident service entities, the
signal routing agent being operative to
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
receive an incoming call from the gateway
addressed to the terminal end-point and to
transmit the incoming call to the terminal
end-point; and a feature selector in
communication with the signal routing
agent, the feature selector being
programmed to, under the predetermined
conditions, determine a corresponding
service entity for the terminal end-point
being called and to transmit a
corresponding signal to the signal routing
agent; whereby the signal routing agent is
responsive to receipt of the signal from the
feature selector to route the incoming call
to the corresponding service entity.
__________
]22[]12[
]20[
ANTAGONISTIC ANALOGS OF
GH-RH INHIBITING IGF-I AND II
031322
GH–RH ‫אנאלוגים אנטגוניסטים של‬
II– ‫ ו‬IGF– I ‫המעכבים‬
]11[
]02[
]22[
23.11.1999
09/199381
]01[ 25.11.1998
]00[ US
Int. Cl.8 A61K 038/25, 038/27, A61P 005/08, 035/00, C07K 014/60
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4832
]/2[
]//[
]/0[
THE ADMINISTRATORS OF THE
TULANE EDUCATIONAL FUND,
U.S.A.
WO/2000/031136
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
R10 is Tyr or Phe(Y), in which Y=H, F, Cl,
Br or OCH3,
R12 is Lys, D-Lys, or Orn,
R13 is Val or Nle,
R14 is Leu or Nle,
R15 is Gly, Ala, Abu, Nle or Gln,
R16 is Gln or Arg,
R18 is Ser or Nle,
R19 is Ala or Abu,
R21 is Lys or Orn,
R22 is Leu, Ala or Aib
R27 is Met, Leu, Nle, Abu, or D-Arg,
R28 is Arg or D-Arg,
R29 is Arg, D-Arg, Har or D-Har,
and pharmaceutically acceptable salts
thereof.
[57] A peptide selected from the group of
the formula
X- R1-R2-Asp- Ala- R5-R6-Thr- R8-R9-R10Arg- R12-R13-R14-R15-R16-Leu- R18-R19Arg-R21-R22-Leu-Gln-Asp-lle-R27-R28-R29NH2
wherein X is PhAc, IndAc, Ibu, Nac, 1- or
2-Npr or Fpr,
R1 is Tyr or His,
R2 is D-Arg or D-Cit
R5 is lle or Val,
R6 is Phe, Nal or Phe(Y), in which Y=F,
Cl, Br,
R8 is Asn, Gln, Ser, Thr, Ala, D-Asn, DGln, D-Ser, D-Thr, Abu, D-Abu or Aib,
R9 is Arg, Har, Lys, Orn, D-Arg, D-Har,
D-Lys, D-Orn, Cit,
__________
]22[]12[
038180
‫תכשירים לעיכוב גדילה של תאים‬
‫נאופלסטים‬
]20[
COMPOSITIONS FOR INHIBITING
NEOPLASTIC CELL GROWTH
]11[
]02[
02.12.1999
60/113296
]01[ 22.12.1998
]00[ US
PCT/US99/05028
3/93092///
WO
/32203101
1293092///
US
/32202002
1/93092///
US
/322001//
2093292///
US
/32200/2/
1393/92///
US
/32202///
1/93/92///
US
PCT/US99/21090
2293/92///
WO
PCT/US99/21547
2293/92///
WO
Int. Cl.8 A61K 038/17, C07K 014/435, 016/18, C12N 015/12
GENENTECH, INC., U.S.A.
WO/2000/037638
]22[
]/2[
]//[
4833
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]/0[
,‫ריינהולד כהן ושותפיו‬
‫ תל‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
‫אביב‬
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] Use of an agent for the preparation
of a medicament for the treatment of
tumour in a mammal, wherein the agent is
a polypeptide having at least 80% amino
acid sequence identity over the full length
of either:
(i) the amino acid sequence of residues 1
or X to 338 shown in Figure 2 (SEQ ID
NO:2), wherein X is any amino acid
residue from 17 to 26,
or
(ii) a fragment of the amino acid sequence
shown in Figure 6, both figures as shown
in the specification, wherein the
polypeptide is at least 10 amino acids in
length and has in vitro antiproliferative
activity against tumour cells.
51041445104144
The applications for division
from this application have not
yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]20[
TRANSDERMAL DELIVERY OF
FINE POWDERS
]11[
]02[
]22[
]/2[
]//[
]/0[
22.12.1999
09/220712
]01[ 24.12.1998
Int. Cl.8 A61N 001/30
TRANSPHARMA MEDICAL LTD.
WO/2000/038781
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A device for delivery of a powder
(28) to the skin of a subject, comprising: a
pad, comprising an insulating material and
having an upper side and a lower side,
which lower side is placed against the skin
after application of the powder thereto; and
an electrical power source (30), which
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
038392
‫העברה תוך–עורית של אבקות דקות‬
]00[
US
‫ יהוד‬,‫טראנספארמה מדיקל בע"מ‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
applies an electrical potential to the pad,
causing the powder to adhere by
electrostatic force to the lower side of the
pad, and which alters the potential so that
the powder is released from the pad and
contacts the skin against which the pad is
placed.
4834
__________
]22[]12[
]20[
THREE DIMENSIONAL
RADIATION DETECTOR
]11[
]22[
]/2[
25.06.2001
Int. Cl.8 G01T 001/24
ORBOTECH MEDICAL
SOLUTIONS LTD.
ARIE SHAHAR, SHIMON KLIER,
URI EL-HANANI, ALEX
TSIEGELMAN, ELDAN
HALBERTAL
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]/1[
]/0[
[57] A three-dimensional radiation
detector assembly comprising: a plurality
of thin semiconductor crystal detector
(102), parallax error reduction modules
each of said parallax error reduction
modules including first and second
oppositely facing planar surfaces
4835
038231
‫גלאי קרינה תלת–ממדי‬
‫ יבנה‬,‫אורבוטק מדיקל סלושנס בע"מ‬
‫ אלכס‬,‫ אורי אלחנני‬,‫ שמעון קליר‬,‫אריה שחר‬
‫ אלדן הלברטל‬,‫צ'גלמן‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
and at least one photon receiving edge
surface between said planar surfaces, said
first planar surface having formed thereon
a single monolithic cathode (108), said
second planar surface having formed
thereon a two-dimensional array of
pixilated anodes (106), outputs of said
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
two-dimensional array of pixilated anodes
containing information useful for
determining depth of interaction of
photons received at said at least one
photon receiving edge surface, the depth of
interaction being indicated by a location of
an anode sensing photon absorption, said
plurality of thin semiconductor crystal
detector parallax error reduction modules
being arranged in a stack such that photon
receiving edge surfaces therefor together
define a photon receiving surface
extending in two dimensions, and together
providing photon impingement location
information in said two dimensions, and
said depth of interaction indicating
information providing photon travel
information, indicating photon travel
having a component in a third dimension,
perpendicular to said two dimensions, for
parallax error reduction.
__________
]22[]12[
033838
–: – ‫ – פניל‬: – ‫ – פנאציל‬0( ‫נגזרות‬
‫ שיטה לייצורן‬,‫פיפרידילאתיל) פיפירידין‬
‫והרכבים ריקחיים הכוללים אותן‬
]20[
(1-PHENACYL- 3 - PHENYL- 3 PIPERIDYLETHYL) PIPERIDINE
DERIVATIVES, METHOD FOR
THE PRODUCTION THEREOF
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]02[
16.07.2001
99/01593
]01[ 10.02.1999
]00[ FR
//23001/
3/93092///
FR
Int. Cl.8 A61K 031/445, A61P 043/00, C07D 401/14, 413/14, 417/14
SANOFI AVENTIS, FRANCE
WO/2000/047572
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]22[
]/2[
]//[
]/0[
[57] A compound of the formula:
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4836
in which: X represents a group
Ar represents a phenyl monosubstituted or
disubstituted with a halogen atom; or a
(C1-C3) alkyl; R1 represents a chlorine
atom, a bromine atom, a (C1-C3) alkyl or a
trifluoromethyl; R2 represents a group –
CR3R4CONR5R6; R3 and R4 represent the
same radical chosen from a methyl, an
ethyl, an n-propyl or an n-butyl; or R3 and
R4, together with the carbon atom to which
they are attached, constitute a (C3-C6)
The applications for division
from this application have
not yet been published
cycloalkyl; R5 and R6 each independently
represent a hydrogen; a (C1-C3) alkyl; or
R5 and R6, together with the nitrogen atom
to which they are attached, constitute a
heterocyclic radical chosen from 1azetidinyl, 1-pyrrolidinyl, 1-piperidiyl, 4morpholinyl, 4-thiomorpholiyl or
perhydro-1-azepinyl; or an acid-addition
salt, solvate or hydrate thereof.
5108448
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]20[
RADIOLABELING KIT AND
BINDING ASSAY FOR
ANTIBODIES
]11[
]02[
]22[
]/2[
29.02.2000
09/259337
]01[ 01.03.1999
Int. Cl.8 G01N 033/534, 033/60
IDEC PHARMACEUTICALS
CORPORATION, U.S.A.
WO/2000/052473
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
4837
039012
‫ערכה לסימון נוגדנים עם רדיו איזוטופ‬
‫ובדיקת קשירה לנוגדונים‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
[57] A method for radiolabeling a
chelator-conjugated antibody comprising:
(i) mixing chelator-conjugated antibody
with a solution containing a radiolabel;
(ii) incubating the mixture for an
appropriate amount of time at appropriate
temperature to produce radiolabeled
antibody having sufficient
radioincorporation, specific activity, and
immunoreactivity that it may be
administered directly to a human patient
without further purification to separate the
radiolabeled antibody from unincorporated
isotope; and
(iii) diluting the labeled antibody to an
appropriate concentration in formulation
buffer for administration to a human
patient without further purification to
separate the radiolabeled antibody from
unincorporated isotope.
__________
]22[]12[
039813
‫מערכת חימום וקירור ושיטה המשתמשת‬
‫באיחסון טרמי‬
]20[
HEATING AND COOLING
SYSTEM AND METHOD USING
THERMAL STORAGE
]11[
]22[
]/2[
]/1[
]/0[
07.09.2001
Int. Cl.8 F24D 003/14, 011/00, F25B 029/00
BRANDSTETTER SYSTEMS LTD.
AHARON BRANDSTETTER
BRANDSTETTER SYSTEMS LTD.,
P.O. B. 457, KEFAR VERADIM
[57] A system for heating and cooling a
structure, the system comprising:
(a) a reversible heat pump including:
(i) an exterior refrigerant heat transfer unit
(2) including a de-icer sensor, and
(ii) an interior refrigerant heat transfer unit
(4), said interior unit having a tank (20) in
which an electric-heater element (23) and a
refrigerant-to-water heat-transfer coil (10)
in close mutual heat transfer relationship
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
,‫ברנדשטטר מערכות בע"מ‬
‫אהרן ברנדשטטר‬
,‫ברנדשטטר מערכות בע"מ‬
,‫כפר ורדים‬, 4.7 .‫ד‬.‫ת‬
are immersed in a substantial amount of
water;
(b) a piping system fluidly communicating
with said tank, said piping system having a
plurality of piping loops for circulating
said water;
(c) at least one thermal storage mass (22A,
22B) disposed within a flooring region
selected from the group of regions
consisting of a floor region and an
4838
interfloor region of a room in the structure,
each thermal storage mass disposed
adjacent to, and in thermal communication
with at least one of said piping loops, each
said thermal storage mass for storing
thermal energy of said water, and for
thermally communicating said thermal
energy to said room, via said flooring
region;
(d) at least one room heat transfer unit
(22c) fluidly communicating with said
piping system, each said room heat transfer
unit connected to at least one of said
piping loops, such that said room heat
transfer unit and said thermal storage mass
are disposed on parallel piping loops;
(e) circulation means for circulating said
water in said tank through said thermal
storage mass and through said room heat
transfer unit, and
(f) control means, said control means
designed and configured to activate said
heater element during de-icing initiated by
said deicer sensor, and to control flow of
said water through said thermal storage
mass.
__________
]22[]12[
]20[
VACUUM ASSISTED CLOSURE
SYSTEM WITH HEATING AND
COOLING PROVISION
]11[
]02[
]22[
]/2[
]//[
]/0[
31.03.2000
60/127596
]01[ 02.04.1999
Int. Cl.8 A61F 007/00
KCI LICENSING, INC., U.S.A.
WO/2000/059418
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
4839
039313
‫מערכת סגירה המסתייעת בוואקום ובעלת‬
‫אמצעי חימום וקירור‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
[57] A device for promoting wound
healing in mammals, comprising:
a negative pressure source; a first pad (11)
for placement within a wound of a
mammal; a drape (14) for maintaining a
reduced pressure within said wound; a
fluid communication means for
communicating between said negative
The applications for division
from this application have
not yet been published
pressure source and said first pad; and a
second pad (13) for effecting metabolic
function at said wound, and positioned
proximate to said first pad, wherein said
second pad has fluid channels for the
circulation of heating or cooling fluid
therein.
5104411
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
033030
‫שיטה ומתקן לניהול מערכת רשת במימד‬
‫זמן באופן גרפי ותוך חיזוי‬
]20[
METHOD AND APPARATUS FOR
PREDICTIVELY AND
GRAPHICALLY ADMINISTERING
A NETWORKED SYSTEM IN A
TIME DIMENSION
]11[
]02[
26.04.2000
60/131018
]01[ 26.04.1999
]00[ US
3/222////
1/93091333
US
Int. Cl.8 G06F 015/173, H04L 012/24, 012/26
COMPUTER ASSOCIATES THINK,
INC., U.S.A.
WO/2000/065466
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]22[
]/2[
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4840
[57] A method for presenting a projected
status of at least one network system
component, the method comprising:
identifying a present reference time;
defining a status time associated with at
least one network system component, the
status time being a future time relative to
the reference time; identifying the at least
one network system component for
presentation; determining a projected
status associated with the at least one
network system component as of the status
time; and outputting for the presentation a
representation of the projected status of the
at least one network system component,
including displaying a three-dimensional
depiction of the at least one network
system component.
__________
]22[]12[
033133
VLA–4 ‫תרכובות מעכבות‬
]20[
VLA-4 INHIBITOR COMPOUNDS
]11[
]02[
30.06.2000
60/141692
]01[ 30.06.1999
]00[ US
/32202/32
0393/92///
US
/32202/31
0393/92///
US
Int. Cl.8 A61K 031/40, A61P 003/10, 011/06, 017/06, 019/02, 029/00, 035/00,
037/00, 041/00, C07D 207/08, 207/12, 209/10, 265/30, 277/04, 401/12, 403/12,
493/04
DAIICHI PHARMACEUTICAL CO.,
LTD., JAPAN
PHARMACOPEIA, INC., U.S.A.
WO/2001/000206
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
4841
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
[57] Compounds of the formula
or a salt thereof wherein
W is a substituted or unsubstituted phenyl;
W1 is a substituted or unsubstituted
divalent group of phenyl, pyridine,
pyrrolidine or thiazole;
A is =O, =S or =NH;
R is –(CH2)n-, wherein n is 1 or 2; X is –
C(O)-, M is chosen from the following
groups
wherein
is a divalent 5- or 6- membered
heterocyclic radical, with the nitrogen
atom being in the position of its attachment
to X; wherein Q represents –CH2-, -S- or –
O-;
R1, R2 and R3 are independently chosen
from the group consisting of –H, -OH,
quinolinyloxy, -NH2, mono- or
dialkylamino, alkylsulfonylamino,
arylsulfonylamino,
naphthalylsulfonylamino, dialkylamino
substituted napthtalylsulfonylamino, C1-C6
alkyl, benzyloxymethyl, halogen, phenyl,
C1-C4 alkoxy, phenyloxy, naphthyloxy,
and phenyloxy substituted with COOH or
halogen; or two of adjacent R1, R2 and R3
taken together may form an alkylene group
having 1 to 5 carbon atoms or
alkylenedioxy group having 1 to 3 carbon
atoms optionally substituted with from 1 to
3 alkyl group(s); R4 represents hydrogen or
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
lower alkyl; Y is chosen from a bond, a
C2-C8 alkenylene group, alkynylene group,
-C(O)-, C(O)-NH- and –(CH2)k-Y2,
wherein
k is chosen from 0, 1, 2 and 3; and
Y2 represents a direct bond or a divalent
radical chosen from –O-, -S-, -S(O)-, S(O)2- and –NY3-;
wherein
Y3 is independently chosen from hydrogen
and lower alkyl; Z represents C3-C8
cycloalkylene, phenylene, pyridylene
optionally substituted with halogen,
piperidine, piperazine, or phenyl
independently substituted with one or two
group(s), chosen from alkyl, alkoxy,
halogen, amino, mono- and
dialkylsubstituted amino, acylamino, nitro,
carboxy, A1 is a direct bond or represents a
bond, (CH2)t, or alkynyl, wherein t is
chosen from 1, 2, 3;
4842
R5 represents OH or lower alkoxy;
and
wherein
R11 is chosen from
wherein
R12 is chosen from –H; lower alkyl
optionally substituted with alkyl, 3-6cycloalkyl, hydroxy, phenyl (optionally
substituted with amino or nitro), amino,
cyclopropylamino, dialkylamino,
diallylamino, methoxymethylamino,
morpholino, dihalogen substituted
pyrrolidino or 4-alkylpiperidino; lower
alkenyl; lower alkynyl; and phenyl; Z3 is
chosen from a divalent aliphatic
hydrocarbon moiety having 1 to 12 carbon
atoms,
wherein
x is 0 or 1;
y is 1, 2 or 3;
R14 is –H or –OH;
provided that Z4 is chosen from the
following three formulated divalent groups
in the limited case of R11 is –NR12;
4843
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein
14
Ra is –H or halogen;
Q2 represents
wherein
R17 and R18 are independently –H or a
lower alkyl;
or phenylene which may be substituted
with halogen, alkoxy, amino, mono or
dialkylamino, acylamino, piperidino, nitro
or carboxy; L1 is chosen from –COOH and
–COOR19 wherein R19 is a lower alkyl.
__________
]22[]12[
]20[
METHOD FOR SELECTIVELY
DETERMINING SEMIVOLATILE BIOGENIC AMINES
]11[
]22[
]/2[
]/1[
22.11.2001
Int. Cl.8 G01N 030/00, 033/48, 033/50
Q-SCENT LTD.
AVRAHAM LORBER, ZEEV
KARPAS
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
033323
‫שיטה לקביעה סלקטיבית של אמינים‬
‫ביוגניים מתנדפים למחצה‬
‫ ערבה‬.‫נ‬.‫ ד‬,‫סנט בע"מ‬-‫קיו‬
‫ זאב כרפס‬,‫אברהם לורבר‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
4844
[57] Method for selectively detecting
biogenic amines in samples, which
comprises successively adding a base and
an acid, in either possible succession, to
the sample and analyzing the vapors
emitted by the sample under heating, to
enhance the detection of the less volatile
amines.
__________
]22[]12[
]20[
USE OF THE COMBING PROCESS
FOR THE IDENTIFICATION OF
DNA ORIGINS OF REPLICATION
]11[
]02[
]22[
]/2[
29.05.2000
60/136792
]01[ 28.05.1999
Int. Cl.8 C12Q 001/68
INSTITUT PASTEUR, FRANCE
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
(CNRS), FRANCE
WO/2000/073503
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A method for detecting an origin of
replication in a DNA molecule,
comprising:
(a) incubating DNA undergoing replication
in the presence of labeled nucleotides,
wherein the labeled nucleotides are
incorporated into the replicating DNA;
033223
‫שימוש בתהליך מסרק לקביעת מקורות‬
‫ לשיכפול‬DNA
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
(b) aligning the DNA from step (a) on a
substrate by molecular combing; and
(c) detecting the labeled nucleotides that
were incorporated into the DNA during
replication, wherein the labeled
nucleotides are located in a region that
corresponds to the origin of replication.
__________
]22[]12[
]20[
SYSTEM AND METHOD FOR
CALL RECORD CREATION AND
PROCESSING
]11[
]02[
08.06.2000
328299
01/1/0
01/1/2
4845
]01[
08.06.1999
3/93/92///
3/93/92///
033210
‫מערכת ושיטה להקלטת שיחה ועיבוד‬
]00[
US
US
US
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
01/1//
3/93/92///
Int. Cl.8 H04M 001/65, 001/652, 001/658
NICE SYSTEMS INC., U.S.A.
WO/2000/076188
PEARL COHEN ZEDEK LATZER,
5 SHENKAR STREET,
P.O.B. 12704
HERZLIYA 46733
[57] A method for constructing and
maintaining data representations of
lifetimes of telephone calls comprising one
or more segments, audio data for each
segment being recorded on one or more
recorders, the method comprising:
(a) constructing a call record for at least
one telephone call;
(b) receiving data regarding telephony
events associated with one or more
telephone calls;
]22[
]/2[
]//[
]/0[
The applications for division
from this application have
not yet been published
US
,‫פרל כהן צדק לצר‬
,0/714 .‫ד‬.‫ ת‬, . ‫ רח' שנקר‬,0 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
(c) matching a received telephony event
with a constructed call record;
(d) updating the matching call record
based on the received telephony event
data, said received telephony event data
comprising data describing the duration of
the telephone call; and
(e) combining the updated call record with
data indicating the location of recorded
audio data for the segment of the call, to
obtain a master call record representing the
lifetime of the telephone call.
510144451014445101444
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4846
]22[]12[
032033
,‫ תהליך להכנתו‬,‫בנזאימידאזול מותמר‬
‫תכשיר רוקחי ושימוש שלו‬
]20[
SUBSTITUTED BENZIMIDAZOLE,
PROCESS FOR ITS
PREPARATION, A
PHARMACEUTICAL
COMPOSITION AND USE
THEREOF
]11[
]02[
09.06.2000
19928424.5
]01[ 23.06.1999
]00[ DE
2333/1//93
2193191333
DE
Int. Cl.8 A61K 031/395, A61P 043/00, C07D 401/00, 401/14, 403/04, 403/14,
413/12, 417/14, 471/02
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/000610
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]22[
]/2[
]//[
]/0[
[57] Compounds of the formula
and/or a stereoisomeric form thereof
and/or a physiologically tolerable salt
4847
thereof where one of the substituents R1,
R2, R3 and R4 is a radical of the formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
in which
D is –C(O)-, -S(O)- or –S(O)2-.
R8, R9 and Z are as defined in the
specification, R5 is
a hydrogen atom, -OH or =O, and
R6 is
(1) aryl, in which aryl is as defined above
and is unsubsituted or subsituted as above,
(2) phenyl, mono- or disubsituted by
-N(R11)2,
-NH-C(O)-R11,
-S(O)x-R11, in which x is the integer zero,1
or 2,
-C(O)-R11, or
-(C1-C4) – alkyl-NH2,
(3) heteroaryl having 5 to 14 ring
members, in which heteroaryl is as defined
above and is unsubstituted or substituted
by –N-(C3-C6)-cycloalkyl or subsituted as
above or
(4) a heterocycle having 5 to 12 ring
members, in which the heterocycle is as
defined above and is unsubstituted or
substituted by –NH-(C1-C6)-alkyl, -NHphenyl, -NH-(C3-C6)-cycloalkyl or is
monosubstituted, disubstituted or
trisubstituted as above.
__________
]22[]12[
]20[
USE OF (S,S) - REBOXETINE IN
THE PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF PAIN
CONDITIONS AND
INCONTINENCE
]11[
]02[
22.06.2000
60/141968
]01[ 01.07.1999
/32200202
2/93/92///
/3222/12/
3/92392///
/322/30/2
2092192///
Int. Cl.8 A61K 045/00
PHARMACIA & UPJOHN
COMPANY LLC, U.S.A.
WO/2001/001973
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]22[
]/2[
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
032133
‫) – רבוקסטין להכנת‬S,S( –‫שימוש ב‬
‫תרופות לטיפול במצבי כאב ואי התאפקות‬
]00[
US
US
US
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
4848
[57] The use of optically pure (S, S)reboxetine, or a pharmaceutically
acceptable salt thereof, said compound
being substantially free of (R, R)reboxetine, in the manufacture of a
medicament for the treatment or
The applications for division
from this application have
not yet been published
prophylaxis of a disease selected from
chronic pain, incontinence, migraine
headaches, fibromyalgia and other
somatoform disorders, and peripheral
neuropathy.
510441451044115141481
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]20[
APPARATUS FOR TREATING
BRUXISM
]11[
]22[
]/2[
]/1[
]/0[
03.01.2002
Int. Cl.8 A61C 007/00, A61N 001/36
YISRAEL YERUSHALMI
YISRAEL YERUSHALMI
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.
REHOVOT 76209
[57] Apparatus for the treatment of
bruxism, comprising:
a biosensor (12) adapted to sense a
phenomenon associated with a bruxing
event; a drug delivery module (17) in
communication with said biosensor and
adapted to administer a relaxant to a
patient, said relaxant being capable of
relaxing at least one of an obruxism
muscle and an obruxism nerve, and a
4849
032333
‫מתקן לטיפול בברוקסיזם‬
‫ תל אביב‬,‫ישראל ירושלמי‬
‫ישראל ירושלמי‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,/7 ‫חדר‬, 00 ‫מנוחה ונחלה‬
processor (15) in communication with said
biosensor and said drug delivery module
for processing signals received from said
biosensor and for controlling operation of
said drug delivery module, wherein in
response to said phenomenon, said
biosensor communicates a signal to said
processor and said processor operates said
drug delivery module to initiate
administration of said relaxant.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
REAL-TIME DATABASE OBJECT
STATISTICS COLLECTION
]11[
]02[
]22[
]/2[
23.06.2000
09/349197
]01[ 07.07.1999
Int. Cl.8 G06F 017/30
COMPUTER ASSOCIATES THINK,
INC., U.S.A.
WO/2001/004798
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
[57] A method of collecting database
object statistics by a database management
system (DBMS), said method comprising:
(a) selecting one or more objects and
corresponding one or more object fields;
(b) creating a base set of statistics for the
selected object fields;
(c) reading active and archived log records
from active and archived logs
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
032321
‫איסוף נתונים סטטיסטיים לאובייקט בסיס‬
‫נתונים בזמן אמת‬
]00[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
corresponding to the selected database
objects;
(d) updating the base set of statistics when
a change is read in the active and archived
log records, the active and archived logs
maintaining a record of changes made to
the object and the corresponding object
fields;
(e) when an end-of-file of the active and
archive logs is reached, extracting log
4850
records prior to placement in the active and
archived logs; and
(f) updating the update statistics based on
the extracted log records.
__________
]22[]12[
032211
‫אלו–נוגדנים קטליטיים של אנטי–פקטור‬
VIII
]20[
CATALYTIC ANTI-FACTOR VIII
ALLO-ANTIBODIES
]11[
]02[
]22[
]/2[
18.07.2000
99401841.4
]01[ 21.07.1999
]00[ EP
Int. Cl.8 A61K 039/395, C07K 014/755, 016/18, G01N 033/68
INSTITUT NATIONAL DE LA
SANTE ET DE LA RECHERCHE
MEDICALE (I.N.S.E.R.M.), FRANCE
BAYER PHARMA, FRANCE
WO/2001/007918
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
[57] A method of determining the
presence of anti-Factor VIII alloantibodies capable of degrading Factor
VIII in a mammal, wherein said method
comprises:
(i) isolating the plasma from a sample of
blood taken from said mammal,
(ii) isolating anti-Factor VIII allo-
4851
antibodies from said plasma;
(iii) placing said anti-Factor VIII alloantibodies in contact with Factor VIII for a
period of time sufficient to permit any
degradation of said Factor VIII by said
anti-Factor VIII allo-antibodies; and
(iv) determining after said period of time,
whether said Factor VIII has effectively
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
been degraded by said anti-Factor VIII
allo-antibodies.
__________
]22[]12[
]20[
032288
‫גני ארליכיא קניס ותרכיבים‬
EHRLICHIA CANIS GENES AND
VACCINES
]11[
]02[
]22[
]/2[
20.07.2000
358322
]01[ 21.07.1999
]00[ US
Int. Cl.8 A61K 039/02, C07K 014/29, C12N 009/52, 015/31, 015/63
CORNELL RESEARCH
FOUNDATION, INC., U.S.A.
]/1[ YUNG-FU CHANG
]//[ WO/2001/007625
]/0[ JEREMY M. BEN-DAVID & CO.
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
LTD.,
,4.107 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
HAR HOTZVIM HI-TECH PARK,
‫ירושלים‬
P.O.B. 45087,
JERUSALEM 91450
[57] A recombinant DNA comprising
(d) a recombinant DNA that encodes a
said DNA selected from the group
protein having an amino acid sequence as
consisting of:
shown in SEQ. ID. NO. 9;
(a) a recombinant DNA that encodes a
(e) a recombinant DNA that encodes a
protein having an amino acid sequence as
protein having an amino acid sequence as
shown in SEQ. ID. NO 3;
shown in amino acids identified as 1
(b) a recombinant DNA that encodes a
through 31 of SEQ. ID. NO. 11; and
protein having an amino acid sequence as
(f) a recombinant DNA that encodes a
shown in SEQ ID NO. 5;
protein having an amino acid sequence as
(c) a recombinant DNA that encodes a
shown in amino acids identified as 33
protein having an amino acid sequence as
through 139 of SEQ. ID. NO. 11.
shown in amino acids identified as 1
through 449 of SEQ. ID. NO. 7;
__________
]22[]12[
]20[
MODEL-BASED VIDEO CODER
]11[
]02[
04.08.2000
60/147419
]01[ 06.08.1999
3/2/1/220
3293/91333
Int. Cl.8 H04N 007/26, 007/46, 007/50
RICHFX LTD.
YAIR MANN, DANIEL COHEN-OR,
ASSAF MONSA, UDI ARAD,
]22[
]/2[
]/1[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
032232
‫מקדד וידאו מבוסס על מודל‬
]00[
US
US
‫ בני ברק‬,‫ בע"מ‬.‫ אקס‬.‫ריטש אפ‬
‫ אודי‬,‫ אסף מונסה‬,‫אור‬-‫ דניאל כהן‬,‫יאיר מן‬
‫ יהודה שמר‬,‫ארד‬
4852
]//[
]/0[
YEHUDA SHEMER
WO/2001/011888
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] A non-client-server system for
compressing and decompressing video
using a sequence of reference frames,
comprising: an encoder; and a decoder,
wherein: the encoder and decoder are each
configured to generate approximated
reference frames from previous corrected
reference frames in the sequence using
three-dimensional mapping; the encoder is
configured to generate a plurality of
difference reference frames by subtracting
the approximated reference frames from
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
corresponding exact reference frames; the
encoder is configured to provide the
difference reference frames to the decoder
and is configured to use the difference
reference frames in creating the corrected
reference frames at the encoder; and the
decoder is configured to receive the
difference reference frames from the
encoder and is configured to create the
corrected reference frames at the decoder
based on the difference reference frames
and the approximated reference frames.
__________
]22[]12[
]20[
METHOD AND DEVICE FOR
DRYING, SEPARATING,
CLASSIFYING AND
DECOMPOSING RECOVERABLE
WASTE PRODUCTS
]11[
]02[
]22[
02.08.2000
19937521.6
]01[ 03.08.1999
Int. Cl.8 B09B 003/00, F26B 003/08
4853
032280
‫ סיווג ופרוק‬,‫ הפרדה‬,‫שיטה והתקן ליבוש‬
‫מוצרי פסולת הניתנים לקבל בחזרה‬
]00[
DE
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]/2[
]//[
]/0[
HARALD MARTIN, GERMANY
HARTWIG STREITENBERGER,
GERMANY
WO/2001/008823
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
[57] A method for drying, separating,
classifying and decomposing waste
products, the solid waste products from a
degassing and/or gasification process of
waste materials being introduced together
with the exhaust gases into a shaft-like
chamber and being in whole or in part
deposited in the funnel-shaped lower part
of this shaft-like chamber, and at the same
time and/or subsequently, air and the
exhaust gases together with the solid waste
products from the de-gassing and/or
gasification process being introduced
separately from below into the chamber
under pressure, the air being introduced
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
essentially axially and the exhaust gases
together with the solid waste products
being introduced essentially tangentially
into the chamber and as a result a
rotationally symmetric spouting turbulence
of the solid and gaseous substances
proceeds in the chamber, and subsequently
or during the continuous process, the solid
dried, separated, classified and essentially
decomposed products are discharged
downwardly from the chamber and the gas
having the solid particles still present
therein is discharged upwardly from the
chamber via a gas take-off orifice.
__________
]22[]12[
033393
‫תכשירי חיסון משולבים המכילים אנטיגנים‬
HPV–‫ ו‬HSV ‫מהסוגים‬
]20[
COMBINED VACCINE
COMPOSITIONS COMPRISING
HSV AND HPV ANTIGENS
]11[
]02[
]22[
]/2[
07.09.2000
9921146.8
]01[ 07.09.1999
]00[ GB
Int. Cl.8 A61K 039/00, 039/12, 039/125, 039/245, 039/29
SMITHKLINE BEECHAM
BIOLOGICALS S.A., BELGIUM
WO/2001/017551
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A vaccine composition comprising:
(a) a herpes simplex virus (HSV) antigen;
and
(b) a human papillomavirus (HPV) antigen
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
in combination with an adjuvant which is a
preferential stimulator of TH1 cell
response, and wherein the vaccine does not
include a hepatitis B antigen.
4854
__________
]22[]12[
032113
‫ הפוכה למשפעלי‬HPLC ‫טכניקת‬
‫פלסמינוגן‬
]20[
REVERSED-PHASE HPLC FOR
PLASMINOGEN ACTIVATORS
]11[
]02[
]22[
]/2[
]//[
]/0[
01.11.2000
60/163607
]01[ 04.11.1999
]00[ US
Int. Cl.8 C12Q 001/00, 001/02, 001/37, G01N 030/06, 030/26, 030/34
GENENTECH, INC., U.S.A.
WO/2001/032915
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] A process for monitoring the
effectiveness of a purification process in
removing plasminogen activator (PA)
endogenous to Chinese hamster ovary
(CHO) cells from a sample containing
human tPA or variants thereof, which
process comprises incubating the sample
with a protease capable of specifically
cleaving the Arg275 – Ile276 bond of human
wild-type tPA and then with a denaturing
agent and a reducing agent in amounts
effective to reduce the disulfide bonds of
human wild-type tPA; subjecting the
sample to a reversed-phase highperformance liquid chromatography step,
and analyzing the elution profile from the
chromatography step for the amount of PA
endogenous to the CHO cells present
therein.
__________
]22[]12[
032093
‫תולדות די–קטו ארומטיות כמעכבות‬
‫–פוספט טרנסלוקז‬9–‫גלוקוז‬
]20[
AROMATIC DI-KETO
DERIVATIVES AS GLUCOSE-6PHOSPHATE TRANSLOCASE
INHIBITORS
]11[
]02[
]22[
19.08.2000
99121241.6
]01[ 25.10.1999
]00[ EP
Int. Cl.8 A61K 031/10, 031/16, 031/19, 031/21, 031/335, 031/381, 031/40, A61P
003/10, C07C 059/76, 063/00, 065/40, 069/003, 235/02, 323/23, 323/50, 323/64,
327/02, 327/18, 327/20, 327/38, C07D 207/10, 209/02, 307/20, 309/16, 333/26,
333/50, 487/10, 487/20, 491/10, 491/20, 493/10, 493/20, 495/10, 495/20
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/030736
]/2[
]//[
4855
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]/0[
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A compound of the formula
wherein:
R4, R5, R6 and R7 are independently
selected from H, OH, halogen, alkyl, aryl,
acyl, X-alkyl, and X-aryl, wherein X is O,
NH, N-alkyl, or S, and wherein alkyl, acyl,
and aryl are optionally substituted; K is a
group of the formula
L is a group of the formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4856
or K and L form, together with the
respective carbon atoms to which they are
bound, a group of the formula
4857
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein:
R1 and R3 are independently selected from
a cation, H, alkyl, and aryl;
R2 is H, alkyl, aryl, or acyl;
X1, X2, X3, X4, X5, X6, and X7 are
independently selected from O, NH, Nalkyl, and S, and
Cyclus is, together with the C atoms
marked c and d, an optionally substituted
saturated, partly unsaturated, or aromatic,
carbocyclic or heterocyclic, simple or
condensed ring system,
or a pharmaceutically acceptable salt,
ester, or ether, in any stereoisomeric or
tautomeric form, or a mixture thereof in
any ratio; with the exclusion of compounds
wherein K is a group of formula II, and L
is a group of formula IV in which X1, X2,
X3, X4, X5, X6 and X7 are O, R1, R2 and R3
are H, R4 is OH, R5, R6 and R7 are H and
Cyclus is 3, 8-dihydroxyanthraquinone,
and with the exclusion of compounds
wherein K and L form together a group of
formula VI in which X1, X2, X3, X4, X5, X6
and X7 are O, R1 is –CH3, R2 and R3 are H,
R4 is OH, R5, R6 and R7 are H, and Cyclus
is 3,8-dihydroxyanthraquinone.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4858
]22[]12[
]20[
USE OF TYROSINE KINASE
INHIBITORS IN THE
MANUFACTURE OF
MEDICAMENTS FOR TREATING
BREAST CANCER
]11[
]02[
]22[
]/2[
01.11.2000
9925958.2
]01[ 02.11.1999
Int. Cl.8 A61K 045/00, 045/06
THE UNIVERSITY OF
MANCHESTER, UNITED KINGDOM
WO/2001/032155
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] Use of an EGFR tyrosine kinase
inhibitor in the manufacture of a
medicament for use in chemoprevention of
the onset of breast cancer in an invasive
breast cancer-free human by
simultaneously decreasing proliferation
and increasing apoptosis of epithelial cells
in a normal state or in an intermediate
state, between normal epithelium and
malignant invasive epithelium, thereby
(a) reducing the transformation of the cells
from a normal to a malignant state in an
invasive breast cancer-free human;
032023
‫שימוש במעכבי טירוזין קינאז לייצור‬
‫תרופות לסרטן השד‬
]00[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
(b) reducing the transformation of the cells
from an intermediate state, between
normal epithelium, to a malignant state in
an invasive breast cancer-free human; or
(c) causing substantial reversion of the
epithelial tissue back to a normal state
from the intermediate state, between
normal epithelium and malignant invasive
epithelium; which EGFR tyrosine kinase
inhibitor is ZD1839.
__________
4859
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
032319
‫שיטה לייצור גוף מעוצב המכיל עמילן‬
]20[
METHOD FOR PRODUCING A
MOULDED BODY CONTAINING
STARCH
]11[
]02[
]22[
]/2[
16.11.2000
99811071.2
]01[ 19.11.1999
]00[ EP
Int. Cl.8 A61K 009/00, 009/48, C07H 003/06
SWISS CAPS RECHTE AND
LIZENZEN AG, SWITZERLAND
WO/2001/037817
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] Process for the production of a
starch-containing shaped body, in
particular a soft capsule with single-part
capsule shell, characterized by the
following steps
(a) conversion of a mixture comprising at
least one native or chemically modified
starch with an amylopectin content of
greater than or equal to 50% by weight,
based on the weight of the anhydrous
starch, water, and at least one organic
plasticizer, where the content of organic
plasticizer is in the range from 37% by
weight to 50% by weight, based on the
weight of the anhydrous starch, with
melting and kneading, into a homogenized,
thermoplastic molten composition in a first
processing apparatus;
(b) if appropriate, preparation of a storable
intermediate product, in particular of
granules after cooling of the homogenized
melt and subsequent melting of the
intermediate product in a second
processing apparatus;
(c) production of at least one extrudate, in
particular of an extruded film, at the exit
from the first or, if appropriate, second
processing apparatus,
(d) forming of the extrudate to give a
shaped body in a continuous or
intermittent forming process;
(e) if appropriate, drying of the shaped
body,
where the steps (a) to (c) are carried out in
such a way that in step (d) the value of the
Staudinger index of the composition
forming the extrudate is at least 40 ml/g,
preferably at least 50 ml/g and more
preferably at least 60 ml/g.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4860
]22[]12[
032332
‫תולדות פוליציקלואלקילפורין ותכשירי‬
‫רוקחות המכילים אותן‬
]20[
POLYCYCLOALKYLPURINE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]02[
]22[
13.11.2000
60/165191
]01[ 12.11.1999
]00[ US
Int. Cl.8 A61K 031/52, A61P 003/10, 007/10, 009/00, 011/00, 013/12, 025/00, C07D
473/00, 473/04, 473/20, 473/22, 519/00, C07F 009/6561
BIOGEN IDEC MA INC., U.S.A.
WO/2001/034610
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]/2[
]//[
]/0[
[57] A compound of the formula:
or a pharmaceutically acceptable addition
salt thereof; wherein R1 and R2 are
independently selected from the group
consisting of:
(a) hydrogen;
(b) alkyl, alkenyl of not less than 3
carbons, or alkynyl of not less than 3
carbons; wherein said alkyl, alkenyl, or
alkynyl is either unsubstituted or
substituted with one or more substituents
4861
selected from the group consisting of
hydroxy, alkoxy, amino, alkylamino,
dialkylamino, heterocyclyl, acylamino,
alkylsulfonylamino, and
heterocyclylcarbonylamino; and
(c) aryl or substituted aryl;
R3 is a bicyclic, tricyclic or pentacyclic
group selected from the group consisting
of:
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein the bicyclic or tricyclic group is
either unsubstituted or substituted with one
or more substituents selected from the
group consisting of:
(a) alkyl, alkenyl, and alkynyl; wherein
each alkyl, alkenyl, or alkynyl group is
either unsubstituted or substituted with one
or more substituents selected from the
group consisting of (amino) (R5)
acylhydrazinylcarbonyl, (amino) (R5)
acyloxycarboxy, (hydroxy) (carboalkoxy)
alkylcarbamoyl, acyloxy, aldehydo,
alkenylsulfonylamino, alkoxy,
alkoxycarbonyl, alkylaminoalkylamino,
alkylphosphono, alkylsulfonylamino,
carbamoyl, R5, R5-alkoxy, cyano,
cyanoalkylcarbamoyl, cycloalkylamino,
dialkylamino, dialkylaminoalkylamino,
(heterocyclylalkyl) amino,
heterocylylcarbamoyl, hydroxy,
hydroxyalkylsufonylamino, oximino,
phosphono, substituted aralkylamino,
substituted arylcarboxyalkoxycarbonyl,
substituted heteroarylsulfonylamino,
substituted heterocyclyl, thiocarbamoyl,
and trifluoromethyl; and
(b) (alkoxycarbonyl) aralkylcarbamoyl,
aldehydo, alkenoxy, alkenylsufonylamino,
alkoxy, alkoxycarbonyl, alkylcarbamoyl,
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
alkoxycarbonylamino, alkylsulfonylamino,
alkylsulfonyloxy, amino,
aminoalkylaralkylcarbamoyl,
aminoalkylcarbamoyl,
aminoalkylheterocyclylalkylcarbamoyl,
aminocycloalkylalkylcycloalkylcarbamoyl,
aminocycloalkylcarbamoyl,
aralkoxycarbonylamino, arylheterocyclyl,
aryloxy, arylsulfonylamino,
arylsulfonyloxy, carbamoyl, carbonyl, -R5,
R5-alkoxy, R5-alkyl(alkyl) amino, R5alkylalkylcarbamoyl, R5-alkylsulfonyl, R5alkylsulfonylamino, R5-alkylthio, R5heterocyclylcarbonyl, cyano,
cycloalkylamino,
dialkylaminoalkylcarbamoyl, halogen,
heterocyclyl, (heterocyclylalkyl) amino,
hydroxy, oximino, substituted
aralkylamino, substituted heterocyclyl,
substituted heterocyclylsulfonylamino,
sulfoxyacylamino, and thiocarbamoyl; and
R4 is selected from the group consisting of
hydrogen, C1-4-alkyl, C1-4-alkyl-CO2H, and
phenyl, wherein the C1-4-alkyl, C1-4-alkylCO2H, and phenyl groups are either
unsubstituted or substituted with one to
three substituents selected from the group
consisting of halogen, - OH, -OMe, -NH2,
NO2, benzyl, and benzyl substituted with
4862
one to three substituents selected from the
group consisting of halogen, -OH, -OMe, NH2, and –NO2; R5 is selected from the
group consisting of –CH2COOH, C(CF3)2OH, -CONHNHSO2CF3, CONHOR4, -CONHSO2R4, -
CONHSO2NHR4, -C(O)R4PO3H2, NHCOCF3, -NHCONHSO2R4, -NHPO3H2,
-NHSO2R4, -NHSO2NHCOR4, -OPO3H2, OSO3H, -PO(OH)R4, -PO3H2, -SO3H, SO2NHR4, and the following:
X1 and X2 are independently selected from
the group consisting of O and S; Z is
selected from the group consisting of a
single bond, -O-, -(CH2)1-3-, -O(CH2)1-2-, CH2OCH2-, -(CH2)1-2O-, -CH=CHCH2-, -
CH=CH-, and –CH2CH=CH-; and R6 is
selected from the group consisting of
hydrogen, alkyl, acyl, alkylsulfonyl,
aralkyl, substituted aralkyl, substituted
alkyl, and heterocyclyl.
__________
]22[]12[
032913
‫אזפינים מצומדים כאגוניסטים של‬
‫ואסופרסין‬
]20[
CONDENSED AZEPINES AS
VASOPRESSIN AGONISTS
]11[
]02[
]22[
04.01.2001
0000079.4
]01[ 05.01.2000
]00[ GB
Int. Cl.8 A61K 031/55, A61P 013/02, C07D 223/16, 243/12, 403/12, 471/04, 487/00,
487/04, 491/12, 495/04, 498/04
FERRING BV, THE NETHERLANDS
WO/2001/049682
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]/2[
]//[
]/0[
[57] Compounds and
4863
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
pharmaceutically acceptable salts thereof
of the formula
wherein:
A is a bicyclic or tricyclic azepine
derivative selected from
A1, A4, A7 and A10 are each independently
selected from CH2, O and NR8;
A2, A3, A9, A11, A13, A14 and A15 are each
independently selected from CH and N;
either A5 is a covalent bond and A6 is S, or
A5 is N=CH and A6 is a covalent bond;
A8 and A12 are each independently selected
from NH and S;
A16 and A17 are both CH2, or one of A16
and A17 is CH2 and the other is selected
from CH(OH), CF2, O, SOx and NR8,
V1 and V2 are both H, OMe or F, or one of
V1 and V2 is OH, OMe, OBn, OPh, O-acyl,
Br, Cl, F, N3, NH2, NHBn or NH-acyl and
the other is H, or V1 and V2 together are
=O, -S(CH2)pS- or O(CH2)pO-;
W1 is either O or S;
X1 and X2 are both H, or together are =O
or =S;
Y is OR5 or NR6R7;
Z is S or –CH=CH-;
R1, R2, R3 and R4 are independently
selected from H, lower alkyl, lower
alkyloxy, F, Cl and Br;
R5 is selected from H and lower alkyl;
R6 and R7 are independently selected from
H and lower alkyl, or together are -(CH2)n-;
R8 is H or lower alkyl;
n=3, 4, 5 or 6;
p=2 or 3; and
x is 0, 1 or 2.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4864
]22[]12[
]20[
RETRIEVAL OF DIGITAL
OBJECTS BY REDIRECTION OF
CONTROLLED VOCABULARY
SEARCHES
]11[
]02[
]22[
]/2[
09.11.2000
437378
]01[ 10.11.1999
Int. Cl.8 G06F 015/16, 017/30
OCLC ONLINE COMPUTER
LIBRARY CENTER, INC., U.S.A.
WO/2001/035279
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A method for processing user
requests in a network, comprising the steps
of: processing selectively user requests to
access information, the selective
processing directing a request originating
from a user selection of a controlled
vocabulary abstract hyperlink to a
hyperlink redirection facility, said
controlled vocabulary abstract hyperlink
including a semantic value and an URL
(Uniform Resource Locator) address of the
hyperlink redirection facility, said
semantic value being at least one of a
descriptive term and an identifier for the
requested information, said hyperlink
redirection facility being an intermediary
performing redirection of said request and
having more than one possible target
profile for each request, said selective
processing further directing a user request
originating from a user selection of a
hyperlink not including an URL of the
hyperlink redirection facility directly to a
requested resource without first directing
4865
032983
‫שליפת אוביקטים דיגיטלים על ידי הכוונה‬
‫מחדש של חיפושי מלל מבוקרים‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
the request to the hyperlink redirection
facility; receiving at the redirection facility
a communication from the user
contemporaneously with or following the
receipt of the user request to access
information originating from the selection
of the controlled vocabulary abstract
hyperlink; identifying, the identification
based on the information in the received
communication, a user-supplied preference
regarding which service provider to use to
service the request, said user-supplied
preference being identified at the hyperlink
redirection facility prior to any
communication being sent from the
hyperlink redirection facility or server to
the user soliciting said preference; and
directing the request originating from the
selection of the controlled vocabulary
abstract hyperlink from the redirection
facility to a user for forwarding to a
service provider for servicing the request
based on the user-supplied preferences.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
TRANSDERMAL
CONTRACEPTIVE DELIVERY
SYSTEM AND PROCESS
]11[
]02[
]22[
]/2[
22.11.2000
60/167535
]01[ 24.11.1999
Int. Cl.8 A61M 037/00
AGILE THERAPEUTICS, INC.,
U.S.A.
WO/2001/037770
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]//[
]/0[
[57] A transdermal delivery system
comprising a backing layer and an
adhesive polymer matrix affixed to the
backing layer, wherein the adhesive
polymer matrix comprises:
(a) an adhesive polymer;
(b) a humectant;
032399
‫מערכת ותהליך להחדרה תוך–עורית של‬
‫אמצעי מניעה‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(c) a combination of skin permeation
enhancing agents comprising dimethyl
sulfoxide; a fatty (C8-C20) alcohol ester of
lactic acid; a lower (C1-C4) alkyl ester of
lactic acid; and capric acid;
(d) a progestin; and
(e) an estrogen.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4866
]22[]12[
]20[
LIQUID DISPENSER
]11[
]22[
]/2[
]/0[
15.05.2002
Int. Cl.8 B05B 011/00
AMIR GENOSAR
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
[57] A liquid dispenser comprising a
mostly rigid body including two spacedapart major surfaces having interconnected
peripheral edges to delimit therebetween a
closed dispensing body having a liquid to
be dispensed contained therein, a pumping
chamber having an inlet valve and a nonreturn product dispensing valve and
actuated by a pumping button provided
along one of said major surfaces and
displaceable between a first normal
position and a second depressed position,
the arrangement being such that said
dispenser is formed as a compact, selfcontained unitary container and pump,
characterized in that said pumping button
is formed as an integral part of one of said
major surfaces and serves as a wall of said
pumping chamber and depression of the
pumping button to its displaced position
4867
032322
‫מחלק נוזל‬
‫ פרדס חנה‬,‫אמיר גנוסר‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
causes liquid contained in said pumping
chamber to be expelled via said product
dispensing valve, and return of said button
to its first normal position causes liquid to
enter said pumping chamber via said inlet
valve, and further comprising an uptake
conduit in fluid communication with said
inlet valve and positioned to deliver liquid
to said pumping chamber upon return of
said pumping button to its first pumping
position and a non-return pressurecompensation valve leading into said body
wherein return of said button to its first
normal position transfers said liquid from
said uptake conduit to said pumping
chamber which in turn forces liquid from
said body into said uptake tube and causes
air to enter said body via said pressurecompensation valve.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
NEAR INFRARED
FLUORESCENT CONTRAST
AGENT
]11[
]22[
]/2[
15.12.1999
Int. Cl.8 A61K 049/00
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT,
GERMANY
FUJI PHOTO FILM CO. LTD.,
JAPAN
WO/2001/043781
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
[57] A near infrared fluorescent contrast
agent comprising at least one compound
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
032223
–‫חומר ניגוד עם פלואורסצנציה קרוב לתת‬
‫אדום‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
selected from the group consisting of the
compounds of the following formulas:
4868
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪4869‬‬
__________
]22[]12[
]20[
LASER BEAM IRRADIATION
INSTRUMENT
]11[
]02[
]22[
]/2[
]//[
]/0[
08.12.2000
11-348587
]01[ 08.12.1999
Int. Cl.8 A61B 018/20, A61N 005/06
YA-MAN LTD., JAPAN
WO/2001/041872
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
032201
‫מכשיר להקרנה ע"י קרן לייזר‬
]00[
JP
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,04/9 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
4870
[57] A laser beam irradiation instrument
(1), comprising:
a plurality of semiconductor laser diodes
(7) arranged in two lines, with the
semiconductor laser diodes of one line
staggered with respect to those of the other
line, wherein said plurality of
semiconductor laser diodes in each line
define a plurality of parallel optical axes
which in turn define a plane of the
semiconductor laser diodes, and said
planes cross each other and define a
crossing line; and a plurality of condenser
lenses (5) each arranged on a respective
optical axis of said semiconductor laser
diodes, thereby causing each
semiconductor laser to focus on the
crossing line of the two planes.
__________
4871
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
ARRESTING CABLE SUPPORT
ASSEMBLY
]11[
]02[
]22[
]/2[
11.10.2001
689100
]01[ 12.10.2000
Int. Cl.8 B64F 001/02
ENGINEERED ARRESTING
SYSTEMS CORPORATION, U.S.A.
WO/2002/030746
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A hook cable support assembly, for
an aircraft arresting system, comprising: an
assembly enclosure having a detachable
cover with a pivot structure mounted to the
cover; a support arm supported below the
cover by the pivot structure and rotatable
about an axis thereof; a torsion spring
device concentric to said axis and arranged
to rotate the support arm upward to a static
alignment; a cable support block mounted
to the support arm and rotatable between
raised and lowered positions; a four-bar
linkage coupled between the support arm
032213
‫התקן לתמיכה בכבל מעכב‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
and the support block; a cylinder/piston
device coupled between the support arm
and the four-bar linkage and operable on
the four-bar linkage to rotate the support
block to its lowered position; and a
compression spring device mounted
between the support arm and the four-bar
linkage and arranged to cause the linkage
to rotate the support block to its raised
position in the absence of action by the
cylinder/piston device to rotate the support
block to its lowered position.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4872
]22[]12[
]20[
PHARMACEUTICAL
COMPOSITIONS FOR
TREATMENT OF DNA VIRAL
INFECTIONS
]11[
]02[
13.12.2000
9930811.6
]01[ 30.12.1999
3333//090
2193291333
33102//92
1293/91333
Int. Cl.8 A61K 009/08, 045/00, 045/06
HENDERSON MORLEY RESEARCH
AND DEVELOPMENT LIMITED,
UNITED KINGDOM
WO/2001/049242
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
[57] Use of a loop diuretic and a cardiac
glycoside for the preparation of a
091133
‫תכשירי רוקחות לטיפול בזיהומים וירליים‬
DNA– ‫ב‬
]00[
GB
GB
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
pharmaceutical composition for the
treatment of DNA viral infections.
__________
]22[]12[
091913
‫ הליך עבור הכנתן‬,‫תולדות אימידאזול‬
‫ותכשירי רוקחות המכילים אותן‬
]20[
IMIDAZOLE DERIVATIVES,
PROCESS FOR THE
PREPARATION THEREOF AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAID IMIDAZOLE DERIVATIVES
]11[
]02[
]22[
12.01.2001
20000073
]01[ 14.01.2000
]00[ FI
Int. Cl.8 A61K 031/4164, A61P 043/00, C07D 233/64, 401/06, 403/06, 405/06,
409/06
ORION CORPORATION, FINLAND
WO/2001/051472
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, /76 ‫רחוב הירקון‬
P.O.B. 6451,
TEL AVIV 61063
]/2[
]//[
]/0[
[57] An imidazole derivative of the formula
4873
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein X is –CH2-(CH2)p-, -O-, =NH or –
S-;
R1 is phenyl, naphthyl, 1, 2, 3, 4tetrahydronaphthyl, C5-C7 cycloalkyl, C5C7 cycloalkenyl, C5-C7 cycloalkynyl,
pyridyl, primidinyl, thienyl, furyl,
cyclohexyl, piperidyl, piperazinyl or
morpholinyl;
wherein the said phenyl, naphthyl, 1, 2, 3,
4-tetrahydronaphthyl, C5-C7 cycloalkyl,
C5-C7 cycloalkenyl, C5-C7 cycloalkynyl,
pyridyl, pyrimidinyl, thienyl, furyl,
cyclohexyl, piperidyl, piperazinyl or
morpholinyl is optionally substituted with
one to three substituents selected
independently from halogen, -OH, -NH2,
halo- C1-C6 – alkyl, C1-C6-alkyl, C2-C6 –
alkenyl, C2-C6 – alkynyl, C1-C6 – alkoxy,
OH-(C1-C6) – alkyl, NH2- (C1-C6) – alkyl,
NH2 – (C1-C6) – alkyl and mono – or di
(C1-C6 – alkyl) amino;
R2 is H or C1-C6 – alkyl;
R3 is H or C1-C6 – alkyl;
R4 is H or C1-C6 – alkyl;
R5 is H, or R5 and R7 form together a bond;
each R6 is independently halogen, -OH, NH2, halo- C1-C6-alkyl, C1-C6 – alkyl, C1C6 – alkoxy or OH –(C1-C6)-alkyl;
R7 is H, OH or C1-C4-alkyl, or R7 and R5
form together a bond; each R8 is
independently OH, C1-C6 – alkyl, halo- C1C6 – alkyl or C1-C6 – alkoxy;
m is 0, 1, 2 or 3;
n is 0 or 1;
p is 0 or 1;
r is 0 or 1; and
t is 0, 1 or 2;
or a pharmaceutically acceptable ester or
salt thereof.
__________
]22[]12[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
091913
4874
]20[
MULTI-COMPARTMENT IN-RIM
SOLID LAVATORY CLEANSING
DEVICE
]11[
]22[
]/2[
]/2[
]/1[
]/0[
21.12.1998
Int. Cl.8 A47K 017/02, E03D 009/00
127663
NECA CHEMICALS (1952) LTD.
MARCEL FRIEDMAN
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
[57] A multi-compartment in-rim
lavatory cleansing device, comprising a
holder with at least two separate
compartments, a first of said compartments
containing a first cleansing block,
comprising either a foam generating and
stabilizing component separately formed
as a molded block from components
melted together at a temperature of about
60-80oC and then cooled and cast into said
first compartment or a lime scale
preventing acid, separately formed in a
‫התקן רב–תאי לתלייה על סף האסלה‬
‫המכיל חומר מוצק לניקוי האסלה‬
‫ פתח תקוה‬,‫) בע"מ‬06./( ‫נקה כימיקלים‬
‫מרסל פרידמן‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
molded block from components melted
together at a temperature of about 60-80oC
and then cooled and cast into said first
compartment, and a second compartment
containing a transparent air freshening
molded block containing between 2% and
20% of a perfume formulation with air
freshening properties, said device
including means known per se for
attachment thereof to the rim of a lavatory
bowl.
__________
]22[]12[
]20[
TETRAHYDROPYRIDINES,
PREPARATION METHOD AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
SAME
091319
‫ שיטות‬,‫טטרהידרופירדינים חדשניים‬
‫להכנתם ותרכובות פרמצבטיות המכילות‬
‫אותם‬
]11[
]02[
]22[
]/2[
]//[
]/0[
29.12.2000
00/00113
]01[ 06.01.2000
]00[ FR
Int. Cl.8 C07D 405/00
SANOFI AVENTIS, FRANCE
WO/2001/049684
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] TNF-α inhibiting compounds of the formula
4875
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
in which
R1 represents a hydrogen or halogen atom,
or a group CF3;
R2 and R3 represent, independently, a
hydrogen atom or a methyl group;
n and n' each represent, independently, 0
or 1;
* represents the positions of attachment;
A represents N or CH;
X represents a sulfur or oxygen atom;
R4 and R5 represent, independently, a
hydrogen atom or a (C1-C6) alkyl group;
and their salts or solvates.
__________
]22[]12[
091331
‫שימוש של נגזרות של‬
‫פנילהטרואלקילאמין להכנת תרופות‬
]20[
USE OF
PHENYLHETEROALKYLAMINE
DERIVATIVES FOR THE
PREPARATION OF
MEDICAMENTS
]11[
]02[
]22[
20.02.2001
0004151.7
]01[ 23.02.2000
]00[ GB
Int. Cl.8 A61K 031/10, 031/13, 031/275, A61P 019/02, 025/04, 029/00, 043/00, C07C
211/49, 255/58, 317/32, 323/32, 323/63, C07D 263/32, 277/28, 295/12
ASTRAZENECA AB, SWEDEN
DAVID CHESHIRE, STEPHEN
CONNOLLY, DAVID COX, IAN
MILLICHIP
WO/2001/062721
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]/2[
]/1[
]//[
]/0[
[57] The use of compounds of the formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4876
wherein:
X and Y independently represent C1 to 4
alkyl, C1 to 4 alkoxy, halogen, CF3, OCF3,
CN, C≡CH, S(O)mCH3, S(O)pCF3, NO2 or
NHCHO;
m and p independently represent an integer
0, 1 or 2;
Z represents H or fluoro;
V represents S(O)n or NR3;
W represents phenyl or a five or six
membered aromatic heterocyclic ring
containing 1 to 3 heteroatoms
independently selected from O, S and N;
said phenyl or aromatic heterocyclic ring
being optionally substituted by one or
more substituents selected independently
from halogen, C1 to 4 alkyl, C1 to 4
alkoxy, OH, CN, NO2 or NR4R5; said alkyl
or alkoxy group being optionally further
substituted by one or more fluorine atoms;
R1 and R2 independently represent H, C1
to 4 alkyl or C3 to 6 cycloalkyl; said alkyl
group being optionally substituted by C1
to 4 alkoxy, halogen, hydroxy, NR6R7,
phenyl or a five or six membered aromatic
or saturated heterocyclic ring containing 1
to 3 heteroatoms independently selected
from O, S and N; said phenyl or aromatic
heterocyclic ring being optionally further
substituted by halogen, C1 to 4 alkyl, C1
to 4 alkoxy, CF3, OCF3, CN or NO2;
or the group NR1R2 together represents a 4
to 8 membered saturated azacyclic ring
optionally incorporating one further
heteroatom selected from O, S or NR8, said
ring being optionally substituted by C1 to
4 alkyl, C1 to 4 alkoxy or OH; said alkyl
group being optionally substituted by C1
to 4 alkoxy, OH or NR9R10;
R3 represents H or C1 to 4 alkyl;
R4, R5, R6, R7, R9 and R10 independently
represent H or C1 to 4 alkyl;
R8 represents H or C1 to 6 alkyl; said alkyl
group being optionally substituted by C1
to 4 alkoxy, OH, NR11R12, phenyl or a five
or six membered aromatic or saturated
heterocyclic ring containing 1 to 3
heteroatoms independently selected from
O, S and N; said phenyl or aromatic
heterocyclic ring being optionally further
substituted by halogen, C1 to 4 alkyl, C1
to 4 alkoxy, CF3, OCF3, CN or NO2;
R11 and R12 independently represent H or
C1 to 4 alkyl;
n represents an integer 0, 1 or 2;
or a pharmaceutically acceptable salt,
enantiomer or racemate thereof, in the
manufacture of a medicament, for the
treatment or prophylaxis of diseases or
conditions in which inhibition of nitric
oxide synthase activity is beneficial.
__________
4877
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
RAZOR CARTRIDGE AND
CORRESPONDING METHOD OF
ASSEMBLY
]11[
]02[
]22[
]/2[
16.02.2001
09/515621
]01[ 29.02.2000
Int. Cl.8 B26B 021/02
WHEEL TECHNOLOGY LTD.,
CAYMAN ISLANDS
SHLOMO ZUCKER
WO/2001/064403
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]/1[
]//[
]/0[
[57] A razor cartridge comprising:
(i) a plurality of substantially planar
blades, each of said blades having a cutting
edge extending along substantially all of a
major dimension termed length, each of
said blades having an uninterrupted upper
surface, a lower surface, and a width
measured across said upper surface
perpendicular to said length of no more
than about 4 mm;
(ii) a base having at least one series of
spaced-apart ribs configured to provide
abutment features for abutting said lower
surface of each of said blades so as to
091313
‫מחסנית סכין גילוח ושיטה להרכבתה‬
]00[
US
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
define at least partially a predetermined
mounting position of each of said blades;
and
(iii) a cover configured for engaging said
base to form a unitary cartridge structure,
said cover providing at least one abutment
surface for each of said blades, said at least
one abutment surface being configured to
abut said upper surface of a corresponding
one of said blades, thereby pressing said
blade against said corresponding series of
abutment features so as to retain said blade
in said predetermined mounting position.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4878
]22[]12[
]20[
PIPERIDINE-AND PIPERAZINE
SUBSTITUTED NHYDROXYFORMAMIDES AS
INHIBITORS OF
METALLOPROTEINASES, THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]11[
]02[
]22[
]/2[
]/1[
15.02.2001
00400467.7
]01[ 21.02.2000
Int. Cl.8 C07D 239/00
ASTRAZENECA AB, SWEDEN
BERNARD CHRISTOPHE
BARLAAM, ROBERT IAN DOWELL,
NICHOLAS JOHN NEWCOMBE,
HOWARD TUCKER, DAVID
WATERSON, MAURICE RAYMOND
VERSCHOYLE FINLAY
WO/2001/062742
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
]//[
]/0[
091313
‫)) – הידרוקסיפורמאמידים מותמרי‬N
‫פיפרידין ופיפראזין כמעכבי‬
‫ הכנתם ותכשירי‬,‫מטאלופרוטאינאזות‬
‫רוקחות המכילים אותם‬
]00[
EP
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
‫אביב‬
[57] A compound or a pharmaceutically
acceptable salt or an in vivo hydrolysable
ester thereof of the formula
wherein
B is 2-pyridyl or 2-pyridyloxy group
monosubstituted at the 4-, 5- or 6- position
by trifluoromethyl;
X is a nitrogen atom;
R1 is a trimethyl-1-hydantoin C2-alkyl or
a trimethyl-3-hydantoin C2-4alkyl group;
4879
or R1 is phenyl or C2-4alkylphenyl
monosubstituted at the 3- or 4-position by
halogen, trifluoromethyl, thio, C1-3alkyl
or C1-3 alkoxy; or R1 is phenylSO2NHC2-4alkyl; or R1 is 2-pyridyl or 2pyridyl C2-4alkyl; or R1 is 3-pyridyl or 3pyridyl C2-4alkyl; or R1 is 2-pyrimidineFebruary 10, 2008 – ‫ד' באדר א' התשס"ח‬
SCH2CH2; or R1 is 2- or 4-pyrimidinyl
C2-4alkyl optionally monosubstituted by
one of halogen, trifluoromethyl, C1-3
alkyl, C1-3 alkyloxy, 2-pyrazinyl
optionally substituted by halogen or 2pyrazinyl C2-4 alkyl optionally substituted
by halogen.
__________
]22[]12[
]20[
ROTARY LOCKING CYLINDER
FOR A SAFETY LOCK
]11[
]02[
]22[
]/2[
]//[
]/0[
09.01.2001
130/00
]01[ 24.01.2000
Int. Cl.8 E05B 063/00
ERNST KELLER, SWITZERLAND
WO/2001/053638
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A rotary locking cylinder (1) for a
safety lock, with a housing (5) and at least
one armature (8) having a key channel,
with tumblers which are provided to
rotationally release the armature with an
associated key (17), with a driver (6) and
with at least one extension element (3)
attached to the active part (2) of the rotary
091303
‫צילינדר נעילה סיבובי עבור מנעול בטחון‬
]00[
CH
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
locking cylinder, which has a housing and
a rotatable insert (9), characterized in that
at least one extension element is attached
at a distance from the driver outside on the
active part and in that the key shank is
extended substantially corresponding to
the length (A) of this extension element.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4880
]20[
]11[
]02[
]22[
]/2[
]//[
]/0[
]22[]12[
REMOTE PATIENT
MONITORING SYSTEM
25.01.2001
00/00903
]01[ 25.01.2000
Int. Cl.8 A61B 005/05
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
(CNRS), FRANCE
WO/2001/054571
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] System for monitoring patients
undergoing dialysis at home comprising
interface means at the patient's home,
interface means at a doctor's surgery, a
server linked by a network such as a
telephone network to the interface means
at the patient's home and to the interface
means at the doctor's surgery, the said
server receiving from the interface means
at the patient's home, values of
physiological parameters measured by the
patient or by sensors and comprising
means for storing a history, corresponding
to a certain period of time, regarding the
values of physiological parameters which
are transmitted thereto, the said server
furthermore comprising means for
implementing a processing on the values
of physiological parameters transmitted by
the patient with a view to their presentation
and to the presentation of their changes on
the interface means at the doctor's surgery,
the said means implementing on the latest
values of physiological parameters which
are transmitted to the server a processing
comparing the state defined by these
various values of physiological parameters
with alert states defined as a function of
the stored history of the patient and
comprising means for transmitting the
results of this processing to the interface
091321
‫מערכת לניטור חולה רחוק‬
]00[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
means at the doctor's surgery,
characterized in that the processing means
comprise means for comparing the
difference between the patient's measured
weight and his dry weight with threshold
values, comparing the difference between
the patient's blood pressure when standing
and the patient's blood pressure when lying
with threshold values, comparing the mean
of the patient's systolic and diastolic blood
pressures when lying with a threshold
value corresponding to the mean value
over time of this value for the patient,
comparing the mean of the patient's
systolic and diastolic blood pressures when
standing with a threshold value
corresponding to the mean value over time
of this value for the patient, as well as
means for determining values of
parameters of bags dependent on the
volumes measured in the patient's drainage
bags, means for determining trend
parameters, and modifying them as a
function of the results of the comparisons,
and means for comparing these trend
parameters with threshold values, and
when such a threshold value is exceeded,
transmitting an alert message to the
interface means at the doctor's surgery
and/or at the patient's home.
__________
4881
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
091201
‫הרכב אגרוכימיקלי המכיל מלח זרחיתי‬
‫ותהליך להכנתו‬
]20[
AGROCHEMICAL
COMPOSITION CONTAINING
PHOSPHITE AND PROCESS FOR
THE PREPARATION THEREOF
]11[
]22[
]/2[
]/1[
]/0[
25.07.2002
Int. Cl.8 A01N 059/00, C05B 007/00, 017/00
ROTEM AMFERT NEGEV LTD.
‫רותם אמפרט נגב בע"מ‬
ALEXANDER JOSEF
‫אלקסנדר יוסף‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A solid, granular, free-flowing,
agrochemical composition containing a
salt of phosphorous acid and at least one
other NPK nutrient, that is homogeneous
in the chemical composition and uniform
in particle size, that is water-soluble, and
that comprises metal microelements.
__________
]22[]12[
]20[
INFRASTRUCTURE FOR A
TELEPHONY NETWORK
]11[
]02[
]22[
]/2[
30.07.2002
09/918443
]01[ 01.08.2001
Int. Cl.8 H04B 007/185, H04Q 007/22
SHIRON SATELLITE
COMMUNICATIONS (1996) LTD.
]/1[
YEHUDA REST, SALIT DROBINER
GROS, AVRAHAM BARDA
]/0[
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[57] A branch of a cellular telephone
network based on a first synchronous data
communication protocol, comprising
interfaces to a satellite link using a second,
asynchronous, data communication
protocol, wherein said interfaces comprise
converters for converting data of a
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
091222
‫תשתית לרשת טלפוניה‬
]00[
US
‫ פתח‬,‫) בע"מ‬0669( ‫שירון תקשורת לוויינים‬
‫תקוה‬
‫ אברהם‬,‫ סלעית דרובינר גרוס‬,‫יהודה רסט‬
‫ברדה‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
datastream between said first data
communication protocol and said second
data communication protocol, and wherein
said synchronous data protocol allows nondata carrying time slots, and said interfaces
comprising non-data carrying time slot
remover for removing said non-data
4882
carrying time slots during conversion into
said asynchronous protocol and a time slot
regenerator for regenerating non-data
carrying time slots during reconstruction of
said datastream.
__________
]22[]12[
]20[
CONTROLLED HEARTBURN AND
REFLUX DISEASE TREATMENT
APPARATUS
]11[
]02[
07.02.2001
09/501235
]01[ 10.02.2000
3/22322/2
2393191333
Int. Cl.8 A61B 017/12, A61F 002/06
OBTECH MEDICAL AG,
SWITZERLAND
WO/2001/045485
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]22[
]/2[
]//[
]/0[
[57] A heartburn and reflux disease
treatment apparatus, comprising: an
operable restriction device (56) to be
implanted in a patient having heartburn
and reflux disease to engage the esophagus
(58) or the stomach close to the cardia
4883
090083
‫מתקן מבוקר לטפול בצרבת ובמחלת‬
‫רפלוקס‬
]00[
US
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
without forming an upper pouch of the
stomach that substantially accumulates
food to form a restricted food passageway
in the stomach or esophagus, said
restriction device being designed to work
like an artificial sphincter to allow food to
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
readily pass through the passageway and
operable to restrict the passageway
sufficiently so as to substantially prevent
regurgitation of stomach acids or foods
into the patient's esophagus, a source (64)
of energy external to the patient's body,
and a control device (62) operable from
outside the patient's body for releasing
wireless energy from said source of
energy, said released wireless energy being
used to activate said restriction device,
including to enlarge or contract the
restricted passageway.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4884
]22[]12[
090833
‫שימוש במעכב של פעילות אנזימתית של‬
‫ להכנת תכשירי‬IV ‫דיפפטידיל פפטידז‬
‫רוקחות‬
]20[
USE OF A DIPEPTIDYL
PEPTIDASE IV ENZYME
ACTIVITY EFFECTOR FOR THE
PRODUCTION OF
PHARMACEUTICAL
COMPOSITIONS
]11[
]02[
]22[
02.04.2001
60/194061
]01[ 31.03.2000
]00[ US
Int. Cl.8 A61K 031/40, 031/426, 038/05, 038/48, A61P 003/06, 003/10, C07D
207/16, 295/18
PROSIDION LIMITED, UNITED
KINGDOM
WO/2001/072290
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]/2[
]//[
]/0[
[57] Use of at least one DP IV enzyme
activity inhibitor for the production of a
medicament for repeated administration
for increasing the capacity of insulin
providing cells in an animal by causing
cells present in the pancreas to
differentiate into insulin producing cells.
__________
]22[]12[
090828
‫תכשירי רוקחות לטיפול בסרטן המכילים‬
‫–בנזודיאזיפין‬0,4 ‫תולדה של‬
]20[
PHARMACEUTICAL
COMPOSITIONS FOR TREATING
CANCER COMPRISING A 1,4BENZODIAZEPINE DERIVATIVE
]11[
]02[
]22[
]/2[
22.03.2001
60/192278
]01[ 27.03.2000
]00[ US
Int. Cl.8 A61K 031/55, A61P 035/00, C07D 403/00
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2001/072721
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
4885
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
[57] Use of (1) at least one agent selected
from the group consisting of antiproliferative cytotoxic agents and
cytostatic agents and (2) a compound of
the formula
or a pharmaceutically acceptable salt
thereof wherein
R1 is Cl, Br, CN, optionally substituted
phenyl, or optionally substituted 2-, 3- or
4-pyridyl;
R2 is optionally substituted lower alkyl, or
optionally substituted aralkyl;
R3 and R5 are each independently
optionally substituted lower alkyl,
optionally substituted aryl, or optionally
substituted heterocyclo;
R4 is hydrogen or lower alkyl;
Z1 is CO, SO2, CO2 or SO2N(R5)-; and
n is 1 or 2;
provided that the cytotoxic agent and/or
cytostatic agent is administered
simultaneously with or prior to the formula
I compound for the manufacture of a
medicament for the synergistical treatment
of cancer in a mammalian specie
substantially as described in the
specification.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4886
]22[]12[
090901
‫טיפול באמצעות החלפת הורמונים‬
‫בשימוש בצירוף אסטרוגנים מצומדים‬
‫ומדרוקסיפרוגסטרון אצטאט‬
]20[
HORMONE REPLACEMENT
THERAPY USING
A COMBINATION OF
CONJUGATED
ESTROGENS AND
MEDROXYPROGESTERONE
ACETATE
]11[
]02[
16.03.2001
60/190630
]01[ 20.03.2000
]00[ US
/321///3/
2093191332
US
Int. Cl.8 A61K 031/57, A61P 005/30, C07J 001/00, 005/00
WYETH, U.S.A.
WO/2001/070208
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
[57] Use of conjugated estrogens and
medroxyprogesterone acetate in the
manufacture of pharmaceutical packs
comprising daily dosage units for the
treatment or inhibition of menopausal or
postmenopausal disorders in a
perimenopausal, menopausal, or
postmenopausal woman in need thereof,
wherein each daily dosage unit comprises
a combination of conjugated estrogens and
a daily dosage of about 1.5 mg of
medroxyprogesterone acetate.
__________
4887
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
090919
‫ המשתמש בתשתית אלחוטית‬GPS ‫מקלט‬
]20[
GPS RECEIVER UTILIZING
WIRELESS INFRASTRUCTURE
]11[
]02[
13.03.2001
60/193236
]01[ 30.03.2000
]00[ US
3/2/1//21
3092191333
US
Int. Cl.8 G01S 001/00, 005/14, H03J 007/02
CELLGUIDE LTD.
‫ רחובות‬,‫סלגייד בע"מ‬
HANOCH COHEN, BARUCH
‫ יוסף ניר‬,‫ ברוך שייביץ‬,‫חנוך כהן‬
SHAYEVITS, JOSEPH NIR
WO/2001/075473
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
]22[
]/2[
]/1[
]//[
]/0[
[57] A locator integrated with a mobile
receiver unit of a cellular network for
determining pseudoranges to Navstar
satellites, wherein a local oscillator of said
locator receives synchronization data from
said cellular network for correcting a
frequency shift of said local oscillator
relative to time tagged indications of said
cellular network, comprising: a frequency
measuring module for determining a
number of digital numbers produced by
said local oscillator per nominal interval
between time tagged indications
transmitted by said cellular network, and a
GPS processor for Navstar signals and for
receiving said local oscillator frequency,
and for receiving an output of said
frequency measuring module.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4888
]22[]12[
]20[
METHOD AND APPARATUS FOR
IMPROVING SAFETY DURING
EXPOSURE TO AN INTENSE
PULSED LIGHT SOURCE
]11[
]22[
]/2[
]/1[
]/0[
11.09.2002
Int. Cl.8 A61B 018/20
INOLASE 2002 LTD.
MICHAEL SLATKINE
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] Apparatus for the non-invasive and
spectrally selective treatment of skin
disorders with an intense pulsed light
source while providing eye and bodily
safety of bystanders exposed to said
intense pulsed light source, comprising:
(a) a flash lamp;
(b) means for causing said flash lamp to
generate at least one pulse of light;
(c) a light propagation assembly with a
distal end for directing the light generated
by said flash lamp to said distal end;
(d) diverging means attached to said distal
end;
(e) means for directing the intense pulsed
light which is transmitted through said
distal end to a skin target; and
(f) means for positioning said distal end to
be substantially in contact with said skin
target, wherein the radiance of said
diverged light which is transmitted from
4889
090323
‫שיטה ומתקן לשיפור הבטיחות בעת‬
‫חשיפה למקור הבזקי אור מרוכז‬
‫ נתניה דרום‬,‫ בע"מ‬/11/ ‫אינולייז‬
‫מיכאל זלטקין‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
said distal end is significantly less than the
radiance of said flash lamp, at a direct line
of sight therewith, wherein the radiance of
said diverged light is less than
10*k1*k2(t^1/3) J/cm2/sr, where k2=1 and
t is a pulse duration in seconds, k1=1 for a
wavelength ranging from 580 to 700 nm,
k1=1.3 for a wavelength of approximately
570 nm, k1=1.6 for a wavelength of
approximately 830 nm, k1=3 for a
wavelength of approximately 940 nm, and
k1=5 for a wavelength greater than 1050
nm, wherein the energy density of said
diverged light at said distal end ranges
from 5 to 100 J/cm2, wherein the pulse
duration of the light generated by said
flash lamp ranges from 0.1 to 900
milliseconds, and a wavelength band of the
light generated by said flash lamp ranges
from 400 to 1300 nm, wherein said distal
end has a dimension greater than 5 mm.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
090283
‫שיטה למחיזור כימי של פסולת‬
‫פוליאתילן–טרפטלט‬
]20[
METHOD OF CHEMICAL
RECYCLING OF
POLYETHYLENE
TEREPHTHALATE WASTE
]11[
]02[
]22[
]/2[
08.03.2001
PV2000/969
]01[ 17.03.2000
]00[ CZ
Int. Cl.8 C07C 027/02, 029/09, 051/09, 063/26, C08J 011/14
MILAN SIREK, CZECH REPUBLIC
JAROSLAV JIROUSEK, CZECH
REPUBLIC
WO/2001/068581
JEREMY M. BEN-DAVID & CO.
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
LTD.,
,4.107 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
HAR HOTZVIM HI-TECH PARK,
‫ירושלים‬
P.O.B. 45087,
JERUSALEM 91450
]//[
]/0[
[57] The method of chemical recycling of
polyethylene terephthalate waste to
terephthalic acid and ethandiol with the
hydrolysis of polyethylene terephthalate
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
waste, the purpose being its
depolymerization, characterized in that it
consists of a continuous series of gradual
steps namely (a) separation of the
4890
polyethylene terephthalate component of
the input material by its conversion to
brittle form through crystallization,
grinding and subsequent sifting, followed
by (a) continuous two-stage hydrolysis of
the polyethylene terephthalate, carried out
in the first stage by feeding steam to the
polymer melt, and in the second stage, by
the reaction of the products of the first
stage of hydrolysis with ammonium
hydroxide, followed by (c) condensation of
terephthalic acid from an aqueous solution
of the second-stage hydrolysis products by
inorganic acid, and its separation by means
of filtration, and finally (d) rectification
separation of ethandiol from a solution of
the products of the second stage of
hydrolysis, after the separation of
terephthalic acid.
__________
]22[]12[
]20[
INSERTION OF ASYNCHRONOUS
DATA INTO A SYNCHRONOUS
STREAM
]11[
]02[
29.03.2001
60/193405
]01[ 29.03.2000
3/2/2//3/
1093091332
Int. Cl.8 H04N 007/24, 007/52
INTELLOCITY USA, INC., U.S.A.
WO/2001/074084
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]22[
]/2[
]//[
]/0[
[57] A method for inserting asynchronous
data into a synchronous data stream,
comprising: receiving information
including a first time value when said
asynchronous data may be used;
determining a transfer interval for said
asynchronous data; inserting said
asynchronous data into said synchronous
data stream at a time prior to said first time
value by an amount that is greater than or
equal to said transfer interval; wherein
4891
090291
‫הכנסת נתונים אסינכרוניים למערכת‬
‫סינכרונית‬
]00[
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
determining the transfer interval further
comprises: determining a file size of said
asynchronous data; determining a data
transfer rate for said asynchronous data;
dividing said file size by said data transfer
rate to calculate a duration; determining a
ratio of data stream bandwidth available
for transfer of said asynchronous data, and
modifying said duration by multiplying
said duration by the inverse of said ratio.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
091118
‫תולדות פירימידין ותכשירי רוקחות‬
‫המכילים אותן‬
]20[
PYRIMIDINE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]02[
26.04.2001
2000-126489 ]01[ 26.04.2000
]00[ JP
1333-113210
1293/91333
JP
Int. Cl.8 A61K 031/505, A61P 001/10, 043/00, C07D 401/04, 401/14, 405/14,
409/14, 413/14
EISAI R&D MANAGEMENT CO.,
,
LTD.
WO/2001/080893
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]22[
]/2[
]//[
]/0[
[57] A compound of the formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4892
(wherein A represents a phenyl group,
pyridyl group, thienyl group or furyl group
which may be substituted with one or two
groups selected from a halogen atom, a
hydroxyl group, a C1-6 alkyl group, a C1-6
alkoxy group and a C1-6 alkoxy-carbonyl
group;
B represents a pyridyl group which may be
substituted with one or more groups
selected from a halogen atom, hydroxyl
group, a C1-6 alkyl group and amino group;
R1 represents a hydrogen atom, a
morpholinyl group or a group represented
by the formula –NR1aR1b (wherein R1a and
R1b are the same as or different from each
other and each represents a hydrogen atom,
a C1-6 alkyl group, a C1-6 acyl group, a
phenyl group or a C1-6 alkylsulfonyl
group); and R2 represents a hydrogen atom
or a group represented by the formula –
NR2aR2b (wherein R2a and R2b are the same
as or different from each other and each
represents a hydrogen atom or a C1-6 alkyl
group), provided that, in the above
definition, the cases (i) where, A is a 4fluorophenyl group;
B is a 4-pyridyl group;
R1 is a amino group;
and R2 is a hydrogen atom and (ii) where
A is a 4-fluorophenyl group;
B is a 4-pyridyl group, R1 is an acetamide
group; and R2 is a hydrogen atom are
excluded) or a salt thereof.
5100841
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]20[
METHOD AND INSTALLATION
FOR THE PRODUCTION OF A
CONDENSED NON WOVEN AND
CONDENSER DEVICE
]11[
]02[
]22[
]/2[
]/0[
30.09.2002
01/12716
]01[ 03.10.2001
Int. Cl.8 D04H 003/00
THIBEAU, FRANCE
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] Method for producing a condensed
nonwoven web (w3) according to which at
least one first nonwoven web (w1) is
produced by means of a carding machine
(1), said method being characterized in that
said first nonwoven web issued from the
4893
091180
‫שיטה ומתקן לייצור בד לא ארוג דחוס‬
‫והתקן דחיסה‬
]00[
FR
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
carding machine is transported by means
of a first transport surface (s1) to a rotating
transfer element (20), said first nonwoven
web being transferred onto a second
transport surface (52) by means of said
transfer element, the second transport
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
surface being driven at a linear speed (v2)
slower than the circumferential speed (VT)
of the transfer element.
__________
]22[]12[
]20[
PHOTOCHROMIC SPIRO
(INDOLINE) NAPHTHOXAZINES
]11[
]02[
05.04.2001
135531
]01[ 06.04.2000
20/13/
3/93/91333
Int. Cl.8 C07D 498/10
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
VALERI KRONGAUZ, ALEXANDRE
CHIF, VLADIMIR
TCHERNOIVANOV, ALEXANDRE
AIZIKOVICH
WO/2001/077112
PAULINA BEN-AMI, BEN-AMI &
ASSOCIATES,
P.O.B. 94,
REHOVOT 76100
]22[
]/2[
]/1[
]//[
]/0[
[57] A spiro(indoline)naphtho(2,1b)(1,4)oxazine or
spiro(indoline)naphtha(1,2-b)(1,4)oxazine
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
091132
‫ספירו (אינדולין) נאפתאוקסאזינים‬
‫פוטוכרומיים‬
]00[
IL
IL
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
‫ אלכסנדר‬,‫ אלכסנדר שיף‬,‫ולרי קרונגאוז‬
‫אייזיקוביץ‬
,'‫ בן עמי ושות‬, ‫עמי‬-‫פאולינה בן‬
‫ רחובות‬,64 .‫ד‬.‫ת‬
having the following formulas Ia and Ib,
respectively:
4894
wherein (a) n is an integer from 1 to 6; p is
1 or 2; and q is an integer from 1 to 6;
(b) R2 and R3 represent independently a
radical selected from the group consisting
of:
(i) C1-C6 alkyl optionally substituted by
fluoro, C1-C4 alkoxy or fluoroalkoxy, C1C4 alkylcarbonyloxy, C2-C4
alkenylcarbonyloxy, C3-C6 cycloalkyl or
aryl;
(ii) C2-C6 alkenyl with a terminal double
bond;
(iii) C3-C6 cycloalkyl optionally
substituted by fluoro;
(iv) aryl; and (v) alkylcarbonyl; or (vi) one
of R2 and R3 is a group –COOR wherein R
4895
is a radical (i) to (iv) as defined
hereinbefore and the other of R2 and R3 is
a radical (i) to (iv) as defined hereinbefore;
or (vii) R2 and R3 together with the carbon
atom at position 3 of the indoline ring form
a 3-7 membered saturated ring optionally
containing a heteroatom selected from
nitrogen, oxygen or sulfur, and
(c) R4 and R5 represent independently (i)
hydrogen; (ii) halogen, optionally fluoro;
or a radical selected from the group
consisting of: (iii) cyano; (iv) aryloxy
optionally substituted by C1-C6 alkyl, C1C4 alkoxy or amino; (v) C1-C4 alkoxy
optionally substituted by halogen,
optionally di- and trifluoromethoxy; (vii)
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
C1-C6 alkyl optionally substituted by C1-C4
alkoxy, halogen, optionally
trifluoromethyl, C3-C6 cycloalkyl,
polycycloalkyl (optionally norbornane or
adamantane), aryl; (viii) aryl optionally
substituted with amino or alkoxy group,
optionally dialkylaminophenyl or
methoxyphenyl; (ix) amide (-CONH2); (x)
sulfonamide (-SO2NH2); (xi) –NR6R7,
wherein R6 and R7 are independently
selected from the group consisting of alkyl,
alkenyl, cycloalkyl, aryl, alkylaryl and
fluoroalkyl (optionally trifluoromethyl) or
R6 and R7 together with the nitrogen atom
form a 3-7 membered saturated ring
optionally containing a further heteroatom
selected from the group consisting of
nitrogen, oxygen or sulfur atom, optionally
piperidino, piperazino or morpholino; (xii)
R4 may further be –OCF3, in which case p
is 1; and (xiii) R5 may further be an
aryl(dialkyl)methyl group of the formula –
C(aryl)(CnH2n+1)(CmH2m+1), wherein n and
m are integers from 1 to 5, linked to one of
the benzene rings of the naphthoxazine
part of the molecule, in which case q is an
integer from 1 to 5.
__________
]22[]12[
]20[
SURGICAL DISTRACTION
DEVICE
]11[
]02[
]22[
]/2[
12.04.2001
0009107.4
]01[ 13.04.2000
Int. Cl.8 A61B 017/72
UNIVERSITY COLLEGE LONDON,
UNITED KINGDOM
WO/2001/078614
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A surgical distraction device for
applying an extending or tensioning force
non-invasively to a patient's skeleton or to
an implant which comprises anchoring
means (4) for attaching first (1) and second
(2) components of the device to a bone (5)
or to adjoining bones, said components
being connected by a linkage (6) of an
extendable length, a magnet (8) connected
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
091133
‫התקן ניתוחי לפיזור‬
]00[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
to the linkage via a reduction gearbox (9)
having two or more gear reductions
whereby the gearbox has a gear ratio of
100:1 or greater and actuating means (10)
located externally of the patient for
generating a moving or varying electromagnetic field, thereby causing the magnet
to rotate and the linkage to be extended.
4896
‫__________‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪4897‬‬
]22[]12[
‫רפלקטור‬
]20[
REFLECTOR
]11[
]02[
]22[
]/2[
27.04.2001
00810397.0
]01[ 09.05.2000
Int. Cl.8 G02B 005/08
ALCAN TECHNOLOGY &
MANAGEMENT LTD.,
SWITZERLAND
TOMAS KRAMER, VOLKMAR
GILLICH, ROMAN FUCHS
WO/2001/086327
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]/1[
]//[
]/0[
091303
[57] Weatherproof and corrosion-resistant
reflector (1) for electromagnetic radiation,
in particular for infrared radiation, visible
light and ultraviolet radiation, with a high
total reflection, containing a reflector body
(2) of aluminium or an aluminium alloy
with a reflective surface or containing a
reflector body with a reflection layer of
aluminium or an aluminium alloy forming
a reflective surface, characterized in that
the reflective surface of aluminium or an
aluminium alloy has a roughness Ra of less
]00[
EP
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
than 0.1 μm to DIN 4761 to 4768 and the
reflector has an external final transparent
protective layer (4) which is a sol-gel
lacquer, preferably a sol-gel lacquer of a
polysiloxane, in particular a sol-gel lacquer
of a polysiloxane produced from an
alcoholic silane solution, and a watery
colloidal silicic acid solution of a thickness
greater than 1 μm and the reflector
according to the 2000 h QUV test to
ASTM G53-96 has losses of total
reflection and brilliance of less than 5%.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4898
]22[]12[
]20[
SUSTAINED RELEASE
PHARMACEUTICAL
COMPOSITIONS FOR
PARENTERAL ADMINISTRATION
OF HYDROPHILIC COMPOUNDS
]11[
]02[
]22[
]/2[
]//[
]/0[
23.05.2001
MI2000A001173 ]01[ 26.05.2000
Int. Cl.8 A61K 009/107, 038/22
ITALFARMACO S.P.A., ITALY
WO/2001/089479
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A stable, biologically compatible,
well tolerated w/o microemulsion, suitable
for the parenteral administration of
biologically active compounds which are
hydrophilic or are made hydrophilic by
suitable derivatization, providing the
sustained release of the active compounds
contained therein, said microemulsion
consisting of:
(a) up to 20% of an internal hydrophilic
aqueous phase containing the
therapeutically active hydrophilic
compound;
(b) 30 to 98% of a hydrophobic external
phase selected from esters of C8-C20
098100
‫תכשירי רוקחות לשחרור מושהה‬
‫להחדרה תוך ורידית של תרכובות‬
‫הידרופיליות‬
]00[
IT
,‫ריינהולד כהן ושותפיו‬
‫ תל‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
‫אביב‬
saturated or unsaturated carboxylic acids
with a C2-C8 alcohol residue or mono, diand triglycerides of C8-C20 fatty acids;
(c) up to 50% of a surfactant in admixture
with a co-surfactant, said surfactant being
selected from natural or synthetic
glycerophospholipids containing residues
of C4-C20 saturated or unsaturated
carboxylic acids having as phosphoester
moiety a residue of choline, ethanolamine,
serine, glycerol, and said co-surfactant
being selected from C8-C20 fatty acids or
C2-C12 alcohols, and wherein the
surfactant/co-surfactant ratio is ≥ 2.
__________
4899
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
METHOD AND APPARATUS FOR
MAXIMIZING TEST COVERAGE
]11[
]02[
03.06.2001
60/208822
]01[ 02.06.2000
3/2///3/2
3/93091332
Int. Cl.8 G01R 031/3183
VERISITY LTD.
WO/2001/092903
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]22[
]/2[
]//[
]/0[
[57] A method for determining functional
coverage of a device under test (DUT) in a
test environment during a test verification
process, the coverage metric being
constructed from a plurality of coverage
items, the method comprising: obtaining a
functional coverage group for examining
during the test verification process, said
coverage group including at least one
functional coverage item; providing a set
098191
‫שיטה ומכשיר להגדלת כיסוי ניסוי‬
]00[
US
US
‫ ראש העין‬,‫וריסיטי בע"מ‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
of input values to the test verification
process; performing the test verification
process with said set of input test values to
obtain a value for each coverage item;
examining coverage obtained with said
coverage group according to said value
obtained from each coverage item; and
automatically altering said set of input test
values.
__________
]22[]12[
]20[
INDOLINOSPIROPYRAN
COMPOUNDS AND METHODS
FOR THEIR MANUFACTURE
]11[
]02[
]22[
]/2[
24.05.2001
09/585108
]01[ 31.05.2000
Int. Cl.8 C07D 491/10, 491/107
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE), FRANCE
WO/2001/092265
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
098133
‫תרכובות אינדולינוספיראן ושיטות לייצורן‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
4900
[57] A compound of the formula
wherein R1 is C1-C18 alkyl, allyl, phenyl,
phen (C1-C4) alkyl, or (C1-C4)
alkoxycarbonyl (C1-C4) alkyl, R2 and R3
are each independently C1-C4 alkyl,
phenyl, benzyl, or combined to form a
cyclic ring that is a cyclohexyl, norbornyl
or adamantyl ring, R4 is hydrogen,
hydroxy, trichloromethyl, trifluoromethyl,
formyl, C1-C4 alkyl, halogen, C1-C4
alkoxy, nitro, cyano, C1-C4 monohaloalkyl,
C1-C4 alkoxycarbonyl, or an aromatic
sharing the two adjacent carbon atoms
with the benzene portion of the pyran ring
to form a condensed aromatic ring, and x
equals 1, 2, or 3.
Also claimed is an indoline loaded resin of
the formula
which is an intermediate in the preparation
of compounds of formula (I).
__________
4901
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
098102
‫חומר שטוח במיוחד בצורת גיליון או רצועה‬
‫ומערך נטול פחם‬
]20[
FLAT MATERIAL ESPECIALLY
IN THE FORM OF A SHEET OR A
STRIP AND CARBONLESS SET
]11[
]02[
19.05.2001
10027574.5
]01[ 02.06.2000
]00[
233212109/
1092391333
2332///190
1/92291333
Int. Cl.8 B41M 005/30, G03G 005/00, 005/16
WOLFGANG BOSSERT, GERMANY
WO/2001/092961
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]22[
]/2[
]//[
]/0[
[57] Flat sheet material for manufacturing
plate-shaped sheets (1) for receiving an
information with at least one coating (4),
applied to the sheet material (2), in which
coating there are embedded particles (5)
which in an electric and/or magnetic field
are adapted to supply an information,
characterized in that the coating comprises
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
DE
DE
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
fine cavities (3), that the particles are
electrically activatable and/or
magnetizable particles, and that by
activation and/or targeted magnetization of
these particles already present in the sheet
material the information is depositable into
the sheet material as well as readable and
changeable.
4902
__________
]22[]12[
]20[
COMBINED DOCUMENT
BINDER AND PAPER PUNCH
]11[
]22[
]/2[
08.12.2002
Int. Cl.8 B42F 013/40
LAP-INSTITUTE FOR ADVANCED
SURGERY LTD.
]/0[
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
[57] A combined document binder and
paper punch, comprising
(a) a stiff-cover document binder;
(b) a base member rigidly attached to said
binder;
(c) a plurality of spaced-apart documentretaining axially-movable prongs at least
indirectly supported by said base member;
4903
098809
‫תיק מסמכים משולב עם מנקב נייר‬
-‫ תל‬,‫המכון לכירורגיה מתקדמת בע"מ‬-‫לאפ‬
‫אביב‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
(d) a plurality of spaced-apart curved
prongs each having a first end hinged
proximate to said base member, and a
second end adapted to be brought into
register and to align with an upper end of
an adjacent axially-movable prong;
(e) a plurality of spaced-apart apertures
provided in said base member;
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
(f) a plurality of axially-movable paper
punches, each having a cutting lower end
and arranged to punch a hole in a paper
document in combination with said
apertures; and
(g) a mechanism and operating handle for
operating and displacing at least said
curved prongs; the arrangement being such
that said curved prongs are displaceable
between an open position allowing the
introduction of documents onto either pair
of prongs, an intermediate position
contacting said axially-movable prongs to
a downward position, and wherein said
axially-movable paper punches are
provided with an upper end normally in
contact with lower ends of said axiallymovable prongs, said paper punches being
positioned to enter said apertures when
said axially-movable prongs are pressed
into said downward position to punch a
plurality of holes in a document previously
inserted between said paper punches and
said base member.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4904
]22[]12[
098393
‫קומבינציות רפואיות של חומצות שומניות‬
]20[
THERAPEUTIC COMBINATIONS
OF FATTY ACIDS
]11[
]02[
]22[
]/2[
20.06.2001
0016045.7
]01[ 29.06.2000
]00[ GB
Int. Cl.8 A61K 009/00, 031/185, 031/202, A61P 025/00, C07C 057/12
AMARIN NEUROSCIENCE
LIMITED, UNITED KINGDOM
DAVID FREDERICK HORROBIN
WO/2002/002105
JEREMY M. BEN-DAVID & CO.
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
LTD.,
,4.107 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
HAR HOTZVIM HI-TECH PARK,
‫ירושלים‬
P.O.B. 45087,
JERUSALEM 91450
]/1[
]//[
]/0[
[57] Use of a composition consisting
essentially wholly of
(a) biologically assimilable
eicosapentaenoic acid (EPA), or any
appropriate derivative, having a purity of
at least 90%, and
(b) biologically assimilable arachidonic
acid (AA), a precursor of AA, or any
appropriate derivative, having a purity of
at least 90%, wherein the ratio of EPA to
AA, or precursor of AA, is between 1:1
and 20:1, respectively, with the proviso
that if a derivative is used, this is not a
phospholipid containing both fatty acids
EPA and AA or precursor in the
manufacture of a medicament for the
treatment of a neurological degenerative
disorder or a peripheral nervous system
disease.
__________
4905
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
IMMUNOSENSOR
]11[
]02[
13.07.2001
616556
]01[ 14.07.2000
/22//2
2093/91333
/2/000
2093/91333
/2/221
2093/91333
Int. Cl.8 G01N 033/483
LIFESCAN, INC., U.S.A.
WO/2002/008763
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
[57] A disposable device (20) for use in
detecting a target antigen (50) in a fluid
sample having a pH, the device comprising
a reaction chamber (22) having an internal
surface (40), a proximal end (74) and a
distal end; an immobilized antibody (44)
fixed within the reaction chamber, the
antibody being capable of binding to the
target antigen; a reporter complex present
within the reaction chamber and not bound
to the immobilized antibody prior to the
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
098939
‫גלאי חיסוני‬
]00[
US
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
introduction of a fluid sample, the complex
comprising a probe, the reporter complex
being capable of mixing with the sample; a
detection chamber (28) having a wall (60),
an internal surface, a distal end and a
proximal end; a sample ingress (24) at the
distal end of the reaction chamber; and a
sample passageway (38) between the distal
end of the reaction chamber and the
proximal end of the detection chamber.
4906
‫__________‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪4907‬‬
]22[]12[
]20[
USE OF STRAINS OF THE
PARAPOX OVIS VIRUS FOR
PRODUCING ANTIVIRAL
PHARMACEUTICALS AND
ANTICANCER
PHARMACEUTICALS
]11[
]02[
]22[
]/2[
11.07.2001
10122451.6
]01[ 09.05.2001
Int. Cl.8 A61K 035/76
AICURIS GMBH & CO. KG,
GERMANY
WO/2002/004002
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] Use of viruses which belong
taxonomically to the Parapoxvirus ovis
strain NZ2, for producing medicaments
098338
‫שימוש בזנים של וירוס פאראפוקס אוביס‬
‫ליצור תכשירי רוקחות נוגדי וירוסים ונוגדי‬
‫גידולים‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
directed against viral infections and cancer
in humans and animals.
__________
]22[]12[
]20[
UNINTERRUPTED AUTOMATIC
CALL DISTRIBUTION DURING
FAILURE AND RECOVERY OF
COMPUTER-TELEPHONY
INTEGRATION
]11[
]02[
]22[
]/2[
]/0[
29.12.2002
10/037274
]01[ 03.01.2002
Int. Cl.8 H04M 003/22, 003/42, 003/51
AVAYA INC., U.S.A.
FENSTER & COMPANY,
INTELLECTUAL PROPERTY LTD.,
12 BASEL ST.,
ENTRANCE 1,
P.O.B. 10256 ,
PETACH TIKVA
[57] An automatic call distribution (ACD)
system for enqueuing calls in call queues
of the ACD system under control of a host
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
098281
‫הפצת שיחות אוטומטית ללא הפוגה בזמן‬
‫כשלון ואחזור אינטגרצית מחשב–טלפון‬
]00[
US
,‫קניין רוחני בע"מ‬,'‫פנסטר ושות‬
,01/.9 .‫ד‬.‫ ת‬, ‫ קרית אריה‬,0 ‫ כניסה‬0/ ‫בזל‬
‫פתח תקוה‬
processor that is separate from the ACD
system and for assigning the calls to agents
for servicing under the control of the host
4908
processor in a contact center, comprising:
first means in the ACD system responsive
to the host processor losing the control of
the enqueuing, for controlling the
enqueuing by the ACD system, and
responsive to the host processor regaining
ability to control the enqueuing, for
returning control of the enqueuing to the
host processor; and second means in the
ACD system responsive to the host
processor losing the control of the
assigning, for controlling the assigning by
the ACD system, and responsive to the
host processor regaining ability to control
the assigning, for continuing controlling of
the assigning by the ACD system from
each of said call queues until said call
queue is emptied of at least calls that were
enqueued therein under control of the
ACD system and only then returning
control of the assigning from the call
queue to the host processor.
__________
]22[]12[
098313
‫זנים של וירוס פאראפוקס אוביס לשיםוש‬
‫נגד לייפת של איבר‬
]20[
STRAINS OF THE PARAPOX OVIS
VIRUS FOR USE AGAINST
ORGAN FIBROSIS
]11[
]02[
11.07.2001
10033581.0
]01[ 11.07.2000
]00[ DE
2321110092
3/93291332
DE
Int. Cl.8 A61K 039/12, 039/275, C12N 007/08
AICURIS GMBH & CO. KG,
GERMANY
WO/2002/004019
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
4909
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
[57] Use of a non-recombinant isolate of
parapoxvirus for producing medicaments
which have a curative effect on organ
fibroses in humans.
__________
]22[]12[
098312
–‫יצירה דינמית של תכולת וידאו להצגה על‬
‫ידי שרת מדיה‬
]20[
DYNAMIC GENERATION OF
VIDEO CONTENT
FOR PRESENTATION BY A
MEDIA SERVER
]11[
]02[
]22[
]/2[
13.07.2001
615468
]01[ 13.07.2000
]00[ US
Int. Cl.8 H04N 005/00, 005/765, 007/173
BROADBAND ROYALTY
CORPORATION, U.S.A.
WO/2002/007439
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A method for generating a digital
video stream, comprising: loading user
preferences corresponding to a manner in
which the digital video stream is to be
configured, wherein the user preferences
include a plurality of time zones in which
various parts of a system that is to be
tested with the digital video stream may be
simulated to operate in; identifying media
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
required by a media generator to satisfy the
user preferences; loading said media; using
said media to generate intermediate digital
content based on the user preferences;
transferring the intermediate digital
content to an encoder; and encoding said
intermediate digital content into said
digital video stream.
4910
__________
]22[]12[
]20[
MISSILE FIN LOCK SYSTEM
]11[
]02[
]22[
]/2[
31.07.2001
09/631149
]01[ 02.08.2000
Int. Cl.8 F42B 010/02
RAYTHEON COMPANY, U.S.A.
RAYTHEON COMPANY, U.S.A.
]//[
]/0[
WO/2002/010670
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A fin lock device (12) for a missile
comprising: a first mechanism for locking
a missile fin (14) by grasping an edge of
said fin, and a second mechanism (32) for
retracting said first mechanism to release
said fin, characterized in that: said first
4911
093132
‫מערכת לנעילת סנפירי טילים‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
mechanism comprises a piston (18) for
extending from an airframe (16) of said
missile, said piston having a notch (20)
therein for receiving said fin edge, and said
second mechanism is for causing said
piston to retract into said airframe.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
093193
‫תרופות מקדמיות לליגנדים של קולטני‬
NMDA
]20[
PRODRUGS TO NMDA
RECEPTOR LIGANDS
]11[
]02[
]22[
20.08.2001
00117918.3
]01[ 21.08.2000
]00[ EP
Int. Cl.8 A61K 031/445, 031/496, 031/675, A61P 025/28, C07D 211/42, 401/12,
413/12, C07F 009/09
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2002/016321
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]/2[
]//[
]/0[
[57] Compounds of the formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4912
wherein R is
(a) –C(O)(CH2)nC(O)OH,
(b)
wherein R1 is –N(R2)(R3) or a five or six
member aromatic or non-aromatic
heterocyclic ring containing one or more
heteroatoms selected from nitrogen,
oxygen or sulfur, said ring being
unsubstituted or substituted by lower alkyl;
(c) –P(O)(OH)2, or is
(d) –C(O)(CH2)nNHC(O)(CH2)nN(R2)(R3);
R2, R3 are hydrogen or lower alkyl; and
n is 1, 2, 3 or 4; or a pharmaceutically
acceptable acid addition salt thereof.
__________
]22[]12[
]20[
NIOBIUM BASED CAPACITOR
ANODE
]11[
]02[
]22[
]/2[
]//[
]/0[
14.08.2001
10041901.1
]01[ 25.08.2000
Int. Cl.8 H01G 009/04
H.C. STARCK GMBH, GERMANY
WO/2002/017338
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] An anode comprising:
(a) a niobium metal core,
(b) a conducting niobium suboxide layer,
and
093880
‫אנודת קבל המבוססת על ניאוביום‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
(c) a dielectric barrier layer comprising
niobium pentoxide, wherein the conductive
niobium suboxide layer is situated between
the niobium pentoxide layer and the
niobium metal core.
__________
4913
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
093321
‫תרופה לשימוש בשיטה לטיפול בתפקוד‬
‫זיקפה לקוי והגדלת היצר המיני בגברים‬
]20[
MEDICAMENT FOR USE IN A
METHOD OF TREATING
ERECTILE DYSFUNCTION AND
INCREASING LIBIDO IN MEN
]11[
]02[
29.08.2001
09/651777
]01[ 30.08.2000
]00[ US
3/2/30/20
3292291333
US
Int. Cl.8 A61K 009/06, 031/565, 047/00, 047/10, 047/14, A61P 005/24, 005/26
UNIMED PHARMACEUTICALS,
INC., U.S.A.
ROBERT E. DUDLEY
WO/2002/017927
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]/1[
]//[
]/0[
[57] Use of a hydroalcoholic gel
comprising a steroid in the testosterone
synthetic pathway, one or more C1-C4
alcohols, a penetration enhancing agent, a
thickener and water, for the manufacture of
a medicament for improving the efficacy
of a pharmaceutical useful for treating
erectile dysfunction in a male subject,
wherein the medicament is percutaneously
administered to a subject, wherein the
pharmaceutical is a phosphodiesterase type
5 inhibitor.
__________
]22[]12[
]20[
SEAR MECHANISM FOR
FIREARMS
]11[
]02[
]22[
]/2[
10.03.2003
MI2002A000623 ]01[ 26.03.2002
Int. Cl.8 F41A 017/56
FABBRICA D'ARMI PIETRO BERETTA
S.P.A., ITALY
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]/0[
[57] Sear mechanism for firearms
comprising a sear box (12), a trigger (15)
mounted at said sear box on a rotation pin
(18) and upon which acts an elastic return
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
093383
‫מנגנון של דוקרן לנשק חם‬
]00[
IT
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
element (25), a hammer (16) mounted at
said sear box on a pin of the hammer (31,
31') and upon which acts an elastic thrust
element (33), in which said hammer is
4914
equipped with a mounting tooth (40) for
the engagement with a sear tooth (41), and
a breechblock carrier (13) carrying a firing
pin (14), as well as comprising a sear
device (17), to give said hammer, when
controlled by said trigger, motion between
a cocking position (A) in engagement with
said sear tooth and a striking position (B)
against said firing pin, characterized in that
said sear tooth is fixed and integral with
said sear box, said pin of the hammer is in
engagement with a slot (32) of said sear
box and in that said sear device comprises
at one end an engagement element (43)
with said pin of the hammer suitable for
causing it to advance in said slot, said
motion between said cocking position and
said striking position of said hammer being
made up of an initial translation step and a
subsequent rotary step under the action of
said elastic thrust element, said sear device
being connected at an opposite end thereof
to said trigger.
__________
]22[]12[
]20[
TEST STRIP CONTAINERS AND
METHODS OF USING THE SAME
]11[
]02[
]22[
]/2[
]/0[
18.03.2003
116086
]01[ 02.04.2002
Int. Cl.8 G01N 033/483
LIFESCAN, INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A device (2) for containing at least
one test strip (30) and dispensing a single
test strip at a time, said device comprising:
4915
093220
‫מיכלים לרצועות מבחן ושיטות לשימוש‬
‫בהם‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
(a) a base (4) capable of containing at least
one test strip; and
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
(b) a cover (6) separable from the base and
comprising a test strip selecting element
(20) having a continuously reduced crosssectional area (25) and means for selecting
and holding a test strip in a fixed position
relative to the cover so that a test strip
positioned in the base can be gripped by
the cover and removed from the base when
the cover is separated from the base.
__________
]22[]12[
]20[
COUPLING DEVICE FOR GLASS
FIBER CONNECTORS
]11[
]02[
21.09.2001
10047898.0
]01[ 26.09.2000
2320///39/
2293/91332
Int. Cl.8 G02B 006/38
ADC GMBH, GERMANY
WO/2002/027373
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]22[
]/2[
]//[
]/0[
[57] Coupling device for glass-fiber
connectors having a front panel (202) with
insert openings and at least one coupling
(207), which can be inserted into an insert
opening of the front panel from the front
side, and with a latching spring (214),
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
099133
‫מתקן שילוב עבור מחברים מסיבי זכוכית‬
]00[
DE
DE
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, /76 ‫רחוב הירקון‬
which engages behind the front panel and
by means of which the coupling can be
arrested in the front panel, the coupling
being releasable from the front side, the
coupling having a housing with at least one
front plug receptacle (211), a rear plug
4916
receptacle (213) and a flange (212, 212'),
which projects from the housing and is
suitable for bearing against the front panel,
characterized in that the latching spring
(214) comprises two side pieces (203),
which are in close contact laterally with
two opposite-lying outer walls of the
coupling housing, and a pressure plate
(204), the side pieces being formed with
spring lugs (245) and being connected to
each other by means of the pressure plate,
the pressure plate having a spring leg
(223), by means of which the pressure
plate is supported on a third outer surface
of the housing of the coupling, the pressure
plate being accessible from the front side
in the inserted state of the coupling, and
the spring lugs engaging behind the front
panel, it being possible for the coupling to
be unlocked again and removed from the
front panel by pressure being applied to the
pressure plate.
__________
4917
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
099039
‫שיטה לייצור נגזרת מחומר צמח קנביס‬
‫המכילה טטראהידרוקנבינול וקנבידיול‬
‫ונגזרות קנביס‬
]20[
METHOD FOR PRODUCING AN
EXTRACT FROM CANNABIS
PLANT MATTER CONTAINING A
TETRAHYDROCANNABINOL
AND CANNABIDIOL AND
CANNABIS EXTRACTS
]11[
]02[
]22[
]/2[
16.10.2001
10051427.8
]01[ 17.10.2000
]00[
Int. Cl.8 A61K 031/352, C07D 311/00, 311/80
DELTA-9-PHARMA GMBH,
GERMANY
WO/2002/032420
DEKEL PATENT LTD.,
18 MENUHA VENEHALA ST.,
REHOVOT 76209
]//[
]/0[
[57] A process for producing an extract
containing tetrahydrocannabinol,
cannabidiol and optionally the carboxylic
acids thereof from Cannabis plant material,
wherein the dried plant material is
comminuted; characterized in that said
plant material is extracted by means of
CO2 under supercritical pressure and
temperature conditions at a temperature in
a range from 31˚C to 80˚C and at a
DE
,‫דקל פטנט בע"מ‬
‫ רחובות‬,/7 ‫ חדר‬00 ‫מנוחה ונחלה‬
pressure in a range from 75 bar to 500 bar,
or is extracted in the subcricital range at a
temperature of 20˚C to 30˚C and a
supercritical pressure of 100 bar to 350
bar; and the obtained primary extract is
separated out under subcricital conditions
or under conditions subcricital in terms of
pressure and supercritical in terms of
temperature.
__________
]22[]12[
099911
‫מטריצות סטנופרופילוריות ושיטות לייצורן‬
‫ולשימוש בהן‬
]20[
STENOPROPHILURIC MATRICES
AND METHODS FOR MAKING
AND USING THE SAME
]11[
]02[
16.10.2001
60/240792
]01[ 16.10.2000
]00[ US
3/2///2//
3193191332
US
Int. Cl.8 A01N 025/10, 059/16, B32B 009/04
DENNIS A. GURITZA, U.S.A.
WO/2002/036112
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]22[
]/2[
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4918
[57] A bio-supportive medium
comprising: a degradable material; at least
one nutritional source; and at least one biolimiting agent dispersed in the degradable
material; wherein the degradable material,
the at least one nutritional source, and the
at least one bio-limiting agent are provided
in quantities such that the bio-supportive
medium is capable of supporting formation
of a biomass having at least a specific
consortium of organisms of identical or
different species, substantially at
equilibrium within its environment or host
habitat; wherein the at least one nutritional
source and the at least one bio-limiting
agent are selected to control the amount
and type of species present in the biomass.
__________
]22[]12[
]20[
METHODS OF PROTEIN
PURIFICATION AND RECOVERY
]11[
]02[
26.10.2001
60/243965
]01[ 27.10.2000
/321/1/3/
3/93091332
/320030/2
2/92391332
302013
1292391332
Int. Cl.8 A61K 038/21, C07K 014/565
CHIRON CORPORATION, U.S.A.
WO/2002/034791
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
[57] A method for preparing a
composition comprising substantially
monomeric interferon-beta (IFN-β), said
method comprising:
(a) preparing a sample comprising
substantially purified IFN-β;
(b) mixing said sample with guanidine
hydrochloride (HCl) to obtain a first
099922
‫שיטות לטיהור חלבון והפקה‬
]00[
US
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
solution comprising solubilized denatured
IFN-β; and
(c) renaturing said IFN-β by dilution of
said first solution with a first buffer,
wherein said first buffer has a pH of about
3.0 to about 5.0, and wherein a renatured
IFN-β solution comprising substantially
monomeric IFN-β and residual guanidine
HCl is obtained.
__________
4919
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
MODIFIED OXYGEN REDUCED
VALVE METAL OXIDES
]11[
]02[
]22[
]/2[
]//[
]/0[
06.11.2001
60/246042
]01[ 06.11.2000
Int. Cl.8 H01G 009/04
CABOT CORPORATION, U.S.A.
WO/2002/037513
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[57] A method of forming an anode
comprising the steps of pressing a mixture
comprising oxygen reduced niobium oxide
powder and at least one binder or lubricant
099233
‫תחמוצות מופחתות חמצן מותאמות‬
‫למתכות מצופות‬
]00[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,04/9 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
or both to form a pressed anode, wherein
said mixture is prepared by coating said
oxygen reduced niobium oxide powder
with said binder and/or lubricant.
__________
]22[]12[
]20[
CONCRETE FORMWORK WALL
SERVING ALSO AS
REINFORCEMENT
]11[
]02[
]22[
]/2[
10.01.2001
00124716.2
]01[ 13.11.2000
Int. Cl.8 E04B 001/00, 001/74, 002/86
COFFOR INTERNACIONAL
EXPLORACAO DE PATENTES
LDA., PORTUGAL
WO/2002/038878
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
[57] A method for building a wall using a
formwork including two formwork walls
(8) placed face to face and connected by
connecting elements (1) articulately joined
to the formwork walls by stiffeners (2)
attached to the formwork walls, the
connecting elements allowing the walls to
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
099239
‫קיר שלד מבטון המשמש גם כחיזוק‬
]00[
EP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
be kept either spaced apart to define an
interval intended to receive a filler such as
concrete (7) or folded for storage and
transport, comprising the steps of:
unfolding the formwork walls, and filling
the interval between the unfolded
formwork walls with a filler, wherein
4920
either before the setting of the filler, a
casing (11) is applied on the external face
of at least one formwork wall in such a
way to coat the formwork wall, or at least
one formwork wall is attached to but
spaced from the stiffeners and the
connecting elements, and a filler material,
such as concrete, is poured so as to coat
the stiffeners and the connecting elements
thus forming a reinforcement inside the
wall, the stiffeners and the connecting
elements being submerged in the wall and
covered by said casing.
__________
4921
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
099380
‫דוד לחימום מים עם גוף חימום מוגן‬
]20[
HOT WATER TANK WITH
HEATING ELEMENT
PROTECTION
]11[
]22[
]/2[
09.05.2003
Int. Cl.8 F24H 001/20
SEMION BENIN
PINHAS ELKAYAM
]/0[
SEMION BENIN,
36/3 SH. KENNEDY, PARDES
HANNA-KARKUR
[57] A hot water tank (1) comprising: a
stainless steel casing (2) provided with an
inlet port and an outlet port; a conventional
copper electric water heater (3); a copper
hollow tube (6) enclosing said electric
water heater and having water inlet (7) and
water outlet (8) openings provided with
copper shielding elements (9, 10), said
shielding elements being arranged so as to
‫כרכור‬-‫חנה‬-‫ פרדס‬,‫סמיון בנין‬
‫ מושב בית חנינה‬,‫פנחס אלקיים‬
,‫סמיון בנין‬
‫כרכור‬-‫חנה‬-‫ פרדס‬,:9/: ‫שכ' קנדי‬
prevent exposure of said copper electric
water heater to said stainless steel casing
through said water inlet and water outlet
openings, while allowing water freely to
enter into said hollow tube and to
discharge therefrom through said water
inlet and water outlet openings
respectively by providing gaps between the
hollow tube and shielding elements.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4922
]22[]12[
]20[
ROTARY WEDGE SCANNER
]11[
]22[
]/2[
12.05.2003
Int. Cl.8 G02B 026/08
ELBIT SYSTEMS ELECTROOPTICAL ELOP LTD.
]/0[
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
[57] A scanning system, comprising: a
main housing (26), and at least one pair of
optical wedges (6, 10) located within said
main housing; wherein a laser beam
having an optical axis and incident on said
pair of optical wedges, is refracted at least
once by said wedges; characterized in that
4923
099331
‫סורק טריזי סיבובי‬
‫אופטיקה אלאופ‬-‫אלביט מערכות אלקטרו‬
‫ רחובות‬,‫בע"מ‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
said pair of optical wedges is rotatable
about a shaft means (40), and said shaft
means is stationary and passes through the
center of said at least one wedge and that
the optical axis of said incident laser beam
is substantially parallel to, but laterally
offset from said shaft means.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
093109
‫שיטות המשתמשות ב–ותכשירים‬
‫המכילים פוספוליפידים מוגדרים למניעה‬
‫וטיפול בטרשת עורקים‬
]20[
METHODS EMPLOYING AND
COMPOSITIONS CONTAINING
DEFINED OXIDIZED
PHOSPHOLIPIDS FOR
PREVENTION AND TREATMENT
OF ATHEROSCLEROSIS
]11[
]02[
]22[
22.11.2001
60/252574
]01[ 24.11.2000
]00[ US
Int. Cl.8 A61K 031/075, 031/08, 031/11, 031/19, 031/20, 031/24, 031/66, 031/661,
031/683, A61P 009/00, C07F 009/00, 009/10
VASCULAR BIOGENICS LTD.
‫ אור יהודה‬,‫וסקולר ביוג'ניק בע"מ‬
DROR HARATS, JACOB GEORGE,
‫ גדעון הלפרין‬,'‫ יעקב ג'ורג‬,‫דרור חרץ‬
GIDEON HALPERIN
WO/2002/041827
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]/2[
]/1[
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4924
[57] A compound of the formula:
or pharmaceutically acceptable salts
thereof, wherein:
(i) A1 and A2 are each independently
selected from the group consisting of CH2
and C=O, at least one of A1 and A2 being
CH2;
(ii) R1 is selected from the group
consisting of an alkyl chain having 1-27
carbon atoms and
wherein X is an alkyl chain having 1-24
carbon atoms, Y is selected from the group
consisting of:
-OH, -H, alkyl, alkoxy, halogen, acetoxy
and aromatic functional groups; and
Z is selected from the group consisting of:
whereas R4 is an alkyl;
(iii) R2 is
4925
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein X is an alkyl chain having 1-24
carbon atoms, Y is selected from the group
consisting of:
-OH, -H, alkyl, alkoxy, halogen, acetoxy
and aromatic functional groups; and
Z is selected from the group consisting of:
whereas R4 is an alkyl; and
(iv) R3 is selected from the group
consisting of H, acyl, alkyl,
phosphocholine, phosphoethanolamide,
phosphoserine, phosphocardiolipin and
phosphionositol.
The applications for division
from this application have
not yet been published
5144844
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4926
]22[]12[
093381
– N– (1 ‫קומפלכסי ליתיום של‬
– / ,: – ‫הידרוקסימתיל‬
– 7, 4 , 0 – )‫דיהידרוקסיפרופיל‬
– ‫טריקסקרבורסימתיל‬
‫ – טטראזאציקלודודקאן‬01 ,7, 4, 0
]20[
LITHIUM COMPLEXES OF N - (1 HYDROXYMETHYL - 2 ,3 DIHYDROXYPROPYL) - 1,4,7 TRISCARBOXYMETHYL - 1,4, 7,
10 - TETRA
AZACYCLODODECANE, THEIR
PRODUCTION AND USE
THEREOF
]11[
]02[
]22[
]/2[
05.12.2001
10064467.8
]01[ 15.12.2000
]00[ DE
Int. Cl.8 A61K 033/14, C07D 257/02, C07F 001/02
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT,
GERMANY
WO/2002/048119
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A compound of the formula
in which the three X's altogether,
independently, stand for n lithium ions and
m hydrogen atoms, whereby n and m in
each case, independently, mean the
numbers 0 to 3, and the sum of n and m=3,
4927
and Y has the meanings of chloride or
bromide.
A method of producing a compound of the
formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
comprising complexing a compound of
formula I.
__________
]22[]12[
‫שיטה לייצור התקן מוליך למחצה‬
]20[
METHOD FOR
MANUFACTURING A
SEMICONDUCTOR DEVICE
]11[
]02[
27.12.2001
2000-402834 ]01[ 28.12.2000
1332-3/0102
1/93091332
Int. Cl.8 H01L 021/316
FOUNDATION FOR
ADVANCEMENT OF
INTERNATIONAL SCIENCE, JAPAN
WO/2002/054473
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]22[
]/2[
]//[
]/0[
[57] A semiconductor device comprising a
silicon compound layer formed on a
silicon surface, wherein said silicon
compound layer contains at least a
The applications for division
from this application have
not yet been published
093302
]00[
JP
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
predetermined inert gas and has a
hydrogen content of 1011/cm2 or less in
terms of surface density.
5101848
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4928
]22[]12[
]20[
PENETRATION INHIBITING
MATERIAL
]11[
]02[
]22[
]/2[
08.03.2002
01200979.1
]01[ 15.03.2001
Int. Cl.8 F41H 001/02
TEIJIN TWARON GMBH,
GERMANY
WO/2002/075237
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] Penetration-resistant material
comprising at least one layer having a
thickness D, the layer comprising a first
and second layer of woven fabric, with the
first and second layers being bonded
together with an adhesive material, the first
layer of fabric composed of a first set of
threads comprising 3.5 to 20 threads/cm,
having a linear density of at least 210 dtex,
the filaments forming the threads having a
diameter F1, and comprising at least 65%
of the first layer fabric weight, and a
second set of threads comprising 0.5 to 16
threads/cm and having a linear density of
at least 50 dtex, with the second set of
threads being at an angle of > 0˚ to 90˚
with respect to the first set of threads, and
the ratio of the number of threads/cm of
the first set to that of the second set being
greater than 1:1, and the second layer of
093331
‫חומר המונע חדירה‬
]00[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
fabric being composed of a first set of
threads comprising 0.5 to 16 threads/cm
and having a linear density of at least 50
dtex, and a second set of threads
comprising 3.5 to 20 threads/cm, having a
linear density of at least 210 dtex, and
comprising at least 65% of the second
layer fabric weight, the filaments forming
the threads having a diameter F2, with the
second set of threads being at an angle of >
0˚ to 90˚ with respect to the first set of
threads, and the ratio of the number of
threads/cm of the second set to that of the
first set being greater than 1:1, and the first
and second sets of threads of the first
fabric layer being oriented parallel to the
first and second sets of threads,
respectively, of the second fabric layer and
the ratio D/F1 and D/F2 being 14.5 to 40.
__________
4929
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
093213
‫מערכת להשתלט על פטוגנים‬
]20[
PATHOGEN MANAGEMENT
SYSTEM
]11[
]02[
16.01.2002
60/261923
]01[ 16.01.2001
]00[ US
/3202/30/
0393/91332
US
Int. Cl.8 A01N 059/00, A23B 004/14, C02F 001/00
TOMCO2 EQUIPMENT COMPANY,
U.S.A.
WO/2002/079392
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
[57] In a system to control pathogens on a
target element, the system including
subjecting the target element to a pathogen
reducing agent, the improvement
comprising subjecting the target element to
hypochlorous acid formed by the following
steps:
(a) combining an acid with a first carrier
stream to form a first mixed stream;
(b) introducing a chlorination agent into a
control stream, the chlorination agent
increasing the concentration of
hypochlorous acid and hypochlorite of the
control stream;
(c) combining the first mixed stream with
the control stream having the chlorination
agent to form the hypochlorous acid
stream, wherein about 77 to about 99
percent of the chlorination agent in the
hypochlorous acid stream is hypochlorous
acid.
__________
]22[]12[
]20[
DATA RETRIEVAL AND REPORT
GENERATION SYSTEM FOR
FOODSTUFFS
]11[
]02[
16.01.2002
60/262287
]01[ 16.01.2001
/321//0//
1393091332
Int. Cl.8 G06F 017/30
KIP HOLDINGS INC., U.S.A.
WO/2002/080074
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]22[
]/2[
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
093229
‫מערכת לאחזור מידע והפקת דווח עבור‬
‫מצרכי מזון‬
]00[
US
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,00461 .‫ד‬.‫ ת‬, 0/4 ‫אבן גבירול‬
4930
[57] A method for certifying a food
quality regarding a product from a
manufacturer, the product composed of at
least first and second ingredients from
respective at least first and second
suppliers, each of the at least first and
second ingredients having been certified as
to a food quality for the respective supplier
by a respective at least first and second
certification agencies, the method
comprising the steps of: defining at least
first and second unique identifiers
associated with respective at least first and
second ingredients, each such identifier
indicative of a source of information
regarding the certification of the respective
ingredient, the information stored in a
computer database; communicating the at
least first and second unique identifiers to
a certification agency associated with the
manufacturer, the certification agency
associated with the manufacturer being
non-identical to the first certification
agency and being non-identical to the
second certification agency; retrieving by
means of the identifiers, information
regarding the certification of the
ingredients; and certifying the food quality
regarding the product, based in part on the
information.
__________
4931
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
DEFORMABLE CURVATURE
MIRROR
]11[
]02[
]22[
]/2[
22.01.2002
09/769988
]01[ 25.01.2001
Int. Cl.8 G02B 026/08
AOPTIX TECHNOLOGIES, INC.,
U.S.A.
WO/2002/059674
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]//[
]/0[
[57] A deformable curvature mirror (14)
capable of controlled deformation by
applying electrical voltages, comprising:
first and second parallel plates (30, 32) of
an electro-restrictive material, said plates
having parallel adjacent inner surfaces
joined together with a conductive layer
(34, 36) sandwiched between said adjacent
inner surfaces, said conductive layer
having an electrical terminal (44-N)
connected to electrical ground; said first
plate having an outer surface parallel to
said inner surface thereof with an
unpatterned outer conductive layer (42) on
092011
‫ראי עקמומי גמיש‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
said outer surface and a mirrored surface
(48) on said outer conductive layer, said
outer conductive layer having an electrical
terminal (44-N) for connecting to electrical
ground; and said second plate having an
outer surface parallel to said inner surface
thereof with a pattern of electrode
segments (40-N) on said second plate outer
surface, each said segment having a
separate electrical terminal (44-N) for
applying a variable electrical voltage
thereto for selectively deforming the
curvature mirror.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4932
]22[]12[
]20[
MIXTURE OF BACILLUS
THURINGIENSIS SUBSPECIES
ISRAELENSIS AND BACILLUS
SPHAERICUS FOR
MANAGEMENT OF RESISTANCE
TO MOSQUITO LARVICIDES
]11[
]02[
]22[
]/2[
13.02.2002
60/269513
]01[ 16.02.2001
Int. Cl.8 A01N 063/00, C12N 001/20
VALENT BIOSCIENCES,
CORPORATION, U.S.A.
WO/2002/065835
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]//[
]/0[
[57] A method of preparing a composition
comprising a combination of a strain of
Bacillus thuringiensis subspecies
israelensis and a strain of Bacillus
sphaericus comprising the steps of
fermenting the strains separately,
concentrating each strain to the desired
092031
‫תערובת של בצילוס טורינג'נזיס מתת–זן‬
‫ישראל נזיס ובצילוס ספאריקוס עבור‬
‫שליטה בעמידות לקוטלי יתושים‬
]00[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,00461 .‫ד‬.‫ ת‬, 0/4 ‫אבן גבירול‬
solids, concentration or activity,
combining the concentrated strains to form
a slurry mixture and spray drying the
slurry mixture to yield individual particles
which contain toxins from both Bacillus
thuringiensis subspecies israelensis and
Bacillus sphaericus.
__________
]22[]12[
]20[
STRUCTURE CABLING SYSTEM
]11[
]02[
19.12.1999
60/115628
]01[ 12.01.1999
3/21/0000
2/93092///
3/20/22/0
3193/92///
Int. Cl.8 G06F 001/26, H02G 003/38
DIVISION FROM 144040
MICROSEMI CORP - ANALOG
MIXED SIGNAL GROUP LTD
]22[
]/1[
]/2[
]//[
]/0[
4933
WO/2000/041496
POWERDSINE LTD.,
1 HANAGAR ST.,
P.O.B. 7220,
HOD HASHARON 45421
092121
‫מערכת כבלים בעלת מבנה‬
]00[
US
US
US
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
‫ הוד השרון‬,‫גרופ בע"מ‬
,‫פאורדסיין בע"מ‬
‫השרון‬-‫ הוד‬,7//1 .‫ד‬.‫ ת‬, 0‫רח' הנגר‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
[57] A LAN switch serving a plurality of
local area network nodes which are
connected, for data communication, via
communication cabling, to said switch, the
LAN switch comprising: coupler circuitry
coupling power into the communication
cabling substantially without interfering
with data communication; and current
limiting circuitry connected to the coupler
circuitry and controlling current delivered
by the coupler circuitry into the
communication cabling, said current
limiting circuitry being operative to
provide a first current limit level which is
never exceeded, wherein said LAN switch
is operative to provide at least some power
to at least some of said plurality of nodes
via said communication cabling, wherein
the current limiting circuitry is operative to
provide a second current limit level which
is not exceeded for more than a
predetermined period of time; and wherein
the LAN switch also comprises a power
management and control unit operative to
interrogate at least one node to which it is
intended to transmit power over the
communication cabling in order to
determine whether the node's
characteristics allow it to receive power
over the communication cabling.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4934
]22[]12[
]20[
OPTICAL PROJECTION OF A
THERMAL TARGET
]11[
]22[
]/2[
11.08.2003
Int. Cl.8 F41J 002/02, H05B 003/26
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY
LTD.
SAAR BOBROV, SHMUEL OSCAR
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]/1[
]/0[
[57] A method for generating a thermal
target comprising:
(a) generating hot-body thermal radiation
from a heated source (10), said thermal
radiation emanating from a projection
region (12) having a first maximum
dimension (DP); and
092882
‫היטל אופטי של מטרה טרמית‬
,‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפא"ל‬
‫חיפה‬
‫ שמואל אוסקר‬,‫סער בוברוב‬
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
(b) employing an optical arrangement (14)
to project at least part of said thermal
radiation onto a target region of a surface
(16), said target region having a second
maximum dimension (DT) greater than
said first maximum dimension.
__________
4935
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
METHOD AND INSTALLATION
FOR CONTROLLING THE
ADVANCE OF A NEEDLED FIBER
PLATE
]11[
]02[
]22[
]/2[
]//[
]/0[
26.02.2002
01/02555
]01[ 26.02.2001
Int. Cl.8 D04H 018/00
MESSIER-BUGATTI, FRANCE
WO/2002/068747
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] An installation for needling a fiber
structure (10), the installation comprising a
needling head (24) carrying a plurality of
needles (28), a device for driving the
needling head to impart reciprocating
motion to the needles, a support (12, 14)
for the fiber structure to be needled
situated facing the needling head, and a
device (60) for driving the fiber structure
so as to impart an advance movement
092310
‫שיטה והתקן לשליטה בקידום לוח סיבי‬
‫מחורר‬
]00[
FR
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
thereto on said support, wherein the fiber
structure drive device is designed to enable
the speed of advance of the fiber structure
carried by the support to decrease
momentarily in response to the resistance
to advance exerted by the needles
penetrating into the fiber structure, without
completely interrupting advance
throughout the duration of the needles
being present in the fiber structure.
__________
]22[]12[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
092992
4936
]20[
APPARATUS AND METHOD FOR
CONTROLLING MOVING
VEHICLES
]11[
]22[
]/2[
]/0[
24.08.2003
Int. Cl.8 G07B 015/00, G08G 001/017
ARON MATALON
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] Apparatus for controlling vehicles
particularly for security purposes, law
enforcement and fleet management,
comprising:
(a) a car unit (CU) permanently mounted
in each of a plurality of vehicles and stored
with vehicle identifying data, for
transmitting said vehicle identifying data;
(b) a portable personal unit (PU) stored
with driver identifying data and adapted to
transmit said driver identifying data to a
corresponding CU, said corresponding CU
suitable for transmitting a CU signal that
includes said driver identifying data and
said vehicle identifying data; and
4937
‫שיטה ומתקן לשליטה על כלי–רכב בתנועה‬
‫ תל אביב‬,‫אהרון מטלון‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(c) a road unit (RU) for receiving and
validating the content of said CU signal
from the CU of each passing vehicle,
wherein said RU is suitable for validating
the content of said CU signal by:
(i) determining whether a CU signal was
not transmitted by a passing vehicle;
(ii) validating the transmitted driver
identifying data;
(iii) validating the transmitted vehicle
identifying data; and/or
(iv) comparing the combination of the
transmitted driver identifying data and the
transmitted vehicle identifying data with
stored information within a database.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
FUNGICIDE COMPOSITIONS
BASED ON
PYRIDYLMETHYLBENZAMIDE
AND PROPAMOCARB
DERIVATIVE
]11[
]02[
]22[
]/2[
19.02.2002
01/03141
]01[ 08.03.2001
Int. Cl.8 A01N 043/00
BAYER CROPSCIENCE S.A.,
FRANCE
WO/2002/069714
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
092223
‫תכשירים חדשים קוטלי פטריות‬
‫המבוססיםעל פירידילמתילבנזאמיד ונגזרת‬
‫של פרופמוקרב‬
]00[
FR
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
4938
[57] Fungicidal compositions comprising:
(a) at least one pyridylmethylbenzamide
derivative of the formula
in which: R1 is selected from a hydrogen
atom, an optionally substituted alkyl
radical and an optionally substituted acyl
radical;
R2 is selected from a hydrogen atom and
an optionally substituted alkyl radical;
R3 and R4, which are identical or different,
are selected independently from a halogen
atom, a hydroxyl radical, a cyano radical, a
nitro radical, an –SF5 radical, a trialkylsilyl
radical, an optionally substituted amino
radical, an acyl radical, and a group E, OE
or SE in which E is selected from an alkyl,
alkenyl, alkynyl, cycloalkyl, cycloalkenyl,
aryl and heterocyclyl radical, each of
which can be optionally substituted;
c represents 0, 1, 2, 3 or 4;
q represents 0, 1, 2, 3 or 4;
and their possible optical and/or geometric
isomers, tautomers and addition salts with
an acid or a base that are acceptable in the
agricultural field;
and (b) at least one compound, which is
propamocarb.
__________
]22[]12[
]20[
ESPRESSO BREWING DEVICE
]11[
]02[
]22[
]/2[
]//[
]/0[
20.03.2002
20105672.0
]01[ 31.03.2001
Int. Cl.8 A47J 031/40
NESTEC S.A., SWITZERLAND
WO/2002/078499
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] Espresso brewing device with a
brewing unit, with a magazine able to
rotate via an electric motor (30) and
provided with a magazine table (17)
supporting several magazine tubes (20),
located along its circumference and open
4939
092338
‫התקן חליטת אספרסו‬
]00[
DE
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, /76 ‫רחוב הירקון‬
below, for holding single-serving capsules
(16) containing coffee powder, and with
means for dispensing the single-serving
capsules individually into the brewing unit,
whereby a control system is provided for
controlling the rotation of the magazine up
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
to the point where a magazine tube
containing the desired coffee type is in the
dispensing position, characterized by the
fact that the brewing unit, the capsule
conveying device and the magazine are
positioned on a support frame (45) and that
the magazine is supported by a magazine
table drawer (18) mounted on the support
frame and able to be pulled out.
__________
]22[]12[
]20[
METHOD FOR SAMPLE
IDENTIFICATION IN A MAMMAL
AS WELL AS A KIT FOR
PERFORMING THIS METHOD
]11[
]02[
]22[
]/2[
]//[
]/0[
14.03.2002
10112470.8
]01[ 15.03.2001
Int. Cl.8 G01N 033/483
RUPRECHT KELLER, GERMANY
WO/2002/075307
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] Method for the investigation of
biological samples from a mammal for at
least one component, wherein the method
includes the following steps:
(a) orally administering a combination of
at least two marker substances to a
mammal;
(b) waiting for a length of time which is
sufficient for the combination of the at
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
092202
‫שיטה לזיהוי דוגמה ביונק וכן ערכה לבצוע‬
‫שיטה זו‬
]00[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
least two marker substances to reach the
location of sample removal;
(c) removing a biological sample from the
mammal;
(d) investigating the biological sample for
the presence and/or amount of the
combination of at least two marker
substances or derivatives thereof; and, if
the combination of the at least two marker
4940
substances or the derivatives thereof is
detectable in the biological sample;
(e) investigating the biological sample for
an analyte; wherein the biological sample
from the mammal is urine and the removal
of said urine from the mammal is
accomplished by collection of urine in a
collection vessel, and characterized in that
the at least two marker substances are
chosen from isoprenoids, lipids,
saccharides, polyols, polyethylene glycols
or derivatives thereof.
__________
]22[]12[
]20[
AMPLIFIER
]11[
]02[
]22[
]/2[
26.03.2002
09/820178
]01[ 28.03.2001
Int. Cl.8 H03F 003/38
AMIR KATZ
GUY PICHA
]//[
]/0[
WO/2002/080354
BOROCHOV, KORAKH, ELIEZRI &
CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] System receiving at least one input
signal to be amplified and provided to at
least one respective load element, the
system comprising: a switch, coupled to
said at least one respective load element,
for producing at least one respective
switch output signal for said at least one
input signal; at least one shaper
determining at least one respective shaper
output signal for each said at least one
input signal, according to each said at least
one input signal and said at least one
respective switch output signal; a power
source array, coupled to said switch, said
4941
093122
‫מגבר‬
]00[
US
‫ תל אביב‬,‫אמיר כץ‬
‫גיא פיחה‬
,'‫בורוכוב קורח אליעזרי ושות‬
‫אביב‬-‫ תל‬,.0011 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
power source array including at least one
power source; a power reservoir array,
coupled to said switch, said power
reservoir array including at least one
power reservoir; and a controller, coupled
to said at least one shaper and to said
switch, said controller determining a
switching scheme according to at least a
selected one of said at least one respective
shaper output signal, wherein said switch
applies said switching scheme to said at
least one respective load element, to said
power source array and to said power
reservoir array.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
LAMINATED BALLISTIC
STRUCTURE COMPRISING
ALTERNATING
UNIDIRECTIONAL AND
THERMOPLASTIC LAYERS
]11[
]02[
]22[
]/2[
05.06.2002
01114180.1
]01[ 12.06.2001
Int. Cl.8 F41H 005/04
TEIJIN TWARON GMBH,
GERMANY
WO/2002/101319
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A laminated ballistic structure
comprising an array of layers of
substantially alternating n unidirectional
(UD) layers of ballistic fiber and m
thermoplastic layers, excluding
093382
‫מבנה בליסטי מרובד המורכב משכבות חד‬
‫כיווניות‬
‫תרמופלסטיות לסירוגין‬
]00[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
thermoplastic layers at the outer sides of
the structure, wherein 1/2n≤m<n and the
UD layers comprise 1-25 wt.% of an
elastomeric material based on the dry fiber
weight.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4942
]22[]12[
]20[
ALTITUDE ESTIMATIONS
SYSTEM AND METHOD CROSS
REFERENCE TO RELATED
APPLICATIONS
]11[
]02[
]22[
]/2[
06.05.2002
60/288449
]01[ 04.05.2001
Int. Cl.8 G01S 013/08
LOCKHEED MARTIN
CORPORATION, U.S.A.
RICHARD A. LUDWIG, BONNIE L.
ADAMS, GREGORY A. BAKER
WO/2002/091012
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]/1[
]//[
]/0[
[57] A system for detecting and tracking
the location of a target object (110) using
direct signals (122, 132, 142) transmitted
by one or more independent transmitters
(120, 130, 140) and reflected signals (126,
136, 146) transmitted by the one or more
independent transmitters and reflected by
the target object, comprising: an antenna
(310) for receiving the direct and reflected
signals; a signal processing subsystem
(320) connected to the antenna for
generating signal data by processing the
direct and reflected signals received by the
antenna; an object location processing
subsystem (330) connected to the signal
processing subsystem for calculating target
data including the location of the target
4943
093203
‫מערכת להערכת גובה ושיטה של הפניה‬
‫צולבת ליישומים דומים‬
]00[
US
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,04 ‫ רחוב שנקר‬,‫בית נולטון‬
object based on the signal data received
from the signal processing subsystem,
wherein the object location processing
subsystem calculates altitude data of the
target object using signal data calculated
from an interference effect pattern signal
generated by the combination of the direct
signal and a surface reflected signal from a
transmitter of the one or more transmitters,
reflected by the target object, and received
by the antenna; and a display subsystem
(340) for receiving target data, including
the altitude data, from the object location
processing subsystem and selectively
displaying the target data of the target
object.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫__________‬
‫‪4944‬‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
]22[]12[
]20[
SYSTEM AND METHOD FOR
WIDEBAND PRE-DETECTION
SIGNAL PROCESSING FOR
PASSIVE COHERENT LOCATION
APPLICATIONS
]11[
]02[
]22[
]/2[
06.05.2002
60/288451
]01[ 04.05.2001
Int. Cl.8 G01S 003/08
LOCKHEED MARTIN
CORPORATION, U.S.A.
KEVIN W. BAUGH, ROBERT H.
BENNER
WO/2002/091010
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]/1[
]//[
]/0[
[57] A method for wideband pre-detection
signal processing in Passive Coherent
Location (PCL) applications comprising:
receiving a first reference signal and a first
target signal; filtering the first reference
signal with respect to the first target signal
using a filter to form a first output
reference signal; combining the first output
reference signal with the first target signal
to form a first output target signal;
093202
‫מערכת ושיטה לעיבוד אותות פס רחב קדם‬
‫גילוי ליישומים של איתור רציף פסיבי‬
]00[
US
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,04 ‫ רחוב שנקר‬,‫בית נולטון‬
receiving a second reference signal and a
second target signal; updating the filter
with respect to a change between the first
target signal and the second target signal;
filtering the second reference signal using
the updated filter to form a second output
reference signal; and combining the second
output reference signal with the second
target signal to form a second output target
signal.
__________
4945
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
093222
‫נגזרות פירימידין היעילות כמעכבות‬
COX–2 ‫בררנות של‬
]20[
PYRIMIDINE DERIVATIVES
USEFUL AS SELECTIVE COX-2
INHIBITORS
]11[
]02[
]22[
]/2[
23.05.2002
0112802.4
]01[ 25.05.2001
]00[ GB
Int. Cl.8 A61K 031/505, A61P 029/00, C07D 239/00, 239/34, 401/12
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2002/096885
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A compound of the formula
in which: R1 is selected from the group
consisting of H, C1-6 alkyl, C1-2 alkyl
substituted by one to five fluorine atoms,
C3-6 alkenyl, C3-6 alkynyl, C3-10 cycloalkyl
C0-6 alkyl, C4-12 bridged cycloalkyl,
A(CR4R5)n and B(CR4R5)n;
R2 is C1-2 alkyl substituted by one to five
fluorine atoms;
R3 is selected from the group consisting of
C1-6 alkyl, NH2 and R7CONH;
R4 and R5 are independently selected from
H or C1-6 alkyl;
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
A is an unsubstituted 5- or 6-membered
heteroaryl or an unsubstituted 6-membered
aryl, or a 5- or 6-membered heteroaryl or a
6-membered aryl substituted by one or
more R6;
R6 is selected from the group consisting of
halogen, C1-6 alkyl, C1-6 alkyl substituted
by one or more fluorine atoms, C1-6
alkoxy, C1-6 alkoxy substituted by one or
more F, NH2SO2 and C1-6 alkylSO2;
B is selected from the group consisting of
4946
where
defines the point of attachment of the ring;
R7 is selected from the group consisting of
H, C1-6 alkyl, C1-6 alkoxy, C1-6 alkyl OC1-6
alkyl, phenyl, HO2CC1-6 alkyl, C1-6 alkyl
OCOC1-6 alkyl, C1-6 alkylOCO, H2NC1-6
alkyl, C1-6 alkyl OCONHC1-6 alkyl
CONHC1-6 alkyl; and n is 0 to 4.
__________
]22[]12[
]20[
DUCTED FAN VEHICLES
PARTICULARLY USEFUL AS
VTOL AIRCRAFT
]11[
]02[
]22[
]/2[
28.05.2002
09/865678
]01[ 29.05.2001
Int. Cl.8 B64C 029/00
URBAN AERONAUTICS LTD.
]/1[
]//[
]/0[
RAFI YOELI
WO/2002/096750
ALPHAPATENT LTD.,
55 REUVEN ST.,
BET-SHEMESH 99544
[57] A vehicle (2), comprising: a vehicle
frame (3); a duct (10) carried by said
vehicle frame with the longitudinal axis of
the duct perpendicular to the longitudinal
axis of the vehicle frame; a propeller (11)
rotatably mounted within said duct about
the longitudinal axis (10a) of the duct to
force an ambient fluid therethrough from
its inlet at the upper end (13) of the duct
through its exit at the lower end (14) of the
duct, and thereby to produce an upward lift
4947
092013
‫כלי טיסה בעלי מדחפים פנימיים‬
‫המתאימים להמראה ונחיתה אנכית‬
]00[
US
‫ שדה תעופה בן‬,‫אורבן איירונוטיקס בע"מ‬
‫גוריון‬
‫רפי יואלי‬
,‫אלפאפטנט עמיתים בע"מ עו"פ‬
‫ בית שמש‬,.. ‫רח' ראובן‬
force applied to the vehicle; and a plurality
of parallel, spaced vanes (15) pivotally
mounted to and across the inlet end of the
duct about pivotal axes (16) perpendicular
to said longitudinal axis of the duct and
substantially parallel to said longitudinal
axis of the vehicle frame, said vanes being
selectively pivotal about their axes to
produce a desired horizontal force
component to the lift force applied to the
vehicle.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
PROCESS FOR THE
PREPARATION OF RACEMIC
CITALOPRAM AND/OR S-OR RCITALOPRAM BY SEPARATION
OF A MIXTURE OF R- AND SCITALOPRAM
]11[
]02[
]22[
]/2[
]//[
]/0[
25.06.2002
PA200100991 ]01[ 25.06.2001
Int. Cl.8 C07D 307/00, 307/87
H. LUNDBECK A/S, DENMARK
WO/2003/000672
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
092112
‫הליך להכנת תערובת ציטלופרם רצמית‬
‫–ציטלופרם ע"י הפרדה של‬R ‫–או‬S ‫או‬/‫ו‬
‫–ציטלופרם‬S ‫–ו‬R ‫תערובת של‬
]00[
DK
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,00461 .‫ד‬.‫ ת‬, 0/4 ‫אבן גבירול‬
4948
[57] A process for the preparation of
racemic citalopram free base or an acid
addition salt thereof and/or R- or Scitalopram as the free base or an acid
addition salt thereof by separation of a
mixture of R- and S-citalopram with more
than 50% of one of the enantiomers into a
fraction consisting of racemic citalopram
and/or a fraction of S-citalopram or Rcitalopram characterized in that
(i) citalopram is precipitated from a
solvent as the free base or as an acid
addition salt thereof;
(ii) the precipitate formed is separated
from the mother liquor;
(iia) if the precipitate is crystalline it is
optionally recrystallised one or more times
to form racemic citalopram, and then
optionally converted into an acid addition
salt thereof;
(iib) if the precipitate is not crystalline,
step (i) and (ii) are optionally repeated
until a crystalline precipitate is obtained
and the crystalline precipitate is optionally
recrystallised one or more times to form
racemic citalopram, and then optionally
converted into an acid addition salt thereof,
(iii) the mother liquor is optionally
subjected to further purification and Scitalopram or R-citalopram is isolated from
the mother liquor and optionally converted
into an acid addition salt thereof.
__________
]22[]12[
092132
‫טבליה המכילה קטיריזין ופסאודו אפדרין‬
]20[
TABLET COMPRISING
CETIRIZINE AND
PSEUDOEPHEDRINE
]11[
]02[
10.06.2002
01115807.8
]01[ 28.06.2001
]00[ EP
/32032123
1/93/91332
US
Int. Cl.8 A61K 009/20, 009/24, A61P 011/04, 011/06, 037/08
UCB FARCHIM S.A.,
SWITZERLAND
WO/2003/002098
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]22[
]/2[
]//[
]/0[
[57] A tablet comprising at least two
distinct segments, one segment of which
comprises as active ingredient
predominantly cetirizine and a second
segment of which comprises as active
ingredient predominantly
pseudoephedrine, said segments being
composed and formed in such a way that
the resulting tablet is substantially free of
impurities formed by reaction of cetirizine
with pseudoephedrine, wherein the
interfacial surface area of the
pseudophedrine segment and cetirizine
segment is less than 180 mm2 and with the
proviso that the tablet comprises less than
5% by weight, relative to the total weight
of the tablet, of an alkalinizing agent.
__________
4949
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
HIGH PITCH CARDIAC HELICAL
SCAN WITH EXTENDED
RECONSTRUCTION WINDOWS
]11[
]02[
]22[
]/2[
18.12.2003
248171
]01[ 23.12.2002
Int. Cl.8 A61B 006/00
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC,
U.S.A.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]/0[
[57] A method of reconstructing cardiac
images comprising: receiving information
selecting a primary phase within a cardiac
cycle; receiving information selecting a
phase compromise value; calculating
compromised phase regions using the
phase compromise value; determining
whether an image position is within the
092382
‫סריקת לב סלילית בזווית גבוהה עם‬
‫חלונות שיחזור מאורכים‬
]00[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,04/9 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
primary phase; generating an image at the
primary phase if the image position is
within the primary phase, and, generating
an image at a compromised phase if the
image position is not within the primary
phase but is within the compromised phase
regions.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4950
]22[]12[
‫אלקטרודת מחט‬
]20[
NEEDLE ELECTRODE
]11[
]02[
]22[
]/2[
10.06.2002
10129912.5
]01[ 21.06.2001
Int. Cl.8 A61N 001/20
EFMT ENTWICKLUNGS-UND
FORSCHUNGSZENTRUM FUR
MIKROTHERAPIE GMBH,
GERMANY
WO/2003/000339
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]/0[
092333
[57] Needle electrode for therapy,
especially percutaneous galvanotherapy of
tumors, which can be visualized by image-
]00[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
generating procedures, characterized in
that it has a platinum-coated titanium
body.
__________
]22[]12[
092323
‫–טריאוקסולאין ותכשירי‬0,/,4 ‫תולדות‬
‫רוקחות המכילים אותן‬
]20[
1,2,4-TRIOXOLANE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]02[
]22[
]/2[
21.06.2002
09/886666
]01[ 21.06.2001
]00[ US
Int. Cl.8 A61K 031/335, 031/357, A61P 033/06, 035/00, C07D 323/00, 323/02
MEDICINES FOR MALARIA
VENTURE, SWITZERLAND
WO/2003/000676
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
[57] A spiro or dispiro ,1,2,4-trioxolane of
the formula
4951
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
wherein R1, R2, R3 and R4 are the same or
different, and are selected from the group
consisting of substituted or unsubstituted
linear or branched alkyl, aryl, and alkaryl
groups and substituted or unsubstituted
alicyclic groups that may be interrupted by
one or more oxygen, sulfur or nitrogen
atoms, and substituted or unsubstituted
aromatic or heterocyclic groups, whereby
none of R1, R2, R3 or R4 may be hydrogen;
and further providing that R1 and R2 taken
together and/or R3 and R4 taken together
may form a substituted or unsubstituted
alicyclic group which is optionally
interrupted by one or more oxygen, sulfur
or nitrogen atoms, wherein R1 and R2
taken together is spiroadamantane and R3
and R4 taken together is a spirocyclohexyl
ring that is functionalized or substituted at
the 4-position.
__________
]22[]12[
]20[
SPANDEX PRODUCED FROM A
POLYURETHANE AND
METHODS FOR THE
PRODUCTION THEREOF
]11[
]02[
]22[
]/2[
24.07.2002
60/307154
]01[ 24.07.2001
Int. Cl.8 C08G 018/48
RADICISPANDEX CORPORATION,
U.S.A.
WO/2003/010216
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
[57] A spandex produced from a
polyurethane, wherein the polyurethane is
made by a method comprising:
(a) mixing at least one polymeric glycol
and at least polyol having an alkoxylated
aromatic functionality;
092992
‫ספנדקס המיוצר מפוליאורתן ושיטות‬
‫להכנתו‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
(b) reacting the product of step (a) with at
least one organic diisocyanate; and
(c) polymerizing the product of step (b)
with at least one diamine.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4952
]22[]12[
]20[
FUNGICIDAL COMPOSITION
AND USE OF THIS
COMPOSITION FOR
CONTROLLING PLANT
DISEASES
]11[
]02[
]22[
]/2[
24.07.2002
01/10301
]01[ 01.08.2001
Int. Cl.8 A01N 043/54
BAYER CROPSCIENCE S.A.,
FRANCE
WO/2003/011030
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
092938
‫תכשיר קוטל פטריות ושימושו לשליטה‬
‫עלמחלות צמחים‬
]00[
FR
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] Composition comprising at least one
fungicidal compound of the family of
anilinopyrimidines and imazalil.
__________
]22[]12[
]20[
STRUCTURE AND METHOD OF
FABRICATING EMBEDDED
VERTICAL DRAM ARRAYS WITH
SILICIDED BITLINE AND
POLYSILICON INTERCONNECT
]11[
]02[
]22[
]/2[
]//[
]/0[
27.06.2002
09/897868
]01[ 02.07.2001
Int. Cl.8 H01L 021/8242
IBM CORPORATION, U.S.A.
WO/2003/005447
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[57] A method of forming a memory array
and support transistors on a semiconductor
substrate, the method comprising:
providing a memory structure having an
array region and a support region separated
by an isolation region, wherein the array
4953
092399
‫ (זכרון‬DRAM ‫מנגנון ושיטה לייצור מערכי‬
‫דינאמי אקראי) אנכיים משובצים עם חיבור‬
‫ביטלין ופוליסיליקון עם משטחים‬
‫סילצידיים‬
]00[
US
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
region includes a plurality of dynamic
random access memory cells embedded in
the substrate, wherein adjacent dynamic
random access memory cells are connected
to each other through bitline diffusion
regions, wherein the memory structure is
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
capped with a top oxide layer; applying a
block mask to protect the array region
while stripping the top oxide layer from
the support region; forming support
implants, forming a support gate oxide
layer and patterning a first polysilicon
layer onto the support gate oxide layer;
forming a conductive nitride barrier layer,
a metal layer and a dielectric capping layer
on all exposed surfaces of the substrate;
removing portions of the nitride barrier
layer, the metal layer and the dielectric
capping layer from the support region to
form a support gate structure and removing
the nitride barrier layer, the metal layer
and the dielectric capping layer from the
isolation region, wherein the support gate
structure comprises the gate oxide layer,
the first polysilicon layer, the nitride
barrier layer, the metal layer and the
dielectric capping layer; forming an
insulated spacer on sidewalls of the gate
structure; forming a protective layer on all
exposed surfaces of the substrate; forming
an array gate structure in contact with the
memory cell and exposing a portion of the
bitline diffusion region by removing
portions of the protective layer, the nitride
barrier layer, the metal layer and the
dielectric capping layer from the array
region, wherein the array gate structure
comprises the oxide layer, the nitride
barrier layer, the metal layer and the
dielectric capping layer, and
simultaneously removing the protective
layer from the isolation region; forming a
spacer layer on sidewalls of the array gate
structure; depositing a second polysilicon
layer onto the substrate; selectively
patterning and etching the second
polysilicon layer in the isolation region to
form a landing pad while removing the
polysilicon layer from the support regions;
and simultaneously forming silicide layers
on an exposed portion of the source and
drain regions in the support region, on the
second polysilicon layer overlaying the
bitline diffusion regions in the array
region, and on the second polysilicon layer
defining the landing pad.
__________
]22[]12[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
031132
4954
]20[
OPTICAL FIBRES PROVIDED
WITH A LENS BY
PHOTOPOLYMERISATION AND
RELATED NOVEL OPTICAL
COMPONENTS
]11[
]02[
]22[
]/2[
26.07.2002
01/10147
]01[ 27.07.2001
Int. Cl.8 G02B 006/287
UNIVERSITE DE TECHNOLOGIE
DE TROYES, FRANCE
PASCAL ROYER, RENAUD
BACHELOT, CAROLE ECOFFET,
DANIEL-JOSEPH LOUGNOT
WO/2003/012504
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]/1[
]//[
]/0[
[57] Method for producing single-mode or
multimode optical fibers with lenses from
a multimode or analog fiber by forming at
least one end taper made of transparent
polymer, comprising a step for depositing
on at least one end of an optical fiber, in
the form of a drop, a fluid mixture that
includes a photopolymerizable base
substance and at least one polymerization
photoinitiator, followed by a step for
exposing the deposited drop to a light
source created to provide a
photopolymerization light, characterized in
that a step for selecting the desired mode
or modes is performed by subjecting the
multimode fiber to at least one mechanical
stress, and in that a check of both the shape
‫שיפור של סיבים אופטיים עם עדשה‬
‫על–ידי פוטופולימריזציה ומרכיבים‬
‫אופטיים חדישים הקשורים בכך‬
]00[
FR
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
and the dimensions of the taper is
performed during said steps for depositing
and exposing the drop, in order to obtain a
predetermined taper height between
several microns and several hundred
microns, said method including the
following steps: a step for conditioning the
mixture at a predetermined temperature in
order to give the mixture an adapted
viscosity, making it possible to obtain a
desired drop height prior to the exposure
step; a step for adjusting the exposure time
and/or the intensity of the
photopolymerization light, in order to
adjust the final radius of curvature of the
taper.
__________
]22[]12[
4955
031031
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]20[
MODEL OPTIMIZATION OF
STRUCTURE WITH ADDITIONAL
MATERIALS
]11[
]02[
]22[
]/2[
02.02.2004
10/357705
]01[ 03.02.2003
Int. Cl.8 G06F 011/00, 017/00
TIMBRE TECHNOLOGIES, INC.,
U.S.A.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]/0[
]00[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A method of modeling wafer
structure profile (100), the method
comprising:
(a) determining one or more termination
criteria;
(b) determining whether a wafer structure
(47) includes at least one layer having
three or more materials along a line within
the at least one layer;
(c) creating an optical metrology model
(40), wherein three or more materials are
incorporated in the model of the at least
one layer having three or more materials;
and
The applications for division
from this application have
not yet been published
‫אופטימיזציה של מודל למבנה עם חומרים‬
‫נוספים‬
(d) simulating a set of diffraction signals
(46, 57) using the optical metrology
model;
(e) determining if the one or more
termination criteria are met by using the
set of simulated diffraction signals and a
set of diffraction signals measured off of
the wafer; and
(f) if the one or more termination criteria
are not met, modifying the optical
metrology model and repeating steps (d)
and (e) until the one or more termination
criteria are met.
5108814
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]20[
MODULAR FURNITURE
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
031191
‫ריהוט מודולרי הכולל ריפוד להחלפה‬
4956
INCLUDING
INTERCHANGEABLE
UPHOLSTERY
]11[
]02[
]22[
]/2[
]//[
]/0[
13.08.2002
928820
]01[ 13.08.2001
Int. Cl.8 A47C 004/02
ALFRED G. NIEDERMAN, U.S.A.
WO/2003/015576
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A bracket for releasably securing
components of an easily assembled and
disassembled modular furniture system
including a base frame, a plurality of
furniture modules including a first arm
module, a second arm module, a seat
suspension module and a backrest module,
said bracket comprising: a blade portion
having a mounting formation configured
for attachment to one of the components,
and an elongate blade formation projecting
from said mounting formation; a sheath
portion defining a chamber for receiving
said blade formation and also having a
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
mounting formation configured for
attachment to an adjacent one of the
components, said sheath portion and said
blade formation being substantially coaxial
upon assembly so that said blade portion
can be readily slidably disassembled from
said sheath portion; said sheath portion
engages an exposed end of said blade
portion, and upon assembly, said sheath
portion encloses said blade formation; and
an open rear end of said chamber and a
locking device for securing said blade
portion to said sheath portion upon passing
through said chamber.
__________
]22[]12[
4957
031122
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]20[
ARTICLE HOLDING SYSTEM
AND METHOD
]11[
]22[
]/2[
10.02.2004
Int. Cl.8 B24B 001/00, 037/00, 049/00
NOVA MEASURING
INSTRUMENTS LTD.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]/0[
[57] An article holding system (10)
comprising a vacuum system having
vacuum pads (16) in the form of spacedapart projections on a surface (10A) of the
holding system by which it faces an article
to be held for contacting a surface of the
article at respective surface regions of the
article, said vacuum system having
‫מערכת ושיטה להחזקת פריט‬
‫ רחובות‬,‫נובה מכשירי מדידה בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
vacuum channels (26A, 26B) for supplying
vacuum to the inside of the pads and a
liquid supplying assembly (27) including a
plurality of liquid flow channels (28) each
for supplying the liquid to the inside of the
respective one of the pads, thereby
enabling to maintain liquid environment
within the contact regions with the article.
__________
]22[]12[
]20[
TOOL FOR REPAIRING
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
031232
‫כלי לתיקון הברגות פגומות‬
4958
DAMAGED SCREW THREADS
]11[
]22[
]/2[
]/1[
]/0[
07.03.2004
Int. Cl.8 B21D 003/14
SHILO TECHNOLOGIES LTD.
MOSHE ABRAHAM, ZEEV STAHL,
BINYAMIN FREDKIN
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
[57] A tool for repair of damaged threads
of screws, comprising: a body (2) having a
projecting portion (4) for accommodating
a screw to be repaired and having two
recessed major surfaces; a cutting blade
(6), having a rear end hingedly articulated
to said body, and a front end in the shape
of a cutting face substantially fitting the
type of thread to be repaired; a guide blade
‫ ירושלים‬,‫שילה טכנולוגיות בע"מ‬
‫ בנימין פרדקין‬,‫ זאב שטאל‬,‫משה אברהם‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
(7) having a rear end hingedly articulated
to said body, and a front end substantially
fitting the type of thread to be repaired,
said guide blade projecting beyond the
cutting face of said cutting blade, and;
means (10, 12, 14) to alter the distance
between said front ends and said projecting
body portion to accommodate screws of
different diameters.
__________
]22[]12[
4959
031231
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]20[
ADAPTER FOR MOUNTING A
FACEPLATE OF A FIRST STYLE
ONTO AN ELECTRICAL
OUTLET CAVITY OF A SECOND
STYLE
]11[
]22[
]/2[
]//[
]/0[
25.09.2001
Int. Cl.8 H02G 003/14
SERCONET LTD.
WO/2003/028181
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
‫מתאם להרכבת מכסה שקע מסגנון ראשון‬
‫לחור שקע חשמלי מסגנון שני‬
‫ רעננה‬,‫סרקונט בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
[57] An adapter for mounting a first
faceplate of a first style on to an electrical
outlet cavity constructed for mounting
thereon a second faceplate of a second
style via a fixture device, the adapter
comprising: a plate (503) having an
opening (505) for passing therethrough
media for connecting to at least one
connector mounted in said first faceplate,
at least one fastener (403) fixed to the plate
for fixedly attaching the adapter to the
outlet cavity, and at least one mounting
point (507) for attaching the first faceplate
thereto, wherein the at least one fastener
comprises a pair of spaced apart clamps for
engaging an inner surface of the outlet
cavity.
__________
]22[]12[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
031230
4960
]20[
PIEZOMOTOR WITH A GUIDE
]11[
]02[
]22[
]/2[
20.09.2002
10146703.6
]01[ 21.09.2001
Int. Cl.8 H02N 002/00
ELLIPTEC RESONANT ACTUATOR
AG, GERMANY
WO/2003/028199
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A drive system, comprising at least
one motor (1) having at least one vibration
generator (2) each as well as at least one
resonator (3) each and a device that is
driven by the motor, wherein the resonator
comprises a contact area (7) that
cooperates with the surface of the device to
‫מנוע פיאזו עם מנחה‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
drive said device, characterized by the
resonator contact area comprising a means
or the device surface comprising a means
that interacts with a contact area of a
resonator, and by the means guiding the
device.
__________
]22[]12[
4961
030913
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]20[
METHOD FOR EMBOSSED AND
COLOURLESS DECORATION
AND BONDING OF A FABRIC
WEB AND DEVICE THEREFOR
]11[
]02[
]22[
]/2[
]//[
]/0[
21.10.2002
10152075.1
]01[ 25.10.2001
Int. Cl.8 D04H 001/46, D06C 023/00
FLEISSNER GMBH, GERMANY
WO/2003/035955
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] Method of producing colourless,
three-dimensional designs (7) in a web of
material and strengthening such web
formed from non-woven or knitted fibers,
that is to say a non-woven fabric (2)
formed from substantially finite fibres,
such as synthetic staple fibers or even
natural fibers, characterized in that some of
the fibers of the web of material which lie
on a first plane provided with the design to
be achieved are displaced into a second
‫שיטה לקישור של רשת אריג ולקישוטו‬
‫ללא צבע ומתקן בשבילה‬
]00[
DE
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
plane by means of high-powered water jets
(4) and maintained there because of an
existing resistance to further displacement,
the impinging fluid is discharged, and the
fibers of the web of material are
intermingled with one another in both
planes by the effect of the water jets and,
in consequence, the non-woven fabric is
strengthened over its whole surface and
provided with a design.
__________
]22[]12[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
030923
4962
]20[
PESTICIDAL FORMULATIONS
]11[
]02[
]22[
]/2[
15.10.2002
0126144.5
]01[ 31.10.2001
Int. Cl.8 A01N 025/02, 043/54
SYNGENTA LIMITED, UNITED
KINGDOM
WO/2003/037084
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
[57] A concentrated pesticidal solution
which comprises one or more water-
‫תכשירים קוטלי מזיקים‬
]00[
GB
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
insoluble pesticides and lignin dissolved in
a water miscible, polar solvent.
__________
]22[]12[
]20[
SHELF-STABLE VEGETABLE
COMPOSITION AND METHOD
OF MAKING
]11[
]02[
]22[
]/2[
18.12.2002
01205157.9
]01[ 25.12.2001
Int. Cl.8 A23B 007/154
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2003/055321
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]//[
]/0[
[57] A shelf stable vegetable composition
comprising a non-dehydrated vegetable
having a green color and a water-soluble
compound in an amount sufficient to
impart to the composition a water activity
of 0.65 or less and a pH of 6.5 to 7.5 at
ambient conditions for preservation of the
030230
‫תכשיר צמחי עמיד ושיטת ייצורו‬
]00[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, /76 ‫רחוב הירקון‬
green color of the vegetable, wherein the
water-soluble compound is an organic acid
salt selected from the group consisting of
acetate salt, aspartate salt, fumarate salt,
malate salt, tartrate salt, succinate salt,
lactate salt, and combinations thereof.
__________
]22[]12[
4963
031038
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫תכשירים רפואיים המכילים‬
‫גליבנקלאמיד ומטפורמין לטיפול בסוכרת‬
II ‫נעורים סוג‬
]20[
PHARMACEUTICAL
COMPOSITIONS COMPRISING
METFORMIN AND
GLIBENCLAMIDE FOR THE
TREATMENT OF TYPE-II
DIABETES MELLITUS
]11[
]02[
]22[
]/2[
29.11.2002
FI2001A000230 ]01[ 29.11.2001
]00[ IT
Int. Cl.8 A61K 009/00, 009/20, 009/24, 031/155, 031/175, 047/42, A61P 003/10
MENARINI INTERNATIONAL
OPERATIONS LUXEMBOURG S.A.,
LUXEMBOURG
ALESSANDRO TOSETTI, MAURO
GUIDUCCI, GIOVANNI VITI
WO/2003/045355
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]/1[
]//[
]/0[
[57] Pharmaceutical formulations for oral
administration in tablet form, comprising
glibenclamide and metformin, or
pharmaceutically acceptable salts thereof
as active ingredients, characterized by the
fact that said active ingredients are
comprised in layers separated from each
other.
__________
]22[]12[
]20[
INFRARED-REFLECTIVE,
TRANSPARENT, MULTI-LAYER
PLASTIC LAMINATES
]11[
]02[
]22[
]/2[
27.11.2002
10160569.2
]01[ 10.12.2001
Int. Cl.8 B32B 027/18
BAYER MATERIALSCIENCE AG,
GERMANY
WO/2003/053689
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] Multi-layer product comprising three
layers A, B and C, wherein layer A
comprises a transparent thermoplastic
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
031183
‫שכבתי מרובד שקוף המחזיר‬-‫פלסטיק רב‬
‫אור אינפרה אדום‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
plastics material, and wherein layer B
comprises a transparent thermoplastic
plastics material and a pigment consisting
4964
of a transparent support material and a
titanium dioxide layer located above the
support material and having a thickness of
from 150 to 200 nm, and wherein layer C
comprises a transparent thermoplastic
plastics material, and wherein further
layers may be applied over the titanium
dioxide layer, and wherein the transparent
thermoplastic plastics material contained
in layers A, B and C is selected from the
group cosnsiting of polycarbonate and a
copolyester derived from dicarboxylic
acids and diols, wherein the dicarboxylic
acids are selected from the group
consisting of terephthalic acid, isophthalic
acid and cyclohexane-1,4-dicarboxylic
acid and wherein the diols are selected
from the group consisting of ethylene
glycol, cyclohexanedimethanol and
diethylene glycol, and wherein repeating
units derived from diethylene glycol
account for less than 5 mol% of all
repeating units derived from diols.
__________
]22[]12[
031129
‫שיטה ומערכת לאספקת גז‬
]20[
GAS SUPPLYING METHOD AND
SYSTEM
]11[
]02[
]22[
]/2[
04.12.2002
2001-369905 ]01[ 04.12.2001
]00[ JP
Int. Cl.8 B01D 053/34, B01J 004/00, C01B 023/00, C23C 016/44
TAIYO NIPPON SANSO
CORPORATION, JAPAN
TADAHIRO OHMI, JAPAN
WO/2003/047731
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
[57] A method for collecting exhaust gas
discharged from a gas using facility,
comprising steps of: collecting an exhaust
gas discharged from a gas using facility
into a gas storage tank, wherein the
exhaust gas comprises an effective
component gas and an atmospheric gas or
a sealing gas; adding a replenishing gas of
the same components as the effective
component gas to the gas storage tank
containing the exhaust gas discharge from
the gas using facility, so that the
component ratio of the gas to be separated
and purified becomes constant; separating
the effective component gas contained in
the exhaust gas from the atmospheric gas
or the sealing gas; purifying the effective
component gas separated by the separating
step; and supplying the effective
component gas thus obtained to the gas
using facility.
__________
]22[]12[
4965
031832
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫הכנת תולדות טרנס דחוסות של‬
– ‫ –דיבנזו‬H2 – ‫ – טטרהידרו‬b,8,3a,30/
‫] פוראן‬b– 0,/[ ‫] ציקלוהפטה‬:,4:9,7[
]20[
PREPARATION OF TRANS-FUSED
3,3A,8,12B-TETRAHYDRO-2HDIBENZO [3,4:6,7]CYCLOHEPTA
[1,2-B]FURAN DERIVATIVES
]11[
]02[
]22[
]/2[
02.12.2002
01204961.5
]01[ 07.12.2001
]00[ EP
Int. Cl.8 A61K 031/34, A61P 001/00, 025/00, C07D 307/00, 307/93
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2003/048146
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4191 .‫ד‬.‫ ת‬, /0 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]//[
]/0[
[57] A process for preparing each
individual diastereoisomer of the formula
wherein the substituent on carbon atoms 3a
and 12b have the trans configuration, the
substituent on carbon atom 2 may have the
R or the S configuration, comprising the
steps of cyclizing a compound of the
formula
wherein R represents C1-3 alkylcarbonyl;
OR1 represents a leaving group and the
substituents –OR and –CH2-CHOH-
CH2OR1 have the cis configuration, in a
reaction inert solvent in the presence of an
acid, whereby
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4966
Intermediate compounds of formula (I) of
the formula
wherein OR1 represents a leaving group
4967
and compounds of the formula
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
in free base form or a pharmaceutically
acceptable acid addition salt form thereof
are also claimed as novel.
__________
]22[]12[
]20[
CHOLINE-SILICIC ACID
COMPLEX WITH OSMOLYTES
AND DIVALENT TRACE
ELEMENTS
]11[
]02[
]22[
]/2[
]//[
]/0[
20.03.2003
02076099.7
]01[ 20.03.2002
Int. Cl.8 A01N 059/00, A23K 001/16
BIO MINERALS N.V., BELGIUM
WO/2003/077657
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] Biological preparation comprising
orthosilicic and silicic acid, a primary
033081
‫מערכת של חומצה כולין–צורנית עם‬
‫אוסמוליטים ועקבות של יסודות דו–ערכיים‬
]00[
EP
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
osmolyte choline and a weak alkalinizing
agent without free hydroxyl groups.
__________
]22[]12[
]20[
]11[
]22[
]/2[
]/0[
HERBAL COMPOSITIONS FOR
THE TREATMENT OF DIABETES
033110
‫תכשירים צמחיים לטיפול בסוכרת‬
21.09.2004
Int. Cl.8 A61K 003/600000 003/688600 A61P 003/10
CHAIM Z. MICHAELO, KENYA
PAULINA BEN-AMI, BEN-AMI &
,'‫ בן עמי ושות‬, ‫עמי‬-‫פאולינה בן‬
ASSOCIATES,
‫ רחובות‬,64 .‫ד‬.‫ת‬
P.O.B. 94,
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4968
REHOVOT 76100
[57] An herbal composition useful for the
treatment of diabetes and associated
complications comprising a plant extract
from Azadirachta indica, Aloe vera, and
cinnamon.
__________
]22[]12[
]20[
GAS SEPARATION METHOD
]11[
]02[
]22[
]/2[
11.04.2003
2002-112145 ]01[ 15.04.2002
Int. Cl.8 B01D 053/047
TAIYO NIPPON SANSO
CORPORATION, JAPAN
WO/2003/086586
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]//[
]/0[
[57] A gas separation method which uses
a pressure swing adsorption method to
separate from a mixed gas containing at
least two components, a first component
and a second component, using a first
adsorption column (11) containing a first
adsorbent on which said first component is
less readily adsorbable and said second
component is more readily adsorbable, and
a second adsorption column (21)
containing a second adsorbent on which
said first component is more readily
adsorbable and said second component is
less readily adsorbable, comprising: a first
step comprising an adsorption step in
which in said first adsorption column, said
mixed gas is supplied at a high pressure
and said second component is selectively
adsorbed and said first component is
separated as a first product gas, and a
regeneration step in which in said second
adsorption column, said first component is
desorbed by depressurization; a second
step comprising an equalization
depressurization step in which said first
4969
033393
‫שיטה להפרדת גז‬
]00[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
adsorption column is depressurized by
connecting said first adsorption column
and said second adsorption column, and
introducing the gas in said first adsorption
column into said second adsorption
column, to pressure equalize said first and
second adsorption columns, and an
equalization pressurization step in which
said second adsorption column is
pressurized to equalize the pressure of said
first and second adsorption columns; a
third step comprising a regeneration step in
which in said first adsorption column, said
second component is desorbed by
depressurization, and an adsorption step in
which in said second adsorption column,
said mixed gas is supplied at a high
pressure, and said first component is
selectively adsorbed, and said second
component is separated as a second
product gas; and a fourth step comprising
an equalization depressurization step in
which said second adsorption column is
depressurized by connecting said second
adsorption column and said first adsorption
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
column, and introducing the gas in said
second adsorption column into said first
adsorption column, to pressure equalize
said first and second adsorption columns,
and an equalization pressurization step in
which said first adsorption column is
pressurized to equalize the pressure of said
first and second adsorption columns,
wherein a first product gas storage tank
that stores said first product gas and a
second product gas storage tank that stores
said second product gas are used, and in
said regeneration step in said first and
second adsorption columns, each product
gas in said first and the second product gas
storage tanks is introduced into said first
and the second adsorption columns
respectively, and in said equalization
pressurization step in said first and second
adsorption columns, each product gas in
said first and the second product gas
storage tanks is introduced into said first
and second adsorption columns
respectively.
__________
]22[]12[
033382
‫תכשירים לטפול בנרתיק המכילים‬
‫מיקרואורגניזימים חיים‬
]20[
VAGINAL CARE COMPOSITIONS
CONTAINING VIABLE
MICROORGANISMS
]11[
]02[
]22[
]/2[
17.10.2004
03025152.4
]01[ 03.11.2003
]00[ EP
Int. Cl.8 A61K 000/899000 009/02, 009/06, 035/74, 039/02
PETER-HANSEN VOLKMANN,
GERMANY
WOLFF, BREGMAN AND GOLLER,
]/0[
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
,‫ ברגמן וגולר‬,‫וולף‬
4970
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
[57] Vaginal care composition,
comprising viable Lactobacillus and/or
Bifidobacterium microorganisms,
preferably Lactobacillus bifidus; non-
viable Saccharomyces cultures,
prefereably Saccharomyces cerevisiae;
saccharide(s); vitamin A/retinol, and zinc.
__________
]22[]12[
]20[
PIPE COUPLING
]11[
]22[
]/2[
30.05.2002
Int. Cl.8 F16L 023/028
ARKAL FILTRATION SYSTEMS
C.S. LTD.
]//[
]/0[
WO/2003/102458
DANIEL FREIMANN & CO.,
5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
[57] A pipe coupling for connecting a pipe
(16) to a counter flange (12) associated
with another pipe in a sealed manner,
wherein the pipe is formed with a
circumferential groove (10a), the coupling
comprising a gasket (20), a mounting ring,
and a mounting flange (22), characterized
in that the mounting ring is elastically
expandable, and formed with projection
means adapted to fit into the
4971
039093
‫מחבר צינור‬
‫אגודה שיתופית‬,‫ארקל מערכות סינון‬
‫חקלאית בע"מ‬
,'‫דניאל פריימן ושות‬
‫ תל אביב‬,01 ‫ בית כלל קומה‬.‫דרויאנוב‬
circumferential groove and hold the
mounting ring affixed to the pipe while the
mounting flange is tightened against both
the mounting ring and the counter-flange;
and an outer cone-shaped surface (18c);
and the mounting flange being formed
with an inner cone-shaped surface (22a)
matching the outer cone-shaped surface of
the mounting ring.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
__________
]22[]12[
]20[
FASTENER AND FASTENER
DRIVER
]11[
]02[
]22[
]/2[
18.01.2005
10/932436
]01[ 02.09.2004
Int. Cl.8 F16B 023/00, F25B 023/00
EAZYPOWER CORPORATION,
U.S.A.
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.,
P.O.B. 1352,
JERUSALEM 91013
]/0[
[57] A fastener and fastener-driver
combination, the combination comprising:
(a) a fastener having a threaded shank and
a head (10), said head comprising a
periphery (18), a center (16), and three
convex regions separated by a first slot
(21), a second slot (22), and a third slot
(23) extending radially from said center
wherein said slots each have a longitudinal
axis (21', 22', 23'), such that in said head
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
033899
‫מהדק ומוביל מהדק‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
between the first slot and the second slot
and between the first slot and the third slot
there is an angular separation of between
120 and 144 degrees between their
longitudinal axes; and
(b) a 3-blade fastener driver (30) having a
first blade, a second blade, and a third
blade, with each said blade having a
longitudinal axis; and with said blades
configured to be received by said slots.
4972
__________
]22[]12[
]20[
PRINTING WITH A MULTISEGMENT PRINTHEAD
]11[
]22[
]/1[
]/2[
30.06.2000
Int. Cl.8 B41J 002/21
DIVISION FROM 153724
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/002339
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
[57] A print engine for a pagewidth
printhead that includes one or more
printhead chips that each include an array
of micro-electromechanical nozzle
arrangements positioned on a substrate, the
print engine including page data input
means (11) for receiving page data
representing pages (21) to be printed; a
memory buffer (12) for storing said page
data and from which said page data can be
retrieved for print processing; and a print
engine controller (10) that is configured to
4973
033310
‫מנוע הדפסה לראש מדפסת רוחב דף‬
–‫המשלב סדרים של פתחים מיקרו‬
‫אלקטרומכנים‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
transfer the page data to the memory buffer
and to retrieve page data from the buffer,
the print engine controller including: a data
bus (90) that is connected to the memory
buffer; an input interface (89) that is
interposed between the page data input
means and the data bus so that page data
can be written to the memory buffer; page
data processing circuitry connected to the
data bus to receive the page data and
configured to process the page data
according to printing parameters; and a
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
printhead interface (32) connected to the
page data processing circuitry for receiving
the processed page data and configured to
format the processed page data for printing
by the pagewidth printhead.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4974
]22[]12[
]20[
PRINT ENGINE/CONTROLLER
AND PRINTHEAD INTERFACE
CHIP INCORPORATING THE
ENGINE/CONTROLLER
]11[
]22[
]/1[
]/2[
24.05.2000
Int. Cl.8 B41J 002/01, 002/21, 011/04
DIVISION FROM 153031
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2001/089851
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]//[
]/0[
[57] A print engine controller (10) for a
page width inkjet print head, the print
engine controller including: at least one
integrated circuit which is configured to
define: an input interface (14) which is
configured to receive data representing
compressed pages; a continuous tone
image data decoder connected to the input
interface to decode any data representing
compressed continuous tone images
received from the input interface; a bilevel image data decoder connected to the
032011
‫מווסת מנוע הדפסה לראש מדפסת הזרקת‬
‫דיו לרוחב עמוד ושיטה לעיבוד נתוני תמונה‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:./ .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
input interface to decode any data
representing compressed bi-level image
data received from the input interface; a
half-toner connected to the input interface
for dithering continuous tone images; a
compositor (18, 19) connected to the input
interface for compositing bi-level images;
and a print head interface (20) that is
configured to receive data representing
dithered and composite images and to
generate data that is readable by the inkjet
print head.
__________
4975
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
032181
)IFN–Y ( ‫שימוש במעכב אינטרפרון – גמה‬
‫ בהכנת תרופה לטיפול‬TNFa ‫ומעכב‬
‫במחלת דלקת המעי‬
]20[
USE OF AN INTERFERON GAMMA (IFN- Y )AND TNF
ALPHA INHIBITOR IN THE
PREPARATION OF A
MEDICAMENT FOR TREATMENT
OF INFLAMMATORY BOWEL
DISEASE
]11[
]02[
]22[
13.12.1993
07/997835
]01[ 29.12.1992
]00[ US
Int. Cl.8 A61K 038/00, 039/395, A61P 001/00, 001/04, 043/00, C07K 002/00,
014/57, 014/715, 016/00, 016/24, 016/28, 019/00
DIVISION FROM 108007
GENENTECH, INC., U.S.A.
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
]/1[
]/2[
]/0[
[57] Use of an interferon-gamma (INF-γ)
inhibitor which inhibits the binding of
native INF-γ to its native receptor and a
TNFα inhibitor, in the preparation of a
medicament for the treatment of
inflammatory bowel disease.
__________
]22[]12[
]20[
SILICON CARBIDE
COMPOSITES
AND METHODS FOR MAKING
SAME
]11[
]22[
]/1[
]/2[
23.07.1999
Int. Cl.8 C04B 035/573
DIVISION FROM 147600
M CUBED TECHNOLOGIES, INC.,
U.S.A.
WO/2001/007377
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]//[
]/0[
[57] An article of manufacture selected
from the group consisting of an air bearing
support frame, a mirror substrate, a mirror
stage, a semiconductor wafer chuck, a
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
032313
‫תרכובות קרביד צורן ושיטות להכנתן‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,//7: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
machine tool bridge, a machine tool base
and a flat panel display setter, said article
comprising: a composite material
comprising a silicon carbide component
4976
and a metal component distributed
throughout said silicon carbide, said metal
component comprising at least about 40
percent by weight of silicon and at least 10
percent by volume of at least one metal
selected from the group consisting of
aluminium, zinc and copper.
__________
]22[]12[
]20[
INTERMEDIATES FOR THE
PREPARATION OF
ANTIHISTAMINIC PIPERIDINE
DERIVATIVES
]11[
]02[
]22[
]/1[
]/2[
17.06.1999
09/109542
]01[ 02.07.1998
Int. Cl.8 C07C 069/738
DIVISION FROM 140649
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2000/001671
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]/0[
020131
‫חומרי ביניים להכנת תולדות פיפרידין‬
‫אנטיהיסטמיניות‬
]00[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,0/900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] Intermediate compounds of the formula
wherein R1 is H or C1-C6 alkyl and the C3C6 alkyl moiety is straight or branched;
R2 and R3 are each independently C1-C6
alkyl and the C3-C6 alkyl moiety is straight
or branched; or stereoisomers thereof.
__________
4977
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
METHOD FOR PRODUCING A
PRINTED COMMUNITY
MAGAZINE
]11[
]22[
]/2[
26.10.2005
Int. Cl.8 B41J 011/00, G03B 027/58
RAMI DOTAN
TAL PETEL
]/0[
RAMI DOTAN,
P.O.B. 52334
TEL AVIV 67210
[57] A method for producing a community
printed magazine, the method comprising
the steps of:
providing a desired number of pages and
page-size of said magazine; providing
content to be included within said
020992
‫שיטה להפקת מגזין קהילתי מודפס‬
‫ תל אביב‬,‫רמי דותן‬
‫ תל אביב‬,‫טל פטל‬
,‫רמי דותן‬
‫ תל אביב‬,./::4 .‫ד‬.‫ ת‬,
magazine; editing said content until the
occupation ratio of said magazine falls
within a range; adjusting the layout of said
content in the pages of said magazine to an
occupation ratio of about 100 percent; and
printing out said magazine.
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4978
]22[]12[
]20[
SMALL AND EFFICIENT
DISTILLATION APPARATUS
FOR EXTRACTION OF
ESSENTIAL OIL FROM PLANT
MATTER
022331
‫מתקן זיקוק קטן ויעיל למיצוי שמנים נדיפים‬
‫מחומרים צמחיים‬
]11[
]22[
]/2[
]/1[
]/0[
05.12.2006
Int. Cl.8 B01D 003/02
MOSHE BALASS
MOSHE BALASS
MOSHE BALASS,
59 HERZL ST.,
OR YEHUDA 60211
[57] A distillation apparatus for extracting
volatile oils from plant matter, the
apparatus comprising the following
components:
(a) at least one vessel comprising a
container with an open mouth, the
container being divided into at least one
upper chamber and at least one lower
chamber by at least one removable grid;
(b) a lid for covering the open mouth;
(c) at least one condenser detachably
coupled to said vessel via at least one
delivery tube;
‫ אור יהודה‬,‫משה בלס‬
‫משה בלס‬
,‫משה בלס‬
‫ אור יהודה‬,.6‫הרצל‬
(d) at least one collector for collecting a
distillate;
(e) at least one return tube coupling the
collector to the vessel, and
(f) a recirculating cooling system
comprising at least one electric pump and
outgoing and incoming conduits for
coupling to at least one reservoir of
contained coolant liquid, wherein the
dimensions of the components are selected
such that the condenser, collector and
return tube are storable within the vessel.
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬44 ‫פירוט זה נבחן בהתאם לתקנה‬
1840 – ‫ תשכ"ח‬5‫הפטנטים‬
__________
4979
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
]22[]12[
]20[
METHOD AND SYSTEM FOR
REMOTELY CONTROLLING, BY
A SERVER, OF AN OFF-SCREEN
SURFACE AT A CLIENT
COUPLED TO THE SERVER
033321
‫ באמצעות‬,‫שיטה ומערכת לבקרה מרחוק‬
‫ בזמן אי–שידור משטח לקוח המחובר‬,‫שרת‬
‫לרשת‬
]11[
]02[
29.05.2001
60/207532
]01[ 26.05.2000
]00[ US
/3211212/
2093/91333
US
]22[ Int. Cl.8 G06F 003/153, H04L 029/06
]/1[ DIVISION FROM 152797
]/2[ CITRIX SYSTEMS, INC., U.S.A.
]//[ WO/2001/092973
]/0[ WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
[57] A method of remotely controlling, by
allocation to the off-screen surface, the
a server, the formation of an off-screen
first memory region corresponding to a
surface at a client coupled to the server via
memory coupled to the client; instructing
a communication network, the method
the client to copy the graphical data
being performed at the server and
associated with the indicia to a particular
comprising the steps of: instructing the
location within the first memory region.
client to select a first memory region for
141484
‫בקשת הורה לבקשה זו שטרם‬
The parent application from which
‫פורסמה‬
this application has been divided has
not yet been published
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4980
]22[]12[
]20[
METHOD AND SYSTEM FOR
EFFICIENTLY REDUCING THE
AMOUNT OF GRAPHICAL DATA
TRANSMITTED FROM A SERVER
TO A CLIENT VIA A
COMMUNICATION NETWORK
033328
‫שיטה ומערכת להפחתה יעילה של כמות‬
‫נתונים גרפיים המשודרים משרת ללקוח‬
‫דרך רשת תיקשורת‬
]11[
]02[
29.05.2001
60/207532
]01[ 26.05.2000
]00[ US
/3211212/
2093/91333
US
]22[ Int. Cl.8 G06F 003/14, 003/153, 017/30, H04L 029/06
]/1[ DIVISION FROM 152797
]/2[ CITRIX SYSTEMS, INC., U.S.A.
]//[ WO/2001/092973
]/0[ WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.,
‫ ירושלים‬,0:./ .‫ד‬.‫ ת‬, '‫ב‬06 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
[57] A method of efficiently reducing the
plurality of strips, and transmitting the
amount of graphical data transmitted from
protocol stream from the server to the
a server to a client via a communications
client via the communications network,
network, the method comprising the steps
characterized in that each of the plurality
of: separating a path into a plurality of
of strips having a beginning and an
strips; determining a quantized angle
endpoint coordinate defined within a
associated with the absolute angle for each
coordinate system, a strip length and an
of the plurality of strips; forming a
absolute angle associated therewith, the
protocol stream at the server, the protocol
coordinate system corresponding to a
stream including a beginning coordinate of
region of a display surface associated with
the path and the strip length and an indicia
the client.
of the quantized angle of each of the
4981
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
The parent application from which
this application has been divided has
not yet been published
141484
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4982
‫פטנטים‬
PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
21103/
20/1//
223/00
221211
2200/2
220/30
200//3
22////
22/0/2
21/2/3
202//0
20//01
20/0/0
20/2/0
21022/
200220
200//0
2//013
2/23/1
4983
2112/2
20///2
2220//
2212//
220/1/
220/3/
202/2/
22/3//
22/2/3
21/02/
20/32/
20////
20/0/2
20/2//
212/31
200/20
202122
2//3/1
211/31
20313/
2220/1
221/0/
220/00
220/02
202/21
22/3/3
22//2/
21///1
20/2/0
20//03
20//30
20////
21//21
200/03
2/1//2
2//2//
21031/
20310/
222/11
221/01
220/22
2222//
20//00
22/03/
2/2133
2030/1
20//02
20///0
20//12
20//1/
2020/2
200///
2/0/2/
2/////
20/111
202113
221302
22012/
22033/
2221//
22/311
22/1//
2/2223
202///
20//32
20///3
20//1/
20////
20130/
200333
2/02//
2//2/2
20/301
2231/1
221233
2200/2
22020/
201/02
22/011
22/1/2
2/2///
202/2/
20/3/1
20/332
20////
20//03
2010//
2003/1
2/0220
2//2//
20/2/1
22301/
22120/
220030
220/30
2002//
22//00
22/1//
2/13/0
2010/3
20/233
20/320
20///2
22322/
201/13
200220
2/2030
2//2//
20/102
22320/
221022
220003
220/0/
200/1/
22///0
22/0/1
220/2/
2022//
20/20/
20/0/1
20///3
223213
201//0
2001//
2//122
2/23/2
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪/03//‬‬
‫‪/022/‬‬
‫‪/01/0‬‬
‫‪23/3/2‬‬
‫‪23/002‬‬
‫‪23/0/0‬‬
‫‪23/010‬‬
‫‪23/2/3‬‬
‫‪2112/0‬‬
‫‪211/21‬‬
‫‪21032/‬‬
‫‪210212‬‬
‫‪21/20/‬‬
‫‪21/022‬‬
‫‪20310/‬‬
‫‪203/1/‬‬
‫‪203/20‬‬
‫‪203/20‬‬
‫‪203/0/‬‬
‫‪203///‬‬
‫‪20221/‬‬
‫‪201323‬‬
‫‪2002/0‬‬
‫‪20/301‬‬
‫‪203///‬‬
‫‪200/03‬‬
‫‪2002/2‬‬
‫‪20/31/‬‬
‫‪20/1//‬‬
‫‪20/21/‬‬
‫‪20//23‬‬
‫‪20//00‬‬
‫‪20/0/0‬‬
‫‪20//02‬‬
‫‪20/2/3‬‬
‫‪20///2‬‬
‫‪2230/0‬‬
‫‪22221/‬‬
‫‪222///‬‬
‫‪221020‬‬
‫‪220010‬‬
‫‪220///‬‬
‫‪222/02‬‬
‫‪4984‬‬
‫‪/03/3‬‬
‫‪/0221‬‬
‫‪/01/3‬‬
‫‪23////‬‬
‫‪23/003‬‬
‫‪23/0/3‬‬
‫‪23/022‬‬
‫‪23/21/‬‬
‫‪21103/‬‬
‫‪211/3/‬‬
‫‪210322‬‬
‫‪2103//‬‬
‫‪212/00‬‬
‫‪21/1/0‬‬
‫‪20313/‬‬
‫‪203/22‬‬
‫‪203///‬‬
‫‪203/03‬‬
‫‪203/0/‬‬
‫‪203///‬‬
‫‪2023/0‬‬
‫‪202//2‬‬
‫‪2003//‬‬
‫‪20/00/‬‬
‫‪20301/‬‬
‫‪200/0/‬‬
‫‪2002/2‬‬
‫‪202//0‬‬
‫‪20/10/‬‬
‫‪20/21/‬‬
‫‪20//03‬‬
‫‪20//02‬‬
‫‪20/012‬‬
‫‪20///3‬‬
‫‪20/000‬‬
‫‪20//1/‬‬
‫‪22301/‬‬
‫‪222322‬‬
‫‪222/12‬‬
‫‪221000‬‬
‫‪220111‬‬
‫‪220//2‬‬
‫‪222/3/‬‬
‫‪/03/2‬‬
‫‪/0201‬‬
‫‪/01/0‬‬
‫‪23/001‬‬
‫‪23/012‬‬
‫‪23/0//‬‬
‫‪23/021‬‬
‫‪23/232‬‬
‫‪2112/3‬‬
‫‪211//2‬‬
‫‪210332‬‬
‫‪2103/0‬‬
‫‪212///‬‬
‫‪21//21‬‬
‫‪2032/3‬‬
‫‪2032//‬‬
‫‪203//3‬‬
‫‪203/0/‬‬
‫‪203/22‬‬
‫‪203//0‬‬
‫‪2023/2‬‬
‫‪202/3/‬‬
‫‪200///‬‬
‫‪20/1/0‬‬
‫‪20/032‬‬
‫‪20023/‬‬
‫‪2001//‬‬
‫‪202/21‬‬
‫‪20/20/‬‬
‫‪20/22/‬‬
‫‪20//3/‬‬
‫‪20///2‬‬
‫‪20/1/0‬‬
‫‪20//2/‬‬
‫‪20/03/‬‬
‫‪20////‬‬
‫‪2230//‬‬
‫‪222330‬‬
‫‪222/11‬‬
‫‪221033‬‬
‫‪221//2‬‬
‫‪220///‬‬
‫‪22222/‬‬
‫‪/0313‬‬
‫‪/0211‬‬
‫‪/010/‬‬
‫‪230/00‬‬
‫‪23/02/‬‬
‫‪23/0/2‬‬
‫‪23/031‬‬
‫‪23/232‬‬
‫‪2120/2‬‬
‫‪211///‬‬
‫‪211/2/‬‬
‫‪2103/0‬‬
‫‪210221‬‬
‫‪21///2‬‬
‫‪203223‬‬
‫‪20322/‬‬
‫‪203///‬‬
‫‪203/0/‬‬
‫‪203/3/‬‬
‫‪203//2‬‬
‫‪2023//‬‬
‫‪202022‬‬
‫‪200012‬‬
‫‪20//12‬‬
‫‪20/103‬‬
‫‪200320‬‬
‫‪200101‬‬
‫‪2022//‬‬
‫‪20/232‬‬
‫‪20/221‬‬
‫‪20/2//‬‬
‫‪20///1‬‬
‫‪20/332‬‬
‫‪20//13‬‬
‫‪20/1/2‬‬
‫‪20//2/‬‬
‫‪2231/1‬‬
‫‪223//3‬‬
‫‪222/30‬‬
‫‪2211/2‬‬
‫‪221/2/‬‬
‫‪220/00‬‬
‫‪22203/‬‬
‫‪/1//3‬‬
‫‪/0213‬‬
‫‪/0101‬‬
‫‪///1/‬‬
‫‪23/022‬‬
‫‪23/0/3‬‬
‫‪23/0/2‬‬
‫‪23/0/2‬‬
‫‪2121/3‬‬
‫‪211//2‬‬
‫‪211/2/‬‬
‫‪210320‬‬
‫‪210222‬‬
‫‪21/0/0‬‬
‫‪21///1‬‬
‫‪203222‬‬
‫‪203/22‬‬
‫‪203/0/‬‬
‫‪203/30‬‬
‫‪203///‬‬
‫‪2023/0‬‬
‫‪202100‬‬
‫‪201/02‬‬
‫‪20/2//‬‬
‫‪20//22‬‬
‫‪201//0‬‬
‫‪20031/‬‬
‫‪202122‬‬
‫‪20//32‬‬
‫‪20/0//‬‬
‫‪20/2//‬‬
‫‪20////‬‬
‫‪20///0‬‬
‫‪20///2‬‬
‫‪20/123‬‬
‫‪20//10‬‬
‫‪2231/1‬‬
‫‪223//0‬‬
‫‪222/22‬‬
‫‪221233‬‬
‫‪221/22‬‬
‫‪220222‬‬
‫‪220//0‬‬
‫‪/1/2/‬‬
‫‪/022/‬‬
‫‪/013/‬‬
‫‪//31/‬‬
‫‪23/03/‬‬
‫‪23/02/‬‬
‫‪23/0/0‬‬
‫‪23/00/‬‬
‫‪22///2‬‬
‫‪211/2/‬‬
‫‪211/20‬‬
‫‪210321‬‬
‫‪21013/‬‬
‫‪21//31‬‬
‫‪21/0/2‬‬
‫‪2030/1‬‬
‫‪203//2‬‬
‫‪203/01‬‬
‫‪203//1‬‬
‫‪203/2/‬‬
‫‪20232/‬‬
‫‪2022//‬‬
‫‪201/0/‬‬
‫‪20/10/‬‬
‫‪20//2/‬‬
‫‪201/22‬‬
‫‪20032/‬‬
‫‪202202‬‬
‫‪20/03/‬‬
‫‪20/0//‬‬
‫‪20/2/2‬‬
‫‪20///0‬‬
‫‪20///3‬‬
‫‪20//1/‬‬
‫‪20/13/‬‬
‫‪20//32‬‬
‫‪22322/‬‬
‫‪223/3/‬‬
‫‪2222//‬‬
‫‪221302‬‬
‫‪221/22‬‬
‫‪2200/3‬‬
‫‪220/00‬‬
‫‪/1//2‬‬
‫‪/022/‬‬
‫‪/02//‬‬
‫‪//32/‬‬
‫‪23/1/0‬‬
‫‪23/00/‬‬
‫‪23/0/1‬‬
‫‪23/01/‬‬
‫‪23//3/‬‬
‫‪211/0/‬‬
‫‪211/0/‬‬
‫‪210302‬‬
‫‪2102//‬‬
‫‪21/20/‬‬
‫‪21/02/‬‬
‫‪2030/0‬‬
‫‪203/2/‬‬
‫‪203/12‬‬
‫‪203//1‬‬
‫‪203/20‬‬
‫‪20233/‬‬
‫‪20220/‬‬
‫‪201//2‬‬
‫‪20/2//‬‬
‫‪20/00/‬‬
‫‪2010/0‬‬
‫‪200333‬‬
‫‪200/23‬‬
‫‪20/11/‬‬
‫‪20/0/3‬‬
‫‪20/220‬‬
‫‪20//12‬‬
‫‪20//20‬‬
‫‪20//1/‬‬
‫‪20/2/3‬‬
‫‪20/2/0‬‬
‫‪2233/0‬‬
‫‪223//0‬‬
‫‪22222/‬‬
‫‪22130/‬‬
‫‪221/2/‬‬
‫‪2200/2‬‬
‫‪220/30‬‬
‫‪/0202‬‬
‫‪/023/‬‬
‫‪/02/2‬‬
‫‪//32/‬‬
‫‪23/1/0‬‬
‫‪23/00/‬‬
‫‪23/0/0‬‬
‫‪23/01/‬‬
‫‪23/2/3‬‬
‫‪211/01‬‬
‫‪211/0/‬‬
‫‪21031/‬‬
‫‪210200‬‬
‫‪21/0/2‬‬
‫‪21/1/0‬‬
‫‪203102‬‬
‫‪203/0/‬‬
‫‪203/13‬‬
‫‪203///‬‬
‫‪203/0/‬‬
‫‪20233/‬‬
‫‪202203‬‬
‫‪201///‬‬
‫‪202130‬‬
‫‪20/2/1‬‬
‫‪20222/‬‬
‫‪200///‬‬
‫‪200/3/‬‬
‫‪20/22/‬‬
‫‪20/0/1‬‬
‫‪20/220‬‬
‫‪20//2/‬‬
‫‪20//02‬‬
‫‪20//30‬‬
‫‪20///2‬‬
‫‪20/2/1‬‬
‫‪20///0‬‬
‫‪22323/‬‬
‫‪2220//‬‬
‫‪222//2‬‬
‫‪2210/2‬‬
‫‪220012‬‬
‫‪220//1‬‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪22//2/‬‬
‫‪22/33/‬‬
‫‪22/123‬‬
‫‪22/030‬‬
‫‪2/1//0‬‬
‫‪2/0/32‬‬
‫‪2/2/30‬‬
‫‪22//00‬‬
‫‪22//2/‬‬
‫‪22/103‬‬
‫‪22/302‬‬
‫‪2/122/‬‬
‫‪2/02/2‬‬
‫‪2/03/2‬‬
‫‪22//10‬‬
‫‪22//20‬‬
‫‪22/10/‬‬
‫‪22/30/‬‬
‫‪2/13/0‬‬
‫‪2/0220‬‬
‫‪2////0‬‬
‫‪22/230‬‬
‫‪22////‬‬
‫‪22/201‬‬
‫‪22////‬‬
‫‪2/2133‬‬
‫‪2/0/02‬‬
‫‪2///1/‬‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪22/0//‬‬
‫‪22////‬‬
‫‪22/3//‬‬
‫‪22//20‬‬
‫‪2/3001‬‬
‫‪2/00//‬‬
‫‪2///0/‬‬
‫‪22/0/1‬‬
‫‪22//0/‬‬
‫‪22/3/0‬‬
‫‪22////‬‬
‫‪2/3010‬‬
‫‪2/01/1‬‬
‫‪2//122‬‬
‫‪22/112‬‬
‫‪22///0‬‬
‫‪22/3/0‬‬
‫‪22/1//‬‬
‫‪2/3220‬‬
‫‪2/1//2‬‬
‫‪2/222/‬‬
‫‪22/20/‬‬
‫‪22///2‬‬
‫‪22/3//‬‬
‫‪22//00‬‬
‫‪2/321/‬‬
‫‪2/1/30‬‬
‫‪2/0/2/‬‬
‫‪2//320‬‬
‫‪4985‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
/322/
/3//0
232/0/
23/3/2
213//3
2123/0
210302
21/022
21/222
21//20
20122/
200/0/
20/22/
221022
/32/2
/3///
232/21
23/3/1
213///
2123//
210120
21/010
21/20/
21//2/
2003/3
200/20
20/20/
2203//
/3/03
/3/20
232//2
23/3/2
212312
2123/2
21//3/
21/01/
21/20/
21//2/
2000//
200/2/
20/20/
220033
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
/3/03
/3/00
232//3
23/211
21231/
2123//
21////
21/002
21/2/1
21//22
20223/
200/10
20/203
222312
/3/22
/3/0/
23/332
23/20/
212303
2123/0
21////
21/0/2
21//2/
21/30/
20/12/
200//2
20/3//
22/3//
/3//3
/3/00
23/32/
2132//
212302
2123/0
21/3//
21/0/1
21////
21/2//
20/0//
2020/2
20/310
22/2//
/3///
232/21
23/31/
2132//
212303
2123/2
21/1/2
21/230
21//33
21/23/
202/11
202///
20/10/
22/2/0
/3//3
232/0/
23/3/3
213//0
212301
212200
21/030
21/23/
21//20
203//2
20021/
20/231
20/0/1
22//3/
4986
‫פטנטים שחודשו לעשרים שנה‬
‫‪PATENTS RENEWED FOR 20 YEARS‬‬
‫‪200200‬‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪201023‬‬
‫‪20/103‬‬
‫‪4987‬‬
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
//2//
‫הודעה‬
NOTICE
‫ לחוק‬91 ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
20020/
021330
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
VISTO CORPORATION
Title of invention:
:‫שם האמצאה‬
‫זמני של דואר אלקטרוני על פני רשת תקשורת‬-‫שיטה ומערכת לתאום בו‬
SYSTEM AND METHOD FOR SYNCHRONIZING ELECTRONIC MAIL ACROSS A
NETWORK
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
6/ ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0690
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4988
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
4989
20311/
/21332
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0690
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2022//
212133/
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0690
4990
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
4991
20131/
2221332
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0690
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
NOTICE UNDER SECTION 64P.(2) OF
– ‫) לחוק הפטנטים‬/(.‫טז‬94 ‫הודעה לפי סעיף‬
THE PATENTS LAWPatent extension order
‫צו הארכת פטנט‬
Granted to Patent No.
84863
'‫ניתן לפטנט מס‬
Until:
15.12.2012
:‫עד ליום‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4992
‫ארכת פטנט‬
PATENT EXTENSION
Patent Extension Order
Granted to Patent No. 84863
4993
‫צו הארכת פטנט‬
0409: ‫ניתן לפטנט מספר‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי שם הבעלים‬
CHANGE OF NAME OF PROPRIETORS
No. of Patent:
,201/// ,201/0/ ,21/120 ,21/3/2 ,21/3/0
20012/ ,200122
:‫מס' פטנט‬
:‫השם הקודם‬
Previous name:
WOLFF WALSRODE AG
:‫השם החדש‬
New name:
DOW WOLFF CELLULOSICS GMBH
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4994
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
MX
4995
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
4996
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
41458
4(02)
2.10.2005
‫סוג‬
COLGATE-PALMOLIVE COMPANY
Toothbrush
Convention date (U.S.A.)
1.4.2005
Class
41459
4(02)
2.10.2005
‫מברשת שיניים‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
COLGATE-PALMOLIVE COMPANY
Toothbrush
8.4.2005
Convention date (U.S.A.)
Class
41836
24(02)
9.1.2006
‫מברשת שיניים‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
LIFESCAN SCOTLAND LTD.
Glucose meter
Convention date (U.S.A.)
Class
11.7.2005
42255
2(04)
2.4.2006
ANTELOPE SHIVUK (1994) LTD.
‫מד גלוקוס‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫) בע"מ‬0664( ‫אנטילופ שיווק‬
‫סוליה‬
Sole
Class
ERAN EZRA
Chair
4997
42430
6(01)
7.5.2006
‫סוג‬
‫ערן עזרא‬
‫כסא‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
42432
10(02)
7.5.2006
Class
‫סוג‬
‫אופטו ליין בע"מ‬-‫אחים סגל‬
SEGAL BROS-OPTO LINE LTD.
‫מערכת שעון וטבעות הברגה‬
Watch and screwable ring system
Class
42445, 42446, 42447, 42448
2(04)
11.5.2006
‫סוג‬
CROCS, INC.
Upper
Convention date (U.S.A.)
Class
8.12.2005
42638
15(09)
21.6.2006
‫גפה‬
)‫הברית‬
)‫ארצותהברית‬
‫(ארצות‬
( ‫האמנה‬
‫תאריך אמנה‬
‫סוג‬
‫ מפעלי מתכת בע"מ‬.‫א‬.‫ב‬.‫ש‬
S.B.A. METAL WORKS LTD.
‫כלי עבודה‬
Tool
Class
42697
3(01)
5.7.2006
‫סוג‬
‫מירב גינגולד‬
MEIRAV GINGOLD
‫מנשא לתיקים‬
Bag carrier
Class
42714
14(03)
16.11.2004
‫סוג‬
RESEARCH IN MOTION LTD.
Handheld communication device
Convention date (U.S.A.)
Class
SANWA (1984) LTD.
Jar lid
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
2/9291330
42761
7(01)
17.7.2006
‫מכשיר תקשורת ידני‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫) בע"מ‬0604( ‫זנוה‬
‫מכסה לצנצנת‬
4998
42762
6(01)
18.7.2006
Class
‫סוג‬
NICOLETTI S.P.A.
Sofa
Convention date (Italy)
‫ספה‬
)‫הברית‬
)‫(איטליה‬
‫האמנה(ארצות‬
‫יך אמנה‬
‫תאריך‬
‫תאר‬
2/929133/
42824, 43539
23(02)
27.7.2006
Class
‫סוג‬
VIEGA GMBH & CO. KG
‫התקן שטיפה סניטרי לקיר‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Wall-mounted flushing device
0909133/
Convention date (OHIM)
42839, 42840, 42841
25(01)
3.8.2006
Class
‫סוג‬
)‫ אפקס ישראל (שיווק‬.‫ר‬.‫חברת א‬
‫בע"מ‬
A.R. APEX ISRAEL (EXPORT)
LTD.
‫פרופיל‬
Profile
42982
8(05)
31.8.2006
Class
‫סוג‬
GREAT STUFF, INC.
‫גולל‬
Reel
Class
42988
7(07)
3.9.2006
‫סוג‬
‫מילקו תעשיות בע"מ‬
MILCO INDUSTRIES LTD.
‫כלי קיבול לקופסא‬
Box container
Class
43027
13(03)
7.9.2006
ADI APELEWICZ AND RAM MEIR
Set of covering plates for electrical devices
4999
‫סוג‬
‫עדי אפלביץ ורם מאיר‬
‫מערכת לוחות כיסוי למתקנים חשמליים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
43119, 43122, 43123, 43124, 43127, 43128, 43129
Class
6(06)
‫סוג‬
26.9.2006
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫רגליים של ספה‬
Feet of a couch
Class
43120, 43121, 43125
6(06)
26.9.2006
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫רגליים של ספה‬
Feed of a couch
Class
43145
6(13)
28.9.2006
‫סוג‬
‫שולי פרינטי‬
SHULI PARIENTI
‫סדין‬
Bed sheet
Class
43207
7(07)
18.10.2006
‫סוג‬
‫שולי פרינטי‬
SHULI PARIENTI
‫נייר אפייה‬
Baking paper
Class
43333
23(01)
16.11.2006
‫סוג‬
‫רן שגיא‬
RAN SAGY
‫התקן להושטת נוזל‬
Liquid dispensing device
Class
AMI AVITAL
Hanukkia
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
43358
26(01)
23.11.2006
‫סוג‬
‫עמי אביטל‬
‫חנוכיה‬
5000
Class
43413, 43414, 43415
6(09)
30.11.2006
‫סוג‬
‫מיכל פירסט‬
MICHAL FIRST
‫כרית רחצה‬
Washing cushion
Class
43502
25(01)
14.12.2006
‫סוג‬
‫יחזקאל טוינה‬
YEHEZKEL TWINA
‫מכסה לארגז תריס‬
Cover for box shutter
Class
43621
9(03)
15.1.2007
‫סוג‬
‫) בע"מ‬0660( ‫מוצרי שלם אריזות‬
SHALAM PRODUCTS
PACKAGING (1998) LTD.
‫דלי‬
Bucket
Class
43646, 43647
2(03)
18.1.2007
‫סוג‬
‫גלי רימר‬
GALI RIEMER
‫כובע‬
Helmet
Class
43757
7(06)
7.2.2007
‫סוג‬
‫אביגיל זיוי‬
AVIGAIL ZIVI
‫מחזיק כוסות‬
Cup holder
Class
ECI TELECOM LTD.
Device for optical connectors
5001
43880
8(08)
27.2.2007
‫סוג‬
‫איי טלקום בע"מ‬.‫סי‬.‫אי‬
‫התקן למחברים אופטיים‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
43890
25(02)
1.3.2007
Class
‫סוג‬
WOLFMAN INDUSTRIES LTD.
‫וולפמן תעשיות בע"מ‬
Inlet cover for directing drainage
‫פלטת הטיה לתא תפיסה‬
43896
8(06)
1.3.2007
Class
‫סוג‬
‫לינאה מקלחונים בע"מ‬
LINEA MIKLAHONIM LTD.
‫ידית‬
Handle
43898
8(08)
1.3.2007
Class
‫סוג‬
‫לינאה מקלחונים בע"מ‬
LINEA MIKLAHONIM LTD.
‫מגשר‬
Bridge
43899
12(16)
1.3.2007
Class
‫סוג‬
‫הדר רוזן בע"מ‬
HADAR ROSEN LTD.
‫כיסוי מושבים לרכב‬
Vehicle seat cover
44018
19(06)
1.4.2007
Class
‫סוג‬
STILOLINEA S.R.L.
Writing instrument
Convention date (OHIM)
Class
209239133/
44022
2(04)
10.4.2007
ANTELOPE SHIVUK (1994) LTD.
Sole
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מכשיר כתיבה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫תאריך‬
‫סוג‬
‫) בע"מ‬0664( ‫אנטילופ שיווק‬
‫סוליה‬
5002
44045
7(01)
12.4.2007
Class
‫סוג‬
‫ מעיינות בע"מ‬.‫א‬.‫א‬
A.A. MAAYANOT LTD.
‫מתקן מי שתייה קרים וחמים‬
Hot and cold water dispenser
44050
7(01)
12.4.2007
Class
‫סוג‬
VILLEROY & BOCH AG
‫קערה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Bowl
25.10.2006
Convention date (OHIM)
44053
9(03)
15.4.2007
Class
‫סוג‬
‫מנשה רוגוטנר‬
MENASHE ROGOTNER
‫מגש‬
Tray
44071
7(01)
19.4.2007
Class
‫סוג‬
‫ מעיינות בע"מ‬.‫א‬.‫א‬
A.A. MAAYANOT LTD.
‫מתקן מי שתייה קרים וחמים‬
Hot and cold water dispenser
44089
9(01)
26.4.2007
Class
‫סוג‬
UNILEVER PLC
Bottle with pump
Convention date (OHIM)
Class
AMPA APPLIANCES LTD.
Magnetic water scale inhibitor
5003
6.11.2006
44098
15(05)
1.5.2007
‫בקבוק עם משאבה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫אמפא מוצרי צריכה בע"מ‬
‫מונע אבנית מגנטי‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
44134
26(04)
6.5.2007
Class
‫סוג‬
‫ארומטיה בע"מ‬
AROMATYA LTD.
‫נר‬
Candle
44155
7(06)
9.5.2007
Class
‫סוג‬
ZCHARIA CHOKRAN
‫זכריה צ'וקראן‬
Device for segmenting pizza
‫מתקן לחלוקת פיצה‬
Class
44171
8(06)
13.5.2007
‫סוג‬
SMILDO S.L.
‫ידית‬
Handle
Class
44188
24(02)
15.5.2007
‫סוג‬
‫גבריאל שרון‬
GAVRIEL SHARON
‫ממקם לטיפול עיניים‬
Eye drop dispenser
Class
44211
26(01)
21.5.2007
‫סוג‬
‫איתן צקוני‬
EYTAN TZKONI
‫מנורה‬
Lamp
Class
44248
26(03)
28.5.2007
GAASH LIGHTING PRODUCTS
LTD.
Street lamp
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫סוג‬
‫געש מוצרי תאורה בע"מ‬
‫פנס רחוב‬
5004
44293, 44294, 44295, 44296, 44297, 44298, 44299,
44300, 44301, 44302
Class
3(01)
‫סוג‬
5.6.2007
FOBUS INTERNATIONAL LTD.
‫פובוס אינטרנשיונל בע"מ‬
‫נרתיק אקדח‬
Gun holster
44335
8(06)
12.6.2007
Class
‫סוג‬
UNION KNOPF GMBH
‫ידית‬
Handle
44355
2(04)
14.6.2007
Class
‫סוג‬
CROCS, INC.
Footwear
Convention date (U.S.A.)
Convention date (U.S.A.)
Convention date (U.S.A.)
Class
15.12.2006
16.12.2006
30.5.2007
44367
20(03)
18.6.2007
‫נעל‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫ערן אסיס‬
ERAN ASIS
‫פאנל פרסומי למתקני מים‬
Advertisment panel for water dispensers
Class
44386
12(02)
20.6.2007
‫ראובן ינאי‬
REUVEN YANAY
‫עגלה מתקפלת‬
Foldable cart
Class
ISRAEL GURMAN
5005
‫סוג‬
44425
7(07)
1.7.2007
‫ישראל גורמן‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מערכת טבעות למטבח‬
Set of rings for kitchen
Class
44426, 44427, 44428
8(06)
1.7.2007
‫סוג‬
F.M.N. MARTINELLI S.R.L.
‫ידית‬
Handle
44480
6(09)
9.7.2007
Class
‫סוג‬
‫אריאלה קדר‬
ARIELLA KADAR
‫כרית תמיכה לבקבוק‬
Bottle feeding aid
44485
11(01)
10.7.2007
Class
‫סוג‬
‫יעקב צרור‬
JACKOB TSROR
‫יהלום‬
Diamond
44489
25(01)
12.7.2007
Class
‫סוג‬
‫רול פרופיל בע"מ‬
ROLL PROFILE LTD.
‫פרופיל‬
Profile
Class
44492, 44494, 44495
8(06)
12.7.2007
‫סוג‬
‫בועז כהן‬
BOAZ COHEN
‫ידית‬
Handle
Class
44520
13(02)
18.7.2007
‫סוג‬
EVEREADY BATTERY COMPANY, INC.
External power device
Convention date (U.S.A.)
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
25.1.2007
‫ספק כח חיצוני‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
5006
44539, 44540
25(01)
22.7.2007
Class
‫סוג‬
‫כל חן בע"מ וחיים אזולאי‬
KOL CHEN LTD. AND HAIM
AZOULAY
‫פרופיל‬
Profile
Class
44558
2(04)
25.7.2007
‫סוג‬
CROCS, INC.
Footwear
Convention date (U.S.A.)
Convention date (U.S.A.)
Class
25.1.2007
24.7.2007
44569
8(09)
29.7.2007
‫נעל‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג‬
‫מרדכי קבסו‬
MORDEHAY CABASSO
‫מנוף לתריס‬
Lever for shutter
Class
44570
11(01)
29.7.2007
‫סוג‬
‫טוביה לבני‬
TUVIA LIVNI
‫תכשיט‬
Jewel
Class
44574
2(04)
30.7.2007
‫סוג‬
CROCS, INC.
Footwear
Convention date (U.S.A.)
Convention date (U.S.A.)
Class
5007
30.1.2007
3.6.2007
44578, 44579
8(06)
‫נעל‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
30.7.2007
UNION KNOPF GMBH
‫ידית‬
Handle
44581
7(05)
31.7.2007
Class
‫סוג‬
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Iron
6.2.1007
Convention date (OHIM)
‫מגהץ‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
44592, 44593
13(02)
1.8.2007
Class
‫סוג‬
‫יהודה תנעמי‬
YUDA TANAMI
‫מטען‬
Battery charger
44601
11(01)
5.8.2007
Class
‫סוג‬
‫רוני סטשיק‬
RONI STESHIK
‫תכשיט‬
Jewel
44676
24(04)
23.8.2007
Class
‫סוג‬
PFIZER LIMITED
Inhaler
28.2.2007
Convention date (OHIM)
Class
‫משאף‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
44784, 44785
28(03)
11.9.2007
‫סוג‬
THE GILLETTE COMPANY
Razor cartridge container
Convention date (U.S.A.)
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
20.3.2007
‫מיכל למחסנית להב‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
5008
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪1/1/1‬‬
‫‪0/0/3‬‬
‫‪0/001‬‬
‫‪0/022‬‬
‫‪0/220‬‬
‫‪0//0/‬‬
‫‪1/2/2‬‬
‫‪1/202‬‬
‫‪0/1//‬‬
‫‪0/03/‬‬
‫‪0/221‬‬
‫‪0//23‬‬
‫‪1/3/2‬‬
‫‪1/0/2‬‬
‫‪0/1/1‬‬
‫‪0/030‬‬
‫‪0/223‬‬
‫‪0/2/1‬‬
‫‪1/33/‬‬
‫‪1/00/‬‬
‫‪0/12/‬‬
‫‪0/0/2‬‬
‫‪0/23/‬‬
‫‪0/2/0‬‬
‫‪0//22‬‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪1/332‬‬
‫‪1/00/‬‬
‫‪0/221‬‬
‫‪0/0/2‬‬
‫‪0/0/1‬‬
‫‪0/2/1‬‬
‫‪0//20‬‬
‫‪1///0‬‬
‫‪1/001‬‬
‫‪0/322‬‬
‫‪0/002‬‬
‫‪0/0//‬‬
‫‪0/22/‬‬
‫‪0//20‬‬
‫‪1//1/‬‬
‫‪1/00/‬‬
‫‪0////‬‬
‫‪0/000‬‬
‫‪0/00/‬‬
‫‪0/222‬‬
‫‪0//21‬‬
‫‪28287‬‬
‫‪1/1//‬‬
‫‪0////‬‬
‫‪0/000‬‬
‫‪0/00/‬‬
‫‪0/220‬‬
‫‪0////‬‬
‫‪5009‬‬
‫מדגמים שבוטלו‬
DESIGNS VOID
13113
131//
1/32/
1/31/
1/302
1/3/2
1/3/1
1/002
0/2//
0//1/
0/20/
1310/
131//
1/313
1/31/
1/30/
1/3//
1/3/0
0/2/1
0//33
0//0/
13122
13031
1/312
1/31/
1/30/
1/3//
1/3//
0/2/0
0//32
0//0/
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
1312/
1/330
1/311
1/303
1/30/
1/3//
1/3//
0/2/0
0//31
0//0/
131/2
1/33/
1/310
1/302
1/322
1/3//
1/233
0/2/2
0//20
0//22
131/3
1/32/
1/310
1/301
1/3/1
1/3/3
1/222
0/2/0
0//22
0//2/
131/2
1/32/
1/312
1/300
1/3/0
1/3/3
1/211
0/2/0
0//2/
0//2/
131//
1/32/
1/31/
1/300
1/3/0
1/3/2
1/210
0/2//
0//10
0/20/
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
5010
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪5011‬‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫אהרון מטלון ‪0.7..7‬‬
‫אורבוטק מדיקל סלושנס בע"מ ‪04:601‬‬
‫אורבן איירונוטיקס בע"מ ‪0.6019‬‬
‫אימארד מערכות הדמייה בע"מ ‪04:601‬‬
‫אינולייז ‪ /11/‬בע"מ ‪0.0964‬‬
‫אלביט מערכות אלקטרו‪-‬אופטיקה אלאופ‬
‫בע"מ ‪0..091‬‬
‫אמיר גנוסר ‪046977‬‬
‫אמיר כץ ‪0.0166‬‬
‫ארקל מערכות סינון‪,‬אגודה שיתופית‬
‫חקלאית בע"מ ‪09.0.0‬‬
‫‪NAME INDEX‬‬
‫מיקרוסמי קורפ ‪ -‬אנאלוג מיקסד סינגל‬
‫גרופ בע"מ ‪0.7/6/‬‬
‫משה בלס ‪07604/‬‬
‫נובה מכשירי מדידה בע"מ ‪091/67‬‬
‫נקה כימיקלים (‪ )06./‬בע"מ ‪0.1.10‬‬
‫סלגייד בע"מ ‪0.0./.‬‬
‫סמיון בנין ‪0..0:0‬‬
‫סרקונט בע"מ ‪091641‬‬
‫פנחס אלקיים ‪0..0:0‬‬
‫ביוסנס בע"מ ‪0:.961‬‬
‫ברנדשטטר מערכות בע"מ ‪04.:/0‬‬
‫גיא פיחה ‪0.0166‬‬
‫וסקולר ביוג'ניק בע"מ ‪0.910.‬‬
‫וריסיטי בע"מ ‪0.:1.1‬‬
‫קיו‪-‬סנט בע"מ ‪049960‬‬
‫קרדיוסיף בע"מ ‪04/::/‬‬
‫קרדיוסנס בע"מ ‪0:0010‬‬
‫טל פטל ‪070..6‬‬
‫טראנספארמה מדיקל בע"מ ‪04:0.7‬‬
‫רותם אמפרט נגב בע"מ ‪0.1601‬‬
‫ריטש אפ‪ .‬אקס‪ .‬בע"מ ‪047707‬‬
‫רמי דותן ‪070..6‬‬
‫רפא"ל‪-‬רשות לפיתוח אמצעי לחימה‬
‫בע"מ ‪0.7::6‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪,00/11/‬‬
‫‪0./197‬‬
‫ישראל ירושלמי ‪047490‬‬
‫שילה טכנולוגיות בע"מ ‪091797‬‬
‫שירון תקשורת לוויינים (‪ )0669‬בע"מ‬
‫‪0.1667‬‬
‫לאפ‪-‬המכון לכירורגיה מתקדמת בע"מ‬
‫‪0.::0.‬‬
‫‪ADC‬‬
‫‪BETEILIGUNGSGESELLSCHAFT‬‬
‫‪MBH 155048‬‬
‫ד' באדר א' התשס"ח – ‪February 10, 2008‬‬
‫‪ABBOTT LABORATORIES 135519‬‬
‫‪i‬‬
ADC GMBH 155048
AGILE THERAPEUTICS, INC. 149655
AICURIS GMBH & CO. KG 153643,
153826
ALCAN TECHNOLOGY &
MANAGEMENT LTD. 152616
ALCATEL 153827
ALFRED G. NIEDERMAN 160250
AMARIN NEUROSCIENCE LIMITED
153458
AMGEN, INC. 141894
AMIR GENOSAR 149677
AMIR KATZ 158099
AOPTIX TECHNOLOGIES, INC.
157100
ARKAL FILTRATION SYSTEMS C.S.
LTD. 165158
ARM LIMITED 139250
ARON MATALON 157557
ASTRAZENECA AB 150640
ASTRAZENECA AB 150806
AVAYA INC. 153732
AVENTIS PHARMA S.A. 131340
AVENTIS PHARMACEUTICALS INC.
171060
BAYER AKTIENGESELLSCHAFT
153643, 153826
BAYER CROPSCIENCE S.A. 157776,
159583
BAYER MATERIALSCIENCE AG
162234
BAYER PHARMA 147700
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT 149798
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT 156432
BIO MINERALS N.V. 164132
BIOGEN IDEC MA INC. 132882
Biogen Idec MA Inc. 149487
BIOSENSE LTD. 135690
BRANDSTETTER SYSTEMS LTD.
145328
BRISTOL-MYERS SQUIBB
COMPANY 151373
BROADBAND ROYALTY
CORPORATION 153827
CABOT CORPORATION 155746
CARDIOSAFE LIMITED 142332
CARDIOSENSE LTD. 131108
CELLGUIDE LTD. 151525
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE (CNRS)
146796, 150872
CHAIM Z. MICHAELO 164201
CHIRON CORPORATION 155577
CITRIX SYSTEMS, INC. 184892,
184893
COFFOR INTERNACIONAL
EXPLORACAO DE PATENTES LDA.
155765
COMPUTER ASSOCIATES THINK,
INC. 146181
COMPUTER ASSOCIATES THINK,
INC. 147492
CONOR MEDSYSTEMS INC. 138285
CORNELL RESEARCH
FOUNDATION, INC. 147733
DAIICHI PHARMACEUTICAL CO.,
LTD. 146288
DELTA-9-PHARMA GMBH 155185
DENNIS A. GURITZA 155500
DICTAPHONE CORPORATION 146901
DUKE UNIVERSITY 135949
EAZYPOWER CORPORATION 166355
EFMT ENTWICKLUNGS-UND
FORSCHUNGSZENTRUM FUR
MIKROTHERAPIE GMBH 159446
EISAI CO.,LTD. 152023
EISAI R&D MANAGEMENT CO., LTD.
152023
ELBIT SYSTEMS ELECTRO-OPTICAL
ELOP LTD. 155860
ELLIPTEC RESONANT ACTUATOR
AG 160941
ENGINEERED ARRESTING SYSTEMS
CORPORATION 149928
ERNST KELLER 150814
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE) 153084
F. HOFFMANN-LA ROCHE AG 154254
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
ii
FABBRICA D'ARMI PIETRO
BERETTA S.P.A. 154836
FERRING BV 149528
FLEISSNER GMBH 161508
FOUNDATION FOR ADVANCEMENT
OF INTERNATIONAL SCIENCE
156619
FUJI PHOTO FILM CO. LTD. 149798
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC
159437
GENENTECH, INC. 123872, 127891,
134647, 140917, 143031
GENENTECH, INC. 149006, 169032
GLAXO GROUP LIMITED 158799
GUY PICHA 158099
H. LUNDBECK A/S 159229
H.C. STARCK GMBH 154331
HARALD MARTIN 147931
HARTWIG STREITENBERGER 147931
HEMA-QUEBEC 136049
HENDERSON MORLEY RESEARCH
AND DEVELOPMENT LIMITED
150286
HER MAJESTY THE QUEEN IN
RIGHT OF CANADA AS
REPRESENTED BY THE MINISTER
OF AGRICULTURE AND AGRIFOOD CANADA 136049
IBM CORPORATION 159655
IDEC PHARMACEUTICALS
CORPORATION 145109
IMARAD IMAGING SYSTEMS LTD.
143980
INNOVATIONAL HOLDINGS, LLC
138285
INOLASE 2002 LTD. 151694
INSTITUT NATIONAL DE LA SANTE
ET DE LA RECHERCHE MEDICALE
(I.N.S.E.R.M.) 147700
INSTITUT PASTEUR 146796
INTELLOCITY USA, INC. 151950
ITALFARMACO S.P.A. 153011
iii
JANSSEN PHARMACEUTICA N.V.
162349
JAROSLAV JIROUSEK 151736
JOHNSON & JOHNSON VISION
CARE, INC. 153084
KCI LICENSING, INC. 145628
KINETIC CONCEPTS, INC. 145628
KIP HOLDINGS INC. 156975
KISSEI PHARMACEUTICAL CO.,
LTD. 133863
LAP-INSTITUTE FOR ADVANCED
SURGERY LTD. 153315
LEK PHARMACEUTICAL AND
CHEMICAL COMPANY d.d. 137782
LIFESCAN, INC. 153585
LIFESCAN, INC. 154971
LOCKHEED MARTIN CORPORATION
158716, 158717
M CUBED TECHNOLOGIES, INC.
169426
MEDICINES FOR MALARIA
VENTURE 159474
MENARINI INTERNATIONAL
OPERATIONS LUXEMBOURG S.A.
162143
MESSIER-BUGATTI 157421
MICROSEMI CORP - ANALOG
MIXED SIGNAL GROUP LTD 157292
MILAN SIREK 151736
MOSHE BALASS 179842
NCUBE CORPORATION 153827
NECA CHEMICALS (1952) LTD.
150508
NESTEC S.A. 157863
NICE SYSTEMS INC. 146901
NOVA MEASURING INSTRUMENTS
LTD. 160297
NOVARTIS AG 141236
OBTECH MEDICAL AG 151136
OCLC ONLINE COMPUTER LIBRARY
CENTER, INC. 149536
OMEGA ENGINEERING, INC. 140818
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
OPENLY INFORMATICS, INC. 149536
ORBOTECH MEDICAL SOLUTIONS
LTD. 143980
ORION CORPORATION 150506
S.A. 161941
SWISS CAPS RECHTE AND
LIZENZEN AG 149425
SYNGENTA LIMITED 161596
PETER-HANSEN VOLKMANN 164637
PFIZER INC. 139299
PHARMACIA & UPJOHN COMPANY
LLC 147246
PHARMACOPEIA, INC. 146288
PHARMACOPEIA, INC. 146288
PINHAS ELKAYAM 155831
PROBIODRUG AG 151368
PROSIDION LIMITED 151368
TADAHIRO OHMI 162275
TAIYO NIPPON SANSO
CORPORATION 162275, 164456
TAL PETEL 171559
TEIJIN TWARON GMBH 156840,
158639
THE ADMINISTRATORS OF THE
TULANE EDUCATIONAL FUND
142899
THE UNITED STATES OF AMERICA
AS REPRESENTED BY THE
SECRETARY OF THE U.S.
DEPARTMENT OF THE NAVY,
DEPUTY COUNSEL FOR NAVY
INTELLECTUAL PROPERTY, OFFICE
132882
THE UNIVERSITY OF MANCHESTER
149176
THIBEAU 152031
THIRDSPACE LIVING LTD. 153827
TIMBRE TECHNOLOGIES, INC.
160180
TOKYO ELECTRON LTD 156619
TOMCO2 EQUIPMENT COMPANY
156908
TRANSPHARMA MEDICAL LTD.
143857
Q-SCENT LTD. 146698
RADICISPANDEX CORPORATION
159557
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
157339
RAMI DOTAN 171559
RAYTHEON COMPANY 154249
RAYTHEON COMPANY 154249
RICHFX LTD. 147787
ROTEM AMFERT NEGEV LTD.
150910
RUPRECHT KELLER 157917
SANOFI AVENTIS 144363
SANOFI AVENTIS 150605
SANOFI-AVENTIS DEUTSCHLAND
GMBH 147184
SANOFI-AVENTIS DEUTSCHLAND
GMBH 149156
SCHERING CORPORATION 140449
SEMION BENIN 155831
SERCONET LTD. 160940
SHILO TECHNOLOGIES LTD. 160767
SHIRON SATELLITE
COMMUNICATIONS (1996) LTD.
150997
SILVERBROOK RESEARCH PTY.
LTD. 166421, 167100
SMITHKLINE BEECHAM
BIOLOGICALS S.A. 148456
SOCIETE DES PRODUITS NESTLE
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
UCB FARCHIM S.A. 159287
UNIMED PHARMACEUTICALS, INC.
154692
UNIVERSITE DE TECHNOLOGIE DE
TROYES 160089
UNIVERSITE LAVAL 136049
UNIVERSITY COLLEGE LONDON
152264
UNIVERSITY OF SOUTH FLORIDA
129501
URBAN AERONAUTICS LTD. 159106
VALENT BIOSCIENCES,
CORPORATION 157140
VASCULAR BIOGENICS LTD. 156015
iv
VERISITY LTD. 153050
VERIZON LABORATORIES INC.
142739, 142745
WHEEL TECHNOLOGY LTD. 150804
WOLFGANG BOSSERT 153217
WYETH 151512
XTENT, INC. 142332
YA-MAN LTD. 149912
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. 112002,
152067
YISRAEL YERUSHALMI 147468
v
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01K – 129501
B24B – 160297
A01N – 150910, 155500, 156908,
157140, 157776, 159583,
161596, 164132
B26B – 150804
B32B – 162234
A23B – 161941
B41J – 166421, 167100
A47C – 160250
B41M – 153217
A47J – 157863
B42F – 153315
A47K – 150508
B64C – 159106
A61B – 135690, 150872, 151694,
152264, 159437
B64F – 149928
A61F – 138285, 145628, 151136
C04B – 169426
A61K – 132882, 135949, 141236,
143031,147246, 147700,
148456, 149176, 149425,
149798, 150286, 151368,
151373, 153011, 153643,
154692, 155577, 158799,
159287, 162143, 164201,
164637
C07C – 133863, 149156, 150640,
151736, 153458, 171060
A61M – 142332, 149655
A61N – 131108, 143857, 147468,
149912, 159446
C07D – 139299, 140449, 144363,
146288, 147184, 149487,
149528, 150506, 150605,
150806, 152023, 152067,
153084, 154254, 155185,
156432, 159229, 159474,
162349
C07F - 156015
C07H – 131340, 135519
B01D – 164456, 179842
C07J – 151512
C07F - 156015
B01J -162275
C07K – 123872, 134647, 141894,
142899, 169032
B05B – 149677
C08G – 159557
B09B – 147931
C12N – 112002, 127891, 136049,
140917, 147733, 153826
B21D – 160767
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
vi
C12P – 137782
G01S – 151525, 158716, 158717
C12Q – 146796, 149006
G01T – 143980
D04H – 152031, 157421
G02B – 152616, 155048, 155860,
157100, 160089
D06C – 161508
G03B – 171559
E04B – 155765
E05B – 150814
G06F – 139250, 147492, 149536,
156975, 160180
F16L – 165158
G08G – 157557, 159557
F24H – 155831
H01G – 154331, 155746
F25B – 145328, 166355
H01L – 156619, 159655
F41A – 154836
H02G – 157292, 160940
F41H – 156840, 158639
H02N – 160941
F41J – 157339
H03F – 158099
F42B – 154249
G01D – 140818
G01N – 145109, 146698, 153585,
154971, 157917
H04L – 142745, 146181, 184892,
184893
H04M – 146901, 153732
H04N – 147787, 151950, 153827
G01R – 153050
H04Q – 142739, 150997
vii
February 10, 2008 – ‫ד' באדר א' התשס"ח‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER